library(readxl)
library(janitor)
##
## Attaching package: 'janitor'
## The following objects are masked from 'package:stats':
##
## chisq.test, fisher.test
library(tidyverse)
## ── Attaching packages ──────────────────────────────────────────────────────── tidyverse 1.3.0 ──
## ✓ ggplot2 3.2.1 ✓ purrr 0.3.3
## ✓ tibble 2.1.3 ✓ dplyr 0.8.4
## ✓ tidyr 1.0.2 ✓ stringr 1.4.0
## ✓ readr 1.3.1 ✓ forcats 0.4.0
## ── Conflicts ─────────────────────────────────────────────────────────── tidyverse_conflicts() ──
## x dplyr::filter() masks stats::filter()
## x dplyr::lag() masks stats::lag()
library(gt)
library(rvest)
## Loading required package: xml2
##
## Attaching package: 'rvest'
## The following object is masked from 'package:gt':
##
## html
## The following object is masked from 'package:purrr':
##
## pluck
## The following object is masked from 'package:readr':
##
## guess_encoding
webpage <- read_html(“https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426671/”) tbls <- html_nodes(webpage, “table”) head(tbls)
tbls_ls <- webpage %>% html_nodes(“table”) %>% .[[1]] %>% html_table(fill = TRUE) tbls_ls
tbls_ls <- webpage %>% html_nodes(“#Table1”) %>% html_table(fill = TRUE)
tbls2_ls <- list()
tbls2_ls$Table1 <- webpage %>%
html_nodes("#Table1") %>%
html_table(fill = TRUE) %>%
head(tbls2_ls)
# This includes the direct medical costs associated with key STIs in the U.S.. I
# will be looking at the costs of HIV, chlamydia, gonorrhea, and I think
# syphilis as well. The prices listed are in 2006 USD, so I will create
# another column that calculates the 2019 USD cost for each infection.I have used the pivot long function to create a new column relating to sex. The data should be clean and I have used the slice function to get rid of unwanted rows.
table_costs_messy <- list()
table_costs_messy <- read_html("https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426671/")%>%
html_node("table") %>%
html_table(header = TRUE) %>%
clean_names() %>%
slice(-1) %>%
slice(1:17)
table_costs_messy[table_costs_messy == "not applicable"] <-NA
colnames(table_costs_messy)[2:3] <- c("xF", "xM")
table_costs_clean <- table_costs_messy %>%
pivot_longer(cols = starts_with("x"),
names_to = "Sex",
names_prefix = "x",
values_to = "Cost",
values_drop_na = FALSE
)
table_costs_clean
## # A tibble: 34 x 4
## parameter range_applied Sex Cost
## <chr> <chr> <chr> <chr>
## 1 Average cost per case of PID [23–25] ± 50% F $1,995
## 2 Average cost per case of PID [23–25] ± 50% M <NA>
## 3 Average cost per case of epididymitis [26] ± 50% F <NA>
## 4 Average cost per case of epididymitis [26] ± 50% M $274
## 5 Average sequelae costs per case of syphilis [5] ± 50% F $572*
## 6 Average sequelae costs per case of syphilis [5] ± 50% M $572*
## 7 Average cost per case of chlamydia [5] ± 50% F $315
## 8 Average cost per case of chlamydia [5] ± 50% M $26
## 9 Average cost per case of gonorrhea [5] ± 50% F $343
## 10 Average cost per case of gonorrhea [5] ± 50% M $68
## # … with 24 more rows
tidy_wb_data1 <- wb_data %>% pivot_longer(cols = starts_with(“x”), names_to = “Year”, names_prefix = “x”, names_ptypes = list(Year = integer()), values_to = “CO2_emissions”, values_drop_na = TRUE) %>% select(“country_name”, “country_code”, “Year”, “CO2_emissions”)
tidy_wb_data1
# empty data set where I will store the files once they'e loaded in.
prep_data_1 <- data.frame()
# Listing out all the files in this particular folder. All of this data relates to PrEP usage in the U.S..
list <- list.files("Data_Sets/PrEP_Data")
# Here I have the actual function which is picking up on every document that ends in ".xlsx" in the "PrEP_Data" folder. The function reads in all of the data, and then spits each one into the empty dataframe that I have created. Each row is appended onto the preceding year's data.
listxlsx <- dir(pattern = "*.xlsx")
for (i in 1:length(list)){
print(list[i])
temp_data <- read_xlsx(paste("Data_Sets/PrEP_Data/",
list[i], sep = ""),
skip = 1) %>%
clean_names()
prep_data_1 = rbind(prep_data_1, temp_data)
}
## [1] "AIDSVu_National_PrEP_2012.xlsx"
## [1] "AIDSVu_National_PrEP_2013.xlsx"
## [1] "AIDSVu_National_PrEP_2014.xlsx"
## [1] "AIDSVu_National_PrEP_2015.xlsx"
## [1] "AIDSVu_National_PrEP_2016.xlsx"
## [1] "AIDSVu_National_PrEP_2017.xlsx"
## [1] "AIDSVu_National_PrEP_2018.xlsx"
prep_data_1 <- prep_data_1 %>%
gt()
# Here I read in all the CDC data for Chlamydia and Gonorrhea rates from 2000 to 2017. I still should rename the columns so that it is clear which values are for which variable when I join the datasets.
chlamydia_gonorrhea <-read_xlsx("Data_Sets/CDC_Data/ATLAS_CDC_Chlamydia&Gonorrhea.xlsx",
skip = 5) %>%
clean_names()
chlamydia_gonorrhea[chlamydia_gonorrhea == "Data not available"] <-NA
chlamydia_gonorrhea <- chlamydia_gonorrhea %>%
gt()
chlamydia_gonorrhea
| indicator | year | race_ethnicity | sex | age_group | cases | rate_per_100000 |
|---|---|---|---|---|---|---|
| Chlamydia | 2000 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Chlamydia | 2000 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Chlamydia | 2000 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Chlamydia | 2000 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Chlamydia | 2000 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Chlamydia | 2000 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Chlamydia | 2000 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Chlamydia | 2000 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Chlamydia | 2000 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Chlamydia | 2000 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Chlamydia | 2000 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Chlamydia | 2000 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Chlamydia | 2000 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Chlamydia | 2000 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Chlamydia | 2000 | Asian | Female | 0-14 | NA | NA |
| Chlamydia | 2000 | Asian | Female | 15-19 | NA | NA |
| Chlamydia | 2000 | Asian | Female | 20-24 | NA | NA |
| Chlamydia | 2000 | Asian | Female | 25-29 | NA | NA |
| Chlamydia | 2000 | Asian | Female | 30-34 | NA | NA |
| Chlamydia | 2000 | Asian | Female | 35-39 | NA | NA |
| Chlamydia | 2000 | Asian | Female | 40-44 | NA | NA |
| Chlamydia | 2000 | Asian | Male | 0-14 | NA | NA |
| Chlamydia | 2000 | Asian | Male | 15-19 | NA | NA |
| Chlamydia | 2000 | Asian | Male | 20-24 | NA | NA |
| Chlamydia | 2000 | Asian | Male | 25-29 | NA | NA |
| Chlamydia | 2000 | Asian | Male | 30-34 | NA | NA |
| Chlamydia | 2000 | Asian | Male | 35-39 | NA | NA |
| Chlamydia | 2000 | Asian | Male | 40-44 | NA | NA |
| Chlamydia | 2000 | Black/African American | Female | 0-14 | NA | NA |
| Chlamydia | 2000 | Black/African American | Female | 15-19 | NA | NA |
| Chlamydia | 2000 | Black/African American | Female | 20-24 | NA | NA |
| Chlamydia | 2000 | Black/African American | Female | 25-29 | NA | NA |
| Chlamydia | 2000 | Black/African American | Female | 30-34 | NA | NA |
| Chlamydia | 2000 | Black/African American | Female | 35-39 | NA | NA |
| Chlamydia | 2000 | Black/African American | Female | 40-44 | NA | NA |
| Chlamydia | 2000 | Black/African American | Male | 0-14 | NA | NA |
| Chlamydia | 2000 | Black/African American | Male | 15-19 | NA | NA |
| Chlamydia | 2000 | Black/African American | Male | 20-24 | NA | NA |
| Chlamydia | 2000 | Black/African American | Male | 25-29 | NA | NA |
| Chlamydia | 2000 | Black/African American | Male | 30-34 | NA | NA |
| Chlamydia | 2000 | Black/African American | Male | 35-39 | NA | NA |
| Chlamydia | 2000 | Black/African American | Male | 40-44 | NA | NA |
| Chlamydia | 2000 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Chlamydia | 2000 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Chlamydia | 2000 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Chlamydia | 2000 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Chlamydia | 2000 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Chlamydia | 2000 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Chlamydia | 2000 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Chlamydia | 2000 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Chlamydia | 2000 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Chlamydia | 2000 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Chlamydia | 2000 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Chlamydia | 2000 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Chlamydia | 2000 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Chlamydia | 2000 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Chlamydia | 2000 | Multiple races | Female | 0-14 | NA | NA |
| Chlamydia | 2000 | Multiple races | Female | 15-19 | NA | NA |
| Chlamydia | 2000 | Multiple races | Female | 20-24 | NA | NA |
| Chlamydia | 2000 | Multiple races | Female | 25-29 | NA | NA |
| Chlamydia | 2000 | Multiple races | Female | 30-34 | NA | NA |
| Chlamydia | 2000 | Multiple races | Female | 35-39 | NA | NA |
| Chlamydia | 2000 | Multiple races | Female | 40-44 | NA | NA |
| Chlamydia | 2000 | Multiple races | Male | 0-14 | NA | NA |
| Chlamydia | 2000 | Multiple races | Male | 15-19 | NA | NA |
| Chlamydia | 2000 | Multiple races | Male | 20-24 | NA | NA |
| Chlamydia | 2000 | Multiple races | Male | 25-29 | NA | NA |
| Chlamydia | 2000 | Multiple races | Male | 30-34 | NA | NA |
| Chlamydia | 2000 | Multiple races | Male | 35-39 | NA | NA |
| Chlamydia | 2000 | Multiple races | Male | 40-44 | NA | NA |
| Chlamydia | 2000 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Chlamydia | 2000 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Chlamydia | 2000 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Chlamydia | 2000 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Chlamydia | 2000 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Chlamydia | 2000 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Chlamydia | 2000 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Chlamydia | 2000 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Chlamydia | 2000 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Chlamydia | 2000 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Chlamydia | 2000 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Chlamydia | 2000 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Chlamydia | 2000 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Chlamydia | 2000 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Chlamydia | 2000 | Unknown | Female | 0-14 | NA | NA |
| Chlamydia | 2000 | Unknown | Female | 15-19 | NA | NA |
| Chlamydia | 2000 | Unknown | Female | 20-24 | NA | NA |
| Chlamydia | 2000 | Unknown | Female | 25-29 | NA | NA |
| Chlamydia | 2000 | Unknown | Female | 30-34 | NA | NA |
| Chlamydia | 2000 | Unknown | Female | 35-39 | NA | NA |
| Chlamydia | 2000 | Unknown | Female | 40-44 | NA | NA |
| Chlamydia | 2000 | Unknown | Male | 0-14 | NA | NA |
| Chlamydia | 2000 | Unknown | Male | 15-19 | NA | NA |
| Chlamydia | 2000 | Unknown | Male | 20-24 | NA | NA |
| Chlamydia | 2000 | Unknown | Male | 25-29 | NA | NA |
| Chlamydia | 2000 | Unknown | Male | 30-34 | NA | NA |
| Chlamydia | 2000 | Unknown | Male | 35-39 | NA | NA |
| Chlamydia | 2000 | Unknown | Male | 40-44 | NA | NA |
| Chlamydia | 2000 | White | Female | 0-14 | NA | NA |
| Chlamydia | 2000 | White | Female | 15-19 | NA | NA |
| Chlamydia | 2000 | White | Female | 20-24 | NA | NA |
| Chlamydia | 2000 | White | Female | 25-29 | NA | NA |
| Chlamydia | 2000 | White | Female | 30-34 | NA | NA |
| Chlamydia | 2000 | White | Female | 35-39 | NA | NA |
| Chlamydia | 2000 | White | Female | 40-44 | NA | NA |
| Chlamydia | 2000 | White | Male | 0-14 | NA | NA |
| Chlamydia | 2000 | White | Male | 15-19 | NA | NA |
| Chlamydia | 2000 | White | Male | 20-24 | NA | NA |
| Chlamydia | 2000 | White | Male | 25-29 | NA | NA |
| Chlamydia | 2000 | White | Male | 30-34 | NA | NA |
| Chlamydia | 2000 | White | Male | 35-39 | NA | NA |
| Chlamydia | 2000 | White | Male | 40-44 | NA | NA |
| Chlamydia | 2001 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Chlamydia | 2001 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Chlamydia | 2001 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Chlamydia | 2001 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Chlamydia | 2001 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Chlamydia | 2001 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Chlamydia | 2001 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Chlamydia | 2001 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Chlamydia | 2001 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Chlamydia | 2001 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Chlamydia | 2001 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Chlamydia | 2001 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Chlamydia | 2001 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Chlamydia | 2001 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Chlamydia | 2001 | Asian | Female | 0-14 | NA | NA |
| Chlamydia | 2001 | Asian | Female | 15-19 | NA | NA |
| Chlamydia | 2001 | Asian | Female | 20-24 | NA | NA |
| Chlamydia | 2001 | Asian | Female | 25-29 | NA | NA |
| Chlamydia | 2001 | Asian | Female | 30-34 | NA | NA |
| Chlamydia | 2001 | Asian | Female | 35-39 | NA | NA |
| Chlamydia | 2001 | Asian | Female | 40-44 | NA | NA |
| Chlamydia | 2001 | Asian | Male | 0-14 | NA | NA |
| Chlamydia | 2001 | Asian | Male | 15-19 | NA | NA |
| Chlamydia | 2001 | Asian | Male | 20-24 | NA | NA |
| Chlamydia | 2001 | Asian | Male | 25-29 | NA | NA |
| Chlamydia | 2001 | Asian | Male | 30-34 | NA | NA |
| Chlamydia | 2001 | Asian | Male | 35-39 | NA | NA |
| Chlamydia | 2001 | Asian | Male | 40-44 | NA | NA |
| Chlamydia | 2001 | Black/African American | Female | 0-14 | NA | NA |
| Chlamydia | 2001 | Black/African American | Female | 15-19 | NA | NA |
| Chlamydia | 2001 | Black/African American | Female | 20-24 | NA | NA |
| Chlamydia | 2001 | Black/African American | Female | 25-29 | NA | NA |
| Chlamydia | 2001 | Black/African American | Female | 30-34 | NA | NA |
| Chlamydia | 2001 | Black/African American | Female | 35-39 | NA | NA |
| Chlamydia | 2001 | Black/African American | Female | 40-44 | NA | NA |
| Chlamydia | 2001 | Black/African American | Male | 0-14 | NA | NA |
| Chlamydia | 2001 | Black/African American | Male | 15-19 | NA | NA |
| Chlamydia | 2001 | Black/African American | Male | 20-24 | NA | NA |
| Chlamydia | 2001 | Black/African American | Male | 25-29 | NA | NA |
| Chlamydia | 2001 | Black/African American | Male | 30-34 | NA | NA |
| Chlamydia | 2001 | Black/African American | Male | 35-39 | NA | NA |
| Chlamydia | 2001 | Black/African American | Male | 40-44 | NA | NA |
| Chlamydia | 2001 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Chlamydia | 2001 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Chlamydia | 2001 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Chlamydia | 2001 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Chlamydia | 2001 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Chlamydia | 2001 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Chlamydia | 2001 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Chlamydia | 2001 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Chlamydia | 2001 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Chlamydia | 2001 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Chlamydia | 2001 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Chlamydia | 2001 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Chlamydia | 2001 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Chlamydia | 2001 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Chlamydia | 2001 | Multiple races | Female | 0-14 | NA | NA |
| Chlamydia | 2001 | Multiple races | Female | 15-19 | NA | NA |
| Chlamydia | 2001 | Multiple races | Female | 20-24 | NA | NA |
| Chlamydia | 2001 | Multiple races | Female | 25-29 | NA | NA |
| Chlamydia | 2001 | Multiple races | Female | 30-34 | NA | NA |
| Chlamydia | 2001 | Multiple races | Female | 35-39 | NA | NA |
| Chlamydia | 2001 | Multiple races | Female | 40-44 | NA | NA |
| Chlamydia | 2001 | Multiple races | Male | 0-14 | NA | NA |
| Chlamydia | 2001 | Multiple races | Male | 15-19 | NA | NA |
| Chlamydia | 2001 | Multiple races | Male | 20-24 | NA | NA |
| Chlamydia | 2001 | Multiple races | Male | 25-29 | NA | NA |
| Chlamydia | 2001 | Multiple races | Male | 30-34 | NA | NA |
| Chlamydia | 2001 | Multiple races | Male | 35-39 | NA | NA |
| Chlamydia | 2001 | Multiple races | Male | 40-44 | NA | NA |
| Chlamydia | 2001 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Chlamydia | 2001 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Chlamydia | 2001 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Chlamydia | 2001 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Chlamydia | 2001 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Chlamydia | 2001 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Chlamydia | 2001 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Chlamydia | 2001 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Chlamydia | 2001 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Chlamydia | 2001 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Chlamydia | 2001 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Chlamydia | 2001 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Chlamydia | 2001 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Chlamydia | 2001 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Chlamydia | 2001 | Unknown | Female | 0-14 | NA | NA |
| Chlamydia | 2001 | Unknown | Female | 15-19 | NA | NA |
| Chlamydia | 2001 | Unknown | Female | 20-24 | NA | NA |
| Chlamydia | 2001 | Unknown | Female | 25-29 | NA | NA |
| Chlamydia | 2001 | Unknown | Female | 30-34 | NA | NA |
| Chlamydia | 2001 | Unknown | Female | 35-39 | NA | NA |
| Chlamydia | 2001 | Unknown | Female | 40-44 | NA | NA |
| Chlamydia | 2001 | Unknown | Male | 0-14 | NA | NA |
| Chlamydia | 2001 | Unknown | Male | 15-19 | NA | NA |
| Chlamydia | 2001 | Unknown | Male | 20-24 | NA | NA |
| Chlamydia | 2001 | Unknown | Male | 25-29 | NA | NA |
| Chlamydia | 2001 | Unknown | Male | 30-34 | NA | NA |
| Chlamydia | 2001 | Unknown | Male | 35-39 | NA | NA |
| Chlamydia | 2001 | Unknown | Male | 40-44 | NA | NA |
| Chlamydia | 2001 | White | Female | 0-14 | NA | NA |
| Chlamydia | 2001 | White | Female | 15-19 | NA | NA |
| Chlamydia | 2001 | White | Female | 20-24 | NA | NA |
| Chlamydia | 2001 | White | Female | 25-29 | NA | NA |
| Chlamydia | 2001 | White | Female | 30-34 | NA | NA |
| Chlamydia | 2001 | White | Female | 35-39 | NA | NA |
| Chlamydia | 2001 | White | Female | 40-44 | NA | NA |
| Chlamydia | 2001 | White | Male | 0-14 | NA | NA |
| Chlamydia | 2001 | White | Male | 15-19 | NA | NA |
| Chlamydia | 2001 | White | Male | 20-24 | NA | NA |
| Chlamydia | 2001 | White | Male | 25-29 | NA | NA |
| Chlamydia | 2001 | White | Male | 30-34 | NA | NA |
| Chlamydia | 2001 | White | Male | 35-39 | NA | NA |
| Chlamydia | 2001 | White | Male | 40-44 | NA | NA |
| Chlamydia | 2002 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Chlamydia | 2002 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Chlamydia | 2002 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Chlamydia | 2002 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Chlamydia | 2002 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Chlamydia | 2002 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Chlamydia | 2002 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Chlamydia | 2002 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Chlamydia | 2002 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Chlamydia | 2002 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Chlamydia | 2002 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Chlamydia | 2002 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Chlamydia | 2002 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Chlamydia | 2002 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Chlamydia | 2002 | Asian | Female | 0-14 | NA | NA |
| Chlamydia | 2002 | Asian | Female | 15-19 | NA | NA |
| Chlamydia | 2002 | Asian | Female | 20-24 | NA | NA |
| Chlamydia | 2002 | Asian | Female | 25-29 | NA | NA |
| Chlamydia | 2002 | Asian | Female | 30-34 | NA | NA |
| Chlamydia | 2002 | Asian | Female | 35-39 | NA | NA |
| Chlamydia | 2002 | Asian | Female | 40-44 | NA | NA |
| Chlamydia | 2002 | Asian | Male | 0-14 | NA | NA |
| Chlamydia | 2002 | Asian | Male | 15-19 | NA | NA |
| Chlamydia | 2002 | Asian | Male | 20-24 | NA | NA |
| Chlamydia | 2002 | Asian | Male | 25-29 | NA | NA |
| Chlamydia | 2002 | Asian | Male | 30-34 | NA | NA |
| Chlamydia | 2002 | Asian | Male | 35-39 | NA | NA |
| Chlamydia | 2002 | Asian | Male | 40-44 | NA | NA |
| Chlamydia | 2002 | Black/African American | Female | 0-14 | NA | NA |
| Chlamydia | 2002 | Black/African American | Female | 15-19 | NA | NA |
| Chlamydia | 2002 | Black/African American | Female | 20-24 | NA | NA |
| Chlamydia | 2002 | Black/African American | Female | 25-29 | NA | NA |
| Chlamydia | 2002 | Black/African American | Female | 30-34 | NA | NA |
| Chlamydia | 2002 | Black/African American | Female | 35-39 | NA | NA |
| Chlamydia | 2002 | Black/African American | Female | 40-44 | NA | NA |
| Chlamydia | 2002 | Black/African American | Male | 0-14 | NA | NA |
| Chlamydia | 2002 | Black/African American | Male | 15-19 | NA | NA |
| Chlamydia | 2002 | Black/African American | Male | 20-24 | NA | NA |
| Chlamydia | 2002 | Black/African American | Male | 25-29 | NA | NA |
| Chlamydia | 2002 | Black/African American | Male | 30-34 | NA | NA |
| Chlamydia | 2002 | Black/African American | Male | 35-39 | NA | NA |
| Chlamydia | 2002 | Black/African American | Male | 40-44 | NA | NA |
| Chlamydia | 2002 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Chlamydia | 2002 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Chlamydia | 2002 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Chlamydia | 2002 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Chlamydia | 2002 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Chlamydia | 2002 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Chlamydia | 2002 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Chlamydia | 2002 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Chlamydia | 2002 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Chlamydia | 2002 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Chlamydia | 2002 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Chlamydia | 2002 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Chlamydia | 2002 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Chlamydia | 2002 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Chlamydia | 2002 | Multiple races | Female | 0-14 | NA | NA |
| Chlamydia | 2002 | Multiple races | Female | 15-19 | NA | NA |
| Chlamydia | 2002 | Multiple races | Female | 20-24 | NA | NA |
| Chlamydia | 2002 | Multiple races | Female | 25-29 | NA | NA |
| Chlamydia | 2002 | Multiple races | Female | 30-34 | NA | NA |
| Chlamydia | 2002 | Multiple races | Female | 35-39 | NA | NA |
| Chlamydia | 2002 | Multiple races | Female | 40-44 | NA | NA |
| Chlamydia | 2002 | Multiple races | Male | 0-14 | NA | NA |
| Chlamydia | 2002 | Multiple races | Male | 15-19 | NA | NA |
| Chlamydia | 2002 | Multiple races | Male | 20-24 | NA | NA |
| Chlamydia | 2002 | Multiple races | Male | 25-29 | NA | NA |
| Chlamydia | 2002 | Multiple races | Male | 30-34 | NA | NA |
| Chlamydia | 2002 | Multiple races | Male | 35-39 | NA | NA |
| Chlamydia | 2002 | Multiple races | Male | 40-44 | NA | NA |
| Chlamydia | 2002 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Chlamydia | 2002 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Chlamydia | 2002 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Chlamydia | 2002 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Chlamydia | 2002 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Chlamydia | 2002 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Chlamydia | 2002 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Chlamydia | 2002 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Chlamydia | 2002 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Chlamydia | 2002 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Chlamydia | 2002 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Chlamydia | 2002 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Chlamydia | 2002 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Chlamydia | 2002 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Chlamydia | 2002 | Unknown | Female | 0-14 | NA | NA |
| Chlamydia | 2002 | Unknown | Female | 15-19 | NA | NA |
| Chlamydia | 2002 | Unknown | Female | 20-24 | NA | NA |
| Chlamydia | 2002 | Unknown | Female | 25-29 | NA | NA |
| Chlamydia | 2002 | Unknown | Female | 30-34 | NA | NA |
| Chlamydia | 2002 | Unknown | Female | 35-39 | NA | NA |
| Chlamydia | 2002 | Unknown | Female | 40-44 | NA | NA |
| Chlamydia | 2002 | Unknown | Male | 0-14 | NA | NA |
| Chlamydia | 2002 | Unknown | Male | 15-19 | NA | NA |
| Chlamydia | 2002 | Unknown | Male | 20-24 | NA | NA |
| Chlamydia | 2002 | Unknown | Male | 25-29 | NA | NA |
| Chlamydia | 2002 | Unknown | Male | 30-34 | NA | NA |
| Chlamydia | 2002 | Unknown | Male | 35-39 | NA | NA |
| Chlamydia | 2002 | Unknown | Male | 40-44 | NA | NA |
| Chlamydia | 2002 | White | Female | 0-14 | NA | NA |
| Chlamydia | 2002 | White | Female | 15-19 | NA | NA |
| Chlamydia | 2002 | White | Female | 20-24 | NA | NA |
| Chlamydia | 2002 | White | Female | 25-29 | NA | NA |
| Chlamydia | 2002 | White | Female | 30-34 | NA | NA |
| Chlamydia | 2002 | White | Female | 35-39 | NA | NA |
| Chlamydia | 2002 | White | Female | 40-44 | NA | NA |
| Chlamydia | 2002 | White | Male | 0-14 | NA | NA |
| Chlamydia | 2002 | White | Male | 15-19 | NA | NA |
| Chlamydia | 2002 | White | Male | 20-24 | NA | NA |
| Chlamydia | 2002 | White | Male | 25-29 | NA | NA |
| Chlamydia | 2002 | White | Male | 30-34 | NA | NA |
| Chlamydia | 2002 | White | Male | 35-39 | NA | NA |
| Chlamydia | 2002 | White | Male | 40-44 | NA | NA |
| Chlamydia | 2003 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Chlamydia | 2003 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Chlamydia | 2003 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Chlamydia | 2003 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Chlamydia | 2003 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Chlamydia | 2003 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Chlamydia | 2003 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Chlamydia | 2003 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Chlamydia | 2003 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Chlamydia | 2003 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Chlamydia | 2003 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Chlamydia | 2003 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Chlamydia | 2003 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Chlamydia | 2003 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Chlamydia | 2003 | Asian | Female | 0-14 | NA | NA |
| Chlamydia | 2003 | Asian | Female | 15-19 | NA | NA |
| Chlamydia | 2003 | Asian | Female | 20-24 | NA | NA |
| Chlamydia | 2003 | Asian | Female | 25-29 | NA | NA |
| Chlamydia | 2003 | Asian | Female | 30-34 | NA | NA |
| Chlamydia | 2003 | Asian | Female | 35-39 | NA | NA |
| Chlamydia | 2003 | Asian | Female | 40-44 | NA | NA |
| Chlamydia | 2003 | Asian | Male | 0-14 | NA | NA |
| Chlamydia | 2003 | Asian | Male | 15-19 | NA | NA |
| Chlamydia | 2003 | Asian | Male | 20-24 | NA | NA |
| Chlamydia | 2003 | Asian | Male | 25-29 | NA | NA |
| Chlamydia | 2003 | Asian | Male | 30-34 | NA | NA |
| Chlamydia | 2003 | Asian | Male | 35-39 | NA | NA |
| Chlamydia | 2003 | Asian | Male | 40-44 | NA | NA |
| Chlamydia | 2003 | Black/African American | Female | 0-14 | NA | NA |
| Chlamydia | 2003 | Black/African American | Female | 15-19 | NA | NA |
| Chlamydia | 2003 | Black/African American | Female | 20-24 | NA | NA |
| Chlamydia | 2003 | Black/African American | Female | 25-29 | NA | NA |
| Chlamydia | 2003 | Black/African American | Female | 30-34 | NA | NA |
| Chlamydia | 2003 | Black/African American | Female | 35-39 | NA | NA |
| Chlamydia | 2003 | Black/African American | Female | 40-44 | NA | NA |
| Chlamydia | 2003 | Black/African American | Male | 0-14 | NA | NA |
| Chlamydia | 2003 | Black/African American | Male | 15-19 | NA | NA |
| Chlamydia | 2003 | Black/African American | Male | 20-24 | NA | NA |
| Chlamydia | 2003 | Black/African American | Male | 25-29 | NA | NA |
| Chlamydia | 2003 | Black/African American | Male | 30-34 | NA | NA |
| Chlamydia | 2003 | Black/African American | Male | 35-39 | NA | NA |
| Chlamydia | 2003 | Black/African American | Male | 40-44 | NA | NA |
| Chlamydia | 2003 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Chlamydia | 2003 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Chlamydia | 2003 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Chlamydia | 2003 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Chlamydia | 2003 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Chlamydia | 2003 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Chlamydia | 2003 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Chlamydia | 2003 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Chlamydia | 2003 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Chlamydia | 2003 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Chlamydia | 2003 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Chlamydia | 2003 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Chlamydia | 2003 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Chlamydia | 2003 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Chlamydia | 2003 | Multiple races | Female | 0-14 | NA | NA |
| Chlamydia | 2003 | Multiple races | Female | 15-19 | NA | NA |
| Chlamydia | 2003 | Multiple races | Female | 20-24 | NA | NA |
| Chlamydia | 2003 | Multiple races | Female | 25-29 | NA | NA |
| Chlamydia | 2003 | Multiple races | Female | 30-34 | NA | NA |
| Chlamydia | 2003 | Multiple races | Female | 35-39 | NA | NA |
| Chlamydia | 2003 | Multiple races | Female | 40-44 | NA | NA |
| Chlamydia | 2003 | Multiple races | Male | 0-14 | NA | NA |
| Chlamydia | 2003 | Multiple races | Male | 15-19 | NA | NA |
| Chlamydia | 2003 | Multiple races | Male | 20-24 | NA | NA |
| Chlamydia | 2003 | Multiple races | Male | 25-29 | NA | NA |
| Chlamydia | 2003 | Multiple races | Male | 30-34 | NA | NA |
| Chlamydia | 2003 | Multiple races | Male | 35-39 | NA | NA |
| Chlamydia | 2003 | Multiple races | Male | 40-44 | NA | NA |
| Chlamydia | 2003 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Chlamydia | 2003 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Chlamydia | 2003 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Chlamydia | 2003 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Chlamydia | 2003 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Chlamydia | 2003 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Chlamydia | 2003 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Chlamydia | 2003 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Chlamydia | 2003 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Chlamydia | 2003 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Chlamydia | 2003 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Chlamydia | 2003 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Chlamydia | 2003 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Chlamydia | 2003 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Chlamydia | 2003 | Unknown | Female | 0-14 | NA | NA |
| Chlamydia | 2003 | Unknown | Female | 15-19 | NA | NA |
| Chlamydia | 2003 | Unknown | Female | 20-24 | NA | NA |
| Chlamydia | 2003 | Unknown | Female | 25-29 | NA | NA |
| Chlamydia | 2003 | Unknown | Female | 30-34 | NA | NA |
| Chlamydia | 2003 | Unknown | Female | 35-39 | NA | NA |
| Chlamydia | 2003 | Unknown | Female | 40-44 | NA | NA |
| Chlamydia | 2003 | Unknown | Male | 0-14 | NA | NA |
| Chlamydia | 2003 | Unknown | Male | 15-19 | NA | NA |
| Chlamydia | 2003 | Unknown | Male | 20-24 | NA | NA |
| Chlamydia | 2003 | Unknown | Male | 25-29 | NA | NA |
| Chlamydia | 2003 | Unknown | Male | 30-34 | NA | NA |
| Chlamydia | 2003 | Unknown | Male | 35-39 | NA | NA |
| Chlamydia | 2003 | Unknown | Male | 40-44 | NA | NA |
| Chlamydia | 2003 | White | Female | 0-14 | NA | NA |
| Chlamydia | 2003 | White | Female | 15-19 | NA | NA |
| Chlamydia | 2003 | White | Female | 20-24 | NA | NA |
| Chlamydia | 2003 | White | Female | 25-29 | NA | NA |
| Chlamydia | 2003 | White | Female | 30-34 | NA | NA |
| Chlamydia | 2003 | White | Female | 35-39 | NA | NA |
| Chlamydia | 2003 | White | Female | 40-44 | NA | NA |
| Chlamydia | 2003 | White | Male | 0-14 | NA | NA |
| Chlamydia | 2003 | White | Male | 15-19 | NA | NA |
| Chlamydia | 2003 | White | Male | 20-24 | NA | NA |
| Chlamydia | 2003 | White | Male | 25-29 | NA | NA |
| Chlamydia | 2003 | White | Male | 30-34 | NA | NA |
| Chlamydia | 2003 | White | Male | 35-39 | NA | NA |
| Chlamydia | 2003 | White | Male | 40-44 | NA | NA |
| Chlamydia | 2004 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Chlamydia | 2004 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Chlamydia | 2004 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Chlamydia | 2004 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Chlamydia | 2004 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Chlamydia | 2004 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Chlamydia | 2004 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Chlamydia | 2004 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Chlamydia | 2004 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Chlamydia | 2004 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Chlamydia | 2004 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Chlamydia | 2004 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Chlamydia | 2004 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Chlamydia | 2004 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Chlamydia | 2004 | Asian | Female | 0-14 | NA | NA |
| Chlamydia | 2004 | Asian | Female | 15-19 | NA | NA |
| Chlamydia | 2004 | Asian | Female | 20-24 | NA | NA |
| Chlamydia | 2004 | Asian | Female | 25-29 | NA | NA |
| Chlamydia | 2004 | Asian | Female | 30-34 | NA | NA |
| Chlamydia | 2004 | Asian | Female | 35-39 | NA | NA |
| Chlamydia | 2004 | Asian | Female | 40-44 | NA | NA |
| Chlamydia | 2004 | Asian | Male | 0-14 | NA | NA |
| Chlamydia | 2004 | Asian | Male | 15-19 | NA | NA |
| Chlamydia | 2004 | Asian | Male | 20-24 | NA | NA |
| Chlamydia | 2004 | Asian | Male | 25-29 | NA | NA |
| Chlamydia | 2004 | Asian | Male | 30-34 | NA | NA |
| Chlamydia | 2004 | Asian | Male | 35-39 | NA | NA |
| Chlamydia | 2004 | Asian | Male | 40-44 | NA | NA |
| Chlamydia | 2004 | Black/African American | Female | 0-14 | NA | NA |
| Chlamydia | 2004 | Black/African American | Female | 15-19 | NA | NA |
| Chlamydia | 2004 | Black/African American | Female | 20-24 | NA | NA |
| Chlamydia | 2004 | Black/African American | Female | 25-29 | NA | NA |
| Chlamydia | 2004 | Black/African American | Female | 30-34 | NA | NA |
| Chlamydia | 2004 | Black/African American | Female | 35-39 | NA | NA |
| Chlamydia | 2004 | Black/African American | Female | 40-44 | NA | NA |
| Chlamydia | 2004 | Black/African American | Male | 0-14 | NA | NA |
| Chlamydia | 2004 | Black/African American | Male | 15-19 | NA | NA |
| Chlamydia | 2004 | Black/African American | Male | 20-24 | NA | NA |
| Chlamydia | 2004 | Black/African American | Male | 25-29 | NA | NA |
| Chlamydia | 2004 | Black/African American | Male | 30-34 | NA | NA |
| Chlamydia | 2004 | Black/African American | Male | 35-39 | NA | NA |
| Chlamydia | 2004 | Black/African American | Male | 40-44 | NA | NA |
| Chlamydia | 2004 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Chlamydia | 2004 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Chlamydia | 2004 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Chlamydia | 2004 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Chlamydia | 2004 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Chlamydia | 2004 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Chlamydia | 2004 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Chlamydia | 2004 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Chlamydia | 2004 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Chlamydia | 2004 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Chlamydia | 2004 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Chlamydia | 2004 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Chlamydia | 2004 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Chlamydia | 2004 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Chlamydia | 2004 | Multiple races | Female | 0-14 | NA | NA |
| Chlamydia | 2004 | Multiple races | Female | 15-19 | NA | NA |
| Chlamydia | 2004 | Multiple races | Female | 20-24 | NA | NA |
| Chlamydia | 2004 | Multiple races | Female | 25-29 | NA | NA |
| Chlamydia | 2004 | Multiple races | Female | 30-34 | NA | NA |
| Chlamydia | 2004 | Multiple races | Female | 35-39 | NA | NA |
| Chlamydia | 2004 | Multiple races | Female | 40-44 | NA | NA |
| Chlamydia | 2004 | Multiple races | Male | 0-14 | NA | NA |
| Chlamydia | 2004 | Multiple races | Male | 15-19 | NA | NA |
| Chlamydia | 2004 | Multiple races | Male | 20-24 | NA | NA |
| Chlamydia | 2004 | Multiple races | Male | 25-29 | NA | NA |
| Chlamydia | 2004 | Multiple races | Male | 30-34 | NA | NA |
| Chlamydia | 2004 | Multiple races | Male | 35-39 | NA | NA |
| Chlamydia | 2004 | Multiple races | Male | 40-44 | NA | NA |
| Chlamydia | 2004 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Chlamydia | 2004 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Chlamydia | 2004 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Chlamydia | 2004 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Chlamydia | 2004 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Chlamydia | 2004 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Chlamydia | 2004 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Chlamydia | 2004 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Chlamydia | 2004 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Chlamydia | 2004 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Chlamydia | 2004 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Chlamydia | 2004 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Chlamydia | 2004 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Chlamydia | 2004 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Chlamydia | 2004 | Unknown | Female | 0-14 | NA | NA |
| Chlamydia | 2004 | Unknown | Female | 15-19 | NA | NA |
| Chlamydia | 2004 | Unknown | Female | 20-24 | NA | NA |
| Chlamydia | 2004 | Unknown | Female | 25-29 | NA | NA |
| Chlamydia | 2004 | Unknown | Female | 30-34 | NA | NA |
| Chlamydia | 2004 | Unknown | Female | 35-39 | NA | NA |
| Chlamydia | 2004 | Unknown | Female | 40-44 | NA | NA |
| Chlamydia | 2004 | Unknown | Male | 0-14 | NA | NA |
| Chlamydia | 2004 | Unknown | Male | 15-19 | NA | NA |
| Chlamydia | 2004 | Unknown | Male | 20-24 | NA | NA |
| Chlamydia | 2004 | Unknown | Male | 25-29 | NA | NA |
| Chlamydia | 2004 | Unknown | Male | 30-34 | NA | NA |
| Chlamydia | 2004 | Unknown | Male | 35-39 | NA | NA |
| Chlamydia | 2004 | Unknown | Male | 40-44 | NA | NA |
| Chlamydia | 2004 | White | Female | 0-14 | NA | NA |
| Chlamydia | 2004 | White | Female | 15-19 | NA | NA |
| Chlamydia | 2004 | White | Female | 20-24 | NA | NA |
| Chlamydia | 2004 | White | Female | 25-29 | NA | NA |
| Chlamydia | 2004 | White | Female | 30-34 | NA | NA |
| Chlamydia | 2004 | White | Female | 35-39 | NA | NA |
| Chlamydia | 2004 | White | Female | 40-44 | NA | NA |
| Chlamydia | 2004 | White | Male | 0-14 | NA | NA |
| Chlamydia | 2004 | White | Male | 15-19 | NA | NA |
| Chlamydia | 2004 | White | Male | 20-24 | NA | NA |
| Chlamydia | 2004 | White | Male | 25-29 | NA | NA |
| Chlamydia | 2004 | White | Male | 30-34 | NA | NA |
| Chlamydia | 2004 | White | Male | 35-39 | NA | NA |
| Chlamydia | 2004 | White | Male | 40-44 | NA | NA |
| Chlamydia | 2005 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Chlamydia | 2005 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Chlamydia | 2005 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Chlamydia | 2005 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Chlamydia | 2005 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Chlamydia | 2005 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Chlamydia | 2005 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Chlamydia | 2005 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Chlamydia | 2005 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Chlamydia | 2005 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Chlamydia | 2005 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Chlamydia | 2005 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Chlamydia | 2005 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Chlamydia | 2005 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Chlamydia | 2005 | Asian | Female | 0-14 | NA | NA |
| Chlamydia | 2005 | Asian | Female | 15-19 | NA | NA |
| Chlamydia | 2005 | Asian | Female | 20-24 | NA | NA |
| Chlamydia | 2005 | Asian | Female | 25-29 | NA | NA |
| Chlamydia | 2005 | Asian | Female | 30-34 | NA | NA |
| Chlamydia | 2005 | Asian | Female | 35-39 | NA | NA |
| Chlamydia | 2005 | Asian | Female | 40-44 | NA | NA |
| Chlamydia | 2005 | Asian | Male | 0-14 | NA | NA |
| Chlamydia | 2005 | Asian | Male | 15-19 | NA | NA |
| Chlamydia | 2005 | Asian | Male | 20-24 | NA | NA |
| Chlamydia | 2005 | Asian | Male | 25-29 | NA | NA |
| Chlamydia | 2005 | Asian | Male | 30-34 | NA | NA |
| Chlamydia | 2005 | Asian | Male | 35-39 | NA | NA |
| Chlamydia | 2005 | Asian | Male | 40-44 | NA | NA |
| Chlamydia | 2005 | Black/African American | Female | 0-14 | NA | NA |
| Chlamydia | 2005 | Black/African American | Female | 15-19 | NA | NA |
| Chlamydia | 2005 | Black/African American | Female | 20-24 | NA | NA |
| Chlamydia | 2005 | Black/African American | Female | 25-29 | NA | NA |
| Chlamydia | 2005 | Black/African American | Female | 30-34 | NA | NA |
| Chlamydia | 2005 | Black/African American | Female | 35-39 | NA | NA |
| Chlamydia | 2005 | Black/African American | Female | 40-44 | NA | NA |
| Chlamydia | 2005 | Black/African American | Male | 0-14 | NA | NA |
| Chlamydia | 2005 | Black/African American | Male | 15-19 | NA | NA |
| Chlamydia | 2005 | Black/African American | Male | 20-24 | NA | NA |
| Chlamydia | 2005 | Black/African American | Male | 25-29 | NA | NA |
| Chlamydia | 2005 | Black/African American | Male | 30-34 | NA | NA |
| Chlamydia | 2005 | Black/African American | Male | 35-39 | NA | NA |
| Chlamydia | 2005 | Black/African American | Male | 40-44 | NA | NA |
| Chlamydia | 2005 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Chlamydia | 2005 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Chlamydia | 2005 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Chlamydia | 2005 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Chlamydia | 2005 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Chlamydia | 2005 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Chlamydia | 2005 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Chlamydia | 2005 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Chlamydia | 2005 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Chlamydia | 2005 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Chlamydia | 2005 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Chlamydia | 2005 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Chlamydia | 2005 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Chlamydia | 2005 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Chlamydia | 2005 | Multiple races | Female | 0-14 | NA | NA |
| Chlamydia | 2005 | Multiple races | Female | 15-19 | NA | NA |
| Chlamydia | 2005 | Multiple races | Female | 20-24 | NA | NA |
| Chlamydia | 2005 | Multiple races | Female | 25-29 | NA | NA |
| Chlamydia | 2005 | Multiple races | Female | 30-34 | NA | NA |
| Chlamydia | 2005 | Multiple races | Female | 35-39 | NA | NA |
| Chlamydia | 2005 | Multiple races | Female | 40-44 | NA | NA |
| Chlamydia | 2005 | Multiple races | Male | 0-14 | NA | NA |
| Chlamydia | 2005 | Multiple races | Male | 15-19 | NA | NA |
| Chlamydia | 2005 | Multiple races | Male | 20-24 | NA | NA |
| Chlamydia | 2005 | Multiple races | Male | 25-29 | NA | NA |
| Chlamydia | 2005 | Multiple races | Male | 30-34 | NA | NA |
| Chlamydia | 2005 | Multiple races | Male | 35-39 | NA | NA |
| Chlamydia | 2005 | Multiple races | Male | 40-44 | NA | NA |
| Chlamydia | 2005 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Chlamydia | 2005 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Chlamydia | 2005 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Chlamydia | 2005 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Chlamydia | 2005 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Chlamydia | 2005 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Chlamydia | 2005 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Chlamydia | 2005 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Chlamydia | 2005 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Chlamydia | 2005 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Chlamydia | 2005 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Chlamydia | 2005 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Chlamydia | 2005 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Chlamydia | 2005 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Chlamydia | 2005 | Unknown | Female | 0-14 | NA | NA |
| Chlamydia | 2005 | Unknown | Female | 15-19 | NA | NA |
| Chlamydia | 2005 | Unknown | Female | 20-24 | NA | NA |
| Chlamydia | 2005 | Unknown | Female | 25-29 | NA | NA |
| Chlamydia | 2005 | Unknown | Female | 30-34 | NA | NA |
| Chlamydia | 2005 | Unknown | Female | 35-39 | NA | NA |
| Chlamydia | 2005 | Unknown | Female | 40-44 | NA | NA |
| Chlamydia | 2005 | Unknown | Male | 0-14 | NA | NA |
| Chlamydia | 2005 | Unknown | Male | 15-19 | NA | NA |
| Chlamydia | 2005 | Unknown | Male | 20-24 | NA | NA |
| Chlamydia | 2005 | Unknown | Male | 25-29 | NA | NA |
| Chlamydia | 2005 | Unknown | Male | 30-34 | NA | NA |
| Chlamydia | 2005 | Unknown | Male | 35-39 | NA | NA |
| Chlamydia | 2005 | Unknown | Male | 40-44 | NA | NA |
| Chlamydia | 2005 | White | Female | 0-14 | NA | NA |
| Chlamydia | 2005 | White | Female | 15-19 | NA | NA |
| Chlamydia | 2005 | White | Female | 20-24 | NA | NA |
| Chlamydia | 2005 | White | Female | 25-29 | NA | NA |
| Chlamydia | 2005 | White | Female | 30-34 | NA | NA |
| Chlamydia | 2005 | White | Female | 35-39 | NA | NA |
| Chlamydia | 2005 | White | Female | 40-44 | NA | NA |
| Chlamydia | 2005 | White | Male | 0-14 | NA | NA |
| Chlamydia | 2005 | White | Male | 15-19 | NA | NA |
| Chlamydia | 2005 | White | Male | 20-24 | NA | NA |
| Chlamydia | 2005 | White | Male | 25-29 | NA | NA |
| Chlamydia | 2005 | White | Male | 30-34 | NA | NA |
| Chlamydia | 2005 | White | Male | 35-39 | NA | NA |
| Chlamydia | 2005 | White | Male | 40-44 | NA | NA |
| Chlamydia | 2006 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Chlamydia | 2006 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Chlamydia | 2006 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Chlamydia | 2006 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Chlamydia | 2006 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Chlamydia | 2006 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Chlamydia | 2006 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Chlamydia | 2006 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Chlamydia | 2006 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Chlamydia | 2006 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Chlamydia | 2006 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Chlamydia | 2006 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Chlamydia | 2006 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Chlamydia | 2006 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Chlamydia | 2006 | Asian | Female | 0-14 | NA | NA |
| Chlamydia | 2006 | Asian | Female | 15-19 | NA | NA |
| Chlamydia | 2006 | Asian | Female | 20-24 | NA | NA |
| Chlamydia | 2006 | Asian | Female | 25-29 | NA | NA |
| Chlamydia | 2006 | Asian | Female | 30-34 | NA | NA |
| Chlamydia | 2006 | Asian | Female | 35-39 | NA | NA |
| Chlamydia | 2006 | Asian | Female | 40-44 | NA | NA |
| Chlamydia | 2006 | Asian | Male | 0-14 | NA | NA |
| Chlamydia | 2006 | Asian | Male | 15-19 | NA | NA |
| Chlamydia | 2006 | Asian | Male | 20-24 | NA | NA |
| Chlamydia | 2006 | Asian | Male | 25-29 | NA | NA |
| Chlamydia | 2006 | Asian | Male | 30-34 | NA | NA |
| Chlamydia | 2006 | Asian | Male | 35-39 | NA | NA |
| Chlamydia | 2006 | Asian | Male | 40-44 | NA | NA |
| Chlamydia | 2006 | Black/African American | Female | 0-14 | NA | NA |
| Chlamydia | 2006 | Black/African American | Female | 15-19 | NA | NA |
| Chlamydia | 2006 | Black/African American | Female | 20-24 | NA | NA |
| Chlamydia | 2006 | Black/African American | Female | 25-29 | NA | NA |
| Chlamydia | 2006 | Black/African American | Female | 30-34 | NA | NA |
| Chlamydia | 2006 | Black/African American | Female | 35-39 | NA | NA |
| Chlamydia | 2006 | Black/African American | Female | 40-44 | NA | NA |
| Chlamydia | 2006 | Black/African American | Male | 0-14 | NA | NA |
| Chlamydia | 2006 | Black/African American | Male | 15-19 | NA | NA |
| Chlamydia | 2006 | Black/African American | Male | 20-24 | NA | NA |
| Chlamydia | 2006 | Black/African American | Male | 25-29 | NA | NA |
| Chlamydia | 2006 | Black/African American | Male | 30-34 | NA | NA |
| Chlamydia | 2006 | Black/African American | Male | 35-39 | NA | NA |
| Chlamydia | 2006 | Black/African American | Male | 40-44 | NA | NA |
| Chlamydia | 2006 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Chlamydia | 2006 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Chlamydia | 2006 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Chlamydia | 2006 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Chlamydia | 2006 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Chlamydia | 2006 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Chlamydia | 2006 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Chlamydia | 2006 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Chlamydia | 2006 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Chlamydia | 2006 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Chlamydia | 2006 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Chlamydia | 2006 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Chlamydia | 2006 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Chlamydia | 2006 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Chlamydia | 2006 | Multiple races | Female | 0-14 | NA | NA |
| Chlamydia | 2006 | Multiple races | Female | 15-19 | NA | NA |
| Chlamydia | 2006 | Multiple races | Female | 20-24 | NA | NA |
| Chlamydia | 2006 | Multiple races | Female | 25-29 | NA | NA |
| Chlamydia | 2006 | Multiple races | Female | 30-34 | NA | NA |
| Chlamydia | 2006 | Multiple races | Female | 35-39 | NA | NA |
| Chlamydia | 2006 | Multiple races | Female | 40-44 | NA | NA |
| Chlamydia | 2006 | Multiple races | Male | 0-14 | NA | NA |
| Chlamydia | 2006 | Multiple races | Male | 15-19 | NA | NA |
| Chlamydia | 2006 | Multiple races | Male | 20-24 | NA | NA |
| Chlamydia | 2006 | Multiple races | Male | 25-29 | NA | NA |
| Chlamydia | 2006 | Multiple races | Male | 30-34 | NA | NA |
| Chlamydia | 2006 | Multiple races | Male | 35-39 | NA | NA |
| Chlamydia | 2006 | Multiple races | Male | 40-44 | NA | NA |
| Chlamydia | 2006 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Chlamydia | 2006 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Chlamydia | 2006 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Chlamydia | 2006 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Chlamydia | 2006 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Chlamydia | 2006 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Chlamydia | 2006 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Chlamydia | 2006 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Chlamydia | 2006 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Chlamydia | 2006 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Chlamydia | 2006 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Chlamydia | 2006 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Chlamydia | 2006 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Chlamydia | 2006 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Chlamydia | 2006 | Unknown | Female | 0-14 | NA | NA |
| Chlamydia | 2006 | Unknown | Female | 15-19 | NA | NA |
| Chlamydia | 2006 | Unknown | Female | 20-24 | NA | NA |
| Chlamydia | 2006 | Unknown | Female | 25-29 | NA | NA |
| Chlamydia | 2006 | Unknown | Female | 30-34 | NA | NA |
| Chlamydia | 2006 | Unknown | Female | 35-39 | NA | NA |
| Chlamydia | 2006 | Unknown | Female | 40-44 | NA | NA |
| Chlamydia | 2006 | Unknown | Male | 0-14 | NA | NA |
| Chlamydia | 2006 | Unknown | Male | 15-19 | NA | NA |
| Chlamydia | 2006 | Unknown | Male | 20-24 | NA | NA |
| Chlamydia | 2006 | Unknown | Male | 25-29 | NA | NA |
| Chlamydia | 2006 | Unknown | Male | 30-34 | NA | NA |
| Chlamydia | 2006 | Unknown | Male | 35-39 | NA | NA |
| Chlamydia | 2006 | Unknown | Male | 40-44 | NA | NA |
| Chlamydia | 2006 | White | Female | 0-14 | NA | NA |
| Chlamydia | 2006 | White | Female | 15-19 | NA | NA |
| Chlamydia | 2006 | White | Female | 20-24 | NA | NA |
| Chlamydia | 2006 | White | Female | 25-29 | NA | NA |
| Chlamydia | 2006 | White | Female | 30-34 | NA | NA |
| Chlamydia | 2006 | White | Female | 35-39 | NA | NA |
| Chlamydia | 2006 | White | Female | 40-44 | NA | NA |
| Chlamydia | 2006 | White | Male | 0-14 | NA | NA |
| Chlamydia | 2006 | White | Male | 15-19 | NA | NA |
| Chlamydia | 2006 | White | Male | 20-24 | NA | NA |
| Chlamydia | 2006 | White | Male | 25-29 | NA | NA |
| Chlamydia | 2006 | White | Male | 30-34 | NA | NA |
| Chlamydia | 2006 | White | Male | 35-39 | NA | NA |
| Chlamydia | 2006 | White | Male | 40-44 | NA | NA |
| Chlamydia | 2007 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Chlamydia | 2007 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Chlamydia | 2007 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Chlamydia | 2007 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Chlamydia | 2007 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Chlamydia | 2007 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Chlamydia | 2007 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Chlamydia | 2007 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Chlamydia | 2007 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Chlamydia | 2007 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Chlamydia | 2007 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Chlamydia | 2007 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Chlamydia | 2007 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Chlamydia | 2007 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Chlamydia | 2007 | Asian | Female | 0-14 | NA | NA |
| Chlamydia | 2007 | Asian | Female | 15-19 | NA | NA |
| Chlamydia | 2007 | Asian | Female | 20-24 | NA | NA |
| Chlamydia | 2007 | Asian | Female | 25-29 | NA | NA |
| Chlamydia | 2007 | Asian | Female | 30-34 | NA | NA |
| Chlamydia | 2007 | Asian | Female | 35-39 | NA | NA |
| Chlamydia | 2007 | Asian | Female | 40-44 | NA | NA |
| Chlamydia | 2007 | Asian | Male | 0-14 | NA | NA |
| Chlamydia | 2007 | Asian | Male | 15-19 | NA | NA |
| Chlamydia | 2007 | Asian | Male | 20-24 | NA | NA |
| Chlamydia | 2007 | Asian | Male | 25-29 | NA | NA |
| Chlamydia | 2007 | Asian | Male | 30-34 | NA | NA |
| Chlamydia | 2007 | Asian | Male | 35-39 | NA | NA |
| Chlamydia | 2007 | Asian | Male | 40-44 | NA | NA |
| Chlamydia | 2007 | Black/African American | Female | 0-14 | NA | NA |
| Chlamydia | 2007 | Black/African American | Female | 15-19 | NA | NA |
| Chlamydia | 2007 | Black/African American | Female | 20-24 | NA | NA |
| Chlamydia | 2007 | Black/African American | Female | 25-29 | NA | NA |
| Chlamydia | 2007 | Black/African American | Female | 30-34 | NA | NA |
| Chlamydia | 2007 | Black/African American | Female | 35-39 | NA | NA |
| Chlamydia | 2007 | Black/African American | Female | 40-44 | NA | NA |
| Chlamydia | 2007 | Black/African American | Male | 0-14 | NA | NA |
| Chlamydia | 2007 | Black/African American | Male | 15-19 | NA | NA |
| Chlamydia | 2007 | Black/African American | Male | 20-24 | NA | NA |
| Chlamydia | 2007 | Black/African American | Male | 25-29 | NA | NA |
| Chlamydia | 2007 | Black/African American | Male | 30-34 | NA | NA |
| Chlamydia | 2007 | Black/African American | Male | 35-39 | NA | NA |
| Chlamydia | 2007 | Black/African American | Male | 40-44 | NA | NA |
| Chlamydia | 2007 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Chlamydia | 2007 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Chlamydia | 2007 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Chlamydia | 2007 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Chlamydia | 2007 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Chlamydia | 2007 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Chlamydia | 2007 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Chlamydia | 2007 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Chlamydia | 2007 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Chlamydia | 2007 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Chlamydia | 2007 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Chlamydia | 2007 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Chlamydia | 2007 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Chlamydia | 2007 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Chlamydia | 2007 | Multiple races | Female | 0-14 | NA | NA |
| Chlamydia | 2007 | Multiple races | Female | 15-19 | NA | NA |
| Chlamydia | 2007 | Multiple races | Female | 20-24 | NA | NA |
| Chlamydia | 2007 | Multiple races | Female | 25-29 | NA | NA |
| Chlamydia | 2007 | Multiple races | Female | 30-34 | NA | NA |
| Chlamydia | 2007 | Multiple races | Female | 35-39 | NA | NA |
| Chlamydia | 2007 | Multiple races | Female | 40-44 | NA | NA |
| Chlamydia | 2007 | Multiple races | Male | 0-14 | NA | NA |
| Chlamydia | 2007 | Multiple races | Male | 15-19 | NA | NA |
| Chlamydia | 2007 | Multiple races | Male | 20-24 | NA | NA |
| Chlamydia | 2007 | Multiple races | Male | 25-29 | NA | NA |
| Chlamydia | 2007 | Multiple races | Male | 30-34 | NA | NA |
| Chlamydia | 2007 | Multiple races | Male | 35-39 | NA | NA |
| Chlamydia | 2007 | Multiple races | Male | 40-44 | NA | NA |
| Chlamydia | 2007 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Chlamydia | 2007 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Chlamydia | 2007 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Chlamydia | 2007 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Chlamydia | 2007 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Chlamydia | 2007 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Chlamydia | 2007 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Chlamydia | 2007 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Chlamydia | 2007 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Chlamydia | 2007 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Chlamydia | 2007 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Chlamydia | 2007 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Chlamydia | 2007 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Chlamydia | 2007 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Chlamydia | 2007 | Unknown | Female | 0-14 | NA | NA |
| Chlamydia | 2007 | Unknown | Female | 15-19 | NA | NA |
| Chlamydia | 2007 | Unknown | Female | 20-24 | NA | NA |
| Chlamydia | 2007 | Unknown | Female | 25-29 | NA | NA |
| Chlamydia | 2007 | Unknown | Female | 30-34 | NA | NA |
| Chlamydia | 2007 | Unknown | Female | 35-39 | NA | NA |
| Chlamydia | 2007 | Unknown | Female | 40-44 | NA | NA |
| Chlamydia | 2007 | Unknown | Male | 0-14 | NA | NA |
| Chlamydia | 2007 | Unknown | Male | 15-19 | NA | NA |
| Chlamydia | 2007 | Unknown | Male | 20-24 | NA | NA |
| Chlamydia | 2007 | Unknown | Male | 25-29 | NA | NA |
| Chlamydia | 2007 | Unknown | Male | 30-34 | NA | NA |
| Chlamydia | 2007 | Unknown | Male | 35-39 | NA | NA |
| Chlamydia | 2007 | Unknown | Male | 40-44 | NA | NA |
| Chlamydia | 2007 | White | Female | 0-14 | NA | NA |
| Chlamydia | 2007 | White | Female | 15-19 | NA | NA |
| Chlamydia | 2007 | White | Female | 20-24 | NA | NA |
| Chlamydia | 2007 | White | Female | 25-29 | NA | NA |
| Chlamydia | 2007 | White | Female | 30-34 | NA | NA |
| Chlamydia | 2007 | White | Female | 35-39 | NA | NA |
| Chlamydia | 2007 | White | Female | 40-44 | NA | NA |
| Chlamydia | 2007 | White | Male | 0-14 | NA | NA |
| Chlamydia | 2007 | White | Male | 15-19 | NA | NA |
| Chlamydia | 2007 | White | Male | 20-24 | NA | NA |
| Chlamydia | 2007 | White | Male | 25-29 | NA | NA |
| Chlamydia | 2007 | White | Male | 30-34 | NA | NA |
| Chlamydia | 2007 | White | Male | 35-39 | NA | NA |
| Chlamydia | 2007 | White | Male | 40-44 | NA | NA |
| Chlamydia | 2008 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Chlamydia | 2008 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Chlamydia | 2008 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Chlamydia | 2008 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Chlamydia | 2008 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Chlamydia | 2008 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Chlamydia | 2008 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Chlamydia | 2008 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Chlamydia | 2008 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Chlamydia | 2008 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Chlamydia | 2008 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Chlamydia | 2008 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Chlamydia | 2008 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Chlamydia | 2008 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Chlamydia | 2008 | Asian | Female | 0-14 | NA | NA |
| Chlamydia | 2008 | Asian | Female | 15-19 | NA | NA |
| Chlamydia | 2008 | Asian | Female | 20-24 | NA | NA |
| Chlamydia | 2008 | Asian | Female | 25-29 | NA | NA |
| Chlamydia | 2008 | Asian | Female | 30-34 | NA | NA |
| Chlamydia | 2008 | Asian | Female | 35-39 | NA | NA |
| Chlamydia | 2008 | Asian | Female | 40-44 | NA | NA |
| Chlamydia | 2008 | Asian | Male | 0-14 | NA | NA |
| Chlamydia | 2008 | Asian | Male | 15-19 | NA | NA |
| Chlamydia | 2008 | Asian | Male | 20-24 | NA | NA |
| Chlamydia | 2008 | Asian | Male | 25-29 | NA | NA |
| Chlamydia | 2008 | Asian | Male | 30-34 | NA | NA |
| Chlamydia | 2008 | Asian | Male | 35-39 | NA | NA |
| Chlamydia | 2008 | Asian | Male | 40-44 | NA | NA |
| Chlamydia | 2008 | Black/African American | Female | 0-14 | NA | NA |
| Chlamydia | 2008 | Black/African American | Female | 15-19 | NA | NA |
| Chlamydia | 2008 | Black/African American | Female | 20-24 | NA | NA |
| Chlamydia | 2008 | Black/African American | Female | 25-29 | NA | NA |
| Chlamydia | 2008 | Black/African American | Female | 30-34 | NA | NA |
| Chlamydia | 2008 | Black/African American | Female | 35-39 | NA | NA |
| Chlamydia | 2008 | Black/African American | Female | 40-44 | NA | NA |
| Chlamydia | 2008 | Black/African American | Male | 0-14 | NA | NA |
| Chlamydia | 2008 | Black/African American | Male | 15-19 | NA | NA |
| Chlamydia | 2008 | Black/African American | Male | 20-24 | NA | NA |
| Chlamydia | 2008 | Black/African American | Male | 25-29 | NA | NA |
| Chlamydia | 2008 | Black/African American | Male | 30-34 | NA | NA |
| Chlamydia | 2008 | Black/African American | Male | 35-39 | NA | NA |
| Chlamydia | 2008 | Black/African American | Male | 40-44 | NA | NA |
| Chlamydia | 2008 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Chlamydia | 2008 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Chlamydia | 2008 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Chlamydia | 2008 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Chlamydia | 2008 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Chlamydia | 2008 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Chlamydia | 2008 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Chlamydia | 2008 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Chlamydia | 2008 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Chlamydia | 2008 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Chlamydia | 2008 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Chlamydia | 2008 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Chlamydia | 2008 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Chlamydia | 2008 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Chlamydia | 2008 | Multiple races | Female | 0-14 | NA | NA |
| Chlamydia | 2008 | Multiple races | Female | 15-19 | NA | NA |
| Chlamydia | 2008 | Multiple races | Female | 20-24 | NA | NA |
| Chlamydia | 2008 | Multiple races | Female | 25-29 | NA | NA |
| Chlamydia | 2008 | Multiple races | Female | 30-34 | NA | NA |
| Chlamydia | 2008 | Multiple races | Female | 35-39 | NA | NA |
| Chlamydia | 2008 | Multiple races | Female | 40-44 | NA | NA |
| Chlamydia | 2008 | Multiple races | Male | 0-14 | NA | NA |
| Chlamydia | 2008 | Multiple races | Male | 15-19 | NA | NA |
| Chlamydia | 2008 | Multiple races | Male | 20-24 | NA | NA |
| Chlamydia | 2008 | Multiple races | Male | 25-29 | NA | NA |
| Chlamydia | 2008 | Multiple races | Male | 30-34 | NA | NA |
| Chlamydia | 2008 | Multiple races | Male | 35-39 | NA | NA |
| Chlamydia | 2008 | Multiple races | Male | 40-44 | NA | NA |
| Chlamydia | 2008 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Chlamydia | 2008 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Chlamydia | 2008 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Chlamydia | 2008 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Chlamydia | 2008 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Chlamydia | 2008 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Chlamydia | 2008 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Chlamydia | 2008 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Chlamydia | 2008 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Chlamydia | 2008 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Chlamydia | 2008 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Chlamydia | 2008 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Chlamydia | 2008 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Chlamydia | 2008 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Chlamydia | 2008 | Unknown | Female | 0-14 | NA | NA |
| Chlamydia | 2008 | Unknown | Female | 15-19 | NA | NA |
| Chlamydia | 2008 | Unknown | Female | 20-24 | NA | NA |
| Chlamydia | 2008 | Unknown | Female | 25-29 | NA | NA |
| Chlamydia | 2008 | Unknown | Female | 30-34 | NA | NA |
| Chlamydia | 2008 | Unknown | Female | 35-39 | NA | NA |
| Chlamydia | 2008 | Unknown | Female | 40-44 | NA | NA |
| Chlamydia | 2008 | Unknown | Male | 0-14 | NA | NA |
| Chlamydia | 2008 | Unknown | Male | 15-19 | NA | NA |
| Chlamydia | 2008 | Unknown | Male | 20-24 | NA | NA |
| Chlamydia | 2008 | Unknown | Male | 25-29 | NA | NA |
| Chlamydia | 2008 | Unknown | Male | 30-34 | NA | NA |
| Chlamydia | 2008 | Unknown | Male | 35-39 | NA | NA |
| Chlamydia | 2008 | Unknown | Male | 40-44 | NA | NA |
| Chlamydia | 2008 | White | Female | 0-14 | NA | NA |
| Chlamydia | 2008 | White | Female | 15-19 | NA | NA |
| Chlamydia | 2008 | White | Female | 20-24 | NA | NA |
| Chlamydia | 2008 | White | Female | 25-29 | NA | NA |
| Chlamydia | 2008 | White | Female | 30-34 | NA | NA |
| Chlamydia | 2008 | White | Female | 35-39 | NA | NA |
| Chlamydia | 2008 | White | Female | 40-44 | NA | NA |
| Chlamydia | 2008 | White | Male | 0-14 | NA | NA |
| Chlamydia | 2008 | White | Male | 15-19 | NA | NA |
| Chlamydia | 2008 | White | Male | 20-24 | NA | NA |
| Chlamydia | 2008 | White | Male | 25-29 | NA | NA |
| Chlamydia | 2008 | White | Male | 30-34 | NA | NA |
| Chlamydia | 2008 | White | Male | 35-39 | NA | NA |
| Chlamydia | 2008 | White | Male | 40-44 | NA | NA |
| Chlamydia | 2009 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Chlamydia | 2009 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Chlamydia | 2009 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Chlamydia | 2009 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Chlamydia | 2009 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Chlamydia | 2009 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Chlamydia | 2009 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Chlamydia | 2009 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Chlamydia | 2009 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Chlamydia | 2009 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Chlamydia | 2009 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Chlamydia | 2009 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Chlamydia | 2009 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Chlamydia | 2009 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Chlamydia | 2009 | Asian | Female | 0-14 | NA | NA |
| Chlamydia | 2009 | Asian | Female | 15-19 | NA | NA |
| Chlamydia | 2009 | Asian | Female | 20-24 | NA | NA |
| Chlamydia | 2009 | Asian | Female | 25-29 | NA | NA |
| Chlamydia | 2009 | Asian | Female | 30-34 | NA | NA |
| Chlamydia | 2009 | Asian | Female | 35-39 | NA | NA |
| Chlamydia | 2009 | Asian | Female | 40-44 | NA | NA |
| Chlamydia | 2009 | Asian | Male | 0-14 | NA | NA |
| Chlamydia | 2009 | Asian | Male | 15-19 | NA | NA |
| Chlamydia | 2009 | Asian | Male | 20-24 | NA | NA |
| Chlamydia | 2009 | Asian | Male | 25-29 | NA | NA |
| Chlamydia | 2009 | Asian | Male | 30-34 | NA | NA |
| Chlamydia | 2009 | Asian | Male | 35-39 | NA | NA |
| Chlamydia | 2009 | Asian | Male | 40-44 | NA | NA |
| Chlamydia | 2009 | Black/African American | Female | 0-14 | NA | NA |
| Chlamydia | 2009 | Black/African American | Female | 15-19 | NA | NA |
| Chlamydia | 2009 | Black/African American | Female | 20-24 | NA | NA |
| Chlamydia | 2009 | Black/African American | Female | 25-29 | NA | NA |
| Chlamydia | 2009 | Black/African American | Female | 30-34 | NA | NA |
| Chlamydia | 2009 | Black/African American | Female | 35-39 | NA | NA |
| Chlamydia | 2009 | Black/African American | Female | 40-44 | NA | NA |
| Chlamydia | 2009 | Black/African American | Male | 0-14 | NA | NA |
| Chlamydia | 2009 | Black/African American | Male | 15-19 | NA | NA |
| Chlamydia | 2009 | Black/African American | Male | 20-24 | NA | NA |
| Chlamydia | 2009 | Black/African American | Male | 25-29 | NA | NA |
| Chlamydia | 2009 | Black/African American | Male | 30-34 | NA | NA |
| Chlamydia | 2009 | Black/African American | Male | 35-39 | NA | NA |
| Chlamydia | 2009 | Black/African American | Male | 40-44 | NA | NA |
| Chlamydia | 2009 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Chlamydia | 2009 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Chlamydia | 2009 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Chlamydia | 2009 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Chlamydia | 2009 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Chlamydia | 2009 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Chlamydia | 2009 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Chlamydia | 2009 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Chlamydia | 2009 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Chlamydia | 2009 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Chlamydia | 2009 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Chlamydia | 2009 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Chlamydia | 2009 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Chlamydia | 2009 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Chlamydia | 2009 | Multiple races | Female | 0-14 | NA | NA |
| Chlamydia | 2009 | Multiple races | Female | 15-19 | NA | NA |
| Chlamydia | 2009 | Multiple races | Female | 20-24 | NA | NA |
| Chlamydia | 2009 | Multiple races | Female | 25-29 | NA | NA |
| Chlamydia | 2009 | Multiple races | Female | 30-34 | NA | NA |
| Chlamydia | 2009 | Multiple races | Female | 35-39 | NA | NA |
| Chlamydia | 2009 | Multiple races | Female | 40-44 | NA | NA |
| Chlamydia | 2009 | Multiple races | Male | 0-14 | NA | NA |
| Chlamydia | 2009 | Multiple races | Male | 15-19 | NA | NA |
| Chlamydia | 2009 | Multiple races | Male | 20-24 | NA | NA |
| Chlamydia | 2009 | Multiple races | Male | 25-29 | NA | NA |
| Chlamydia | 2009 | Multiple races | Male | 30-34 | NA | NA |
| Chlamydia | 2009 | Multiple races | Male | 35-39 | NA | NA |
| Chlamydia | 2009 | Multiple races | Male | 40-44 | NA | NA |
| Chlamydia | 2009 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Chlamydia | 2009 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Chlamydia | 2009 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Chlamydia | 2009 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Chlamydia | 2009 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Chlamydia | 2009 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Chlamydia | 2009 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Chlamydia | 2009 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Chlamydia | 2009 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Chlamydia | 2009 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Chlamydia | 2009 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Chlamydia | 2009 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Chlamydia | 2009 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Chlamydia | 2009 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Chlamydia | 2009 | Unknown | Female | 0-14 | NA | NA |
| Chlamydia | 2009 | Unknown | Female | 15-19 | NA | NA |
| Chlamydia | 2009 | Unknown | Female | 20-24 | NA | NA |
| Chlamydia | 2009 | Unknown | Female | 25-29 | NA | NA |
| Chlamydia | 2009 | Unknown | Female | 30-34 | NA | NA |
| Chlamydia | 2009 | Unknown | Female | 35-39 | NA | NA |
| Chlamydia | 2009 | Unknown | Female | 40-44 | NA | NA |
| Chlamydia | 2009 | Unknown | Male | 0-14 | NA | NA |
| Chlamydia | 2009 | Unknown | Male | 15-19 | NA | NA |
| Chlamydia | 2009 | Unknown | Male | 20-24 | NA | NA |
| Chlamydia | 2009 | Unknown | Male | 25-29 | NA | NA |
| Chlamydia | 2009 | Unknown | Male | 30-34 | NA | NA |
| Chlamydia | 2009 | Unknown | Male | 35-39 | NA | NA |
| Chlamydia | 2009 | Unknown | Male | 40-44 | NA | NA |
| Chlamydia | 2009 | White | Female | 0-14 | NA | NA |
| Chlamydia | 2009 | White | Female | 15-19 | NA | NA |
| Chlamydia | 2009 | White | Female | 20-24 | NA | NA |
| Chlamydia | 2009 | White | Female | 25-29 | NA | NA |
| Chlamydia | 2009 | White | Female | 30-34 | NA | NA |
| Chlamydia | 2009 | White | Female | 35-39 | NA | NA |
| Chlamydia | 2009 | White | Female | 40-44 | NA | NA |
| Chlamydia | 2009 | White | Male | 0-14 | NA | NA |
| Chlamydia | 2009 | White | Male | 15-19 | NA | NA |
| Chlamydia | 2009 | White | Male | 20-24 | NA | NA |
| Chlamydia | 2009 | White | Male | 25-29 | NA | NA |
| Chlamydia | 2009 | White | Male | 30-34 | NA | NA |
| Chlamydia | 2009 | White | Male | 35-39 | NA | NA |
| Chlamydia | 2009 | White | Male | 40-44 | NA | NA |
| Chlamydia | 2010 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Chlamydia | 2010 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Chlamydia | 2010 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Chlamydia | 2010 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Chlamydia | 2010 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Chlamydia | 2010 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Chlamydia | 2010 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Chlamydia | 2010 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Chlamydia | 2010 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Chlamydia | 2010 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Chlamydia | 2010 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Chlamydia | 2010 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Chlamydia | 2010 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Chlamydia | 2010 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Chlamydia | 2010 | Asian | Female | 0-14 | NA | NA |
| Chlamydia | 2010 | Asian | Female | 15-19 | NA | NA |
| Chlamydia | 2010 | Asian | Female | 20-24 | NA | NA |
| Chlamydia | 2010 | Asian | Female | 25-29 | NA | NA |
| Chlamydia | 2010 | Asian | Female | 30-34 | NA | NA |
| Chlamydia | 2010 | Asian | Female | 35-39 | NA | NA |
| Chlamydia | 2010 | Asian | Female | 40-44 | NA | NA |
| Chlamydia | 2010 | Asian | Male | 0-14 | NA | NA |
| Chlamydia | 2010 | Asian | Male | 15-19 | NA | NA |
| Chlamydia | 2010 | Asian | Male | 20-24 | NA | NA |
| Chlamydia | 2010 | Asian | Male | 25-29 | NA | NA |
| Chlamydia | 2010 | Asian | Male | 30-34 | NA | NA |
| Chlamydia | 2010 | Asian | Male | 35-39 | NA | NA |
| Chlamydia | 2010 | Asian | Male | 40-44 | NA | NA |
| Chlamydia | 2010 | Black/African American | Female | 0-14 | NA | NA |
| Chlamydia | 2010 | Black/African American | Female | 15-19 | NA | NA |
| Chlamydia | 2010 | Black/African American | Female | 20-24 | NA | NA |
| Chlamydia | 2010 | Black/African American | Female | 25-29 | NA | NA |
| Chlamydia | 2010 | Black/African American | Female | 30-34 | NA | NA |
| Chlamydia | 2010 | Black/African American | Female | 35-39 | NA | NA |
| Chlamydia | 2010 | Black/African American | Female | 40-44 | NA | NA |
| Chlamydia | 2010 | Black/African American | Male | 0-14 | NA | NA |
| Chlamydia | 2010 | Black/African American | Male | 15-19 | NA | NA |
| Chlamydia | 2010 | Black/African American | Male | 20-24 | NA | NA |
| Chlamydia | 2010 | Black/African American | Male | 25-29 | NA | NA |
| Chlamydia | 2010 | Black/African American | Male | 30-34 | NA | NA |
| Chlamydia | 2010 | Black/African American | Male | 35-39 | NA | NA |
| Chlamydia | 2010 | Black/African American | Male | 40-44 | NA | NA |
| Chlamydia | 2010 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Chlamydia | 2010 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Chlamydia | 2010 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Chlamydia | 2010 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Chlamydia | 2010 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Chlamydia | 2010 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Chlamydia | 2010 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Chlamydia | 2010 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Chlamydia | 2010 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Chlamydia | 2010 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Chlamydia | 2010 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Chlamydia | 2010 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Chlamydia | 2010 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Chlamydia | 2010 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Chlamydia | 2010 | Multiple races | Female | 0-14 | NA | NA |
| Chlamydia | 2010 | Multiple races | Female | 15-19 | NA | NA |
| Chlamydia | 2010 | Multiple races | Female | 20-24 | NA | NA |
| Chlamydia | 2010 | Multiple races | Female | 25-29 | NA | NA |
| Chlamydia | 2010 | Multiple races | Female | 30-34 | NA | NA |
| Chlamydia | 2010 | Multiple races | Female | 35-39 | NA | NA |
| Chlamydia | 2010 | Multiple races | Female | 40-44 | NA | NA |
| Chlamydia | 2010 | Multiple races | Male | 0-14 | NA | NA |
| Chlamydia | 2010 | Multiple races | Male | 15-19 | NA | NA |
| Chlamydia | 2010 | Multiple races | Male | 20-24 | NA | NA |
| Chlamydia | 2010 | Multiple races | Male | 25-29 | NA | NA |
| Chlamydia | 2010 | Multiple races | Male | 30-34 | NA | NA |
| Chlamydia | 2010 | Multiple races | Male | 35-39 | NA | NA |
| Chlamydia | 2010 | Multiple races | Male | 40-44 | NA | NA |
| Chlamydia | 2010 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Chlamydia | 2010 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Chlamydia | 2010 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Chlamydia | 2010 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Chlamydia | 2010 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Chlamydia | 2010 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Chlamydia | 2010 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Chlamydia | 2010 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Chlamydia | 2010 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Chlamydia | 2010 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Chlamydia | 2010 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Chlamydia | 2010 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Chlamydia | 2010 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Chlamydia | 2010 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Chlamydia | 2010 | Unknown | Female | 0-14 | NA | NA |
| Chlamydia | 2010 | Unknown | Female | 15-19 | NA | NA |
| Chlamydia | 2010 | Unknown | Female | 20-24 | NA | NA |
| Chlamydia | 2010 | Unknown | Female | 25-29 | NA | NA |
| Chlamydia | 2010 | Unknown | Female | 30-34 | NA | NA |
| Chlamydia | 2010 | Unknown | Female | 35-39 | NA | NA |
| Chlamydia | 2010 | Unknown | Female | 40-44 | NA | NA |
| Chlamydia | 2010 | Unknown | Male | 0-14 | NA | NA |
| Chlamydia | 2010 | Unknown | Male | 15-19 | NA | NA |
| Chlamydia | 2010 | Unknown | Male | 20-24 | NA | NA |
| Chlamydia | 2010 | Unknown | Male | 25-29 | NA | NA |
| Chlamydia | 2010 | Unknown | Male | 30-34 | NA | NA |
| Chlamydia | 2010 | Unknown | Male | 35-39 | NA | NA |
| Chlamydia | 2010 | Unknown | Male | 40-44 | NA | NA |
| Chlamydia | 2010 | White | Female | 0-14 | NA | NA |
| Chlamydia | 2010 | White | Female | 15-19 | NA | NA |
| Chlamydia | 2010 | White | Female | 20-24 | NA | NA |
| Chlamydia | 2010 | White | Female | 25-29 | NA | NA |
| Chlamydia | 2010 | White | Female | 30-34 | NA | NA |
| Chlamydia | 2010 | White | Female | 35-39 | NA | NA |
| Chlamydia | 2010 | White | Female | 40-44 | NA | NA |
| Chlamydia | 2010 | White | Male | 0-14 | NA | NA |
| Chlamydia | 2010 | White | Male | 15-19 | NA | NA |
| Chlamydia | 2010 | White | Male | 20-24 | NA | NA |
| Chlamydia | 2010 | White | Male | 25-29 | NA | NA |
| Chlamydia | 2010 | White | Male | 30-34 | NA | NA |
| Chlamydia | 2010 | White | Male | 35-39 | NA | NA |
| Chlamydia | 2010 | White | Male | 40-44 | NA | NA |
| Chlamydia | 2011 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Chlamydia | 2011 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Chlamydia | 2011 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Chlamydia | 2011 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Chlamydia | 2011 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Chlamydia | 2011 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Chlamydia | 2011 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Chlamydia | 2011 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Chlamydia | 2011 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Chlamydia | 2011 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Chlamydia | 2011 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Chlamydia | 2011 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Chlamydia | 2011 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Chlamydia | 2011 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Chlamydia | 2011 | Asian | Female | 0-14 | NA | NA |
| Chlamydia | 2011 | Asian | Female | 15-19 | NA | NA |
| Chlamydia | 2011 | Asian | Female | 20-24 | NA | NA |
| Chlamydia | 2011 | Asian | Female | 25-29 | NA | NA |
| Chlamydia | 2011 | Asian | Female | 30-34 | NA | NA |
| Chlamydia | 2011 | Asian | Female | 35-39 | NA | NA |
| Chlamydia | 2011 | Asian | Female | 40-44 | NA | NA |
| Chlamydia | 2011 | Asian | Male | 0-14 | NA | NA |
| Chlamydia | 2011 | Asian | Male | 15-19 | NA | NA |
| Chlamydia | 2011 | Asian | Male | 20-24 | NA | NA |
| Chlamydia | 2011 | Asian | Male | 25-29 | NA | NA |
| Chlamydia | 2011 | Asian | Male | 30-34 | NA | NA |
| Chlamydia | 2011 | Asian | Male | 35-39 | NA | NA |
| Chlamydia | 2011 | Asian | Male | 40-44 | NA | NA |
| Chlamydia | 2011 | Black/African American | Female | 0-14 | NA | NA |
| Chlamydia | 2011 | Black/African American | Female | 15-19 | NA | NA |
| Chlamydia | 2011 | Black/African American | Female | 20-24 | NA | NA |
| Chlamydia | 2011 | Black/African American | Female | 25-29 | NA | NA |
| Chlamydia | 2011 | Black/African American | Female | 30-34 | NA | NA |
| Chlamydia | 2011 | Black/African American | Female | 35-39 | NA | NA |
| Chlamydia | 2011 | Black/African American | Female | 40-44 | NA | NA |
| Chlamydia | 2011 | Black/African American | Male | 0-14 | NA | NA |
| Chlamydia | 2011 | Black/African American | Male | 15-19 | NA | NA |
| Chlamydia | 2011 | Black/African American | Male | 20-24 | NA | NA |
| Chlamydia | 2011 | Black/African American | Male | 25-29 | NA | NA |
| Chlamydia | 2011 | Black/African American | Male | 30-34 | NA | NA |
| Chlamydia | 2011 | Black/African American | Male | 35-39 | NA | NA |
| Chlamydia | 2011 | Black/African American | Male | 40-44 | NA | NA |
| Chlamydia | 2011 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Chlamydia | 2011 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Chlamydia | 2011 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Chlamydia | 2011 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Chlamydia | 2011 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Chlamydia | 2011 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Chlamydia | 2011 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Chlamydia | 2011 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Chlamydia | 2011 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Chlamydia | 2011 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Chlamydia | 2011 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Chlamydia | 2011 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Chlamydia | 2011 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Chlamydia | 2011 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Chlamydia | 2011 | Multiple races | Female | 0-14 | NA | NA |
| Chlamydia | 2011 | Multiple races | Female | 15-19 | NA | NA |
| Chlamydia | 2011 | Multiple races | Female | 20-24 | NA | NA |
| Chlamydia | 2011 | Multiple races | Female | 25-29 | NA | NA |
| Chlamydia | 2011 | Multiple races | Female | 30-34 | NA | NA |
| Chlamydia | 2011 | Multiple races | Female | 35-39 | NA | NA |
| Chlamydia | 2011 | Multiple races | Female | 40-44 | NA | NA |
| Chlamydia | 2011 | Multiple races | Male | 0-14 | NA | NA |
| Chlamydia | 2011 | Multiple races | Male | 15-19 | NA | NA |
| Chlamydia | 2011 | Multiple races | Male | 20-24 | NA | NA |
| Chlamydia | 2011 | Multiple races | Male | 25-29 | NA | NA |
| Chlamydia | 2011 | Multiple races | Male | 30-34 | NA | NA |
| Chlamydia | 2011 | Multiple races | Male | 35-39 | NA | NA |
| Chlamydia | 2011 | Multiple races | Male | 40-44 | NA | NA |
| Chlamydia | 2011 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Chlamydia | 2011 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Chlamydia | 2011 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Chlamydia | 2011 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Chlamydia | 2011 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Chlamydia | 2011 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Chlamydia | 2011 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Chlamydia | 2011 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Chlamydia | 2011 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Chlamydia | 2011 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Chlamydia | 2011 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Chlamydia | 2011 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Chlamydia | 2011 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Chlamydia | 2011 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Chlamydia | 2011 | Unknown | Female | 0-14 | NA | NA |
| Chlamydia | 2011 | Unknown | Female | 15-19 | NA | NA |
| Chlamydia | 2011 | Unknown | Female | 20-24 | NA | NA |
| Chlamydia | 2011 | Unknown | Female | 25-29 | NA | NA |
| Chlamydia | 2011 | Unknown | Female | 30-34 | NA | NA |
| Chlamydia | 2011 | Unknown | Female | 35-39 | NA | NA |
| Chlamydia | 2011 | Unknown | Female | 40-44 | NA | NA |
| Chlamydia | 2011 | Unknown | Male | 0-14 | NA | NA |
| Chlamydia | 2011 | Unknown | Male | 15-19 | NA | NA |
| Chlamydia | 2011 | Unknown | Male | 20-24 | NA | NA |
| Chlamydia | 2011 | Unknown | Male | 25-29 | NA | NA |
| Chlamydia | 2011 | Unknown | Male | 30-34 | NA | NA |
| Chlamydia | 2011 | Unknown | Male | 35-39 | NA | NA |
| Chlamydia | 2011 | Unknown | Male | 40-44 | NA | NA |
| Chlamydia | 2011 | White | Female | 0-14 | NA | NA |
| Chlamydia | 2011 | White | Female | 15-19 | NA | NA |
| Chlamydia | 2011 | White | Female | 20-24 | NA | NA |
| Chlamydia | 2011 | White | Female | 25-29 | NA | NA |
| Chlamydia | 2011 | White | Female | 30-34 | NA | NA |
| Chlamydia | 2011 | White | Female | 35-39 | NA | NA |
| Chlamydia | 2011 | White | Female | 40-44 | NA | NA |
| Chlamydia | 2011 | White | Male | 0-14 | NA | NA |
| Chlamydia | 2011 | White | Male | 15-19 | NA | NA |
| Chlamydia | 2011 | White | Male | 20-24 | NA | NA |
| Chlamydia | 2011 | White | Male | 25-29 | NA | NA |
| Chlamydia | 2011 | White | Male | 30-34 | NA | NA |
| Chlamydia | 2011 | White | Male | 35-39 | NA | NA |
| Chlamydia | 2011 | White | Male | 40-44 | NA | NA |
| Chlamydia | 2012 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Chlamydia | 2012 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Chlamydia | 2012 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Chlamydia | 2012 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Chlamydia | 2012 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Chlamydia | 2012 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Chlamydia | 2012 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Chlamydia | 2012 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Chlamydia | 2012 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Chlamydia | 2012 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Chlamydia | 2012 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Chlamydia | 2012 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Chlamydia | 2012 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Chlamydia | 2012 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Chlamydia | 2012 | Asian | Female | 0-14 | NA | NA |
| Chlamydia | 2012 | Asian | Female | 15-19 | NA | NA |
| Chlamydia | 2012 | Asian | Female | 20-24 | NA | NA |
| Chlamydia | 2012 | Asian | Female | 25-29 | NA | NA |
| Chlamydia | 2012 | Asian | Female | 30-34 | NA | NA |
| Chlamydia | 2012 | Asian | Female | 35-39 | NA | NA |
| Chlamydia | 2012 | Asian | Female | 40-44 | NA | NA |
| Chlamydia | 2012 | Asian | Male | 0-14 | NA | NA |
| Chlamydia | 2012 | Asian | Male | 15-19 | NA | NA |
| Chlamydia | 2012 | Asian | Male | 20-24 | NA | NA |
| Chlamydia | 2012 | Asian | Male | 25-29 | NA | NA |
| Chlamydia | 2012 | Asian | Male | 30-34 | NA | NA |
| Chlamydia | 2012 | Asian | Male | 35-39 | NA | NA |
| Chlamydia | 2012 | Asian | Male | 40-44 | NA | NA |
| Chlamydia | 2012 | Black/African American | Female | 0-14 | NA | NA |
| Chlamydia | 2012 | Black/African American | Female | 15-19 | NA | NA |
| Chlamydia | 2012 | Black/African American | Female | 20-24 | NA | NA |
| Chlamydia | 2012 | Black/African American | Female | 25-29 | NA | NA |
| Chlamydia | 2012 | Black/African American | Female | 30-34 | NA | NA |
| Chlamydia | 2012 | Black/African American | Female | 35-39 | NA | NA |
| Chlamydia | 2012 | Black/African American | Female | 40-44 | NA | NA |
| Chlamydia | 2012 | Black/African American | Male | 0-14 | NA | NA |
| Chlamydia | 2012 | Black/African American | Male | 15-19 | NA | NA |
| Chlamydia | 2012 | Black/African American | Male | 20-24 | NA | NA |
| Chlamydia | 2012 | Black/African American | Male | 25-29 | NA | NA |
| Chlamydia | 2012 | Black/African American | Male | 30-34 | NA | NA |
| Chlamydia | 2012 | Black/African American | Male | 35-39 | NA | NA |
| Chlamydia | 2012 | Black/African American | Male | 40-44 | NA | NA |
| Chlamydia | 2012 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Chlamydia | 2012 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Chlamydia | 2012 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Chlamydia | 2012 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Chlamydia | 2012 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Chlamydia | 2012 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Chlamydia | 2012 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Chlamydia | 2012 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Chlamydia | 2012 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Chlamydia | 2012 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Chlamydia | 2012 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Chlamydia | 2012 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Chlamydia | 2012 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Chlamydia | 2012 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Chlamydia | 2012 | Multiple races | Female | 0-14 | NA | NA |
| Chlamydia | 2012 | Multiple races | Female | 15-19 | NA | NA |
| Chlamydia | 2012 | Multiple races | Female | 20-24 | NA | NA |
| Chlamydia | 2012 | Multiple races | Female | 25-29 | NA | NA |
| Chlamydia | 2012 | Multiple races | Female | 30-34 | NA | NA |
| Chlamydia | 2012 | Multiple races | Female | 35-39 | NA | NA |
| Chlamydia | 2012 | Multiple races | Female | 40-44 | NA | NA |
| Chlamydia | 2012 | Multiple races | Male | 0-14 | NA | NA |
| Chlamydia | 2012 | Multiple races | Male | 15-19 | NA | NA |
| Chlamydia | 2012 | Multiple races | Male | 20-24 | NA | NA |
| Chlamydia | 2012 | Multiple races | Male | 25-29 | NA | NA |
| Chlamydia | 2012 | Multiple races | Male | 30-34 | NA | NA |
| Chlamydia | 2012 | Multiple races | Male | 35-39 | NA | NA |
| Chlamydia | 2012 | Multiple races | Male | 40-44 | NA | NA |
| Chlamydia | 2012 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Chlamydia | 2012 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Chlamydia | 2012 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Chlamydia | 2012 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Chlamydia | 2012 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Chlamydia | 2012 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Chlamydia | 2012 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Chlamydia | 2012 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Chlamydia | 2012 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Chlamydia | 2012 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Chlamydia | 2012 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Chlamydia | 2012 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Chlamydia | 2012 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Chlamydia | 2012 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Chlamydia | 2012 | Unknown | Female | 0-14 | NA | NA |
| Chlamydia | 2012 | Unknown | Female | 15-19 | NA | NA |
| Chlamydia | 2012 | Unknown | Female | 20-24 | NA | NA |
| Chlamydia | 2012 | Unknown | Female | 25-29 | NA | NA |
| Chlamydia | 2012 | Unknown | Female | 30-34 | NA | NA |
| Chlamydia | 2012 | Unknown | Female | 35-39 | NA | NA |
| Chlamydia | 2012 | Unknown | Female | 40-44 | NA | NA |
| Chlamydia | 2012 | Unknown | Male | 0-14 | NA | NA |
| Chlamydia | 2012 | Unknown | Male | 15-19 | NA | NA |
| Chlamydia | 2012 | Unknown | Male | 20-24 | NA | NA |
| Chlamydia | 2012 | Unknown | Male | 25-29 | NA | NA |
| Chlamydia | 2012 | Unknown | Male | 30-34 | NA | NA |
| Chlamydia | 2012 | Unknown | Male | 35-39 | NA | NA |
| Chlamydia | 2012 | Unknown | Male | 40-44 | NA | NA |
| Chlamydia | 2012 | White | Female | 0-14 | NA | NA |
| Chlamydia | 2012 | White | Female | 15-19 | NA | NA |
| Chlamydia | 2012 | White | Female | 20-24 | NA | NA |
| Chlamydia | 2012 | White | Female | 25-29 | NA | NA |
| Chlamydia | 2012 | White | Female | 30-34 | NA | NA |
| Chlamydia | 2012 | White | Female | 35-39 | NA | NA |
| Chlamydia | 2012 | White | Female | 40-44 | NA | NA |
| Chlamydia | 2012 | White | Male | 0-14 | NA | NA |
| Chlamydia | 2012 | White | Male | 15-19 | NA | NA |
| Chlamydia | 2012 | White | Male | 20-24 | NA | NA |
| Chlamydia | 2012 | White | Male | 25-29 | NA | NA |
| Chlamydia | 2012 | White | Male | 30-34 | NA | NA |
| Chlamydia | 2012 | White | Male | 35-39 | NA | NA |
| Chlamydia | 2012 | White | Male | 40-44 | NA | NA |
| Chlamydia | 2013 | American Indian/Alaska Native | Female | 0-14 | 207 | 79.8 |
| Chlamydia | 2013 | American Indian/Alaska Native | Female | 15-19 | 3878 | 4282.9 |
| Chlamydia | 2013 | American Indian/Alaska Native | Female | 20-24 | 4964 | 5061.9 |
| Chlamydia | 2013 | American Indian/Alaska Native | Female | 25-29 | 2528 | 2971.7 |
| Chlamydia | 2013 | American Indian/Alaska Native | Female | 30-34 | 1145 | 1439.6 |
| Chlamydia | 2013 | American Indian/Alaska Native | Female | 35-39 | 483 | 668.8 |
| Chlamydia | 2013 | American Indian/Alaska Native | Female | 40-44 | 236 | 315 |
| Chlamydia | 2013 | American Indian/Alaska Native | Male | 0-14 | 18 | 6.7 |
| Chlamydia | 2013 | American Indian/Alaska Native | Male | 15-19 | 865 | 918.8 |
| Chlamydia | 2013 | American Indian/Alaska Native | Male | 20-24 | 1386 | 1346.2 |
| Chlamydia | 2013 | American Indian/Alaska Native | Male | 25-29 | 793 | 915.8 |
| Chlamydia | 2013 | American Indian/Alaska Native | Male | 30-34 | 411 | 519.9 |
| Chlamydia | 2013 | American Indian/Alaska Native | Male | 35-39 | 158 | 223.4 |
| Chlamydia | 2013 | American Indian/Alaska Native | Male | 40-44 | 93 | 127.9 |
| Chlamydia | 2013 | Asian | Female | 0-14 | 53 | 3.8 |
| Chlamydia | 2013 | Asian | Female | 15-19 | 2133 | 440.8 |
| Chlamydia | 2013 | Asian | Female | 20-24 | 4586 | 764.7 |
| Chlamydia | 2013 | Asian | Female | 25-29 | 2415 | 347.5 |
| Chlamydia | 2013 | Asian | Female | 30-34 | 1147 | 154.4 |
| Chlamydia | 2013 | Asian | Female | 35-39 | 585 | 82 |
| Chlamydia | 2013 | Asian | Female | 40-44 | 324 | 45.5 |
| Chlamydia | 2013 | Asian | Male | 0-14 | 5 | 0.3 |
| Chlamydia | 2013 | Asian | Male | 15-19 | 330 | 66.2 |
| Chlamydia | 2013 | Asian | Male | 20-24 | 1342 | 216.4 |
| Chlamydia | 2013 | Asian | Male | 25-29 | 1096 | 167.2 |
| Chlamydia | 2013 | Asian | Male | 30-34 | 674 | 103.2 |
| Chlamydia | 2013 | Asian | Male | 35-39 | 379 | 60.4 |
| Chlamydia | 2013 | Asian | Male | 40-44 | 247 | 39.5 |
| Chlamydia | 2013 | Black/African American | Female | 0-14 | 4664 | 112.6 |
| Chlamydia | 2013 | Black/African American | Female | 15-19 | 104637 | 6943.5 |
| Chlamydia | 2013 | Black/African American | Female | 20-24 | 117928 | 6961.9 |
| Chlamydia | 2013 | Black/African American | Female | 25-29 | 39684 | 2718.6 |
| Chlamydia | 2013 | Black/African American | Female | 30-34 | 14880 | 1041.8 |
| Chlamydia | 2013 | Black/African American | Female | 35-39 | 5661 | 431.7 |
| Chlamydia | 2013 | Black/African American | Female | 40-44 | 2341 | 169.1 |
| Chlamydia | 2013 | Black/African American | Male | 0-14 | 888 | 20.8 |
| Chlamydia | 2013 | Black/African American | Male | 15-19 | 33559 | 2156.6 |
| Chlamydia | 2013 | Black/African American | Male | 20-24 | 53669 | 3116.2 |
| Chlamydia | 2013 | Black/African American | Male | 25-29 | 26066 | 1865.4 |
| Chlamydia | 2013 | Black/African American | Male | 30-34 | 12546 | 961 |
| Chlamydia | 2013 | Black/African American | Male | 35-39 | 6139 | 523.7 |
| Chlamydia | 2013 | Black/African American | Male | 40-44 | 3493 | 283.7 |
| Chlamydia | 2013 | Hispanic/Latino | Female | 0-14 | 1412 | 19.2 |
| Chlamydia | 2013 | Hispanic/Latino | Female | 15-19 | 42405 | 1894.3 |
| Chlamydia | 2013 | Hispanic/Latino | Female | 20-24 | 56665 | 2546 |
| Chlamydia | 2013 | Hispanic/Latino | Female | 25-29 | 24222 | 1171 |
| Chlamydia | 2013 | Hispanic/Latino | Female | 30-34 | 10935 | 521.6 |
| Chlamydia | 2013 | Hispanic/Latino | Female | 35-39 | 5148 | 260 |
| Chlamydia | 2013 | Hispanic/Latino | Female | 40-44 | 2253 | 121.7 |
| Chlamydia | 2013 | Hispanic/Latino | Male | 0-14 | 202 | 2.6 |
| Chlamydia | 2013 | Hispanic/Latino | Male | 15-19 | 9418 | 400 |
| Chlamydia | 2013 | Hispanic/Latino | Male | 20-24 | 19319 | 791.3 |
| Chlamydia | 2013 | Hispanic/Latino | Male | 25-29 | 11671 | 503.1 |
| Chlamydia | 2013 | Hispanic/Latino | Male | 30-34 | 5938 | 260.3 |
| Chlamydia | 2013 | Hispanic/Latino | Male | 35-39 | 2890 | 138.9 |
| Chlamydia | 2013 | Hispanic/Latino | Male | 40-44 | 1533 | 80.3 |
| Chlamydia | 2013 | Multiple races | Female | 0-14 | 78 | 6.3 |
| Chlamydia | 2013 | Multiple races | Female | 15-19 | 1771 | 554.8 |
| Chlamydia | 2013 | Multiple races | Female | 20-24 | 1810 | 654.1 |
| Chlamydia | 2013 | Multiple races | Female | 25-29 | 607 | 279.7 |
| Chlamydia | 2013 | Multiple races | Female | 30-34 | 218 | 113.6 |
| Chlamydia | 2013 | Multiple races | Female | 35-39 | 68 | 43.3 |
| Chlamydia | 2013 | Multiple races | Female | 40-44 | 27 | 18.7 |
| Chlamydia | 2013 | Multiple races | Male | 0-14 | 6 | 0.5 |
| Chlamydia | 2013 | Multiple races | Male | 15-19 | 349 | 107.4 |
| Chlamydia | 2013 | Multiple races | Male | 20-24 | 687 | 256.3 |
| Chlamydia | 2013 | Multiple races | Male | 25-29 | 340 | 173.2 |
| Chlamydia | 2013 | Multiple races | Male | 30-34 | 160 | 93.5 |
| Chlamydia | 2013 | Multiple races | Male | 35-39 | 65 | 46.7 |
| Chlamydia | 2013 | Multiple races | Male | 40-44 | 39 | 30.2 |
| Chlamydia | 2013 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | 22 | 38 |
| Chlamydia | 2013 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | 605 | 3091.2 |
| Chlamydia | 2013 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | 1004 | 4304 |
| Chlamydia | 2013 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | 503 | 2125.1 |
| Chlamydia | 2013 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | 207 | 923.9 |
| Chlamydia | 2013 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | 68 | 357.3 |
| Chlamydia | 2013 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | 30 | 166.3 |
| Chlamydia | 2013 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | 1 | 1.7 |
| Chlamydia | 2013 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | 97 | 470.8 |
| Chlamydia | 2013 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | 263 | 1057.5 |
| Chlamydia | 2013 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | 184 | 731.2 |
| Chlamydia | 2013 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | 91 | 386.3 |
| Chlamydia | 2013 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | 36 | 181.2 |
| Chlamydia | 2013 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | 30 | 164.4 |
| Chlamydia | 2013 | Unknown | Female | 0-14 | 3100 | NA |
| Chlamydia | 2013 | Unknown | Female | 15-19 | 83871 | NA |
| Chlamydia | 2013 | Unknown | Female | 20-24 | 104540 | NA |
| Chlamydia | 2013 | Unknown | Female | 25-29 | 41587 | NA |
| Chlamydia | 2013 | Unknown | Female | 30-34 | 18675 | NA |
| Chlamydia | 2013 | Unknown | Female | 35-39 | 8846 | NA |
| Chlamydia | 2013 | Unknown | Female | 40-44 | 4505 | NA |
| Chlamydia | 2013 | Unknown | Male | 0-14 | 556 | NA |
| Chlamydia | 2013 | Unknown | Male | 15-19 | 20667 | NA |
| Chlamydia | 2013 | Unknown | Male | 20-24 | 38627 | NA |
| Chlamydia | 2013 | Unknown | Male | 25-29 | 21029 | NA |
| Chlamydia | 2013 | Unknown | Male | 30-34 | 11202 | NA |
| Chlamydia | 2013 | Unknown | Male | 35-39 | 5822 | NA |
| Chlamydia | 2013 | Unknown | Male | 40-44 | 3728 | NA |
| Chlamydia | 2013 | White | Female | 0-14 | 1990 | 12.9 |
| Chlamydia | 2013 | White | Female | 15-19 | 77138 | 1359.5 |
| Chlamydia | 2013 | White | Female | 20-24 | 108048 | 1737.6 |
| Chlamydia | 2013 | White | Female | 25-29 | 39187 | 643.1 |
| Chlamydia | 2013 | White | Female | 30-34 | 15207 | 251.4 |
| Chlamydia | 2013 | White | Female | 35-39 | 5861 | 104.8 |
| Chlamydia | 2013 | White | Female | 40-44 | 2785 | 44 |
| Chlamydia | 2013 | White | Male | 0-14 | 164 | 1 |
| Chlamydia | 2013 | White | Male | 15-19 | 13119 | 218.6 |
| Chlamydia | 2013 | White | Male | 20-24 | 37809 | 581.3 |
| Chlamydia | 2013 | White | Male | 25-29 | 21011 | 335.6 |
| Chlamydia | 2013 | White | Male | 30-34 | 9995 | 162.2 |
| Chlamydia | 2013 | White | Male | 35-39 | 4668 | 82.3 |
| Chlamydia | 2013 | White | Male | 40-44 | 3037 | 47.6 |
| Chlamydia | 2014 | American Indian/Alaska Native | Female | 0-14 | 178 | 68.90000000000001 |
| Chlamydia | 2014 | American Indian/Alaska Native | Female | 15-19 | 3634 | 4060.2 |
| Chlamydia | 2014 | American Indian/Alaska Native | Female | 20-24 | 4819 | 4893.3 |
| Chlamydia | 2014 | American Indian/Alaska Native | Female | 25-29 | 2497 | 2863.7 |
| Chlamydia | 2014 | American Indian/Alaska Native | Female | 30-34 | 1241 | 1531.8 |
| Chlamydia | 2014 | American Indian/Alaska Native | Female | 35-39 | 508 | 698.3 |
| Chlamydia | 2014 | American Indian/Alaska Native | Female | 40-44 | 247 | 333.6 |
| Chlamydia | 2014 | American Indian/Alaska Native | Male | 0-14 | 25 | 9.4 |
| Chlamydia | 2014 | American Indian/Alaska Native | Male | 15-19 | 776 | 836.6 |
| Chlamydia | 2014 | American Indian/Alaska Native | Male | 20-24 | 1390 | 1343.9 |
| Chlamydia | 2014 | American Indian/Alaska Native | Male | 25-29 | 810 | 904.6 |
| Chlamydia | 2014 | American Indian/Alaska Native | Male | 30-34 | 417 | 519.9 |
| Chlamydia | 2014 | American Indian/Alaska Native | Male | 35-39 | 229 | 318.6 |
| Chlamydia | 2014 | American Indian/Alaska Native | Male | 40-44 | 119 | 166.4 |
| Chlamydia | 2014 | Asian | Female | 0-14 | 54 | 3.8 |
| Chlamydia | 2014 | Asian | Female | 15-19 | 2076 | 420.2 |
| Chlamydia | 2014 | Asian | Female | 20-24 | 4654 | 766.8 |
| Chlamydia | 2014 | Asian | Female | 25-29 | 2610 | 361.5 |
| Chlamydia | 2014 | Asian | Female | 30-34 | 1328 | 172.8 |
| Chlamydia | 2014 | Asian | Female | 35-39 | 658 | 90.3 |
| Chlamydia | 2014 | Asian | Female | 40-44 | 357 | 48.8 |
| Chlamydia | 2014 | Asian | Male | 0-14 | 3 | 0.2 |
| Chlamydia | 2014 | Asian | Male | 15-19 | 342 | 67.7 |
| Chlamydia | 2014 | Asian | Male | 20-24 | 1451 | 230.4 |
| Chlamydia | 2014 | Asian | Male | 25-29 | 1273 | 185.5 |
| Chlamydia | 2014 | Asian | Male | 30-34 | 773 | 113.1 |
| Chlamydia | 2014 | Asian | Male | 35-39 | 410 | 64.2 |
| Chlamydia | 2014 | Asian | Male | 40-44 | 314 | 48.9 |
| Chlamydia | 2014 | Black/African American | Female | 0-14 | 4268 | 103.1 |
| Chlamydia | 2014 | Black/African American | Female | 15-19 | 98467 | 6664.6 |
| Chlamydia | 2014 | Black/African American | Female | 20-24 | 117916 | 6935.4 |
| Chlamydia | 2014 | Black/African American | Female | 25-29 | 42498 | 2810.9 |
| Chlamydia | 2014 | Black/African American | Female | 30-34 | 15595 | 1086.3 |
| Chlamydia | 2014 | Black/African American | Female | 35-39 | 6080 | 455.2 |
| Chlamydia | 2014 | Black/African American | Female | 40-44 | 2420 | 176.1 |
| Chlamydia | 2014 | Black/African American | Male | 0-14 | 750 | 17.6 |
| Chlamydia | 2014 | Black/African American | Male | 15-19 | 32061 | 2103.8 |
| Chlamydia | 2014 | Black/African American | Male | 20-24 | 53846 | 3089.3 |
| Chlamydia | 2014 | Black/African American | Male | 25-29 | 28095 | 1920.4 |
| Chlamydia | 2014 | Black/African American | Male | 30-34 | 13130 | 994.6 |
| Chlamydia | 2014 | Black/African American | Male | 35-39 | 6476 | 540.7 |
| Chlamydia | 2014 | Black/African American | Male | 40-44 | 3581 | 293.7 |
| Chlamydia | 2014 | Hispanic/Latino | Female | 0-14 | 1336 | 17.9 |
| Chlamydia | 2014 | Hispanic/Latino | Female | 15-19 | 40243 | 1778.2 |
| Chlamydia | 2014 | Hispanic/Latino | Female | 20-24 | 56752 | 2489.4 |
| Chlamydia | 2014 | Hispanic/Latino | Female | 25-29 | 25216 | 1202.1 |
| Chlamydia | 2014 | Hispanic/Latino | Female | 30-34 | 11716 | 552.6 |
| Chlamydia | 2014 | Hispanic/Latino | Female | 35-39 | 5513 | 274.6 |
| Chlamydia | 2014 | Hispanic/Latino | Female | 40-44 | 2520 | 132.9 |
| Chlamydia | 2014 | Hispanic/Latino | Male | 0-14 | 161 | 2.1 |
| Chlamydia | 2014 | Hispanic/Latino | Male | 15-19 | 9230 | 389.2 |
| Chlamydia | 2014 | Hispanic/Latino | Male | 20-24 | 19372 | 781.9 |
| Chlamydia | 2014 | Hispanic/Latino | Male | 25-29 | 12724 | 541.4 |
| Chlamydia | 2014 | Hispanic/Latino | Male | 30-34 | 6732 | 290.9 |
| Chlamydia | 2014 | Hispanic/Latino | Male | 35-39 | 3406 | 160.8 |
| Chlamydia | 2014 | Hispanic/Latino | Male | 40-44 | 1888 | 96.90000000000001 |
| Chlamydia | 2014 | Multiple races | Female | 0-14 | 71 | 5.6 |
| Chlamydia | 2014 | Multiple races | Female | 15-19 | 1914 | 584.5 |
| Chlamydia | 2014 | Multiple races | Female | 20-24 | 2012 | 695.7 |
| Chlamydia | 2014 | Multiple races | Female | 25-29 | 732 | 322.1 |
| Chlamydia | 2014 | Multiple races | Female | 30-34 | 231 | 116.9 |
| Chlamydia | 2014 | Multiple races | Female | 35-39 | 77 | 47.1 |
| Chlamydia | 2014 | Multiple races | Female | 40-44 | 29 | 19.8 |
| Chlamydia | 2014 | Multiple races | Male | 0-14 | 5 | 0.4 |
| Chlamydia | 2014 | Multiple races | Male | 15-19 | 378 | 112.6 |
| Chlamydia | 2014 | Multiple races | Male | 20-24 | 742 | 260.9 |
| Chlamydia | 2014 | Multiple races | Male | 25-29 | 494 | 237.9 |
| Chlamydia | 2014 | Multiple races | Male | 30-34 | 285 | 161.8 |
| Chlamydia | 2014 | Multiple races | Male | 35-39 | 150 | 103.4 |
| Chlamydia | 2014 | Multiple races | Male | 40-44 | 99 | 75.8 |
| Chlamydia | 2014 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | 13 | 22.2 |
| Chlamydia | 2014 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | 604 | 3126.1 |
| Chlamydia | 2014 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | 980 | 4243.9 |
| Chlamydia | 2014 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | 464 | 1924 |
| Chlamydia | 2014 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | 226 | 979.1 |
| Chlamydia | 2014 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | 103 | 524.5 |
| Chlamydia | 2014 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | 29 | 158.6 |
| Chlamydia | 2014 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | 1 | 1.6 |
| Chlamydia | 2014 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | 94 | 458.1 |
| Chlamydia | 2014 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | 264 | 1085.2 |
| Chlamydia | 2014 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | 195 | 755.6 |
| Chlamydia | 2014 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | 86 | 354.4 |
| Chlamydia | 2014 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | 33 | 161 |
| Chlamydia | 2014 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | 24 | 129.5 |
| Chlamydia | 2014 | Unknown | Female | 0-14 | 2854 | NA |
| Chlamydia | 2014 | Unknown | Female | 15-19 | 82165 | NA |
| Chlamydia | 2014 | Unknown | Female | 20-24 | 110808 | NA |
| Chlamydia | 2014 | Unknown | Female | 25-29 | 45994 | NA |
| Chlamydia | 2014 | Unknown | Female | 30-34 | 20443 | NA |
| Chlamydia | 2014 | Unknown | Female | 35-39 | 9938 | NA |
| Chlamydia | 2014 | Unknown | Female | 40-44 | 5123 | NA |
| Chlamydia | 2014 | Unknown | Male | 0-14 | 482 | NA |
| Chlamydia | 2014 | Unknown | Male | 15-19 | 21540 | NA |
| Chlamydia | 2014 | Unknown | Male | 20-24 | 43629 | NA |
| Chlamydia | 2014 | Unknown | Male | 25-29 | 24739 | NA |
| Chlamydia | 2014 | Unknown | Male | 30-34 | 13111 | NA |
| Chlamydia | 2014 | Unknown | Male | 35-39 | 6761 | NA |
| Chlamydia | 2014 | Unknown | Male | 40-44 | 4302 | NA |
| Chlamydia | 2014 | White | Female | 0-14 | 1807 | 11.8 |
| Chlamydia | 2014 | White | Female | 15-19 | 74191 | 1322.2 |
| Chlamydia | 2014 | White | Female | 20-24 | 107935 | 1753.6 |
| Chlamydia | 2014 | White | Female | 25-29 | 41782 | 680.1 |
| Chlamydia | 2014 | White | Female | 30-34 | 16280 | 267.2 |
| Chlamydia | 2014 | White | Female | 35-39 | 6668 | 118.1 |
| Chlamydia | 2014 | White | Female | 40-44 | 2937 | 48 |
| Chlamydia | 2014 | White | Male | 0-14 | 141 | 0.9 |
| Chlamydia | 2014 | White | Male | 15-19 | 13487 | 227.5 |
| Chlamydia | 2014 | White | Male | 20-24 | 39110 | 604.7 |
| Chlamydia | 2014 | White | Male | 25-29 | 23399 | 369.6 |
| Chlamydia | 2014 | White | Male | 30-34 | 11456 | 184.6 |
| Chlamydia | 2014 | White | Male | 35-39 | 5429 | 94.59999999999999 |
| Chlamydia | 2014 | White | Male | 40-44 | 3384 | 54.8 |
| Chlamydia | 2015 | American Indian/Alaska Native | Female | 0-14 | 167 | 65.2 |
| Chlamydia | 2015 | American Indian/Alaska Native | Female | 15-19 | 3379 | 3779.4 |
| Chlamydia | 2015 | American Indian/Alaska Native | Female | 20-24 | 4608 | 4750.6 |
| Chlamydia | 2015 | American Indian/Alaska Native | Female | 25-29 | 2518 | 2798.2 |
| Chlamydia | 2015 | American Indian/Alaska Native | Female | 30-34 | 1210 | 1483 |
| Chlamydia | 2015 | American Indian/Alaska Native | Female | 35-39 | 568 | 763.8 |
| Chlamydia | 2015 | American Indian/Alaska Native | Female | 40-44 | 248 | 341.1 |
| Chlamydia | 2015 | American Indian/Alaska Native | Male | 0-14 | 9 | 3.4 |
| Chlamydia | 2015 | American Indian/Alaska Native | Male | 15-19 | 708 | 764.3 |
| Chlamydia | 2015 | American Indian/Alaska Native | Male | 20-24 | 1264 | 1239.5 |
| Chlamydia | 2015 | American Indian/Alaska Native | Male | 25-29 | 932 | 1000.2 |
| Chlamydia | 2015 | American Indian/Alaska Native | Male | 30-34 | 461 | 569.1 |
| Chlamydia | 2015 | American Indian/Alaska Native | Male | 35-39 | 207 | 281.3 |
| Chlamydia | 2015 | American Indian/Alaska Native | Male | 40-44 | 91 | 129.3 |
| Chlamydia | 2015 | Asian | Female | 0-14 | 45 | 3.1 |
| Chlamydia | 2015 | Asian | Female | 15-19 | 2285 | 449.3 |
| Chlamydia | 2015 | Asian | Female | 20-24 | 5155 | 839.1 |
| Chlamydia | 2015 | Asian | Female | 25-29 | 2819 | 375.5 |
| Chlamydia | 2015 | Asian | Female | 30-34 | 1443 | 182.5 |
| Chlamydia | 2015 | Asian | Female | 35-39 | 751 | 100.1 |
| Chlamydia | 2015 | Asian | Female | 40-44 | 409 | 54.8 |
| Chlamydia | 2015 | Asian | Male | 0-14 | 5 | 0.3 |
| Chlamydia | 2015 | Asian | Male | 15-19 | 410 | 79.3 |
| Chlamydia | 2015 | Asian | Male | 20-24 | 1679 | 263.8 |
| Chlamydia | 2015 | Asian | Male | 25-29 | 1581 | 219.9 |
| Chlamydia | 2015 | Asian | Male | 30-34 | 927 | 130.5 |
| Chlamydia | 2015 | Asian | Male | 35-39 | 563 | 86 |
| Chlamydia | 2015 | Asian | Male | 40-44 | 360 | 54.9 |
| Chlamydia | 2015 | Black/African American | Female | 0-14 | 3776 | 91.5 |
| Chlamydia | 2015 | Black/African American | Female | 15-19 | 93727 | 6372.5 |
| Chlamydia | 2015 | Black/African American | Female | 20-24 | 115277 | 6900.8 |
| Chlamydia | 2015 | Black/African American | Female | 25-29 | 45261 | 2873.9 |
| Chlamydia | 2015 | Black/African American | Female | 30-34 | 16034 | 1115.9 |
| Chlamydia | 2015 | Black/African American | Female | 35-39 | 6409 | 467.2 |
| Chlamydia | 2015 | Black/African American | Female | 40-44 | 2500 | 184.8 |
| Chlamydia | 2015 | Black/African American | Male | 0-14 | 628 | 14.8 |
| Chlamydia | 2015 | Black/African American | Male | 15-19 | 32310 | 2131 |
| Chlamydia | 2015 | Black/African American | Male | 20-24 | 54466 | 3159.9 |
| Chlamydia | 2015 | Black/African American | Male | 25-29 | 30459 | 1978.6 |
| Chlamydia | 2015 | Black/African American | Male | 30-34 | 13982 | 1050.8 |
| Chlamydia | 2015 | Black/African American | Male | 35-39 | 7191 | 582 |
| Chlamydia | 2015 | Black/African American | Male | 40-44 | 3706 | 309.2 |
| Chlamydia | 2015 | Hispanic/Latino | Female | 0-14 | 1220 | 16.2 |
| Chlamydia | 2015 | Hispanic/Latino | Female | 15-19 | 40156 | 1741.6 |
| Chlamydia | 2015 | Hispanic/Latino | Female | 20-24 | 57171 | 2476.4 |
| Chlamydia | 2015 | Hispanic/Latino | Female | 25-29 | 26252 | 1222.9 |
| Chlamydia | 2015 | Hispanic/Latino | Female | 30-34 | 12091 | 568.2 |
| Chlamydia | 2015 | Hispanic/Latino | Female | 35-39 | 5808 | 283 |
| Chlamydia | 2015 | Hispanic/Latino | Female | 40-44 | 2694 | 139.4 |
| Chlamydia | 2015 | Hispanic/Latino | Male | 0-14 | 178 | 2.3 |
| Chlamydia | 2015 | Hispanic/Latino | Male | 15-19 | 9324 | 386.4 |
| Chlamydia | 2015 | Hispanic/Latino | Male | 20-24 | 19991 | 802.3 |
| Chlamydia | 2015 | Hispanic/Latino | Male | 25-29 | 13503 | 563.8 |
| Chlamydia | 2015 | Hispanic/Latino | Male | 30-34 | 7174 | 308.1 |
| Chlamydia | 2015 | Hispanic/Latino | Male | 35-39 | 3772 | 172.8 |
| Chlamydia | 2015 | Hispanic/Latino | Male | 40-44 | 2026 | 102.2 |
| Chlamydia | 2015 | Multiple races | Female | 0-14 | 78 | 6.1 |
| Chlamydia | 2015 | Multiple races | Female | 15-19 | 1990 | 590.1 |
| Chlamydia | 2015 | Multiple races | Female | 20-24 | 2175 | 727.2 |
| Chlamydia | 2015 | Multiple races | Female | 25-29 | 726 | 303.2 |
| Chlamydia | 2015 | Multiple races | Female | 30-34 | 235 | 116.3 |
| Chlamydia | 2015 | Multiple races | Female | 35-39 | 86 | 50 |
| Chlamydia | 2015 | Multiple races | Female | 40-44 | 32 | 21.7 |
| Chlamydia | 2015 | Multiple races | Male | 0-14 | 3 | 0.2 |
| Chlamydia | 2015 | Multiple races | Male | 15-19 | 379 | 109.6 |
| Chlamydia | 2015 | Multiple races | Male | 20-24 | 870 | 290.9 |
| Chlamydia | 2015 | Multiple races | Male | 25-29 | 605 | 272.5 |
| Chlamydia | 2015 | Multiple races | Male | 30-34 | 372 | 206.1 |
| Chlamydia | 2015 | Multiple races | Male | 35-39 | 200 | 131.3 |
| Chlamydia | 2015 | Multiple races | Male | 40-44 | 133 | 101.3 |
| Chlamydia | 2015 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | 17 | 28.8 |
| Chlamydia | 2015 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | 605 | 3118.6 |
| Chlamydia | 2015 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | 1031 | 4582.2 |
| Chlamydia | 2015 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | 499 | 2029.7 |
| Chlamydia | 2015 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | 257 | 1092.8 |
| Chlamydia | 2015 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | 99 | 478.5 |
| Chlamydia | 2015 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | 33 | 180.5 |
| Chlamydia | 2015 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | 3 | 4.9 |
| Chlamydia | 2015 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | 110 | 531.5 |
| Chlamydia | 2015 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | 320 | 1356.8 |
| Chlamydia | 2015 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | 217 | 817.3 |
| Chlamydia | 2015 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | 107 | 433.2 |
| Chlamydia | 2015 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | 55 | 257.6 |
| Chlamydia | 2015 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | 21 | 111.2 |
| Chlamydia | 2015 | Unknown | Female | 0-14 | 2898 | NA |
| Chlamydia | 2015 | Unknown | Female | 15-19 | 90467 | NA |
| Chlamydia | 2015 | Unknown | Female | 20-24 | 124039 | NA |
| Chlamydia | 2015 | Unknown | Female | 25-29 | 53884 | NA |
| Chlamydia | 2015 | Unknown | Female | 30-34 | 23346 | NA |
| Chlamydia | 2015 | Unknown | Female | 35-39 | 11599 | NA |
| Chlamydia | 2015 | Unknown | Female | 40-44 | 5948 | NA |
| Chlamydia | 2015 | Unknown | Male | 0-14 | 472 | NA |
| Chlamydia | 2015 | Unknown | Male | 15-19 | 25261 | NA |
| Chlamydia | 2015 | Unknown | Male | 20-24 | 52432 | NA |
| Chlamydia | 2015 | Unknown | Male | 25-29 | 31155 | NA |
| Chlamydia | 2015 | Unknown | Male | 30-34 | 15914 | NA |
| Chlamydia | 2015 | Unknown | Male | 35-39 | 8477 | NA |
| Chlamydia | 2015 | Unknown | Male | 40-44 | 4971 | NA |
| Chlamydia | 2015 | White | Female | 0-14 | 1645 | 10.9 |
| Chlamydia | 2015 | White | Female | 15-19 | 75328 | 1351.6 |
| Chlamydia | 2015 | White | Female | 20-24 | 107316 | 1780 |
| Chlamydia | 2015 | White | Female | 25-29 | 43332 | 698.8 |
| Chlamydia | 2015 | White | Female | 30-34 | 17037 | 278.8 |
| Chlamydia | 2015 | White | Female | 35-39 | 7301 | 127.1 |
| Chlamydia | 2015 | White | Female | 40-44 | 3254 | 55.2 |
| Chlamydia | 2015 | White | Male | 0-14 | 132 | 0.8 |
| Chlamydia | 2015 | White | Male | 15-19 | 14273 | 242.6 |
| Chlamydia | 2015 | White | Male | 20-24 | 41291 | 648.3 |
| Chlamydia | 2015 | White | Male | 25-29 | 26227 | 409.5 |
| Chlamydia | 2015 | White | Male | 30-34 | 13082 | 210.1 |
| Chlamydia | 2015 | White | Male | 35-39 | 6715 | 115 |
| Chlamydia | 2015 | White | Male | 40-44 | 3902 | 65.5 |
| Chlamydia | 2016 | American Indian/Alaska Native | Female | 0-14 | 173 | 68 |
| Chlamydia | 2016 | American Indian/Alaska Native | Female | 15-19 | 3470 | 3883.2 |
| Chlamydia | 2016 | American Indian/Alaska Native | Female | 20-24 | 4475 | 4729 |
| Chlamydia | 2016 | American Indian/Alaska Native | Female | 25-29 | 2737 | 2939.1 |
| Chlamydia | 2016 | American Indian/Alaska Native | Female | 30-34 | 1354 | 1644.3 |
| Chlamydia | 2016 | American Indian/Alaska Native | Female | 35-39 | 633 | 830.5 |
| Chlamydia | 2016 | American Indian/Alaska Native | Female | 40-44 | 279 | 391.6 |
| Chlamydia | 2016 | American Indian/Alaska Native | Male | 0-14 | 14 | 5.3 |
| Chlamydia | 2016 | American Indian/Alaska Native | Male | 15-19 | 862 | 933.6 |
| Chlamydia | 2016 | American Indian/Alaska Native | Male | 20-24 | 1411 | 1423.1 |
| Chlamydia | 2016 | American Indian/Alaska Native | Male | 25-29 | 977 | 1005.7 |
| Chlamydia | 2016 | American Indian/Alaska Native | Male | 30-34 | 553 | 670.5 |
| Chlamydia | 2016 | American Indian/Alaska Native | Male | 35-39 | 269 | 358.9 |
| Chlamydia | 2016 | American Indian/Alaska Native | Male | 40-44 | 129 | 186.7 |
| Chlamydia | 2016 | Asian | Female | 0-14 | 37 | 2.5 |
| Chlamydia | 2016 | Asian | Female | 15-19 | 2375 | 453.4 |
| Chlamydia | 2016 | Asian | Female | 20-24 | 5416 | 867.6 |
| Chlamydia | 2016 | Asian | Female | 25-29 | 2883 | 369.3 |
| Chlamydia | 2016 | Asian | Female | 30-34 | 1444 | 177.7 |
| Chlamydia | 2016 | Asian | Female | 35-39 | 754 | 97.3 |
| Chlamydia | 2016 | Asian | Female | 40-44 | 401 | 52.9 |
| Chlamydia | 2016 | Asian | Male | 0-14 | 4 | 0.3 |
| Chlamydia | 2016 | Asian | Male | 15-19 | 442 | 83.3 |
| Chlamydia | 2016 | Asian | Male | 20-24 | 1917 | 297.8 |
| Chlamydia | 2016 | Asian | Male | 25-29 | 1806 | 240.2 |
| Chlamydia | 2016 | Asian | Male | 30-34 | 1119 | 151 |
| Chlamydia | 2016 | Asian | Male | 35-39 | 625 | 92.59999999999999 |
| Chlamydia | 2016 | Asian | Male | 40-44 | 418 | 62.8 |
| Chlamydia | 2016 | Black/African American | Female | 0-14 | 3549 | 86.09999999999999 |
| Chlamydia | 2016 | Black/African American | Female | 15-19 | 95551 | 6497.7 |
| Chlamydia | 2016 | Black/African American | Female | 20-24 | 112862 | 6953.5 |
| Chlamydia | 2016 | Black/African American | Female | 25-29 | 48261 | 2939.8 |
| Chlamydia | 2016 | Black/African American | Female | 30-34 | 16530 | 1140.1 |
| Chlamydia | 2016 | Black/African American | Female | 35-39 | 6713 | 477.8 |
| Chlamydia | 2016 | Black/African American | Female | 40-44 | 2560 | 193.6 |
| Chlamydia | 2016 | Black/African American | Male | 0-14 | 744 | 17.6 |
| Chlamydia | 2016 | Black/African American | Male | 15-19 | 35462 | 2339.7 |
| Chlamydia | 2016 | Black/African American | Male | 20-24 | 57224 | 3409.2 |
| Chlamydia | 2016 | Black/African American | Male | 25-29 | 33340 | 2056.1 |
| Chlamydia | 2016 | Black/African American | Male | 30-34 | 15547 | 1147.3 |
| Chlamydia | 2016 | Black/African American | Male | 35-39 | 8080 | 636.6 |
| Chlamydia | 2016 | Black/African American | Male | 40-44 | 4017 | 342.3 |
| Chlamydia | 2016 | Hispanic/Latino | Female | 0-14 | 1302 | 17.2 |
| Chlamydia | 2016 | Hispanic/Latino | Female | 15-19 | 40969 | 1740.5 |
| Chlamydia | 2016 | Hispanic/Latino | Female | 20-24 | 56554 | 2431.9 |
| Chlamydia | 2016 | Hispanic/Latino | Female | 25-29 | 26725 | 1209.5 |
| Chlamydia | 2016 | Hispanic/Latino | Female | 30-34 | 11918 | 556.6 |
| Chlamydia | 2016 | Hispanic/Latino | Female | 35-39 | 6198 | 296.3 |
| Chlamydia | 2016 | Hispanic/Latino | Female | 40-44 | 2837 | 144.7 |
| Chlamydia | 2016 | Hispanic/Latino | Male | 0-14 | 203 | 2.6 |
| Chlamydia | 2016 | Hispanic/Latino | Male | 15-19 | 9994 | 406.2 |
| Chlamydia | 2016 | Hispanic/Latino | Male | 20-24 | 20639 | 826.8 |
| Chlamydia | 2016 | Hispanic/Latino | Male | 25-29 | 14517 | 593 |
| Chlamydia | 2016 | Hispanic/Latino | Male | 30-34 | 8024 | 340.2 |
| Chlamydia | 2016 | Hispanic/Latino | Male | 35-39 | 4319 | 193.3 |
| Chlamydia | 2016 | Hispanic/Latino | Male | 40-44 | 2279 | 112.9 |
| Chlamydia | 2016 | Multiple races | Female | 0-14 | 84 | 6.4 |
| Chlamydia | 2016 | Multiple races | Female | 15-19 | 2344 | 676.7 |
| Chlamydia | 2016 | Multiple races | Female | 20-24 | 2591 | 844.4 |
| Chlamydia | 2016 | Multiple races | Female | 25-29 | 952 | 374.4 |
| Chlamydia | 2016 | Multiple races | Female | 30-34 | 347 | 167.5 |
| Chlamydia | 2016 | Multiple races | Female | 35-39 | 150 | 83.40000000000001 |
| Chlamydia | 2016 | Multiple races | Female | 40-44 | 65 | 43.8 |
| Chlamydia | 2016 | Multiple races | Male | 0-14 | 7 | 0.5 |
| Chlamydia | 2016 | Multiple races | Male | 15-19 | 485 | 136.3 |
| Chlamydia | 2016 | Multiple races | Male | 20-24 | 958 | 307.4 |
| Chlamydia | 2016 | Multiple races | Male | 25-29 | 778 | 326.2 |
| Chlamydia | 2016 | Multiple races | Male | 30-34 | 487 | 261.7 |
| Chlamydia | 2016 | Multiple races | Male | 35-39 | 230 | 144.2 |
| Chlamydia | 2016 | Multiple races | Male | 40-44 | 113 | 85.3 |
| Chlamydia | 2016 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | 11 | 18.5 |
| Chlamydia | 2016 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | 662 | 3374.8 |
| Chlamydia | 2016 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | 1055 | 4818.2 |
| Chlamydia | 2016 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | 536 | 2157.9 |
| Chlamydia | 2016 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | 243 | 1001.4 |
| Chlamydia | 2016 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | 123 | 574.7 |
| Chlamydia | 2016 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | 44 | 237.7 |
| Chlamydia | 2016 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | 5 | 8.1 |
| Chlamydia | 2016 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | 127 | 611.9 |
| Chlamydia | 2016 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | 299 | 1312.8 |
| Chlamydia | 2016 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | 237 | 876.9 |
| Chlamydia | 2016 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | 128 | 505.7 |
| Chlamydia | 2016 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | 75 | 335.2 |
| Chlamydia | 2016 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | 28 | 146 |
| Chlamydia | 2016 | Unknown | Female | 0-14 | 2709 | NA |
| Chlamydia | 2016 | Unknown | Female | 15-19 | 91292 | NA |
| Chlamydia | 2016 | Unknown | Female | 20-24 | 124449 | NA |
| Chlamydia | 2016 | Unknown | Female | 25-29 | 55451 | NA |
| Chlamydia | 2016 | Unknown | Female | 30-34 | 24149 | NA |
| Chlamydia | 2016 | Unknown | Female | 35-39 | 12065 | NA |
| Chlamydia | 2016 | Unknown | Female | 40-44 | 5949 | NA |
| Chlamydia | 2016 | Unknown | Male | 0-14 | 470 | NA |
| Chlamydia | 2016 | Unknown | Male | 15-19 | 26811 | NA |
| Chlamydia | 2016 | Unknown | Male | 20-24 | 55873 | NA |
| Chlamydia | 2016 | Unknown | Male | 25-29 | 34607 | NA |
| Chlamydia | 2016 | Unknown | Male | 30-34 | 17880 | NA |
| Chlamydia | 2016 | Unknown | Male | 35-39 | 9960 | NA |
| Chlamydia | 2016 | Unknown | Male | 40-44 | 5546 | NA |
| Chlamydia | 2016 | White | Female | 0-14 | 1870 | 12.4 |
| Chlamydia | 2016 | White | Female | 15-19 | 79976 | 1444.9 |
| Chlamydia | 2016 | White | Female | 20-24 | 110986 | 1884.1 |
| Chlamydia | 2016 | White | Female | 25-29 | 45677 | 729.3 |
| Chlamydia | 2016 | White | Female | 30-34 | 18241 | 297.9 |
| Chlamydia | 2016 | White | Female | 35-39 | 8236 | 140.3 |
| Chlamydia | 2016 | White | Female | 40-44 | 3570 | 63.1 |
| Chlamydia | 2016 | White | Male | 0-14 | 144 | 0.9 |
| Chlamydia | 2016 | White | Male | 15-19 | 15716 | 269.3 |
| Chlamydia | 2016 | White | Male | 20-24 | 43536 | 697.1 |
| Chlamydia | 2016 | White | Male | 25-29 | 28222 | 435.5 |
| Chlamydia | 2016 | White | Male | 30-34 | 14845 | 237.5 |
| Chlamydia | 2016 | White | Male | 35-39 | 8113 | 136 |
| Chlamydia | 2016 | White | Male | 40-44 | 4254 | 74.40000000000001 |
| Chlamydia | 2017 | American Indian/Alaska Native | Female | 0-14 | 179 | 70.7 |
| Chlamydia | 2017 | American Indian/Alaska Native | Female | 15-19 | 3515 | 3961.2 |
| Chlamydia | 2017 | American Indian/Alaska Native | Female | 20-24 | 4565 | 4953.2 |
| Chlamydia | 2017 | American Indian/Alaska Native | Female | 25-29 | 2826 | 2937.6 |
| Chlamydia | 2017 | American Indian/Alaska Native | Female | 30-34 | 1513 | 1810.9 |
| Chlamydia | 2017 | American Indian/Alaska Native | Female | 35-39 | 708 | 918.6 |
| Chlamydia | 2017 | American Indian/Alaska Native | Female | 40-44 | 318 | 446.2 |
| Chlamydia | 2017 | American Indian/Alaska Native | Male | 0-14 | 21 | 8 |
| Chlamydia | 2017 | American Indian/Alaska Native | Male | 15-19 | 872 | 949.6 |
| Chlamydia | 2017 | American Indian/Alaska Native | Male | 20-24 | 1372 | 1430.5 |
| Chlamydia | 2017 | American Indian/Alaska Native | Male | 25-29 | 1117 | 1110.9 |
| Chlamydia | 2017 | American Indian/Alaska Native | Male | 30-34 | 594 | 707.2 |
| Chlamydia | 2017 | American Indian/Alaska Native | Male | 35-39 | 378 | 495.9 |
| Chlamydia | 2017 | American Indian/Alaska Native | Male | 40-44 | 161 | 233 |
| Chlamydia | 2017 | Asian | Female | 0-14 | 50 | 3.3 |
| Chlamydia | 2017 | Asian | Female | 15-19 | 2870 | 535.9 |
| Chlamydia | 2017 | Asian | Female | 20-24 | 5653 | 886.6 |
| Chlamydia | 2017 | Asian | Female | 25-29 | 2936 | 365.1 |
| Chlamydia | 2017 | Asian | Female | 30-34 | 1568 | 189 |
| Chlamydia | 2017 | Asian | Female | 35-39 | 762 | 94.7 |
| Chlamydia | 2017 | Asian | Female | 40-44 | 423 | 55.1 |
| Chlamydia | 2017 | Asian | Male | 0-14 | 2 | 0.1 |
| Chlamydia | 2017 | Asian | Male | 15-19 | 503 | 92.90000000000001 |
| Chlamydia | 2017 | Asian | Male | 20-24 | 2170 | 332.3 |
| Chlamydia | 2017 | Asian | Male | 25-29 | 2098 | 269.6 |
| Chlamydia | 2017 | Asian | Male | 30-34 | 1276 | 167 |
| Chlamydia | 2017 | Asian | Male | 35-39 | 761 | 107.9 |
| Chlamydia | 2017 | Asian | Male | 40-44 | 521 | 77.7 |
| Chlamydia | 2017 | Black/African American | Female | 0-14 | 3584 | 86.90000000000001 |
| Chlamydia | 2017 | Black/African American | Female | 15-19 | 99492 | 6810.1 |
| Chlamydia | 2017 | Black/African American | Female | 20-24 | 113046 | 7151.1 |
| Chlamydia | 2017 | Black/African American | Female | 25-29 | 51573 | 3037.7 |
| Chlamydia | 2017 | Black/African American | Female | 30-34 | 17514 | 1194.8 |
| Chlamydia | 2017 | Black/African American | Female | 35-39 | 7234 | 506.1 |
| Chlamydia | 2017 | Black/African American | Female | 40-44 | 2687 | 204.2 |
| Chlamydia | 2017 | Black/African American | Male | 0-14 | 669 | 15.8 |
| Chlamydia | 2017 | Black/African American | Male | 15-19 | 39191 | 2603.8 |
| Chlamydia | 2017 | Black/African American | Male | 20-24 | 60833 | 3727.1 |
| Chlamydia | 2017 | Black/African American | Male | 25-29 | 36656 | 2162.7 |
| Chlamydia | 2017 | Black/African American | Male | 30-34 | 17316 | 1251.1 |
| Chlamydia | 2017 | Black/African American | Male | 35-39 | 8929 | 688.5 |
| Chlamydia | 2017 | Black/African American | Male | 40-44 | 4484 | 383.9 |
| Chlamydia | 2017 | Hispanic/Latino | Female | 0-14 | 1313 | 17.1 |
| Chlamydia | 2017 | Hispanic/Latino | Female | 15-19 | 45033 | 1879.3 |
| Chlamydia | 2017 | Hispanic/Latino | Female | 20-24 | 60423 | 2584.5 |
| Chlamydia | 2017 | Hispanic/Latino | Female | 25-29 | 28655 | 1256.1 |
| Chlamydia | 2017 | Hispanic/Latino | Female | 30-34 | 12577 | 585 |
| Chlamydia | 2017 | Hispanic/Latino | Female | 35-39 | 6530 | 306.5 |
| Chlamydia | 2017 | Hispanic/Latino | Female | 40-44 | 3171 | 159 |
| Chlamydia | 2017 | Hispanic/Latino | Male | 0-14 | 153 | 1.9 |
| Chlamydia | 2017 | Hispanic/Latino | Male | 15-19 | 11094 | 443.3 |
| Chlamydia | 2017 | Hispanic/Latino | Male | 20-24 | 22760 | 911.1 |
| Chlamydia | 2017 | Hispanic/Latino | Male | 25-29 | 16751 | 667 |
| Chlamydia | 2017 | Hispanic/Latino | Male | 30-34 | 9360 | 393.6 |
| Chlamydia | 2017 | Hispanic/Latino | Male | 35-39 | 5207 | 227.7 |
| Chlamydia | 2017 | Hispanic/Latino | Male | 40-44 | 2817 | 136.7 |
| Chlamydia | 2017 | Multiple races | Female | 0-14 | 95 | 7.2 |
| Chlamydia | 2017 | Multiple races | Female | 15-19 | 2511 | 708.7 |
| Chlamydia | 2017 | Multiple races | Female | 20-24 | 2873 | 913.2 |
| Chlamydia | 2017 | Multiple races | Female | 25-29 | 1052 | 391.3 |
| Chlamydia | 2017 | Multiple races | Female | 30-34 | 345 | 161.7 |
| Chlamydia | 2017 | Multiple races | Female | 35-39 | 150 | 80.2 |
| Chlamydia | 2017 | Multiple races | Female | 40-44 | 69 | 45.2 |
| Chlamydia | 2017 | Multiple races | Male | 0-14 | 9 | 0.7 |
| Chlamydia | 2017 | Multiple races | Male | 15-19 | 564 | 154.9 |
| Chlamydia | 2017 | Multiple races | Male | 20-24 | 1114 | 346.6 |
| Chlamydia | 2017 | Multiple races | Male | 25-29 | 848 | 329.7 |
| Chlamydia | 2017 | Multiple races | Male | 30-34 | 562 | 292 |
| Chlamydia | 2017 | Multiple races | Male | 35-39 | 324 | 195.2 |
| Chlamydia | 2017 | Multiple races | Male | 40-44 | 174 | 128.5 |
| Chlamydia | 2017 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | 19 | 31.6 |
| Chlamydia | 2017 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | 688 | 3469.8 |
| Chlamydia | 2017 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | 1170 | 5431.8 |
| Chlamydia | 2017 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | 591 | 2368.5 |
| Chlamydia | 2017 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | 276 | 1125.8 |
| Chlamydia | 2017 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | 138 | 620.5 |
| Chlamydia | 2017 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | 45 | 236.6 |
| Chlamydia | 2017 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | 5 | 8 |
| Chlamydia | 2017 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | 121 | 579.8 |
| Chlamydia | 2017 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | 345 | 1538.6 |
| Chlamydia | 2017 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | 245 | 911.2 |
| Chlamydia | 2017 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | 167 | 650.1 |
| Chlamydia | 2017 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | 96 | 410.8 |
| Chlamydia | 2017 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | 37 | 188 |
| Chlamydia | 2017 | Unknown | Female | 0-14 | 2829 | NA |
| Chlamydia | 2017 | Unknown | Female | 15-19 | 99052 | NA |
| Chlamydia | 2017 | Unknown | Female | 20-24 | 132030 | NA |
| Chlamydia | 2017 | Unknown | Female | 25-29 | 59059 | NA |
| Chlamydia | 2017 | Unknown | Female | 30-34 | 25272 | NA |
| Chlamydia | 2017 | Unknown | Female | 35-39 | 12980 | NA |
| Chlamydia | 2017 | Unknown | Female | 40-44 | 6378 | NA |
| Chlamydia | 2017 | Unknown | Male | 0-14 | 456 | NA |
| Chlamydia | 2017 | Unknown | Male | 15-19 | 30492 | NA |
| Chlamydia | 2017 | Unknown | Male | 20-24 | 61925 | NA |
| Chlamydia | 2017 | Unknown | Male | 25-29 | 39099 | NA |
| Chlamydia | 2017 | Unknown | Male | 30-34 | 20132 | NA |
| Chlamydia | 2017 | Unknown | Male | 35-39 | 11401 | NA |
| Chlamydia | 2017 | Unknown | Male | 40-44 | 6209 | NA |
| Chlamydia | 2017 | White | Female | 0-14 | 1866 | 12.5 |
| Chlamydia | 2017 | White | Female | 15-19 | 84129 | 1536.5 |
| Chlamydia | 2017 | White | Female | 20-24 | 114290 | 1975.7 |
| Chlamydia | 2017 | White | Female | 25-29 | 47575 | 755.8 |
| Chlamydia | 2017 | White | Female | 30-34 | 19437 | 317.8 |
| Chlamydia | 2017 | White | Female | 35-39 | 9119 | 152.9 |
| Chlamydia | 2017 | White | Female | 40-44 | 3849 | 69.09999999999999 |
| Chlamydia | 2017 | White | Male | 0-14 | 134 | 0.9 |
| Chlamydia | 2017 | White | Male | 15-19 | 17027 | 294.8 |
| Chlamydia | 2017 | White | Male | 20-24 | 45452 | 741.9 |
| Chlamydia | 2017 | White | Male | 25-29 | 30193 | 462.2 |
| Chlamydia | 2017 | White | Male | 30-34 | 16283 | 260.1 |
| Chlamydia | 2017 | White | Male | 35-39 | 9331 | 153.9 |
| Chlamydia | 2017 | White | Male | 40-44 | 4907 | 87.2 |
| Gonorrhea | 2000 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Gonorrhea | 2000 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Gonorrhea | 2000 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Gonorrhea | 2000 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Gonorrhea | 2000 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Gonorrhea | 2000 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Gonorrhea | 2000 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Gonorrhea | 2000 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Gonorrhea | 2000 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Gonorrhea | 2000 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Gonorrhea | 2000 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Gonorrhea | 2000 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Gonorrhea | 2000 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Gonorrhea | 2000 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Gonorrhea | 2000 | Asian | Female | 0-14 | NA | NA |
| Gonorrhea | 2000 | Asian | Female | 15-19 | NA | NA |
| Gonorrhea | 2000 | Asian | Female | 20-24 | NA | NA |
| Gonorrhea | 2000 | Asian | Female | 25-29 | NA | NA |
| Gonorrhea | 2000 | Asian | Female | 30-34 | NA | NA |
| Gonorrhea | 2000 | Asian | Female | 35-39 | NA | NA |
| Gonorrhea | 2000 | Asian | Female | 40-44 | NA | NA |
| Gonorrhea | 2000 | Asian | Male | 0-14 | NA | NA |
| Gonorrhea | 2000 | Asian | Male | 15-19 | NA | NA |
| Gonorrhea | 2000 | Asian | Male | 20-24 | NA | NA |
| Gonorrhea | 2000 | Asian | Male | 25-29 | NA | NA |
| Gonorrhea | 2000 | Asian | Male | 30-34 | NA | NA |
| Gonorrhea | 2000 | Asian | Male | 35-39 | NA | NA |
| Gonorrhea | 2000 | Asian | Male | 40-44 | NA | NA |
| Gonorrhea | 2000 | Black/African American | Female | 0-14 | NA | NA |
| Gonorrhea | 2000 | Black/African American | Female | 15-19 | NA | NA |
| Gonorrhea | 2000 | Black/African American | Female | 20-24 | NA | NA |
| Gonorrhea | 2000 | Black/African American | Female | 25-29 | NA | NA |
| Gonorrhea | 2000 | Black/African American | Female | 30-34 | NA | NA |
| Gonorrhea | 2000 | Black/African American | Female | 35-39 | NA | NA |
| Gonorrhea | 2000 | Black/African American | Female | 40-44 | NA | NA |
| Gonorrhea | 2000 | Black/African American | Male | 0-14 | NA | NA |
| Gonorrhea | 2000 | Black/African American | Male | 15-19 | NA | NA |
| Gonorrhea | 2000 | Black/African American | Male | 20-24 | NA | NA |
| Gonorrhea | 2000 | Black/African American | Male | 25-29 | NA | NA |
| Gonorrhea | 2000 | Black/African American | Male | 30-34 | NA | NA |
| Gonorrhea | 2000 | Black/African American | Male | 35-39 | NA | NA |
| Gonorrhea | 2000 | Black/African American | Male | 40-44 | NA | NA |
| Gonorrhea | 2000 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Gonorrhea | 2000 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Gonorrhea | 2000 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Gonorrhea | 2000 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Gonorrhea | 2000 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Gonorrhea | 2000 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Gonorrhea | 2000 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Gonorrhea | 2000 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Gonorrhea | 2000 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Gonorrhea | 2000 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Gonorrhea | 2000 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Gonorrhea | 2000 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Gonorrhea | 2000 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Gonorrhea | 2000 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Gonorrhea | 2000 | Multiple races | Female | 0-14 | NA | NA |
| Gonorrhea | 2000 | Multiple races | Female | 15-19 | NA | NA |
| Gonorrhea | 2000 | Multiple races | Female | 20-24 | NA | NA |
| Gonorrhea | 2000 | Multiple races | Female | 25-29 | NA | NA |
| Gonorrhea | 2000 | Multiple races | Female | 30-34 | NA | NA |
| Gonorrhea | 2000 | Multiple races | Female | 35-39 | NA | NA |
| Gonorrhea | 2000 | Multiple races | Female | 40-44 | NA | NA |
| Gonorrhea | 2000 | Multiple races | Male | 0-14 | NA | NA |
| Gonorrhea | 2000 | Multiple races | Male | 15-19 | NA | NA |
| Gonorrhea | 2000 | Multiple races | Male | 20-24 | NA | NA |
| Gonorrhea | 2000 | Multiple races | Male | 25-29 | NA | NA |
| Gonorrhea | 2000 | Multiple races | Male | 30-34 | NA | NA |
| Gonorrhea | 2000 | Multiple races | Male | 35-39 | NA | NA |
| Gonorrhea | 2000 | Multiple races | Male | 40-44 | NA | NA |
| Gonorrhea | 2000 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Gonorrhea | 2000 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Gonorrhea | 2000 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Gonorrhea | 2000 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Gonorrhea | 2000 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Gonorrhea | 2000 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Gonorrhea | 2000 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Gonorrhea | 2000 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Gonorrhea | 2000 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Gonorrhea | 2000 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Gonorrhea | 2000 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Gonorrhea | 2000 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Gonorrhea | 2000 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Gonorrhea | 2000 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Gonorrhea | 2000 | Unknown | Female | 0-14 | NA | NA |
| Gonorrhea | 2000 | Unknown | Female | 15-19 | NA | NA |
| Gonorrhea | 2000 | Unknown | Female | 20-24 | NA | NA |
| Gonorrhea | 2000 | Unknown | Female | 25-29 | NA | NA |
| Gonorrhea | 2000 | Unknown | Female | 30-34 | NA | NA |
| Gonorrhea | 2000 | Unknown | Female | 35-39 | NA | NA |
| Gonorrhea | 2000 | Unknown | Female | 40-44 | NA | NA |
| Gonorrhea | 2000 | Unknown | Male | 0-14 | NA | NA |
| Gonorrhea | 2000 | Unknown | Male | 15-19 | NA | NA |
| Gonorrhea | 2000 | Unknown | Male | 20-24 | NA | NA |
| Gonorrhea | 2000 | Unknown | Male | 25-29 | NA | NA |
| Gonorrhea | 2000 | Unknown | Male | 30-34 | NA | NA |
| Gonorrhea | 2000 | Unknown | Male | 35-39 | NA | NA |
| Gonorrhea | 2000 | Unknown | Male | 40-44 | NA | NA |
| Gonorrhea | 2000 | White | Female | 0-14 | NA | NA |
| Gonorrhea | 2000 | White | Female | 15-19 | NA | NA |
| Gonorrhea | 2000 | White | Female | 20-24 | NA | NA |
| Gonorrhea | 2000 | White | Female | 25-29 | NA | NA |
| Gonorrhea | 2000 | White | Female | 30-34 | NA | NA |
| Gonorrhea | 2000 | White | Female | 35-39 | NA | NA |
| Gonorrhea | 2000 | White | Female | 40-44 | NA | NA |
| Gonorrhea | 2000 | White | Male | 0-14 | NA | NA |
| Gonorrhea | 2000 | White | Male | 15-19 | NA | NA |
| Gonorrhea | 2000 | White | Male | 20-24 | NA | NA |
| Gonorrhea | 2000 | White | Male | 25-29 | NA | NA |
| Gonorrhea | 2000 | White | Male | 30-34 | NA | NA |
| Gonorrhea | 2000 | White | Male | 35-39 | NA | NA |
| Gonorrhea | 2000 | White | Male | 40-44 | NA | NA |
| Gonorrhea | 2001 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Gonorrhea | 2001 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Gonorrhea | 2001 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Gonorrhea | 2001 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Gonorrhea | 2001 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Gonorrhea | 2001 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Gonorrhea | 2001 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Gonorrhea | 2001 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Gonorrhea | 2001 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Gonorrhea | 2001 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Gonorrhea | 2001 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Gonorrhea | 2001 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Gonorrhea | 2001 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Gonorrhea | 2001 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Gonorrhea | 2001 | Asian | Female | 0-14 | NA | NA |
| Gonorrhea | 2001 | Asian | Female | 15-19 | NA | NA |
| Gonorrhea | 2001 | Asian | Female | 20-24 | NA | NA |
| Gonorrhea | 2001 | Asian | Female | 25-29 | NA | NA |
| Gonorrhea | 2001 | Asian | Female | 30-34 | NA | NA |
| Gonorrhea | 2001 | Asian | Female | 35-39 | NA | NA |
| Gonorrhea | 2001 | Asian | Female | 40-44 | NA | NA |
| Gonorrhea | 2001 | Asian | Male | 0-14 | NA | NA |
| Gonorrhea | 2001 | Asian | Male | 15-19 | NA | NA |
| Gonorrhea | 2001 | Asian | Male | 20-24 | NA | NA |
| Gonorrhea | 2001 | Asian | Male | 25-29 | NA | NA |
| Gonorrhea | 2001 | Asian | Male | 30-34 | NA | NA |
| Gonorrhea | 2001 | Asian | Male | 35-39 | NA | NA |
| Gonorrhea | 2001 | Asian | Male | 40-44 | NA | NA |
| Gonorrhea | 2001 | Black/African American | Female | 0-14 | NA | NA |
| Gonorrhea | 2001 | Black/African American | Female | 15-19 | NA | NA |
| Gonorrhea | 2001 | Black/African American | Female | 20-24 | NA | NA |
| Gonorrhea | 2001 | Black/African American | Female | 25-29 | NA | NA |
| Gonorrhea | 2001 | Black/African American | Female | 30-34 | NA | NA |
| Gonorrhea | 2001 | Black/African American | Female | 35-39 | NA | NA |
| Gonorrhea | 2001 | Black/African American | Female | 40-44 | NA | NA |
| Gonorrhea | 2001 | Black/African American | Male | 0-14 | NA | NA |
| Gonorrhea | 2001 | Black/African American | Male | 15-19 | NA | NA |
| Gonorrhea | 2001 | Black/African American | Male | 20-24 | NA | NA |
| Gonorrhea | 2001 | Black/African American | Male | 25-29 | NA | NA |
| Gonorrhea | 2001 | Black/African American | Male | 30-34 | NA | NA |
| Gonorrhea | 2001 | Black/African American | Male | 35-39 | NA | NA |
| Gonorrhea | 2001 | Black/African American | Male | 40-44 | NA | NA |
| Gonorrhea | 2001 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Gonorrhea | 2001 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Gonorrhea | 2001 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Gonorrhea | 2001 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Gonorrhea | 2001 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Gonorrhea | 2001 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Gonorrhea | 2001 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Gonorrhea | 2001 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Gonorrhea | 2001 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Gonorrhea | 2001 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Gonorrhea | 2001 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Gonorrhea | 2001 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Gonorrhea | 2001 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Gonorrhea | 2001 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Gonorrhea | 2001 | Multiple races | Female | 0-14 | NA | NA |
| Gonorrhea | 2001 | Multiple races | Female | 15-19 | NA | NA |
| Gonorrhea | 2001 | Multiple races | Female | 20-24 | NA | NA |
| Gonorrhea | 2001 | Multiple races | Female | 25-29 | NA | NA |
| Gonorrhea | 2001 | Multiple races | Female | 30-34 | NA | NA |
| Gonorrhea | 2001 | Multiple races | Female | 35-39 | NA | NA |
| Gonorrhea | 2001 | Multiple races | Female | 40-44 | NA | NA |
| Gonorrhea | 2001 | Multiple races | Male | 0-14 | NA | NA |
| Gonorrhea | 2001 | Multiple races | Male | 15-19 | NA | NA |
| Gonorrhea | 2001 | Multiple races | Male | 20-24 | NA | NA |
| Gonorrhea | 2001 | Multiple races | Male | 25-29 | NA | NA |
| Gonorrhea | 2001 | Multiple races | Male | 30-34 | NA | NA |
| Gonorrhea | 2001 | Multiple races | Male | 35-39 | NA | NA |
| Gonorrhea | 2001 | Multiple races | Male | 40-44 | NA | NA |
| Gonorrhea | 2001 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Gonorrhea | 2001 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Gonorrhea | 2001 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Gonorrhea | 2001 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Gonorrhea | 2001 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Gonorrhea | 2001 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Gonorrhea | 2001 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Gonorrhea | 2001 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Gonorrhea | 2001 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Gonorrhea | 2001 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Gonorrhea | 2001 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Gonorrhea | 2001 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Gonorrhea | 2001 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Gonorrhea | 2001 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Gonorrhea | 2001 | Unknown | Female | 0-14 | NA | NA |
| Gonorrhea | 2001 | Unknown | Female | 15-19 | NA | NA |
| Gonorrhea | 2001 | Unknown | Female | 20-24 | NA | NA |
| Gonorrhea | 2001 | Unknown | Female | 25-29 | NA | NA |
| Gonorrhea | 2001 | Unknown | Female | 30-34 | NA | NA |
| Gonorrhea | 2001 | Unknown | Female | 35-39 | NA | NA |
| Gonorrhea | 2001 | Unknown | Female | 40-44 | NA | NA |
| Gonorrhea | 2001 | Unknown | Male | 0-14 | NA | NA |
| Gonorrhea | 2001 | Unknown | Male | 15-19 | NA | NA |
| Gonorrhea | 2001 | Unknown | Male | 20-24 | NA | NA |
| Gonorrhea | 2001 | Unknown | Male | 25-29 | NA | NA |
| Gonorrhea | 2001 | Unknown | Male | 30-34 | NA | NA |
| Gonorrhea | 2001 | Unknown | Male | 35-39 | NA | NA |
| Gonorrhea | 2001 | Unknown | Male | 40-44 | NA | NA |
| Gonorrhea | 2001 | White | Female | 0-14 | NA | NA |
| Gonorrhea | 2001 | White | Female | 15-19 | NA | NA |
| Gonorrhea | 2001 | White | Female | 20-24 | NA | NA |
| Gonorrhea | 2001 | White | Female | 25-29 | NA | NA |
| Gonorrhea | 2001 | White | Female | 30-34 | NA | NA |
| Gonorrhea | 2001 | White | Female | 35-39 | NA | NA |
| Gonorrhea | 2001 | White | Female | 40-44 | NA | NA |
| Gonorrhea | 2001 | White | Male | 0-14 | NA | NA |
| Gonorrhea | 2001 | White | Male | 15-19 | NA | NA |
| Gonorrhea | 2001 | White | Male | 20-24 | NA | NA |
| Gonorrhea | 2001 | White | Male | 25-29 | NA | NA |
| Gonorrhea | 2001 | White | Male | 30-34 | NA | NA |
| Gonorrhea | 2001 | White | Male | 35-39 | NA | NA |
| Gonorrhea | 2001 | White | Male | 40-44 | NA | NA |
| Gonorrhea | 2002 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Gonorrhea | 2002 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Gonorrhea | 2002 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Gonorrhea | 2002 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Gonorrhea | 2002 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Gonorrhea | 2002 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Gonorrhea | 2002 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Gonorrhea | 2002 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Gonorrhea | 2002 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Gonorrhea | 2002 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Gonorrhea | 2002 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Gonorrhea | 2002 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Gonorrhea | 2002 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Gonorrhea | 2002 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Gonorrhea | 2002 | Asian | Female | 0-14 | NA | NA |
| Gonorrhea | 2002 | Asian | Female | 15-19 | NA | NA |
| Gonorrhea | 2002 | Asian | Female | 20-24 | NA | NA |
| Gonorrhea | 2002 | Asian | Female | 25-29 | NA | NA |
| Gonorrhea | 2002 | Asian | Female | 30-34 | NA | NA |
| Gonorrhea | 2002 | Asian | Female | 35-39 | NA | NA |
| Gonorrhea | 2002 | Asian | Female | 40-44 | NA | NA |
| Gonorrhea | 2002 | Asian | Male | 0-14 | NA | NA |
| Gonorrhea | 2002 | Asian | Male | 15-19 | NA | NA |
| Gonorrhea | 2002 | Asian | Male | 20-24 | NA | NA |
| Gonorrhea | 2002 | Asian | Male | 25-29 | NA | NA |
| Gonorrhea | 2002 | Asian | Male | 30-34 | NA | NA |
| Gonorrhea | 2002 | Asian | Male | 35-39 | NA | NA |
| Gonorrhea | 2002 | Asian | Male | 40-44 | NA | NA |
| Gonorrhea | 2002 | Black/African American | Female | 0-14 | NA | NA |
| Gonorrhea | 2002 | Black/African American | Female | 15-19 | NA | NA |
| Gonorrhea | 2002 | Black/African American | Female | 20-24 | NA | NA |
| Gonorrhea | 2002 | Black/African American | Female | 25-29 | NA | NA |
| Gonorrhea | 2002 | Black/African American | Female | 30-34 | NA | NA |
| Gonorrhea | 2002 | Black/African American | Female | 35-39 | NA | NA |
| Gonorrhea | 2002 | Black/African American | Female | 40-44 | NA | NA |
| Gonorrhea | 2002 | Black/African American | Male | 0-14 | NA | NA |
| Gonorrhea | 2002 | Black/African American | Male | 15-19 | NA | NA |
| Gonorrhea | 2002 | Black/African American | Male | 20-24 | NA | NA |
| Gonorrhea | 2002 | Black/African American | Male | 25-29 | NA | NA |
| Gonorrhea | 2002 | Black/African American | Male | 30-34 | NA | NA |
| Gonorrhea | 2002 | Black/African American | Male | 35-39 | NA | NA |
| Gonorrhea | 2002 | Black/African American | Male | 40-44 | NA | NA |
| Gonorrhea | 2002 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Gonorrhea | 2002 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Gonorrhea | 2002 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Gonorrhea | 2002 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Gonorrhea | 2002 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Gonorrhea | 2002 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Gonorrhea | 2002 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Gonorrhea | 2002 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Gonorrhea | 2002 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Gonorrhea | 2002 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Gonorrhea | 2002 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Gonorrhea | 2002 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Gonorrhea | 2002 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Gonorrhea | 2002 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Gonorrhea | 2002 | Multiple races | Female | 0-14 | NA | NA |
| Gonorrhea | 2002 | Multiple races | Female | 15-19 | NA | NA |
| Gonorrhea | 2002 | Multiple races | Female | 20-24 | NA | NA |
| Gonorrhea | 2002 | Multiple races | Female | 25-29 | NA | NA |
| Gonorrhea | 2002 | Multiple races | Female | 30-34 | NA | NA |
| Gonorrhea | 2002 | Multiple races | Female | 35-39 | NA | NA |
| Gonorrhea | 2002 | Multiple races | Female | 40-44 | NA | NA |
| Gonorrhea | 2002 | Multiple races | Male | 0-14 | NA | NA |
| Gonorrhea | 2002 | Multiple races | Male | 15-19 | NA | NA |
| Gonorrhea | 2002 | Multiple races | Male | 20-24 | NA | NA |
| Gonorrhea | 2002 | Multiple races | Male | 25-29 | NA | NA |
| Gonorrhea | 2002 | Multiple races | Male | 30-34 | NA | NA |
| Gonorrhea | 2002 | Multiple races | Male | 35-39 | NA | NA |
| Gonorrhea | 2002 | Multiple races | Male | 40-44 | NA | NA |
| Gonorrhea | 2002 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Gonorrhea | 2002 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Gonorrhea | 2002 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Gonorrhea | 2002 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Gonorrhea | 2002 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Gonorrhea | 2002 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Gonorrhea | 2002 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Gonorrhea | 2002 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Gonorrhea | 2002 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Gonorrhea | 2002 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Gonorrhea | 2002 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Gonorrhea | 2002 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Gonorrhea | 2002 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Gonorrhea | 2002 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Gonorrhea | 2002 | Unknown | Female | 0-14 | NA | NA |
| Gonorrhea | 2002 | Unknown | Female | 15-19 | NA | NA |
| Gonorrhea | 2002 | Unknown | Female | 20-24 | NA | NA |
| Gonorrhea | 2002 | Unknown | Female | 25-29 | NA | NA |
| Gonorrhea | 2002 | Unknown | Female | 30-34 | NA | NA |
| Gonorrhea | 2002 | Unknown | Female | 35-39 | NA | NA |
| Gonorrhea | 2002 | Unknown | Female | 40-44 | NA | NA |
| Gonorrhea | 2002 | Unknown | Male | 0-14 | NA | NA |
| Gonorrhea | 2002 | Unknown | Male | 15-19 | NA | NA |
| Gonorrhea | 2002 | Unknown | Male | 20-24 | NA | NA |
| Gonorrhea | 2002 | Unknown | Male | 25-29 | NA | NA |
| Gonorrhea | 2002 | Unknown | Male | 30-34 | NA | NA |
| Gonorrhea | 2002 | Unknown | Male | 35-39 | NA | NA |
| Gonorrhea | 2002 | Unknown | Male | 40-44 | NA | NA |
| Gonorrhea | 2002 | White | Female | 0-14 | NA | NA |
| Gonorrhea | 2002 | White | Female | 15-19 | NA | NA |
| Gonorrhea | 2002 | White | Female | 20-24 | NA | NA |
| Gonorrhea | 2002 | White | Female | 25-29 | NA | NA |
| Gonorrhea | 2002 | White | Female | 30-34 | NA | NA |
| Gonorrhea | 2002 | White | Female | 35-39 | NA | NA |
| Gonorrhea | 2002 | White | Female | 40-44 | NA | NA |
| Gonorrhea | 2002 | White | Male | 0-14 | NA | NA |
| Gonorrhea | 2002 | White | Male | 15-19 | NA | NA |
| Gonorrhea | 2002 | White | Male | 20-24 | NA | NA |
| Gonorrhea | 2002 | White | Male | 25-29 | NA | NA |
| Gonorrhea | 2002 | White | Male | 30-34 | NA | NA |
| Gonorrhea | 2002 | White | Male | 35-39 | NA | NA |
| Gonorrhea | 2002 | White | Male | 40-44 | NA | NA |
| Gonorrhea | 2003 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Gonorrhea | 2003 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Gonorrhea | 2003 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Gonorrhea | 2003 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Gonorrhea | 2003 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Gonorrhea | 2003 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Gonorrhea | 2003 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Gonorrhea | 2003 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Gonorrhea | 2003 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Gonorrhea | 2003 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Gonorrhea | 2003 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Gonorrhea | 2003 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Gonorrhea | 2003 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Gonorrhea | 2003 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Gonorrhea | 2003 | Asian | Female | 0-14 | NA | NA |
| Gonorrhea | 2003 | Asian | Female | 15-19 | NA | NA |
| Gonorrhea | 2003 | Asian | Female | 20-24 | NA | NA |
| Gonorrhea | 2003 | Asian | Female | 25-29 | NA | NA |
| Gonorrhea | 2003 | Asian | Female | 30-34 | NA | NA |
| Gonorrhea | 2003 | Asian | Female | 35-39 | NA | NA |
| Gonorrhea | 2003 | Asian | Female | 40-44 | NA | NA |
| Gonorrhea | 2003 | Asian | Male | 0-14 | NA | NA |
| Gonorrhea | 2003 | Asian | Male | 15-19 | NA | NA |
| Gonorrhea | 2003 | Asian | Male | 20-24 | NA | NA |
| Gonorrhea | 2003 | Asian | Male | 25-29 | NA | NA |
| Gonorrhea | 2003 | Asian | Male | 30-34 | NA | NA |
| Gonorrhea | 2003 | Asian | Male | 35-39 | NA | NA |
| Gonorrhea | 2003 | Asian | Male | 40-44 | NA | NA |
| Gonorrhea | 2003 | Black/African American | Female | 0-14 | NA | NA |
| Gonorrhea | 2003 | Black/African American | Female | 15-19 | NA | NA |
| Gonorrhea | 2003 | Black/African American | Female | 20-24 | NA | NA |
| Gonorrhea | 2003 | Black/African American | Female | 25-29 | NA | NA |
| Gonorrhea | 2003 | Black/African American | Female | 30-34 | NA | NA |
| Gonorrhea | 2003 | Black/African American | Female | 35-39 | NA | NA |
| Gonorrhea | 2003 | Black/African American | Female | 40-44 | NA | NA |
| Gonorrhea | 2003 | Black/African American | Male | 0-14 | NA | NA |
| Gonorrhea | 2003 | Black/African American | Male | 15-19 | NA | NA |
| Gonorrhea | 2003 | Black/African American | Male | 20-24 | NA | NA |
| Gonorrhea | 2003 | Black/African American | Male | 25-29 | NA | NA |
| Gonorrhea | 2003 | Black/African American | Male | 30-34 | NA | NA |
| Gonorrhea | 2003 | Black/African American | Male | 35-39 | NA | NA |
| Gonorrhea | 2003 | Black/African American | Male | 40-44 | NA | NA |
| Gonorrhea | 2003 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Gonorrhea | 2003 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Gonorrhea | 2003 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Gonorrhea | 2003 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Gonorrhea | 2003 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Gonorrhea | 2003 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Gonorrhea | 2003 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Gonorrhea | 2003 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Gonorrhea | 2003 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Gonorrhea | 2003 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Gonorrhea | 2003 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Gonorrhea | 2003 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Gonorrhea | 2003 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Gonorrhea | 2003 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Gonorrhea | 2003 | Multiple races | Female | 0-14 | NA | NA |
| Gonorrhea | 2003 | Multiple races | Female | 15-19 | NA | NA |
| Gonorrhea | 2003 | Multiple races | Female | 20-24 | NA | NA |
| Gonorrhea | 2003 | Multiple races | Female | 25-29 | NA | NA |
| Gonorrhea | 2003 | Multiple races | Female | 30-34 | NA | NA |
| Gonorrhea | 2003 | Multiple races | Female | 35-39 | NA | NA |
| Gonorrhea | 2003 | Multiple races | Female | 40-44 | NA | NA |
| Gonorrhea | 2003 | Multiple races | Male | 0-14 | NA | NA |
| Gonorrhea | 2003 | Multiple races | Male | 15-19 | NA | NA |
| Gonorrhea | 2003 | Multiple races | Male | 20-24 | NA | NA |
| Gonorrhea | 2003 | Multiple races | Male | 25-29 | NA | NA |
| Gonorrhea | 2003 | Multiple races | Male | 30-34 | NA | NA |
| Gonorrhea | 2003 | Multiple races | Male | 35-39 | NA | NA |
| Gonorrhea | 2003 | Multiple races | Male | 40-44 | NA | NA |
| Gonorrhea | 2003 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Gonorrhea | 2003 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Gonorrhea | 2003 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Gonorrhea | 2003 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Gonorrhea | 2003 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Gonorrhea | 2003 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Gonorrhea | 2003 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Gonorrhea | 2003 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Gonorrhea | 2003 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Gonorrhea | 2003 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Gonorrhea | 2003 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Gonorrhea | 2003 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Gonorrhea | 2003 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Gonorrhea | 2003 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Gonorrhea | 2003 | Unknown | Female | 0-14 | NA | NA |
| Gonorrhea | 2003 | Unknown | Female | 15-19 | NA | NA |
| Gonorrhea | 2003 | Unknown | Female | 20-24 | NA | NA |
| Gonorrhea | 2003 | Unknown | Female | 25-29 | NA | NA |
| Gonorrhea | 2003 | Unknown | Female | 30-34 | NA | NA |
| Gonorrhea | 2003 | Unknown | Female | 35-39 | NA | NA |
| Gonorrhea | 2003 | Unknown | Female | 40-44 | NA | NA |
| Gonorrhea | 2003 | Unknown | Male | 0-14 | NA | NA |
| Gonorrhea | 2003 | Unknown | Male | 15-19 | NA | NA |
| Gonorrhea | 2003 | Unknown | Male | 20-24 | NA | NA |
| Gonorrhea | 2003 | Unknown | Male | 25-29 | NA | NA |
| Gonorrhea | 2003 | Unknown | Male | 30-34 | NA | NA |
| Gonorrhea | 2003 | Unknown | Male | 35-39 | NA | NA |
| Gonorrhea | 2003 | Unknown | Male | 40-44 | NA | NA |
| Gonorrhea | 2003 | White | Female | 0-14 | NA | NA |
| Gonorrhea | 2003 | White | Female | 15-19 | NA | NA |
| Gonorrhea | 2003 | White | Female | 20-24 | NA | NA |
| Gonorrhea | 2003 | White | Female | 25-29 | NA | NA |
| Gonorrhea | 2003 | White | Female | 30-34 | NA | NA |
| Gonorrhea | 2003 | White | Female | 35-39 | NA | NA |
| Gonorrhea | 2003 | White | Female | 40-44 | NA | NA |
| Gonorrhea | 2003 | White | Male | 0-14 | NA | NA |
| Gonorrhea | 2003 | White | Male | 15-19 | NA | NA |
| Gonorrhea | 2003 | White | Male | 20-24 | NA | NA |
| Gonorrhea | 2003 | White | Male | 25-29 | NA | NA |
| Gonorrhea | 2003 | White | Male | 30-34 | NA | NA |
| Gonorrhea | 2003 | White | Male | 35-39 | NA | NA |
| Gonorrhea | 2003 | White | Male | 40-44 | NA | NA |
| Gonorrhea | 2004 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Gonorrhea | 2004 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Gonorrhea | 2004 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Gonorrhea | 2004 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Gonorrhea | 2004 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Gonorrhea | 2004 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Gonorrhea | 2004 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Gonorrhea | 2004 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Gonorrhea | 2004 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Gonorrhea | 2004 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Gonorrhea | 2004 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Gonorrhea | 2004 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Gonorrhea | 2004 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Gonorrhea | 2004 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Gonorrhea | 2004 | Asian | Female | 0-14 | NA | NA |
| Gonorrhea | 2004 | Asian | Female | 15-19 | NA | NA |
| Gonorrhea | 2004 | Asian | Female | 20-24 | NA | NA |
| Gonorrhea | 2004 | Asian | Female | 25-29 | NA | NA |
| Gonorrhea | 2004 | Asian | Female | 30-34 | NA | NA |
| Gonorrhea | 2004 | Asian | Female | 35-39 | NA | NA |
| Gonorrhea | 2004 | Asian | Female | 40-44 | NA | NA |
| Gonorrhea | 2004 | Asian | Male | 0-14 | NA | NA |
| Gonorrhea | 2004 | Asian | Male | 15-19 | NA | NA |
| Gonorrhea | 2004 | Asian | Male | 20-24 | NA | NA |
| Gonorrhea | 2004 | Asian | Male | 25-29 | NA | NA |
| Gonorrhea | 2004 | Asian | Male | 30-34 | NA | NA |
| Gonorrhea | 2004 | Asian | Male | 35-39 | NA | NA |
| Gonorrhea | 2004 | Asian | Male | 40-44 | NA | NA |
| Gonorrhea | 2004 | Black/African American | Female | 0-14 | NA | NA |
| Gonorrhea | 2004 | Black/African American | Female | 15-19 | NA | NA |
| Gonorrhea | 2004 | Black/African American | Female | 20-24 | NA | NA |
| Gonorrhea | 2004 | Black/African American | Female | 25-29 | NA | NA |
| Gonorrhea | 2004 | Black/African American | Female | 30-34 | NA | NA |
| Gonorrhea | 2004 | Black/African American | Female | 35-39 | NA | NA |
| Gonorrhea | 2004 | Black/African American | Female | 40-44 | NA | NA |
| Gonorrhea | 2004 | Black/African American | Male | 0-14 | NA | NA |
| Gonorrhea | 2004 | Black/African American | Male | 15-19 | NA | NA |
| Gonorrhea | 2004 | Black/African American | Male | 20-24 | NA | NA |
| Gonorrhea | 2004 | Black/African American | Male | 25-29 | NA | NA |
| Gonorrhea | 2004 | Black/African American | Male | 30-34 | NA | NA |
| Gonorrhea | 2004 | Black/African American | Male | 35-39 | NA | NA |
| Gonorrhea | 2004 | Black/African American | Male | 40-44 | NA | NA |
| Gonorrhea | 2004 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Gonorrhea | 2004 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Gonorrhea | 2004 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Gonorrhea | 2004 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Gonorrhea | 2004 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Gonorrhea | 2004 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Gonorrhea | 2004 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Gonorrhea | 2004 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Gonorrhea | 2004 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Gonorrhea | 2004 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Gonorrhea | 2004 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Gonorrhea | 2004 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Gonorrhea | 2004 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Gonorrhea | 2004 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Gonorrhea | 2004 | Multiple races | Female | 0-14 | NA | NA |
| Gonorrhea | 2004 | Multiple races | Female | 15-19 | NA | NA |
| Gonorrhea | 2004 | Multiple races | Female | 20-24 | NA | NA |
| Gonorrhea | 2004 | Multiple races | Female | 25-29 | NA | NA |
| Gonorrhea | 2004 | Multiple races | Female | 30-34 | NA | NA |
| Gonorrhea | 2004 | Multiple races | Female | 35-39 | NA | NA |
| Gonorrhea | 2004 | Multiple races | Female | 40-44 | NA | NA |
| Gonorrhea | 2004 | Multiple races | Male | 0-14 | NA | NA |
| Gonorrhea | 2004 | Multiple races | Male | 15-19 | NA | NA |
| Gonorrhea | 2004 | Multiple races | Male | 20-24 | NA | NA |
| Gonorrhea | 2004 | Multiple races | Male | 25-29 | NA | NA |
| Gonorrhea | 2004 | Multiple races | Male | 30-34 | NA | NA |
| Gonorrhea | 2004 | Multiple races | Male | 35-39 | NA | NA |
| Gonorrhea | 2004 | Multiple races | Male | 40-44 | NA | NA |
| Gonorrhea | 2004 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Gonorrhea | 2004 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Gonorrhea | 2004 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Gonorrhea | 2004 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Gonorrhea | 2004 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Gonorrhea | 2004 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Gonorrhea | 2004 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Gonorrhea | 2004 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Gonorrhea | 2004 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Gonorrhea | 2004 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Gonorrhea | 2004 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Gonorrhea | 2004 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Gonorrhea | 2004 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Gonorrhea | 2004 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Gonorrhea | 2004 | Unknown | Female | 0-14 | NA | NA |
| Gonorrhea | 2004 | Unknown | Female | 15-19 | NA | NA |
| Gonorrhea | 2004 | Unknown | Female | 20-24 | NA | NA |
| Gonorrhea | 2004 | Unknown | Female | 25-29 | NA | NA |
| Gonorrhea | 2004 | Unknown | Female | 30-34 | NA | NA |
| Gonorrhea | 2004 | Unknown | Female | 35-39 | NA | NA |
| Gonorrhea | 2004 | Unknown | Female | 40-44 | NA | NA |
| Gonorrhea | 2004 | Unknown | Male | 0-14 | NA | NA |
| Gonorrhea | 2004 | Unknown | Male | 15-19 | NA | NA |
| Gonorrhea | 2004 | Unknown | Male | 20-24 | NA | NA |
| Gonorrhea | 2004 | Unknown | Male | 25-29 | NA | NA |
| Gonorrhea | 2004 | Unknown | Male | 30-34 | NA | NA |
| Gonorrhea | 2004 | Unknown | Male | 35-39 | NA | NA |
| Gonorrhea | 2004 | Unknown | Male | 40-44 | NA | NA |
| Gonorrhea | 2004 | White | Female | 0-14 | NA | NA |
| Gonorrhea | 2004 | White | Female | 15-19 | NA | NA |
| Gonorrhea | 2004 | White | Female | 20-24 | NA | NA |
| Gonorrhea | 2004 | White | Female | 25-29 | NA | NA |
| Gonorrhea | 2004 | White | Female | 30-34 | NA | NA |
| Gonorrhea | 2004 | White | Female | 35-39 | NA | NA |
| Gonorrhea | 2004 | White | Female | 40-44 | NA | NA |
| Gonorrhea | 2004 | White | Male | 0-14 | NA | NA |
| Gonorrhea | 2004 | White | Male | 15-19 | NA | NA |
| Gonorrhea | 2004 | White | Male | 20-24 | NA | NA |
| Gonorrhea | 2004 | White | Male | 25-29 | NA | NA |
| Gonorrhea | 2004 | White | Male | 30-34 | NA | NA |
| Gonorrhea | 2004 | White | Male | 35-39 | NA | NA |
| Gonorrhea | 2004 | White | Male | 40-44 | NA | NA |
| Gonorrhea | 2005 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Gonorrhea | 2005 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Gonorrhea | 2005 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Gonorrhea | 2005 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Gonorrhea | 2005 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Gonorrhea | 2005 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Gonorrhea | 2005 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Gonorrhea | 2005 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Gonorrhea | 2005 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Gonorrhea | 2005 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Gonorrhea | 2005 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Gonorrhea | 2005 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Gonorrhea | 2005 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Gonorrhea | 2005 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Gonorrhea | 2005 | Asian | Female | 0-14 | NA | NA |
| Gonorrhea | 2005 | Asian | Female | 15-19 | NA | NA |
| Gonorrhea | 2005 | Asian | Female | 20-24 | NA | NA |
| Gonorrhea | 2005 | Asian | Female | 25-29 | NA | NA |
| Gonorrhea | 2005 | Asian | Female | 30-34 | NA | NA |
| Gonorrhea | 2005 | Asian | Female | 35-39 | NA | NA |
| Gonorrhea | 2005 | Asian | Female | 40-44 | NA | NA |
| Gonorrhea | 2005 | Asian | Male | 0-14 | NA | NA |
| Gonorrhea | 2005 | Asian | Male | 15-19 | NA | NA |
| Gonorrhea | 2005 | Asian | Male | 20-24 | NA | NA |
| Gonorrhea | 2005 | Asian | Male | 25-29 | NA | NA |
| Gonorrhea | 2005 | Asian | Male | 30-34 | NA | NA |
| Gonorrhea | 2005 | Asian | Male | 35-39 | NA | NA |
| Gonorrhea | 2005 | Asian | Male | 40-44 | NA | NA |
| Gonorrhea | 2005 | Black/African American | Female | 0-14 | NA | NA |
| Gonorrhea | 2005 | Black/African American | Female | 15-19 | NA | NA |
| Gonorrhea | 2005 | Black/African American | Female | 20-24 | NA | NA |
| Gonorrhea | 2005 | Black/African American | Female | 25-29 | NA | NA |
| Gonorrhea | 2005 | Black/African American | Female | 30-34 | NA | NA |
| Gonorrhea | 2005 | Black/African American | Female | 35-39 | NA | NA |
| Gonorrhea | 2005 | Black/African American | Female | 40-44 | NA | NA |
| Gonorrhea | 2005 | Black/African American | Male | 0-14 | NA | NA |
| Gonorrhea | 2005 | Black/African American | Male | 15-19 | NA | NA |
| Gonorrhea | 2005 | Black/African American | Male | 20-24 | NA | NA |
| Gonorrhea | 2005 | Black/African American | Male | 25-29 | NA | NA |
| Gonorrhea | 2005 | Black/African American | Male | 30-34 | NA | NA |
| Gonorrhea | 2005 | Black/African American | Male | 35-39 | NA | NA |
| Gonorrhea | 2005 | Black/African American | Male | 40-44 | NA | NA |
| Gonorrhea | 2005 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Gonorrhea | 2005 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Gonorrhea | 2005 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Gonorrhea | 2005 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Gonorrhea | 2005 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Gonorrhea | 2005 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Gonorrhea | 2005 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Gonorrhea | 2005 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Gonorrhea | 2005 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Gonorrhea | 2005 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Gonorrhea | 2005 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Gonorrhea | 2005 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Gonorrhea | 2005 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Gonorrhea | 2005 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Gonorrhea | 2005 | Multiple races | Female | 0-14 | NA | NA |
| Gonorrhea | 2005 | Multiple races | Female | 15-19 | NA | NA |
| Gonorrhea | 2005 | Multiple races | Female | 20-24 | NA | NA |
| Gonorrhea | 2005 | Multiple races | Female | 25-29 | NA | NA |
| Gonorrhea | 2005 | Multiple races | Female | 30-34 | NA | NA |
| Gonorrhea | 2005 | Multiple races | Female | 35-39 | NA | NA |
| Gonorrhea | 2005 | Multiple races | Female | 40-44 | NA | NA |
| Gonorrhea | 2005 | Multiple races | Male | 0-14 | NA | NA |
| Gonorrhea | 2005 | Multiple races | Male | 15-19 | NA | NA |
| Gonorrhea | 2005 | Multiple races | Male | 20-24 | NA | NA |
| Gonorrhea | 2005 | Multiple races | Male | 25-29 | NA | NA |
| Gonorrhea | 2005 | Multiple races | Male | 30-34 | NA | NA |
| Gonorrhea | 2005 | Multiple races | Male | 35-39 | NA | NA |
| Gonorrhea | 2005 | Multiple races | Male | 40-44 | NA | NA |
| Gonorrhea | 2005 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Gonorrhea | 2005 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Gonorrhea | 2005 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Gonorrhea | 2005 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Gonorrhea | 2005 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Gonorrhea | 2005 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Gonorrhea | 2005 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Gonorrhea | 2005 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Gonorrhea | 2005 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Gonorrhea | 2005 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Gonorrhea | 2005 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Gonorrhea | 2005 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Gonorrhea | 2005 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Gonorrhea | 2005 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Gonorrhea | 2005 | Unknown | Female | 0-14 | NA | NA |
| Gonorrhea | 2005 | Unknown | Female | 15-19 | NA | NA |
| Gonorrhea | 2005 | Unknown | Female | 20-24 | NA | NA |
| Gonorrhea | 2005 | Unknown | Female | 25-29 | NA | NA |
| Gonorrhea | 2005 | Unknown | Female | 30-34 | NA | NA |
| Gonorrhea | 2005 | Unknown | Female | 35-39 | NA | NA |
| Gonorrhea | 2005 | Unknown | Female | 40-44 | NA | NA |
| Gonorrhea | 2005 | Unknown | Male | 0-14 | NA | NA |
| Gonorrhea | 2005 | Unknown | Male | 15-19 | NA | NA |
| Gonorrhea | 2005 | Unknown | Male | 20-24 | NA | NA |
| Gonorrhea | 2005 | Unknown | Male | 25-29 | NA | NA |
| Gonorrhea | 2005 | Unknown | Male | 30-34 | NA | NA |
| Gonorrhea | 2005 | Unknown | Male | 35-39 | NA | NA |
| Gonorrhea | 2005 | Unknown | Male | 40-44 | NA | NA |
| Gonorrhea | 2005 | White | Female | 0-14 | NA | NA |
| Gonorrhea | 2005 | White | Female | 15-19 | NA | NA |
| Gonorrhea | 2005 | White | Female | 20-24 | NA | NA |
| Gonorrhea | 2005 | White | Female | 25-29 | NA | NA |
| Gonorrhea | 2005 | White | Female | 30-34 | NA | NA |
| Gonorrhea | 2005 | White | Female | 35-39 | NA | NA |
| Gonorrhea | 2005 | White | Female | 40-44 | NA | NA |
| Gonorrhea | 2005 | White | Male | 0-14 | NA | NA |
| Gonorrhea | 2005 | White | Male | 15-19 | NA | NA |
| Gonorrhea | 2005 | White | Male | 20-24 | NA | NA |
| Gonorrhea | 2005 | White | Male | 25-29 | NA | NA |
| Gonorrhea | 2005 | White | Male | 30-34 | NA | NA |
| Gonorrhea | 2005 | White | Male | 35-39 | NA | NA |
| Gonorrhea | 2005 | White | Male | 40-44 | NA | NA |
| Gonorrhea | 2006 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Gonorrhea | 2006 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Gonorrhea | 2006 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Gonorrhea | 2006 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Gonorrhea | 2006 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Gonorrhea | 2006 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Gonorrhea | 2006 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Gonorrhea | 2006 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Gonorrhea | 2006 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Gonorrhea | 2006 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Gonorrhea | 2006 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Gonorrhea | 2006 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Gonorrhea | 2006 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Gonorrhea | 2006 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Gonorrhea | 2006 | Asian | Female | 0-14 | NA | NA |
| Gonorrhea | 2006 | Asian | Female | 15-19 | NA | NA |
| Gonorrhea | 2006 | Asian | Female | 20-24 | NA | NA |
| Gonorrhea | 2006 | Asian | Female | 25-29 | NA | NA |
| Gonorrhea | 2006 | Asian | Female | 30-34 | NA | NA |
| Gonorrhea | 2006 | Asian | Female | 35-39 | NA | NA |
| Gonorrhea | 2006 | Asian | Female | 40-44 | NA | NA |
| Gonorrhea | 2006 | Asian | Male | 0-14 | NA | NA |
| Gonorrhea | 2006 | Asian | Male | 15-19 | NA | NA |
| Gonorrhea | 2006 | Asian | Male | 20-24 | NA | NA |
| Gonorrhea | 2006 | Asian | Male | 25-29 | NA | NA |
| Gonorrhea | 2006 | Asian | Male | 30-34 | NA | NA |
| Gonorrhea | 2006 | Asian | Male | 35-39 | NA | NA |
| Gonorrhea | 2006 | Asian | Male | 40-44 | NA | NA |
| Gonorrhea | 2006 | Black/African American | Female | 0-14 | NA | NA |
| Gonorrhea | 2006 | Black/African American | Female | 15-19 | NA | NA |
| Gonorrhea | 2006 | Black/African American | Female | 20-24 | NA | NA |
| Gonorrhea | 2006 | Black/African American | Female | 25-29 | NA | NA |
| Gonorrhea | 2006 | Black/African American | Female | 30-34 | NA | NA |
| Gonorrhea | 2006 | Black/African American | Female | 35-39 | NA | NA |
| Gonorrhea | 2006 | Black/African American | Female | 40-44 | NA | NA |
| Gonorrhea | 2006 | Black/African American | Male | 0-14 | NA | NA |
| Gonorrhea | 2006 | Black/African American | Male | 15-19 | NA | NA |
| Gonorrhea | 2006 | Black/African American | Male | 20-24 | NA | NA |
| Gonorrhea | 2006 | Black/African American | Male | 25-29 | NA | NA |
| Gonorrhea | 2006 | Black/African American | Male | 30-34 | NA | NA |
| Gonorrhea | 2006 | Black/African American | Male | 35-39 | NA | NA |
| Gonorrhea | 2006 | Black/African American | Male | 40-44 | NA | NA |
| Gonorrhea | 2006 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Gonorrhea | 2006 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Gonorrhea | 2006 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Gonorrhea | 2006 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Gonorrhea | 2006 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Gonorrhea | 2006 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Gonorrhea | 2006 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Gonorrhea | 2006 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Gonorrhea | 2006 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Gonorrhea | 2006 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Gonorrhea | 2006 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Gonorrhea | 2006 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Gonorrhea | 2006 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Gonorrhea | 2006 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Gonorrhea | 2006 | Multiple races | Female | 0-14 | NA | NA |
| Gonorrhea | 2006 | Multiple races | Female | 15-19 | NA | NA |
| Gonorrhea | 2006 | Multiple races | Female | 20-24 | NA | NA |
| Gonorrhea | 2006 | Multiple races | Female | 25-29 | NA | NA |
| Gonorrhea | 2006 | Multiple races | Female | 30-34 | NA | NA |
| Gonorrhea | 2006 | Multiple races | Female | 35-39 | NA | NA |
| Gonorrhea | 2006 | Multiple races | Female | 40-44 | NA | NA |
| Gonorrhea | 2006 | Multiple races | Male | 0-14 | NA | NA |
| Gonorrhea | 2006 | Multiple races | Male | 15-19 | NA | NA |
| Gonorrhea | 2006 | Multiple races | Male | 20-24 | NA | NA |
| Gonorrhea | 2006 | Multiple races | Male | 25-29 | NA | NA |
| Gonorrhea | 2006 | Multiple races | Male | 30-34 | NA | NA |
| Gonorrhea | 2006 | Multiple races | Male | 35-39 | NA | NA |
| Gonorrhea | 2006 | Multiple races | Male | 40-44 | NA | NA |
| Gonorrhea | 2006 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Gonorrhea | 2006 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Gonorrhea | 2006 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Gonorrhea | 2006 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Gonorrhea | 2006 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Gonorrhea | 2006 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Gonorrhea | 2006 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Gonorrhea | 2006 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Gonorrhea | 2006 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Gonorrhea | 2006 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Gonorrhea | 2006 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Gonorrhea | 2006 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Gonorrhea | 2006 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Gonorrhea | 2006 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Gonorrhea | 2006 | Unknown | Female | 0-14 | NA | NA |
| Gonorrhea | 2006 | Unknown | Female | 15-19 | NA | NA |
| Gonorrhea | 2006 | Unknown | Female | 20-24 | NA | NA |
| Gonorrhea | 2006 | Unknown | Female | 25-29 | NA | NA |
| Gonorrhea | 2006 | Unknown | Female | 30-34 | NA | NA |
| Gonorrhea | 2006 | Unknown | Female | 35-39 | NA | NA |
| Gonorrhea | 2006 | Unknown | Female | 40-44 | NA | NA |
| Gonorrhea | 2006 | Unknown | Male | 0-14 | NA | NA |
| Gonorrhea | 2006 | Unknown | Male | 15-19 | NA | NA |
| Gonorrhea | 2006 | Unknown | Male | 20-24 | NA | NA |
| Gonorrhea | 2006 | Unknown | Male | 25-29 | NA | NA |
| Gonorrhea | 2006 | Unknown | Male | 30-34 | NA | NA |
| Gonorrhea | 2006 | Unknown | Male | 35-39 | NA | NA |
| Gonorrhea | 2006 | Unknown | Male | 40-44 | NA | NA |
| Gonorrhea | 2006 | White | Female | 0-14 | NA | NA |
| Gonorrhea | 2006 | White | Female | 15-19 | NA | NA |
| Gonorrhea | 2006 | White | Female | 20-24 | NA | NA |
| Gonorrhea | 2006 | White | Female | 25-29 | NA | NA |
| Gonorrhea | 2006 | White | Female | 30-34 | NA | NA |
| Gonorrhea | 2006 | White | Female | 35-39 | NA | NA |
| Gonorrhea | 2006 | White | Female | 40-44 | NA | NA |
| Gonorrhea | 2006 | White | Male | 0-14 | NA | NA |
| Gonorrhea | 2006 | White | Male | 15-19 | NA | NA |
| Gonorrhea | 2006 | White | Male | 20-24 | NA | NA |
| Gonorrhea | 2006 | White | Male | 25-29 | NA | NA |
| Gonorrhea | 2006 | White | Male | 30-34 | NA | NA |
| Gonorrhea | 2006 | White | Male | 35-39 | NA | NA |
| Gonorrhea | 2006 | White | Male | 40-44 | NA | NA |
| Gonorrhea | 2007 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Gonorrhea | 2007 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Gonorrhea | 2007 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Gonorrhea | 2007 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Gonorrhea | 2007 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Gonorrhea | 2007 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Gonorrhea | 2007 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Gonorrhea | 2007 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Gonorrhea | 2007 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Gonorrhea | 2007 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Gonorrhea | 2007 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Gonorrhea | 2007 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Gonorrhea | 2007 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Gonorrhea | 2007 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Gonorrhea | 2007 | Asian | Female | 0-14 | NA | NA |
| Gonorrhea | 2007 | Asian | Female | 15-19 | NA | NA |
| Gonorrhea | 2007 | Asian | Female | 20-24 | NA | NA |
| Gonorrhea | 2007 | Asian | Female | 25-29 | NA | NA |
| Gonorrhea | 2007 | Asian | Female | 30-34 | NA | NA |
| Gonorrhea | 2007 | Asian | Female | 35-39 | NA | NA |
| Gonorrhea | 2007 | Asian | Female | 40-44 | NA | NA |
| Gonorrhea | 2007 | Asian | Male | 0-14 | NA | NA |
| Gonorrhea | 2007 | Asian | Male | 15-19 | NA | NA |
| Gonorrhea | 2007 | Asian | Male | 20-24 | NA | NA |
| Gonorrhea | 2007 | Asian | Male | 25-29 | NA | NA |
| Gonorrhea | 2007 | Asian | Male | 30-34 | NA | NA |
| Gonorrhea | 2007 | Asian | Male | 35-39 | NA | NA |
| Gonorrhea | 2007 | Asian | Male | 40-44 | NA | NA |
| Gonorrhea | 2007 | Black/African American | Female | 0-14 | NA | NA |
| Gonorrhea | 2007 | Black/African American | Female | 15-19 | NA | NA |
| Gonorrhea | 2007 | Black/African American | Female | 20-24 | NA | NA |
| Gonorrhea | 2007 | Black/African American | Female | 25-29 | NA | NA |
| Gonorrhea | 2007 | Black/African American | Female | 30-34 | NA | NA |
| Gonorrhea | 2007 | Black/African American | Female | 35-39 | NA | NA |
| Gonorrhea | 2007 | Black/African American | Female | 40-44 | NA | NA |
| Gonorrhea | 2007 | Black/African American | Male | 0-14 | NA | NA |
| Gonorrhea | 2007 | Black/African American | Male | 15-19 | NA | NA |
| Gonorrhea | 2007 | Black/African American | Male | 20-24 | NA | NA |
| Gonorrhea | 2007 | Black/African American | Male | 25-29 | NA | NA |
| Gonorrhea | 2007 | Black/African American | Male | 30-34 | NA | NA |
| Gonorrhea | 2007 | Black/African American | Male | 35-39 | NA | NA |
| Gonorrhea | 2007 | Black/African American | Male | 40-44 | NA | NA |
| Gonorrhea | 2007 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Gonorrhea | 2007 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Gonorrhea | 2007 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Gonorrhea | 2007 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Gonorrhea | 2007 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Gonorrhea | 2007 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Gonorrhea | 2007 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Gonorrhea | 2007 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Gonorrhea | 2007 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Gonorrhea | 2007 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Gonorrhea | 2007 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Gonorrhea | 2007 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Gonorrhea | 2007 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Gonorrhea | 2007 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Gonorrhea | 2007 | Multiple races | Female | 0-14 | NA | NA |
| Gonorrhea | 2007 | Multiple races | Female | 15-19 | NA | NA |
| Gonorrhea | 2007 | Multiple races | Female | 20-24 | NA | NA |
| Gonorrhea | 2007 | Multiple races | Female | 25-29 | NA | NA |
| Gonorrhea | 2007 | Multiple races | Female | 30-34 | NA | NA |
| Gonorrhea | 2007 | Multiple races | Female | 35-39 | NA | NA |
| Gonorrhea | 2007 | Multiple races | Female | 40-44 | NA | NA |
| Gonorrhea | 2007 | Multiple races | Male | 0-14 | NA | NA |
| Gonorrhea | 2007 | Multiple races | Male | 15-19 | NA | NA |
| Gonorrhea | 2007 | Multiple races | Male | 20-24 | NA | NA |
| Gonorrhea | 2007 | Multiple races | Male | 25-29 | NA | NA |
| Gonorrhea | 2007 | Multiple races | Male | 30-34 | NA | NA |
| Gonorrhea | 2007 | Multiple races | Male | 35-39 | NA | NA |
| Gonorrhea | 2007 | Multiple races | Male | 40-44 | NA | NA |
| Gonorrhea | 2007 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Gonorrhea | 2007 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Gonorrhea | 2007 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Gonorrhea | 2007 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Gonorrhea | 2007 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Gonorrhea | 2007 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Gonorrhea | 2007 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Gonorrhea | 2007 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Gonorrhea | 2007 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Gonorrhea | 2007 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Gonorrhea | 2007 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Gonorrhea | 2007 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Gonorrhea | 2007 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Gonorrhea | 2007 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Gonorrhea | 2007 | Unknown | Female | 0-14 | NA | NA |
| Gonorrhea | 2007 | Unknown | Female | 15-19 | NA | NA |
| Gonorrhea | 2007 | Unknown | Female | 20-24 | NA | NA |
| Gonorrhea | 2007 | Unknown | Female | 25-29 | NA | NA |
| Gonorrhea | 2007 | Unknown | Female | 30-34 | NA | NA |
| Gonorrhea | 2007 | Unknown | Female | 35-39 | NA | NA |
| Gonorrhea | 2007 | Unknown | Female | 40-44 | NA | NA |
| Gonorrhea | 2007 | Unknown | Male | 0-14 | NA | NA |
| Gonorrhea | 2007 | Unknown | Male | 15-19 | NA | NA |
| Gonorrhea | 2007 | Unknown | Male | 20-24 | NA | NA |
| Gonorrhea | 2007 | Unknown | Male | 25-29 | NA | NA |
| Gonorrhea | 2007 | Unknown | Male | 30-34 | NA | NA |
| Gonorrhea | 2007 | Unknown | Male | 35-39 | NA | NA |
| Gonorrhea | 2007 | Unknown | Male | 40-44 | NA | NA |
| Gonorrhea | 2007 | White | Female | 0-14 | NA | NA |
| Gonorrhea | 2007 | White | Female | 15-19 | NA | NA |
| Gonorrhea | 2007 | White | Female | 20-24 | NA | NA |
| Gonorrhea | 2007 | White | Female | 25-29 | NA | NA |
| Gonorrhea | 2007 | White | Female | 30-34 | NA | NA |
| Gonorrhea | 2007 | White | Female | 35-39 | NA | NA |
| Gonorrhea | 2007 | White | Female | 40-44 | NA | NA |
| Gonorrhea | 2007 | White | Male | 0-14 | NA | NA |
| Gonorrhea | 2007 | White | Male | 15-19 | NA | NA |
| Gonorrhea | 2007 | White | Male | 20-24 | NA | NA |
| Gonorrhea | 2007 | White | Male | 25-29 | NA | NA |
| Gonorrhea | 2007 | White | Male | 30-34 | NA | NA |
| Gonorrhea | 2007 | White | Male | 35-39 | NA | NA |
| Gonorrhea | 2007 | White | Male | 40-44 | NA | NA |
| Gonorrhea | 2008 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Gonorrhea | 2008 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Gonorrhea | 2008 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Gonorrhea | 2008 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Gonorrhea | 2008 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Gonorrhea | 2008 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Gonorrhea | 2008 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Gonorrhea | 2008 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Gonorrhea | 2008 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Gonorrhea | 2008 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Gonorrhea | 2008 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Gonorrhea | 2008 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Gonorrhea | 2008 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Gonorrhea | 2008 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Gonorrhea | 2008 | Asian | Female | 0-14 | NA | NA |
| Gonorrhea | 2008 | Asian | Female | 15-19 | NA | NA |
| Gonorrhea | 2008 | Asian | Female | 20-24 | NA | NA |
| Gonorrhea | 2008 | Asian | Female | 25-29 | NA | NA |
| Gonorrhea | 2008 | Asian | Female | 30-34 | NA | NA |
| Gonorrhea | 2008 | Asian | Female | 35-39 | NA | NA |
| Gonorrhea | 2008 | Asian | Female | 40-44 | NA | NA |
| Gonorrhea | 2008 | Asian | Male | 0-14 | NA | NA |
| Gonorrhea | 2008 | Asian | Male | 15-19 | NA | NA |
| Gonorrhea | 2008 | Asian | Male | 20-24 | NA | NA |
| Gonorrhea | 2008 | Asian | Male | 25-29 | NA | NA |
| Gonorrhea | 2008 | Asian | Male | 30-34 | NA | NA |
| Gonorrhea | 2008 | Asian | Male | 35-39 | NA | NA |
| Gonorrhea | 2008 | Asian | Male | 40-44 | NA | NA |
| Gonorrhea | 2008 | Black/African American | Female | 0-14 | NA | NA |
| Gonorrhea | 2008 | Black/African American | Female | 15-19 | NA | NA |
| Gonorrhea | 2008 | Black/African American | Female | 20-24 | NA | NA |
| Gonorrhea | 2008 | Black/African American | Female | 25-29 | NA | NA |
| Gonorrhea | 2008 | Black/African American | Female | 30-34 | NA | NA |
| Gonorrhea | 2008 | Black/African American | Female | 35-39 | NA | NA |
| Gonorrhea | 2008 | Black/African American | Female | 40-44 | NA | NA |
| Gonorrhea | 2008 | Black/African American | Male | 0-14 | NA | NA |
| Gonorrhea | 2008 | Black/African American | Male | 15-19 | NA | NA |
| Gonorrhea | 2008 | Black/African American | Male | 20-24 | NA | NA |
| Gonorrhea | 2008 | Black/African American | Male | 25-29 | NA | NA |
| Gonorrhea | 2008 | Black/African American | Male | 30-34 | NA | NA |
| Gonorrhea | 2008 | Black/African American | Male | 35-39 | NA | NA |
| Gonorrhea | 2008 | Black/African American | Male | 40-44 | NA | NA |
| Gonorrhea | 2008 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Gonorrhea | 2008 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Gonorrhea | 2008 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Gonorrhea | 2008 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Gonorrhea | 2008 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Gonorrhea | 2008 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Gonorrhea | 2008 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Gonorrhea | 2008 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Gonorrhea | 2008 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Gonorrhea | 2008 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Gonorrhea | 2008 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Gonorrhea | 2008 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Gonorrhea | 2008 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Gonorrhea | 2008 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Gonorrhea | 2008 | Multiple races | Female | 0-14 | NA | NA |
| Gonorrhea | 2008 | Multiple races | Female | 15-19 | NA | NA |
| Gonorrhea | 2008 | Multiple races | Female | 20-24 | NA | NA |
| Gonorrhea | 2008 | Multiple races | Female | 25-29 | NA | NA |
| Gonorrhea | 2008 | Multiple races | Female | 30-34 | NA | NA |
| Gonorrhea | 2008 | Multiple races | Female | 35-39 | NA | NA |
| Gonorrhea | 2008 | Multiple races | Female | 40-44 | NA | NA |
| Gonorrhea | 2008 | Multiple races | Male | 0-14 | NA | NA |
| Gonorrhea | 2008 | Multiple races | Male | 15-19 | NA | NA |
| Gonorrhea | 2008 | Multiple races | Male | 20-24 | NA | NA |
| Gonorrhea | 2008 | Multiple races | Male | 25-29 | NA | NA |
| Gonorrhea | 2008 | Multiple races | Male | 30-34 | NA | NA |
| Gonorrhea | 2008 | Multiple races | Male | 35-39 | NA | NA |
| Gonorrhea | 2008 | Multiple races | Male | 40-44 | NA | NA |
| Gonorrhea | 2008 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Gonorrhea | 2008 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Gonorrhea | 2008 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Gonorrhea | 2008 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Gonorrhea | 2008 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Gonorrhea | 2008 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Gonorrhea | 2008 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Gonorrhea | 2008 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Gonorrhea | 2008 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Gonorrhea | 2008 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Gonorrhea | 2008 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Gonorrhea | 2008 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Gonorrhea | 2008 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Gonorrhea | 2008 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Gonorrhea | 2008 | Unknown | Female | 0-14 | NA | NA |
| Gonorrhea | 2008 | Unknown | Female | 15-19 | NA | NA |
| Gonorrhea | 2008 | Unknown | Female | 20-24 | NA | NA |
| Gonorrhea | 2008 | Unknown | Female | 25-29 | NA | NA |
| Gonorrhea | 2008 | Unknown | Female | 30-34 | NA | NA |
| Gonorrhea | 2008 | Unknown | Female | 35-39 | NA | NA |
| Gonorrhea | 2008 | Unknown | Female | 40-44 | NA | NA |
| Gonorrhea | 2008 | Unknown | Male | 0-14 | NA | NA |
| Gonorrhea | 2008 | Unknown | Male | 15-19 | NA | NA |
| Gonorrhea | 2008 | Unknown | Male | 20-24 | NA | NA |
| Gonorrhea | 2008 | Unknown | Male | 25-29 | NA | NA |
| Gonorrhea | 2008 | Unknown | Male | 30-34 | NA | NA |
| Gonorrhea | 2008 | Unknown | Male | 35-39 | NA | NA |
| Gonorrhea | 2008 | Unknown | Male | 40-44 | NA | NA |
| Gonorrhea | 2008 | White | Female | 0-14 | NA | NA |
| Gonorrhea | 2008 | White | Female | 15-19 | NA | NA |
| Gonorrhea | 2008 | White | Female | 20-24 | NA | NA |
| Gonorrhea | 2008 | White | Female | 25-29 | NA | NA |
| Gonorrhea | 2008 | White | Female | 30-34 | NA | NA |
| Gonorrhea | 2008 | White | Female | 35-39 | NA | NA |
| Gonorrhea | 2008 | White | Female | 40-44 | NA | NA |
| Gonorrhea | 2008 | White | Male | 0-14 | NA | NA |
| Gonorrhea | 2008 | White | Male | 15-19 | NA | NA |
| Gonorrhea | 2008 | White | Male | 20-24 | NA | NA |
| Gonorrhea | 2008 | White | Male | 25-29 | NA | NA |
| Gonorrhea | 2008 | White | Male | 30-34 | NA | NA |
| Gonorrhea | 2008 | White | Male | 35-39 | NA | NA |
| Gonorrhea | 2008 | White | Male | 40-44 | NA | NA |
| Gonorrhea | 2009 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Gonorrhea | 2009 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Gonorrhea | 2009 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Gonorrhea | 2009 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Gonorrhea | 2009 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Gonorrhea | 2009 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Gonorrhea | 2009 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Gonorrhea | 2009 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Gonorrhea | 2009 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Gonorrhea | 2009 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Gonorrhea | 2009 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Gonorrhea | 2009 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Gonorrhea | 2009 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Gonorrhea | 2009 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Gonorrhea | 2009 | Asian | Female | 0-14 | NA | NA |
| Gonorrhea | 2009 | Asian | Female | 15-19 | NA | NA |
| Gonorrhea | 2009 | Asian | Female | 20-24 | NA | NA |
| Gonorrhea | 2009 | Asian | Female | 25-29 | NA | NA |
| Gonorrhea | 2009 | Asian | Female | 30-34 | NA | NA |
| Gonorrhea | 2009 | Asian | Female | 35-39 | NA | NA |
| Gonorrhea | 2009 | Asian | Female | 40-44 | NA | NA |
| Gonorrhea | 2009 | Asian | Male | 0-14 | NA | NA |
| Gonorrhea | 2009 | Asian | Male | 15-19 | NA | NA |
| Gonorrhea | 2009 | Asian | Male | 20-24 | NA | NA |
| Gonorrhea | 2009 | Asian | Male | 25-29 | NA | NA |
| Gonorrhea | 2009 | Asian | Male | 30-34 | NA | NA |
| Gonorrhea | 2009 | Asian | Male | 35-39 | NA | NA |
| Gonorrhea | 2009 | Asian | Male | 40-44 | NA | NA |
| Gonorrhea | 2009 | Black/African American | Female | 0-14 | NA | NA |
| Gonorrhea | 2009 | Black/African American | Female | 15-19 | NA | NA |
| Gonorrhea | 2009 | Black/African American | Female | 20-24 | NA | NA |
| Gonorrhea | 2009 | Black/African American | Female | 25-29 | NA | NA |
| Gonorrhea | 2009 | Black/African American | Female | 30-34 | NA | NA |
| Gonorrhea | 2009 | Black/African American | Female | 35-39 | NA | NA |
| Gonorrhea | 2009 | Black/African American | Female | 40-44 | NA | NA |
| Gonorrhea | 2009 | Black/African American | Male | 0-14 | NA | NA |
| Gonorrhea | 2009 | Black/African American | Male | 15-19 | NA | NA |
| Gonorrhea | 2009 | Black/African American | Male | 20-24 | NA | NA |
| Gonorrhea | 2009 | Black/African American | Male | 25-29 | NA | NA |
| Gonorrhea | 2009 | Black/African American | Male | 30-34 | NA | NA |
| Gonorrhea | 2009 | Black/African American | Male | 35-39 | NA | NA |
| Gonorrhea | 2009 | Black/African American | Male | 40-44 | NA | NA |
| Gonorrhea | 2009 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Gonorrhea | 2009 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Gonorrhea | 2009 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Gonorrhea | 2009 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Gonorrhea | 2009 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Gonorrhea | 2009 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Gonorrhea | 2009 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Gonorrhea | 2009 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Gonorrhea | 2009 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Gonorrhea | 2009 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Gonorrhea | 2009 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Gonorrhea | 2009 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Gonorrhea | 2009 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Gonorrhea | 2009 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Gonorrhea | 2009 | Multiple races | Female | 0-14 | NA | NA |
| Gonorrhea | 2009 | Multiple races | Female | 15-19 | NA | NA |
| Gonorrhea | 2009 | Multiple races | Female | 20-24 | NA | NA |
| Gonorrhea | 2009 | Multiple races | Female | 25-29 | NA | NA |
| Gonorrhea | 2009 | Multiple races | Female | 30-34 | NA | NA |
| Gonorrhea | 2009 | Multiple races | Female | 35-39 | NA | NA |
| Gonorrhea | 2009 | Multiple races | Female | 40-44 | NA | NA |
| Gonorrhea | 2009 | Multiple races | Male | 0-14 | NA | NA |
| Gonorrhea | 2009 | Multiple races | Male | 15-19 | NA | NA |
| Gonorrhea | 2009 | Multiple races | Male | 20-24 | NA | NA |
| Gonorrhea | 2009 | Multiple races | Male | 25-29 | NA | NA |
| Gonorrhea | 2009 | Multiple races | Male | 30-34 | NA | NA |
| Gonorrhea | 2009 | Multiple races | Male | 35-39 | NA | NA |
| Gonorrhea | 2009 | Multiple races | Male | 40-44 | NA | NA |
| Gonorrhea | 2009 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Gonorrhea | 2009 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Gonorrhea | 2009 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Gonorrhea | 2009 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Gonorrhea | 2009 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Gonorrhea | 2009 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Gonorrhea | 2009 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Gonorrhea | 2009 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Gonorrhea | 2009 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Gonorrhea | 2009 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Gonorrhea | 2009 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Gonorrhea | 2009 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Gonorrhea | 2009 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Gonorrhea | 2009 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Gonorrhea | 2009 | Unknown | Female | 0-14 | NA | NA |
| Gonorrhea | 2009 | Unknown | Female | 15-19 | NA | NA |
| Gonorrhea | 2009 | Unknown | Female | 20-24 | NA | NA |
| Gonorrhea | 2009 | Unknown | Female | 25-29 | NA | NA |
| Gonorrhea | 2009 | Unknown | Female | 30-34 | NA | NA |
| Gonorrhea | 2009 | Unknown | Female | 35-39 | NA | NA |
| Gonorrhea | 2009 | Unknown | Female | 40-44 | NA | NA |
| Gonorrhea | 2009 | Unknown | Male | 0-14 | NA | NA |
| Gonorrhea | 2009 | Unknown | Male | 15-19 | NA | NA |
| Gonorrhea | 2009 | Unknown | Male | 20-24 | NA | NA |
| Gonorrhea | 2009 | Unknown | Male | 25-29 | NA | NA |
| Gonorrhea | 2009 | Unknown | Male | 30-34 | NA | NA |
| Gonorrhea | 2009 | Unknown | Male | 35-39 | NA | NA |
| Gonorrhea | 2009 | Unknown | Male | 40-44 | NA | NA |
| Gonorrhea | 2009 | White | Female | 0-14 | NA | NA |
| Gonorrhea | 2009 | White | Female | 15-19 | NA | NA |
| Gonorrhea | 2009 | White | Female | 20-24 | NA | NA |
| Gonorrhea | 2009 | White | Female | 25-29 | NA | NA |
| Gonorrhea | 2009 | White | Female | 30-34 | NA | NA |
| Gonorrhea | 2009 | White | Female | 35-39 | NA | NA |
| Gonorrhea | 2009 | White | Female | 40-44 | NA | NA |
| Gonorrhea | 2009 | White | Male | 0-14 | NA | NA |
| Gonorrhea | 2009 | White | Male | 15-19 | NA | NA |
| Gonorrhea | 2009 | White | Male | 20-24 | NA | NA |
| Gonorrhea | 2009 | White | Male | 25-29 | NA | NA |
| Gonorrhea | 2009 | White | Male | 30-34 | NA | NA |
| Gonorrhea | 2009 | White | Male | 35-39 | NA | NA |
| Gonorrhea | 2009 | White | Male | 40-44 | NA | NA |
| Gonorrhea | 2010 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Gonorrhea | 2010 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Gonorrhea | 2010 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Gonorrhea | 2010 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Gonorrhea | 2010 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Gonorrhea | 2010 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Gonorrhea | 2010 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Gonorrhea | 2010 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Gonorrhea | 2010 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Gonorrhea | 2010 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Gonorrhea | 2010 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Gonorrhea | 2010 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Gonorrhea | 2010 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Gonorrhea | 2010 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Gonorrhea | 2010 | Asian | Female | 0-14 | NA | NA |
| Gonorrhea | 2010 | Asian | Female | 15-19 | NA | NA |
| Gonorrhea | 2010 | Asian | Female | 20-24 | NA | NA |
| Gonorrhea | 2010 | Asian | Female | 25-29 | NA | NA |
| Gonorrhea | 2010 | Asian | Female | 30-34 | NA | NA |
| Gonorrhea | 2010 | Asian | Female | 35-39 | NA | NA |
| Gonorrhea | 2010 | Asian | Female | 40-44 | NA | NA |
| Gonorrhea | 2010 | Asian | Male | 0-14 | NA | NA |
| Gonorrhea | 2010 | Asian | Male | 15-19 | NA | NA |
| Gonorrhea | 2010 | Asian | Male | 20-24 | NA | NA |
| Gonorrhea | 2010 | Asian | Male | 25-29 | NA | NA |
| Gonorrhea | 2010 | Asian | Male | 30-34 | NA | NA |
| Gonorrhea | 2010 | Asian | Male | 35-39 | NA | NA |
| Gonorrhea | 2010 | Asian | Male | 40-44 | NA | NA |
| Gonorrhea | 2010 | Black/African American | Female | 0-14 | NA | NA |
| Gonorrhea | 2010 | Black/African American | Female | 15-19 | NA | NA |
| Gonorrhea | 2010 | Black/African American | Female | 20-24 | NA | NA |
| Gonorrhea | 2010 | Black/African American | Female | 25-29 | NA | NA |
| Gonorrhea | 2010 | Black/African American | Female | 30-34 | NA | NA |
| Gonorrhea | 2010 | Black/African American | Female | 35-39 | NA | NA |
| Gonorrhea | 2010 | Black/African American | Female | 40-44 | NA | NA |
| Gonorrhea | 2010 | Black/African American | Male | 0-14 | NA | NA |
| Gonorrhea | 2010 | Black/African American | Male | 15-19 | NA | NA |
| Gonorrhea | 2010 | Black/African American | Male | 20-24 | NA | NA |
| Gonorrhea | 2010 | Black/African American | Male | 25-29 | NA | NA |
| Gonorrhea | 2010 | Black/African American | Male | 30-34 | NA | NA |
| Gonorrhea | 2010 | Black/African American | Male | 35-39 | NA | NA |
| Gonorrhea | 2010 | Black/African American | Male | 40-44 | NA | NA |
| Gonorrhea | 2010 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Gonorrhea | 2010 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Gonorrhea | 2010 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Gonorrhea | 2010 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Gonorrhea | 2010 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Gonorrhea | 2010 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Gonorrhea | 2010 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Gonorrhea | 2010 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Gonorrhea | 2010 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Gonorrhea | 2010 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Gonorrhea | 2010 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Gonorrhea | 2010 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Gonorrhea | 2010 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Gonorrhea | 2010 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Gonorrhea | 2010 | Multiple races | Female | 0-14 | NA | NA |
| Gonorrhea | 2010 | Multiple races | Female | 15-19 | NA | NA |
| Gonorrhea | 2010 | Multiple races | Female | 20-24 | NA | NA |
| Gonorrhea | 2010 | Multiple races | Female | 25-29 | NA | NA |
| Gonorrhea | 2010 | Multiple races | Female | 30-34 | NA | NA |
| Gonorrhea | 2010 | Multiple races | Female | 35-39 | NA | NA |
| Gonorrhea | 2010 | Multiple races | Female | 40-44 | NA | NA |
| Gonorrhea | 2010 | Multiple races | Male | 0-14 | NA | NA |
| Gonorrhea | 2010 | Multiple races | Male | 15-19 | NA | NA |
| Gonorrhea | 2010 | Multiple races | Male | 20-24 | NA | NA |
| Gonorrhea | 2010 | Multiple races | Male | 25-29 | NA | NA |
| Gonorrhea | 2010 | Multiple races | Male | 30-34 | NA | NA |
| Gonorrhea | 2010 | Multiple races | Male | 35-39 | NA | NA |
| Gonorrhea | 2010 | Multiple races | Male | 40-44 | NA | NA |
| Gonorrhea | 2010 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Gonorrhea | 2010 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Gonorrhea | 2010 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Gonorrhea | 2010 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Gonorrhea | 2010 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Gonorrhea | 2010 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Gonorrhea | 2010 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Gonorrhea | 2010 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Gonorrhea | 2010 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Gonorrhea | 2010 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Gonorrhea | 2010 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Gonorrhea | 2010 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Gonorrhea | 2010 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Gonorrhea | 2010 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Gonorrhea | 2010 | Unknown | Female | 0-14 | NA | NA |
| Gonorrhea | 2010 | Unknown | Female | 15-19 | NA | NA |
| Gonorrhea | 2010 | Unknown | Female | 20-24 | NA | NA |
| Gonorrhea | 2010 | Unknown | Female | 25-29 | NA | NA |
| Gonorrhea | 2010 | Unknown | Female | 30-34 | NA | NA |
| Gonorrhea | 2010 | Unknown | Female | 35-39 | NA | NA |
| Gonorrhea | 2010 | Unknown | Female | 40-44 | NA | NA |
| Gonorrhea | 2010 | Unknown | Male | 0-14 | NA | NA |
| Gonorrhea | 2010 | Unknown | Male | 15-19 | NA | NA |
| Gonorrhea | 2010 | Unknown | Male | 20-24 | NA | NA |
| Gonorrhea | 2010 | Unknown | Male | 25-29 | NA | NA |
| Gonorrhea | 2010 | Unknown | Male | 30-34 | NA | NA |
| Gonorrhea | 2010 | Unknown | Male | 35-39 | NA | NA |
| Gonorrhea | 2010 | Unknown | Male | 40-44 | NA | NA |
| Gonorrhea | 2010 | White | Female | 0-14 | NA | NA |
| Gonorrhea | 2010 | White | Female | 15-19 | NA | NA |
| Gonorrhea | 2010 | White | Female | 20-24 | NA | NA |
| Gonorrhea | 2010 | White | Female | 25-29 | NA | NA |
| Gonorrhea | 2010 | White | Female | 30-34 | NA | NA |
| Gonorrhea | 2010 | White | Female | 35-39 | NA | NA |
| Gonorrhea | 2010 | White | Female | 40-44 | NA | NA |
| Gonorrhea | 2010 | White | Male | 0-14 | NA | NA |
| Gonorrhea | 2010 | White | Male | 15-19 | NA | NA |
| Gonorrhea | 2010 | White | Male | 20-24 | NA | NA |
| Gonorrhea | 2010 | White | Male | 25-29 | NA | NA |
| Gonorrhea | 2010 | White | Male | 30-34 | NA | NA |
| Gonorrhea | 2010 | White | Male | 35-39 | NA | NA |
| Gonorrhea | 2010 | White | Male | 40-44 | NA | NA |
| Gonorrhea | 2011 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Gonorrhea | 2011 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Gonorrhea | 2011 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Gonorrhea | 2011 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Gonorrhea | 2011 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Gonorrhea | 2011 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Gonorrhea | 2011 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Gonorrhea | 2011 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Gonorrhea | 2011 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Gonorrhea | 2011 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Gonorrhea | 2011 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Gonorrhea | 2011 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Gonorrhea | 2011 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Gonorrhea | 2011 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Gonorrhea | 2011 | Asian | Female | 0-14 | NA | NA |
| Gonorrhea | 2011 | Asian | Female | 15-19 | NA | NA |
| Gonorrhea | 2011 | Asian | Female | 20-24 | NA | NA |
| Gonorrhea | 2011 | Asian | Female | 25-29 | NA | NA |
| Gonorrhea | 2011 | Asian | Female | 30-34 | NA | NA |
| Gonorrhea | 2011 | Asian | Female | 35-39 | NA | NA |
| Gonorrhea | 2011 | Asian | Female | 40-44 | NA | NA |
| Gonorrhea | 2011 | Asian | Male | 0-14 | NA | NA |
| Gonorrhea | 2011 | Asian | Male | 15-19 | NA | NA |
| Gonorrhea | 2011 | Asian | Male | 20-24 | NA | NA |
| Gonorrhea | 2011 | Asian | Male | 25-29 | NA | NA |
| Gonorrhea | 2011 | Asian | Male | 30-34 | NA | NA |
| Gonorrhea | 2011 | Asian | Male | 35-39 | NA | NA |
| Gonorrhea | 2011 | Asian | Male | 40-44 | NA | NA |
| Gonorrhea | 2011 | Black/African American | Female | 0-14 | NA | NA |
| Gonorrhea | 2011 | Black/African American | Female | 15-19 | NA | NA |
| Gonorrhea | 2011 | Black/African American | Female | 20-24 | NA | NA |
| Gonorrhea | 2011 | Black/African American | Female | 25-29 | NA | NA |
| Gonorrhea | 2011 | Black/African American | Female | 30-34 | NA | NA |
| Gonorrhea | 2011 | Black/African American | Female | 35-39 | NA | NA |
| Gonorrhea | 2011 | Black/African American | Female | 40-44 | NA | NA |
| Gonorrhea | 2011 | Black/African American | Male | 0-14 | NA | NA |
| Gonorrhea | 2011 | Black/African American | Male | 15-19 | NA | NA |
| Gonorrhea | 2011 | Black/African American | Male | 20-24 | NA | NA |
| Gonorrhea | 2011 | Black/African American | Male | 25-29 | NA | NA |
| Gonorrhea | 2011 | Black/African American | Male | 30-34 | NA | NA |
| Gonorrhea | 2011 | Black/African American | Male | 35-39 | NA | NA |
| Gonorrhea | 2011 | Black/African American | Male | 40-44 | NA | NA |
| Gonorrhea | 2011 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Gonorrhea | 2011 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Gonorrhea | 2011 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Gonorrhea | 2011 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Gonorrhea | 2011 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Gonorrhea | 2011 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Gonorrhea | 2011 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Gonorrhea | 2011 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Gonorrhea | 2011 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Gonorrhea | 2011 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Gonorrhea | 2011 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Gonorrhea | 2011 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Gonorrhea | 2011 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Gonorrhea | 2011 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Gonorrhea | 2011 | Multiple races | Female | 0-14 | NA | NA |
| Gonorrhea | 2011 | Multiple races | Female | 15-19 | NA | NA |
| Gonorrhea | 2011 | Multiple races | Female | 20-24 | NA | NA |
| Gonorrhea | 2011 | Multiple races | Female | 25-29 | NA | NA |
| Gonorrhea | 2011 | Multiple races | Female | 30-34 | NA | NA |
| Gonorrhea | 2011 | Multiple races | Female | 35-39 | NA | NA |
| Gonorrhea | 2011 | Multiple races | Female | 40-44 | NA | NA |
| Gonorrhea | 2011 | Multiple races | Male | 0-14 | NA | NA |
| Gonorrhea | 2011 | Multiple races | Male | 15-19 | NA | NA |
| Gonorrhea | 2011 | Multiple races | Male | 20-24 | NA | NA |
| Gonorrhea | 2011 | Multiple races | Male | 25-29 | NA | NA |
| Gonorrhea | 2011 | Multiple races | Male | 30-34 | NA | NA |
| Gonorrhea | 2011 | Multiple races | Male | 35-39 | NA | NA |
| Gonorrhea | 2011 | Multiple races | Male | 40-44 | NA | NA |
| Gonorrhea | 2011 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Gonorrhea | 2011 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Gonorrhea | 2011 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Gonorrhea | 2011 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Gonorrhea | 2011 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Gonorrhea | 2011 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Gonorrhea | 2011 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Gonorrhea | 2011 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Gonorrhea | 2011 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Gonorrhea | 2011 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Gonorrhea | 2011 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Gonorrhea | 2011 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Gonorrhea | 2011 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Gonorrhea | 2011 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Gonorrhea | 2011 | Unknown | Female | 0-14 | NA | NA |
| Gonorrhea | 2011 | Unknown | Female | 15-19 | NA | NA |
| Gonorrhea | 2011 | Unknown | Female | 20-24 | NA | NA |
| Gonorrhea | 2011 | Unknown | Female | 25-29 | NA | NA |
| Gonorrhea | 2011 | Unknown | Female | 30-34 | NA | NA |
| Gonorrhea | 2011 | Unknown | Female | 35-39 | NA | NA |
| Gonorrhea | 2011 | Unknown | Female | 40-44 | NA | NA |
| Gonorrhea | 2011 | Unknown | Male | 0-14 | NA | NA |
| Gonorrhea | 2011 | Unknown | Male | 15-19 | NA | NA |
| Gonorrhea | 2011 | Unknown | Male | 20-24 | NA | NA |
| Gonorrhea | 2011 | Unknown | Male | 25-29 | NA | NA |
| Gonorrhea | 2011 | Unknown | Male | 30-34 | NA | NA |
| Gonorrhea | 2011 | Unknown | Male | 35-39 | NA | NA |
| Gonorrhea | 2011 | Unknown | Male | 40-44 | NA | NA |
| Gonorrhea | 2011 | White | Female | 0-14 | NA | NA |
| Gonorrhea | 2011 | White | Female | 15-19 | NA | NA |
| Gonorrhea | 2011 | White | Female | 20-24 | NA | NA |
| Gonorrhea | 2011 | White | Female | 25-29 | NA | NA |
| Gonorrhea | 2011 | White | Female | 30-34 | NA | NA |
| Gonorrhea | 2011 | White | Female | 35-39 | NA | NA |
| Gonorrhea | 2011 | White | Female | 40-44 | NA | NA |
| Gonorrhea | 2011 | White | Male | 0-14 | NA | NA |
| Gonorrhea | 2011 | White | Male | 15-19 | NA | NA |
| Gonorrhea | 2011 | White | Male | 20-24 | NA | NA |
| Gonorrhea | 2011 | White | Male | 25-29 | NA | NA |
| Gonorrhea | 2011 | White | Male | 30-34 | NA | NA |
| Gonorrhea | 2011 | White | Male | 35-39 | NA | NA |
| Gonorrhea | 2011 | White | Male | 40-44 | NA | NA |
| Gonorrhea | 2012 | American Indian/Alaska Native | Female | 0-14 | NA | NA |
| Gonorrhea | 2012 | American Indian/Alaska Native | Female | 15-19 | NA | NA |
| Gonorrhea | 2012 | American Indian/Alaska Native | Female | 20-24 | NA | NA |
| Gonorrhea | 2012 | American Indian/Alaska Native | Female | 25-29 | NA | NA |
| Gonorrhea | 2012 | American Indian/Alaska Native | Female | 30-34 | NA | NA |
| Gonorrhea | 2012 | American Indian/Alaska Native | Female | 35-39 | NA | NA |
| Gonorrhea | 2012 | American Indian/Alaska Native | Female | 40-44 | NA | NA |
| Gonorrhea | 2012 | American Indian/Alaska Native | Male | 0-14 | NA | NA |
| Gonorrhea | 2012 | American Indian/Alaska Native | Male | 15-19 | NA | NA |
| Gonorrhea | 2012 | American Indian/Alaska Native | Male | 20-24 | NA | NA |
| Gonorrhea | 2012 | American Indian/Alaska Native | Male | 25-29 | NA | NA |
| Gonorrhea | 2012 | American Indian/Alaska Native | Male | 30-34 | NA | NA |
| Gonorrhea | 2012 | American Indian/Alaska Native | Male | 35-39 | NA | NA |
| Gonorrhea | 2012 | American Indian/Alaska Native | Male | 40-44 | NA | NA |
| Gonorrhea | 2012 | Asian | Female | 0-14 | NA | NA |
| Gonorrhea | 2012 | Asian | Female | 15-19 | NA | NA |
| Gonorrhea | 2012 | Asian | Female | 20-24 | NA | NA |
| Gonorrhea | 2012 | Asian | Female | 25-29 | NA | NA |
| Gonorrhea | 2012 | Asian | Female | 30-34 | NA | NA |
| Gonorrhea | 2012 | Asian | Female | 35-39 | NA | NA |
| Gonorrhea | 2012 | Asian | Female | 40-44 | NA | NA |
| Gonorrhea | 2012 | Asian | Male | 0-14 | NA | NA |
| Gonorrhea | 2012 | Asian | Male | 15-19 | NA | NA |
| Gonorrhea | 2012 | Asian | Male | 20-24 | NA | NA |
| Gonorrhea | 2012 | Asian | Male | 25-29 | NA | NA |
| Gonorrhea | 2012 | Asian | Male | 30-34 | NA | NA |
| Gonorrhea | 2012 | Asian | Male | 35-39 | NA | NA |
| Gonorrhea | 2012 | Asian | Male | 40-44 | NA | NA |
| Gonorrhea | 2012 | Black/African American | Female | 0-14 | NA | NA |
| Gonorrhea | 2012 | Black/African American | Female | 15-19 | NA | NA |
| Gonorrhea | 2012 | Black/African American | Female | 20-24 | NA | NA |
| Gonorrhea | 2012 | Black/African American | Female | 25-29 | NA | NA |
| Gonorrhea | 2012 | Black/African American | Female | 30-34 | NA | NA |
| Gonorrhea | 2012 | Black/African American | Female | 35-39 | NA | NA |
| Gonorrhea | 2012 | Black/African American | Female | 40-44 | NA | NA |
| Gonorrhea | 2012 | Black/African American | Male | 0-14 | NA | NA |
| Gonorrhea | 2012 | Black/African American | Male | 15-19 | NA | NA |
| Gonorrhea | 2012 | Black/African American | Male | 20-24 | NA | NA |
| Gonorrhea | 2012 | Black/African American | Male | 25-29 | NA | NA |
| Gonorrhea | 2012 | Black/African American | Male | 30-34 | NA | NA |
| Gonorrhea | 2012 | Black/African American | Male | 35-39 | NA | NA |
| Gonorrhea | 2012 | Black/African American | Male | 40-44 | NA | NA |
| Gonorrhea | 2012 | Hispanic/Latino | Female | 0-14 | NA | NA |
| Gonorrhea | 2012 | Hispanic/Latino | Female | 15-19 | NA | NA |
| Gonorrhea | 2012 | Hispanic/Latino | Female | 20-24 | NA | NA |
| Gonorrhea | 2012 | Hispanic/Latino | Female | 25-29 | NA | NA |
| Gonorrhea | 2012 | Hispanic/Latino | Female | 30-34 | NA | NA |
| Gonorrhea | 2012 | Hispanic/Latino | Female | 35-39 | NA | NA |
| Gonorrhea | 2012 | Hispanic/Latino | Female | 40-44 | NA | NA |
| Gonorrhea | 2012 | Hispanic/Latino | Male | 0-14 | NA | NA |
| Gonorrhea | 2012 | Hispanic/Latino | Male | 15-19 | NA | NA |
| Gonorrhea | 2012 | Hispanic/Latino | Male | 20-24 | NA | NA |
| Gonorrhea | 2012 | Hispanic/Latino | Male | 25-29 | NA | NA |
| Gonorrhea | 2012 | Hispanic/Latino | Male | 30-34 | NA | NA |
| Gonorrhea | 2012 | Hispanic/Latino | Male | 35-39 | NA | NA |
| Gonorrhea | 2012 | Hispanic/Latino | Male | 40-44 | NA | NA |
| Gonorrhea | 2012 | Multiple races | Female | 0-14 | NA | NA |
| Gonorrhea | 2012 | Multiple races | Female | 15-19 | NA | NA |
| Gonorrhea | 2012 | Multiple races | Female | 20-24 | NA | NA |
| Gonorrhea | 2012 | Multiple races | Female | 25-29 | NA | NA |
| Gonorrhea | 2012 | Multiple races | Female | 30-34 | NA | NA |
| Gonorrhea | 2012 | Multiple races | Female | 35-39 | NA | NA |
| Gonorrhea | 2012 | Multiple races | Female | 40-44 | NA | NA |
| Gonorrhea | 2012 | Multiple races | Male | 0-14 | NA | NA |
| Gonorrhea | 2012 | Multiple races | Male | 15-19 | NA | NA |
| Gonorrhea | 2012 | Multiple races | Male | 20-24 | NA | NA |
| Gonorrhea | 2012 | Multiple races | Male | 25-29 | NA | NA |
| Gonorrhea | 2012 | Multiple races | Male | 30-34 | NA | NA |
| Gonorrhea | 2012 | Multiple races | Male | 35-39 | NA | NA |
| Gonorrhea | 2012 | Multiple races | Male | 40-44 | NA | NA |
| Gonorrhea | 2012 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | NA | NA |
| Gonorrhea | 2012 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | NA | NA |
| Gonorrhea | 2012 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | NA | NA |
| Gonorrhea | 2012 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | NA | NA |
| Gonorrhea | 2012 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | NA | NA |
| Gonorrhea | 2012 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | NA | NA |
| Gonorrhea | 2012 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | NA | NA |
| Gonorrhea | 2012 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | NA | NA |
| Gonorrhea | 2012 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | NA | NA |
| Gonorrhea | 2012 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | NA | NA |
| Gonorrhea | 2012 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | NA | NA |
| Gonorrhea | 2012 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | NA | NA |
| Gonorrhea | 2012 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | NA | NA |
| Gonorrhea | 2012 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | NA | NA |
| Gonorrhea | 2012 | Unknown | Female | 0-14 | NA | NA |
| Gonorrhea | 2012 | Unknown | Female | 15-19 | NA | NA |
| Gonorrhea | 2012 | Unknown | Female | 20-24 | NA | NA |
| Gonorrhea | 2012 | Unknown | Female | 25-29 | NA | NA |
| Gonorrhea | 2012 | Unknown | Female | 30-34 | NA | NA |
| Gonorrhea | 2012 | Unknown | Female | 35-39 | NA | NA |
| Gonorrhea | 2012 | Unknown | Female | 40-44 | NA | NA |
| Gonorrhea | 2012 | Unknown | Male | 0-14 | NA | NA |
| Gonorrhea | 2012 | Unknown | Male | 15-19 | NA | NA |
| Gonorrhea | 2012 | Unknown | Male | 20-24 | NA | NA |
| Gonorrhea | 2012 | Unknown | Male | 25-29 | NA | NA |
| Gonorrhea | 2012 | Unknown | Male | 30-34 | NA | NA |
| Gonorrhea | 2012 | Unknown | Male | 35-39 | NA | NA |
| Gonorrhea | 2012 | Unknown | Male | 40-44 | NA | NA |
| Gonorrhea | 2012 | White | Female | 0-14 | NA | NA |
| Gonorrhea | 2012 | White | Female | 15-19 | NA | NA |
| Gonorrhea | 2012 | White | Female | 20-24 | NA | NA |
| Gonorrhea | 2012 | White | Female | 25-29 | NA | NA |
| Gonorrhea | 2012 | White | Female | 30-34 | NA | NA |
| Gonorrhea | 2012 | White | Female | 35-39 | NA | NA |
| Gonorrhea | 2012 | White | Female | 40-44 | NA | NA |
| Gonorrhea | 2012 | White | Male | 0-14 | NA | NA |
| Gonorrhea | 2012 | White | Male | 15-19 | NA | NA |
| Gonorrhea | 2012 | White | Male | 20-24 | NA | NA |
| Gonorrhea | 2012 | White | Male | 25-29 | NA | NA |
| Gonorrhea | 2012 | White | Male | 30-34 | NA | NA |
| Gonorrhea | 2012 | White | Male | 35-39 | NA | NA |
| Gonorrhea | 2012 | White | Male | 40-44 | NA | NA |
| Gonorrhea | 2013 | American Indian/Alaska Native | Female | 0-14 | 28 | 10.8 |
| Gonorrhea | 2013 | American Indian/Alaska Native | Female | 15-19 | 459 | 506.9 |
| Gonorrhea | 2013 | American Indian/Alaska Native | Female | 20-24 | 785 | 800.5 |
| Gonorrhea | 2013 | American Indian/Alaska Native | Female | 25-29 | 505 | 593.6 |
| Gonorrhea | 2013 | American Indian/Alaska Native | Female | 30-34 | 285 | 358.3 |
| Gonorrhea | 2013 | American Indian/Alaska Native | Female | 35-39 | 150 | 207.7 |
| Gonorrhea | 2013 | American Indian/Alaska Native | Female | 40-44 | 66 | 88.09999999999999 |
| Gonorrhea | 2013 | American Indian/Alaska Native | Male | 0-14 | 3 | 1.1 |
| Gonorrhea | 2013 | American Indian/Alaska Native | Male | 15-19 | 161 | 171 |
| Gonorrhea | 2013 | American Indian/Alaska Native | Male | 20-24 | 376 | 365.2 |
| Gonorrhea | 2013 | American Indian/Alaska Native | Male | 25-29 | 305 | 352.2 |
| Gonorrhea | 2013 | American Indian/Alaska Native | Male | 30-34 | 169 | 213.8 |
| Gonorrhea | 2013 | American Indian/Alaska Native | Male | 35-39 | 79 | 111.7 |
| Gonorrhea | 2013 | American Indian/Alaska Native | Male | 40-44 | 50 | 68.8 |
| Gonorrhea | 2013 | Asian | Female | 0-14 | 6 | 0.4 |
| Gonorrhea | 2013 | Asian | Female | 15-19 | 178 | 36.8 |
| Gonorrhea | 2013 | Asian | Female | 20-24 | 284 | 47.4 |
| Gonorrhea | 2013 | Asian | Female | 25-29 | 179 | 25.8 |
| Gonorrhea | 2013 | Asian | Female | 30-34 | 96 | 12.9 |
| Gonorrhea | 2013 | Asian | Female | 35-39 | 64 | 9 |
| Gonorrhea | 2013 | Asian | Female | 40-44 | 30 | 4.2 |
| Gonorrhea | 2013 | Asian | Male | 0-14 | 1 | 0.1 |
| Gonorrhea | 2013 | Asian | Male | 15-19 | 95 | 19.1 |
| Gonorrhea | 2013 | Asian | Male | 20-24 | 424 | 68.40000000000001 |
| Gonorrhea | 2013 | Asian | Male | 25-29 | 356 | 54.3 |
| Gonorrhea | 2013 | Asian | Male | 30-34 | 275 | 42.1 |
| Gonorrhea | 2013 | Asian | Male | 35-39 | 181 | 28.8 |
| Gonorrhea | 2013 | Asian | Male | 40-44 | 126 | 20.2 |
| Gonorrhea | 2013 | Black/African American | Female | 0-14 | 1268 | 30.6 |
| Gonorrhea | 2013 | Black/African American | Female | 15-19 | 25967 | 1723.1 |
| Gonorrhea | 2013 | Black/African American | Female | 20-24 | 30528 | 1802.2 |
| Gonorrhea | 2013 | Black/African American | Female | 25-29 | 11649 | 798 |
| Gonorrhea | 2013 | Black/African American | Female | 30-34 | 4844 | 339.1 |
| Gonorrhea | 2013 | Black/African American | Female | 35-39 | 1982 | 151.1 |
| Gonorrhea | 2013 | Black/African American | Female | 40-44 | 912 | 65.90000000000001 |
| Gonorrhea | 2013 | Black/African American | Male | 0-14 | 325 | 7.6 |
| Gonorrhea | 2013 | Black/African American | Male | 15-19 | 13821 | 888.2 |
| Gonorrhea | 2013 | Black/African American | Male | 20-24 | 27610 | 1603.1 |
| Gonorrhea | 2013 | Black/African American | Male | 25-29 | 15908 | 1138.5 |
| Gonorrhea | 2013 | Black/African American | Male | 30-34 | 8603 | 659 |
| Gonorrhea | 2013 | Black/African American | Male | 35-39 | 4718 | 402.5 |
| Gonorrhea | 2013 | Black/African American | Male | 40-44 | 2999 | 243.6 |
| Gonorrhea | 2013 | Hispanic/Latino | Female | 0-14 | 169 | 2.3 |
| Gonorrhea | 2013 | Hispanic/Latino | Female | 15-19 | 4158 | 185.7 |
| Gonorrhea | 2013 | Hispanic/Latino | Female | 20-24 | 5477 | 246.1 |
| Gonorrhea | 2013 | Hispanic/Latino | Female | 25-29 | 2887 | 139.6 |
| Gonorrhea | 2013 | Hispanic/Latino | Female | 30-34 | 1448 | 69.09999999999999 |
| Gonorrhea | 2013 | Hispanic/Latino | Female | 35-39 | 722 | 36.5 |
| Gonorrhea | 2013 | Hispanic/Latino | Female | 40-44 | 373 | 20.1 |
| Gonorrhea | 2013 | Hispanic/Latino | Male | 0-14 | 49 | 0.6 |
| Gonorrhea | 2013 | Hispanic/Latino | Male | 15-19 | 2314 | 98.3 |
| Gonorrhea | 2013 | Hispanic/Latino | Male | 20-24 | 5911 | 242.1 |
| Gonorrhea | 2013 | Hispanic/Latino | Male | 25-29 | 4366 | 188.2 |
| Gonorrhea | 2013 | Hispanic/Latino | Male | 30-34 | 2696 | 118.2 |
| Gonorrhea | 2013 | Hispanic/Latino | Male | 35-39 | 1527 | 73.40000000000001 |
| Gonorrhea | 2013 | Hispanic/Latino | Male | 40-44 | 965 | 50.5 |
| Gonorrhea | 2013 | Multiple races | Female | 0-14 | 17 | 1.4 |
| Gonorrhea | 2013 | Multiple races | Female | 15-19 | 315 | 98.7 |
| Gonorrhea | 2013 | Multiple races | Female | 20-24 | 366 | 132.3 |
| Gonorrhea | 2013 | Multiple races | Female | 25-29 | 141 | 65 |
| Gonorrhea | 2013 | Multiple races | Female | 30-34 | 48 | 25 |
| Gonorrhea | 2013 | Multiple races | Female | 35-39 | 21 | 13.4 |
| Gonorrhea | 2013 | Multiple races | Female | 40-44 | 11 | 7.6 |
| Gonorrhea | 2013 | Multiple races | Male | 0-14 | 2 | 0.2 |
| Gonorrhea | 2013 | Multiple races | Male | 15-19 | 108 | 33.2 |
| Gonorrhea | 2013 | Multiple races | Male | 20-24 | 247 | 92.2 |
| Gonorrhea | 2013 | Multiple races | Male | 25-29 | 176 | 89.7 |
| Gonorrhea | 2013 | Multiple races | Male | 30-34 | 125 | 73.09999999999999 |
| Gonorrhea | 2013 | Multiple races | Male | 35-39 | 46 | 33 |
| Gonorrhea | 2013 | Multiple races | Male | 40-44 | 30 | 23.2 |
| Gonorrhea | 2013 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | 2 | 3.5 |
| Gonorrhea | 2013 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | 40 | 204.4 |
| Gonorrhea | 2013 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | 82 | 351.5 |
| Gonorrhea | 2013 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | 51 | 215.5 |
| Gonorrhea | 2013 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | 24 | 107.1 |
| Gonorrhea | 2013 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | 16 | 84.09999999999999 |
| Gonorrhea | 2013 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | 8 | 44.3 |
| Gonorrhea | 2013 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | 0 | 0 |
| Gonorrhea | 2013 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | 18 | 87.40000000000001 |
| Gonorrhea | 2013 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | 86 | 345.8 |
| Gonorrhea | 2013 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | 59 | 234.5 |
| Gonorrhea | 2013 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | 44 | 186.8 |
| Gonorrhea | 2013 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | 18 | 90.59999999999999 |
| Gonorrhea | 2013 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | 10 | 54.8 |
| Gonorrhea | 2013 | Unknown | Female | 0-14 | 528 | NA |
| Gonorrhea | 2013 | Unknown | Female | 15-19 | 9584 | NA |
| Gonorrhea | 2013 | Unknown | Female | 20-24 | 10933 | NA |
| Gonorrhea | 2013 | Unknown | Female | 25-29 | 5158 | NA |
| Gonorrhea | 2013 | Unknown | Female | 30-34 | 2793 | NA |
| Gonorrhea | 2013 | Unknown | Female | 35-39 | 1490 | NA |
| Gonorrhea | 2013 | Unknown | Female | 40-44 | 839 | NA |
| Gonorrhea | 2013 | Unknown | Male | 0-14 | 162 | NA |
| Gonorrhea | 2013 | Unknown | Male | 15-19 | 5228 | NA |
| Gonorrhea | 2013 | Unknown | Male | 20-24 | 10000 | NA |
| Gonorrhea | 2013 | Unknown | Male | 25-29 | 6456 | NA |
| Gonorrhea | 2013 | Unknown | Male | 30-34 | 4144 | NA |
| Gonorrhea | 2013 | Unknown | Male | 35-39 | 2584 | NA |
| Gonorrhea | 2013 | Unknown | Male | 40-44 | 1958 | NA |
| Gonorrhea | 2013 | White | Female | 0-14 | 279 | 1.8 |
| Gonorrhea | 2013 | White | Female | 15-19 | 7048 | 124.2 |
| Gonorrhea | 2013 | White | Female | 20-24 | 11305 | 181.8 |
| Gonorrhea | 2013 | White | Female | 25-29 | 6696 | 109.9 |
| Gonorrhea | 2013 | White | Female | 30-34 | 3605 | 59.6 |
| Gonorrhea | 2013 | White | Female | 35-39 | 1700 | 30.4 |
| Gonorrhea | 2013 | White | Female | 40-44 | 953 | 15.1 |
| Gonorrhea | 2013 | White | Male | 0-14 | 37 | 0.2 |
| Gonorrhea | 2013 | White | Male | 15-19 | 2467 | 41.1 |
| Gonorrhea | 2013 | White | Male | 20-24 | 8401 | 129.2 |
| Gonorrhea | 2013 | White | Male | 25-29 | 7092 | 113.3 |
| Gonorrhea | 2013 | White | Male | 30-34 | 4799 | 77.90000000000001 |
| Gonorrhea | 2013 | White | Male | 35-39 | 2697 | 47.5 |
| Gonorrhea | 2013 | White | Male | 40-44 | 2452 | 38.5 |
| Gonorrhea | 2014 | American Indian/Alaska Native | Female | 0-14 | 31 | 12 |
| Gonorrhea | 2014 | American Indian/Alaska Native | Female | 15-19 | 470 | 525.1 |
| Gonorrhea | 2014 | American Indian/Alaska Native | Female | 20-24 | 870 | 883.4 |
| Gonorrhea | 2014 | American Indian/Alaska Native | Female | 25-29 | 556 | 637.6 |
| Gonorrhea | 2014 | American Indian/Alaska Native | Female | 30-34 | 359 | 443.1 |
| Gonorrhea | 2014 | American Indian/Alaska Native | Female | 35-39 | 146 | 200.7 |
| Gonorrhea | 2014 | American Indian/Alaska Native | Female | 40-44 | 99 | 133.7 |
| Gonorrhea | 2014 | American Indian/Alaska Native | Male | 0-14 | 4 | 1.5 |
| Gonorrhea | 2014 | American Indian/Alaska Native | Male | 15-19 | 181 | 195.1 |
| Gonorrhea | 2014 | American Indian/Alaska Native | Male | 20-24 | 447 | 432.2 |
| Gonorrhea | 2014 | American Indian/Alaska Native | Male | 25-29 | 380 | 424.4 |
| Gonorrhea | 2014 | American Indian/Alaska Native | Male | 30-34 | 220 | 274.3 |
| Gonorrhea | 2014 | American Indian/Alaska Native | Male | 35-39 | 135 | 187.8 |
| Gonorrhea | 2014 | American Indian/Alaska Native | Male | 40-44 | 80 | 111.8 |
| Gonorrhea | 2014 | Asian | Female | 0-14 | 5 | 0.3 |
| Gonorrhea | 2014 | Asian | Female | 15-19 | 141 | 28.5 |
| Gonorrhea | 2014 | Asian | Female | 20-24 | 305 | 50.3 |
| Gonorrhea | 2014 | Asian | Female | 25-29 | 186 | 25.8 |
| Gonorrhea | 2014 | Asian | Female | 30-34 | 130 | 16.9 |
| Gonorrhea | 2014 | Asian | Female | 35-39 | 62 | 8.5 |
| Gonorrhea | 2014 | Asian | Female | 40-44 | 36 | 4.9 |
| Gonorrhea | 2014 | Asian | Male | 0-14 | 1 | 0.1 |
| Gonorrhea | 2014 | Asian | Male | 15-19 | 122 | 24.2 |
| Gonorrhea | 2014 | Asian | Male | 20-24 | 461 | 73.2 |
| Gonorrhea | 2014 | Asian | Male | 25-29 | 530 | 77.2 |
| Gonorrhea | 2014 | Asian | Male | 30-34 | 343 | 50.2 |
| Gonorrhea | 2014 | Asian | Male | 35-39 | 236 | 37 |
| Gonorrhea | 2014 | Asian | Male | 40-44 | 140 | 21.8 |
| Gonorrhea | 2014 | Black/African American | Female | 0-14 | 1165 | 28.2 |
| Gonorrhea | 2014 | Black/African American | Female | 15-19 | 23693 | 1603.6 |
| Gonorrhea | 2014 | Black/African American | Female | 20-24 | 29800 | 1752.7 |
| Gonorrhea | 2014 | Black/African American | Female | 25-29 | 12071 | 798.4 |
| Gonorrhea | 2014 | Black/African American | Female | 30-34 | 4763 | 331.8 |
| Gonorrhea | 2014 | Black/African American | Female | 35-39 | 2118 | 158.6 |
| Gonorrhea | 2014 | Black/African American | Female | 40-44 | 889 | 64.7 |
| Gonorrhea | 2014 | Black/African American | Male | 0-14 | 253 | 5.9 |
| Gonorrhea | 2014 | Black/African American | Male | 15-19 | 12939 | 849.1 |
| Gonorrhea | 2014 | Black/African American | Male | 20-24 | 27592 | 1583 |
| Gonorrhea | 2014 | Black/African American | Male | 25-29 | 17401 | 1189.4 |
| Gonorrhea | 2014 | Black/African American | Male | 30-34 | 9206 | 697.4 |
| Gonorrhea | 2014 | Black/African American | Male | 35-39 | 5004 | 417.8 |
| Gonorrhea | 2014 | Black/African American | Male | 40-44 | 3026 | 248.2 |
| Gonorrhea | 2014 | Hispanic/Latino | Female | 0-14 | 182 | 2.4 |
| Gonorrhea | 2014 | Hispanic/Latino | Female | 15-19 | 4055 | 179.2 |
| Gonorrhea | 2014 | Hispanic/Latino | Female | 20-24 | 5625 | 246.7 |
| Gonorrhea | 2014 | Hispanic/Latino | Female | 25-29 | 3094 | 147.5 |
| Gonorrhea | 2014 | Hispanic/Latino | Female | 30-34 | 1614 | 76.09999999999999 |
| Gonorrhea | 2014 | Hispanic/Latino | Female | 35-39 | 796 | 39.6 |
| Gonorrhea | 2014 | Hispanic/Latino | Female | 40-44 | 375 | 19.8 |
| Gonorrhea | 2014 | Hispanic/Latino | Male | 0-14 | 55 | 0.7 |
| Gonorrhea | 2014 | Hispanic/Latino | Male | 15-19 | 2540 | 107.1 |
| Gonorrhea | 2014 | Hispanic/Latino | Male | 20-24 | 6685 | 269.8 |
| Gonorrhea | 2014 | Hispanic/Latino | Male | 25-29 | 5298 | 225.4 |
| Gonorrhea | 2014 | Hispanic/Latino | Male | 30-34 | 3370 | 145.6 |
| Gonorrhea | 2014 | Hispanic/Latino | Male | 35-39 | 1942 | 91.7 |
| Gonorrhea | 2014 | Hispanic/Latino | Male | 40-44 | 1145 | 58.8 |
| Gonorrhea | 2014 | Multiple races | Female | 0-14 | 22 | 1.7 |
| Gonorrhea | 2014 | Multiple races | Female | 15-19 | 409 | 124.9 |
| Gonorrhea | 2014 | Multiple races | Female | 20-24 | 449 | 155.3 |
| Gonorrhea | 2014 | Multiple races | Female | 25-29 | 193 | 84.90000000000001 |
| Gonorrhea | 2014 | Multiple races | Female | 30-34 | 85 | 43 |
| Gonorrhea | 2014 | Multiple races | Female | 35-39 | 29 | 17.7 |
| Gonorrhea | 2014 | Multiple races | Female | 40-44 | 18 | 12.3 |
| Gonorrhea | 2014 | Multiple races | Male | 0-14 | 1 | 0.1 |
| Gonorrhea | 2014 | Multiple races | Male | 15-19 | 143 | 42.6 |
| Gonorrhea | 2014 | Multiple races | Male | 20-24 | 391 | 137.5 |
| Gonorrhea | 2014 | Multiple races | Male | 25-29 | 396 | 190.7 |
| Gonorrhea | 2014 | Multiple races | Male | 30-34 | 254 | 144.2 |
| Gonorrhea | 2014 | Multiple races | Male | 35-39 | 123 | 84.8 |
| Gonorrhea | 2014 | Multiple races | Male | 40-44 | 95 | 72.7 |
| Gonorrhea | 2014 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | 2 | 3.4 |
| Gonorrhea | 2014 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | 60 | 310.5 |
| Gonorrhea | 2014 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | 87 | 376.8 |
| Gonorrhea | 2014 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | 47 | 194.9 |
| Gonorrhea | 2014 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | 29 | 125.6 |
| Gonorrhea | 2014 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | 20 | 101.8 |
| Gonorrhea | 2014 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | 7 | 38.3 |
| Gonorrhea | 2014 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | 0 | 0 |
| Gonorrhea | 2014 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | 22 | 107.2 |
| Gonorrhea | 2014 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | 84 | 345.3 |
| Gonorrhea | 2014 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | 62 | 240.2 |
| Gonorrhea | 2014 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | 39 | 160.7 |
| Gonorrhea | 2014 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | 17 | 82.90000000000001 |
| Gonorrhea | 2014 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | 12 | 64.7 |
| Gonorrhea | 2014 | Unknown | Female | 0-14 | 495 | NA |
| Gonorrhea | 2014 | Unknown | Female | 15-19 | 8699 | NA |
| Gonorrhea | 2014 | Unknown | Female | 20-24 | 10551 | NA |
| Gonorrhea | 2014 | Unknown | Female | 25-29 | 5221 | NA |
| Gonorrhea | 2014 | Unknown | Female | 30-34 | 2953 | NA |
| Gonorrhea | 2014 | Unknown | Female | 35-39 | 1518 | NA |
| Gonorrhea | 2014 | Unknown | Female | 40-44 | 837 | NA |
| Gonorrhea | 2014 | Unknown | Male | 0-14 | 142 | NA |
| Gonorrhea | 2014 | Unknown | Male | 15-19 | 5303 | NA |
| Gonorrhea | 2014 | Unknown | Male | 20-24 | 11167 | NA |
| Gonorrhea | 2014 | Unknown | Male | 25-29 | 7625 | NA |
| Gonorrhea | 2014 | Unknown | Male | 30-34 | 4794 | NA |
| Gonorrhea | 2014 | Unknown | Male | 35-39 | 3033 | NA |
| Gonorrhea | 2014 | Unknown | Male | 40-44 | 2161 | NA |
| Gonorrhea | 2014 | White | Female | 0-14 | 254 | 1.7 |
| Gonorrhea | 2014 | White | Female | 15-19 | 6872 | 122.5 |
| Gonorrhea | 2014 | White | Female | 20-24 | 11642 | 189.1 |
| Gonorrhea | 2014 | White | Female | 25-29 | 7531 | 122.6 |
| Gonorrhea | 2014 | White | Female | 30-34 | 4055 | 66.5 |
| Gonorrhea | 2014 | White | Female | 35-39 | 1965 | 34.8 |
| Gonorrhea | 2014 | White | Female | 40-44 | 1059 | 17.3 |
| Gonorrhea | 2014 | White | Male | 0-14 | 38 | 0.2 |
| Gonorrhea | 2014 | White | Male | 15-19 | 2731 | 46.1 |
| Gonorrhea | 2014 | White | Male | 20-24 | 9887 | 152.9 |
| Gonorrhea | 2014 | White | Male | 25-29 | 8910 | 140.7 |
| Gonorrhea | 2014 | White | Male | 30-34 | 6123 | 98.7 |
| Gonorrhea | 2014 | White | Male | 35-39 | 3639 | 63.4 |
| Gonorrhea | 2014 | White | Male | 40-44 | 2690 | 43.5 |
| Gonorrhea | 2015 | American Indian/Alaska Native | Female | 0-14 | 36 | 14 |
| Gonorrhea | 2015 | American Indian/Alaska Native | Female | 15-19 | 511 | 571.6 |
| Gonorrhea | 2015 | American Indian/Alaska Native | Female | 20-24 | 848 | 874.2 |
| Gonorrhea | 2015 | American Indian/Alaska Native | Female | 25-29 | 644 | 715.7 |
| Gonorrhea | 2015 | American Indian/Alaska Native | Female | 30-34 | 390 | 478 |
| Gonorrhea | 2015 | American Indian/Alaska Native | Female | 35-39 | 181 | 243.4 |
| Gonorrhea | 2015 | American Indian/Alaska Native | Female | 40-44 | 102 | 140.3 |
| Gonorrhea | 2015 | American Indian/Alaska Native | Male | 0-14 | 4 | 1.5 |
| Gonorrhea | 2015 | American Indian/Alaska Native | Male | 15-19 | 209 | 225.6 |
| Gonorrhea | 2015 | American Indian/Alaska Native | Male | 20-24 | 483 | 473.6 |
| Gonorrhea | 2015 | American Indian/Alaska Native | Male | 25-29 | 468 | 502.2 |
| Gonorrhea | 2015 | American Indian/Alaska Native | Male | 30-34 | 265 | 327.1 |
| Gonorrhea | 2015 | American Indian/Alaska Native | Male | 35-39 | 132 | 179.4 |
| Gonorrhea | 2015 | American Indian/Alaska Native | Male | 40-44 | 72 | 102.3 |
| Gonorrhea | 2015 | Asian | Female | 0-14 | 7 | 0.5 |
| Gonorrhea | 2015 | Asian | Female | 15-19 | 206 | 40.5 |
| Gonorrhea | 2015 | Asian | Female | 20-24 | 349 | 56.8 |
| Gonorrhea | 2015 | Asian | Female | 25-29 | 207 | 27.6 |
| Gonorrhea | 2015 | Asian | Female | 30-34 | 148 | 18.7 |
| Gonorrhea | 2015 | Asian | Female | 35-39 | 81 | 10.8 |
| Gonorrhea | 2015 | Asian | Female | 40-44 | 48 | 6.4 |
| Gonorrhea | 2015 | Asian | Male | 0-14 | 2 | 0.1 |
| Gonorrhea | 2015 | Asian | Male | 15-19 | 173 | 33.4 |
| Gonorrhea | 2015 | Asian | Male | 20-24 | 678 | 106.5 |
| Gonorrhea | 2015 | Asian | Male | 25-29 | 711 | 98.90000000000001 |
| Gonorrhea | 2015 | Asian | Male | 30-34 | 487 | 68.5 |
| Gonorrhea | 2015 | Asian | Male | 35-39 | 290 | 44.3 |
| Gonorrhea | 2015 | Asian | Male | 40-44 | 204 | 31.1 |
| Gonorrhea | 2015 | Black/African American | Female | 0-14 | 1059 | 25.7 |
| Gonorrhea | 2015 | Black/African American | Female | 15-19 | 22856 | 1554 |
| Gonorrhea | 2015 | Black/African American | Female | 20-24 | 29906 | 1790.2 |
| Gonorrhea | 2015 | Black/African American | Female | 25-29 | 13312 | 845.3 |
| Gonorrhea | 2015 | Black/African American | Female | 30-34 | 5209 | 362.5 |
| Gonorrhea | 2015 | Black/African American | Female | 35-39 | 2306 | 168.1 |
| Gonorrhea | 2015 | Black/African American | Female | 40-44 | 988 | 73 |
| Gonorrhea | 2015 | Black/African American | Male | 0-14 | 242 | 5.7 |
| Gonorrhea | 2015 | Black/African American | Male | 15-19 | 13653 | 900.5 |
| Gonorrhea | 2015 | Black/African American | Male | 20-24 | 29291 | 1699.4 |
| Gonorrhea | 2015 | Black/African American | Male | 25-29 | 20704 | 1344.9 |
| Gonorrhea | 2015 | Black/African American | Male | 30-34 | 10832 | 814 |
| Gonorrhea | 2015 | Black/African American | Male | 35-39 | 6217 | 503.1 |
| Gonorrhea | 2015 | Black/African American | Male | 40-44 | 3531 | 294.6 |
| Gonorrhea | 2015 | Hispanic/Latino | Female | 0-14 | 170 | 2.3 |
| Gonorrhea | 2015 | Hispanic/Latino | Female | 15-19 | 4331 | 187.8 |
| Gonorrhea | 2015 | Hispanic/Latino | Female | 20-24 | 6017 | 260.6 |
| Gonorrhea | 2015 | Hispanic/Latino | Female | 25-29 | 3465 | 161.4 |
| Gonorrhea | 2015 | Hispanic/Latino | Female | 30-34 | 1814 | 85.3 |
| Gonorrhea | 2015 | Hispanic/Latino | Female | 35-39 | 937 | 45.7 |
| Gonorrhea | 2015 | Hispanic/Latino | Female | 40-44 | 459 | 23.8 |
| Gonorrhea | 2015 | Hispanic/Latino | Male | 0-14 | 41 | 0.5 |
| Gonorrhea | 2015 | Hispanic/Latino | Male | 15-19 | 2644 | 109.6 |
| Gonorrhea | 2015 | Hispanic/Latino | Male | 20-24 | 7589 | 304.6 |
| Gonorrhea | 2015 | Hispanic/Latino | Male | 25-29 | 6641 | 277.3 |
| Gonorrhea | 2015 | Hispanic/Latino | Male | 30-34 | 4082 | 175.3 |
| Gonorrhea | 2015 | Hispanic/Latino | Male | 35-39 | 2490 | 114.1 |
| Gonorrhea | 2015 | Hispanic/Latino | Male | 40-44 | 1392 | 70.2 |
| Gonorrhea | 2015 | Multiple races | Female | 0-14 | 17 | 1.3 |
| Gonorrhea | 2015 | Multiple races | Female | 15-19 | 464 | 137.6 |
| Gonorrhea | 2015 | Multiple races | Female | 20-24 | 501 | 167.5 |
| Gonorrhea | 2015 | Multiple races | Female | 25-29 | 235 | 98.09999999999999 |
| Gonorrhea | 2015 | Multiple races | Female | 30-34 | 86 | 42.6 |
| Gonorrhea | 2015 | Multiple races | Female | 35-39 | 34 | 19.8 |
| Gonorrhea | 2015 | Multiple races | Female | 40-44 | 14 | 9.5 |
| Gonorrhea | 2015 | Multiple races | Male | 0-14 | 2 | 0.2 |
| Gonorrhea | 2015 | Multiple races | Male | 15-19 | 137 | 39.6 |
| Gonorrhea | 2015 | Multiple races | Male | 20-24 | 500 | 167.2 |
| Gonorrhea | 2015 | Multiple races | Male | 25-29 | 468 | 210.8 |
| Gonorrhea | 2015 | Multiple races | Male | 30-34 | 299 | 165.7 |
| Gonorrhea | 2015 | Multiple races | Male | 35-39 | 199 | 130.6 |
| Gonorrhea | 2015 | Multiple races | Male | 40-44 | 112 | 85.3 |
| Gonorrhea | 2015 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | 5 | 8.5 |
| Gonorrhea | 2015 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | 78 | 402.1 |
| Gonorrhea | 2015 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | 101 | 448.9 |
| Gonorrhea | 2015 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | 47 | 191.2 |
| Gonorrhea | 2015 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | 38 | 161.6 |
| Gonorrhea | 2015 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | 16 | 77.3 |
| Gonorrhea | 2015 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | 7 | 38.3 |
| Gonorrhea | 2015 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | 1 | 1.6 |
| Gonorrhea | 2015 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | 39 | 188.5 |
| Gonorrhea | 2015 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | 109 | 462.2 |
| Gonorrhea | 2015 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | 109 | 410.5 |
| Gonorrhea | 2015 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | 65 | 263.2 |
| Gonorrhea | 2015 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | 34 | 159.2 |
| Gonorrhea | 2015 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | 20 | 105.9 |
| Gonorrhea | 2015 | Unknown | Female | 0-14 | 512 | NA |
| Gonorrhea | 2015 | Unknown | Female | 15-19 | 9355 | NA |
| Gonorrhea | 2015 | Unknown | Female | 20-24 | 11270 | NA |
| Gonorrhea | 2015 | Unknown | Female | 25-29 | 6257 | NA |
| Gonorrhea | 2015 | Unknown | Female | 30-34 | 3304 | NA |
| Gonorrhea | 2015 | Unknown | Female | 35-39 | 1937 | NA |
| Gonorrhea | 2015 | Unknown | Female | 40-44 | 1041 | NA |
| Gonorrhea | 2015 | Unknown | Male | 0-14 | 114 | NA |
| Gonorrhea | 2015 | Unknown | Male | 15-19 | 6302 | NA |
| Gonorrhea | 2015 | Unknown | Male | 20-24 | 13183 | NA |
| Gonorrhea | 2015 | Unknown | Male | 25-29 | 9894 | NA |
| Gonorrhea | 2015 | Unknown | Male | 30-34 | 5986 | NA |
| Gonorrhea | 2015 | Unknown | Male | 35-39 | 3871 | NA |
| Gonorrhea | 2015 | Unknown | Male | 40-44 | 2490 | NA |
| Gonorrhea | 2015 | White | Female | 0-14 | 281 | 1.9 |
| Gonorrhea | 2015 | White | Female | 15-19 | 7676 | 137.7 |
| Gonorrhea | 2015 | White | Female | 20-24 | 12113 | 200.9 |
| Gonorrhea | 2015 | White | Female | 25-29 | 8495 | 137 |
| Gonorrhea | 2015 | White | Female | 30-34 | 4878 | 79.8 |
| Gonorrhea | 2015 | White | Female | 35-39 | 2405 | 41.9 |
| Gonorrhea | 2015 | White | Female | 40-44 | 1239 | 21 |
| Gonorrhea | 2015 | White | Male | 0-14 | 37 | 0.2 |
| Gonorrhea | 2015 | White | Male | 15-19 | 3244 | 55.1 |
| Gonorrhea | 2015 | White | Male | 20-24 | 11456 | 179.9 |
| Gonorrhea | 2015 | White | Male | 25-29 | 11094 | 173.2 |
| Gonorrhea | 2015 | White | Male | 30-34 | 7735 | 124.2 |
| Gonorrhea | 2015 | White | Male | 35-39 | 4965 | 85 |
| Gonorrhea | 2015 | White | Male | 40-44 | 3295 | 55.3 |
| Gonorrhea | 2016 | American Indian/Alaska Native | Female | 0-14 | 30 | 11.8 |
| Gonorrhea | 2016 | American Indian/Alaska Native | Female | 15-19 | 573 | 641.2 |
| Gonorrhea | 2016 | American Indian/Alaska Native | Female | 20-24 | 1007 | 1064.2 |
| Gonorrhea | 2016 | American Indian/Alaska Native | Female | 25-29 | 845 | 907.4 |
| Gonorrhea | 2016 | American Indian/Alaska Native | Female | 30-34 | 486 | 590.2 |
| Gonorrhea | 2016 | American Indian/Alaska Native | Female | 35-39 | 268 | 351.6 |
| Gonorrhea | 2016 | American Indian/Alaska Native | Female | 40-44 | 113 | 158.6 |
| Gonorrhea | 2016 | American Indian/Alaska Native | Male | 0-14 | 3 | 1.1 |
| Gonorrhea | 2016 | American Indian/Alaska Native | Male | 15-19 | 237 | 256.7 |
| Gonorrhea | 2016 | American Indian/Alaska Native | Male | 20-24 | 599 | 604.1 |
| Gonorrhea | 2016 | American Indian/Alaska Native | Male | 25-29 | 588 | 605.3 |
| Gonorrhea | 2016 | American Indian/Alaska Native | Male | 30-34 | 386 | 468 |
| Gonorrhea | 2016 | American Indian/Alaska Native | Male | 35-39 | 195 | 260.1 |
| Gonorrhea | 2016 | American Indian/Alaska Native | Male | 40-44 | 104 | 150.5 |
| Gonorrhea | 2016 | Asian | Female | 0-14 | 8 | 0.5 |
| Gonorrhea | 2016 | Asian | Female | 15-19 | 212 | 40.5 |
| Gonorrhea | 2016 | Asian | Female | 20-24 | 430 | 68.90000000000001 |
| Gonorrhea | 2016 | Asian | Female | 25-29 | 287 | 36.8 |
| Gonorrhea | 2016 | Asian | Female | 30-34 | 152 | 18.7 |
| Gonorrhea | 2016 | Asian | Female | 35-39 | 109 | 14.1 |
| Gonorrhea | 2016 | Asian | Female | 40-44 | 61 | 8 |
| Gonorrhea | 2016 | Asian | Male | 0-14 | 4 | 0.3 |
| Gonorrhea | 2016 | Asian | Male | 15-19 | 184 | 34.7 |
| Gonorrhea | 2016 | Asian | Male | 20-24 | 789 | 122.6 |
| Gonorrhea | 2016 | Asian | Male | 25-29 | 940 | 125 |
| Gonorrhea | 2016 | Asian | Male | 30-34 | 637 | 86 |
| Gonorrhea | 2016 | Asian | Male | 35-39 | 402 | 59.6 |
| Gonorrhea | 2016 | Asian | Male | 40-44 | 263 | 39.5 |
| Gonorrhea | 2016 | Black/African American | Female | 0-14 | 1061 | 25.7 |
| Gonorrhea | 2016 | Black/African American | Female | 15-19 | 24503 | 1666.3 |
| Gonorrhea | 2016 | Black/African American | Female | 20-24 | 31051 | 1913.1 |
| Gonorrhea | 2016 | Black/African American | Female | 25-29 | 15462 | 941.8 |
| Gonorrhea | 2016 | Black/African American | Female | 30-34 | 6106 | 421.1 |
| Gonorrhea | 2016 | Black/African American | Female | 35-39 | 2833 | 201.6 |
| Gonorrhea | 2016 | Black/African American | Female | 40-44 | 1156 | 87.40000000000001 |
| Gonorrhea | 2016 | Black/African American | Male | 0-14 | 339 | 8 |
| Gonorrhea | 2016 | Black/African American | Male | 15-19 | 15755 | 1039.5 |
| Gonorrhea | 2016 | Black/African American | Male | 20-24 | 32653 | 1945.3 |
| Gonorrhea | 2016 | Black/African American | Male | 25-29 | 25283 | 1559.3 |
| Gonorrhea | 2016 | Black/African American | Male | 30-34 | 13525 | 998.1 |
| Gonorrhea | 2016 | Black/African American | Male | 35-39 | 7867 | 619.8 |
| Gonorrhea | 2016 | Black/African American | Male | 40-44 | 4498 | 383.2 |
| Gonorrhea | 2016 | Hispanic/Latino | Female | 0-14 | 253 | 3.3 |
| Gonorrhea | 2016 | Hispanic/Latino | Female | 15-19 | 4854 | 206.2 |
| Gonorrhea | 2016 | Hispanic/Latino | Female | 20-24 | 6839 | 294.1 |
| Gonorrhea | 2016 | Hispanic/Latino | Female | 25-29 | 4180 | 189.2 |
| Gonorrhea | 2016 | Hispanic/Latino | Female | 30-34 | 2219 | 103.6 |
| Gonorrhea | 2016 | Hispanic/Latino | Female | 35-39 | 1225 | 58.6 |
| Gonorrhea | 2016 | Hispanic/Latino | Female | 40-44 | 577 | 29.4 |
| Gonorrhea | 2016 | Hispanic/Latino | Male | 0-14 | 55 | 0.7 |
| Gonorrhea | 2016 | Hispanic/Latino | Male | 15-19 | 3199 | 130 |
| Gonorrhea | 2016 | Hispanic/Latino | Male | 20-24 | 9122 | 365.4 |
| Gonorrhea | 2016 | Hispanic/Latino | Male | 25-29 | 8217 | 335.7 |
| Gonorrhea | 2016 | Hispanic/Latino | Male | 30-34 | 5244 | 222.3 |
| Gonorrhea | 2016 | Hispanic/Latino | Male | 35-39 | 3285 | 147 |
| Gonorrhea | 2016 | Hispanic/Latino | Male | 40-44 | 1813 | 89.8 |
| Gonorrhea | 2016 | Multiple races | Female | 0-14 | 14 | 1.1 |
| Gonorrhea | 2016 | Multiple races | Female | 15-19 | 504 | 145.5 |
| Gonorrhea | 2016 | Multiple races | Female | 20-24 | 615 | 200.4 |
| Gonorrhea | 2016 | Multiple races | Female | 25-29 | 291 | 114.4 |
| Gonorrhea | 2016 | Multiple races | Female | 30-34 | 128 | 61.8 |
| Gonorrhea | 2016 | Multiple races | Female | 35-39 | 64 | 35.6 |
| Gonorrhea | 2016 | Multiple races | Female | 40-44 | 23 | 15.5 |
| Gonorrhea | 2016 | Multiple races | Male | 0-14 | 2 | 0.1 |
| Gonorrhea | 2016 | Multiple races | Male | 15-19 | 204 | 57.3 |
| Gonorrhea | 2016 | Multiple races | Male | 20-24 | 576 | 184.8 |
| Gonorrhea | 2016 | Multiple races | Male | 25-29 | 570 | 239 |
| Gonorrhea | 2016 | Multiple races | Male | 30-34 | 474 | 254.7 |
| Gonorrhea | 2016 | Multiple races | Male | 35-39 | 239 | 149.8 |
| Gonorrhea | 2016 | Multiple races | Male | 40-44 | 125 | 94.40000000000001 |
| Gonorrhea | 2016 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | 2 | 3.4 |
| Gonorrhea | 2016 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | 104 | 530.2 |
| Gonorrhea | 2016 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | 152 | 694.2 |
| Gonorrhea | 2016 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | 88 | 354.3 |
| Gonorrhea | 2016 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | 50 | 206 |
| Gonorrhea | 2016 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | 27 | 126.2 |
| Gonorrhea | 2016 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | 14 | 75.59999999999999 |
| Gonorrhea | 2016 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | 2 | 3.2 |
| Gonorrhea | 2016 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | 46 | 221.6 |
| Gonorrhea | 2016 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | 104 | 456.6 |
| Gonorrhea | 2016 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | 122 | 451.4 |
| Gonorrhea | 2016 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | 76 | 300.3 |
| Gonorrhea | 2016 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | 62 | 277.1 |
| Gonorrhea | 2016 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | 32 | 166.9 |
| Gonorrhea | 2016 | Unknown | Female | 0-14 | 469 | NA |
| Gonorrhea | 2016 | Unknown | Female | 15-19 | 9927 | NA |
| Gonorrhea | 2016 | Unknown | Female | 20-24 | 11811 | NA |
| Gonorrhea | 2016 | Unknown | Female | 25-29 | 6991 | NA |
| Gonorrhea | 2016 | Unknown | Female | 30-34 | 3828 | NA |
| Gonorrhea | 2016 | Unknown | Female | 35-39 | 2221 | NA |
| Gonorrhea | 2016 | Unknown | Female | 40-44 | 1263 | NA |
| Gonorrhea | 2016 | Unknown | Male | 0-14 | 140 | NA |
| Gonorrhea | 2016 | Unknown | Male | 15-19 | 6933 | NA |
| Gonorrhea | 2016 | Unknown | Male | 20-24 | 14921 | NA |
| Gonorrhea | 2016 | Unknown | Male | 25-29 | 12203 | NA |
| Gonorrhea | 2016 | Unknown | Male | 30-34 | 7537 | NA |
| Gonorrhea | 2016 | Unknown | Male | 35-39 | 4908 | NA |
| Gonorrhea | 2016 | Unknown | Male | 40-44 | 2993 | NA |
| Gonorrhea | 2016 | White | Female | 0-14 | 286 | 1.9 |
| Gonorrhea | 2016 | White | Female | 15-19 | 9033 | 163.2 |
| Gonorrhea | 2016 | White | Female | 20-24 | 14025 | 238.1 |
| Gonorrhea | 2016 | White | Female | 25-29 | 10737 | 171.4 |
| Gonorrhea | 2016 | White | Female | 30-34 | 6337 | 103.5 |
| Gonorrhea | 2016 | White | Female | 35-39 | 3483 | 59.3 |
| Gonorrhea | 2016 | White | Female | 40-44 | 1728 | 30.5 |
| Gonorrhea | 2016 | White | Male | 0-14 | 41 | 0.3 |
| Gonorrhea | 2016 | White | Male | 15-19 | 3758 | 64.40000000000001 |
| Gonorrhea | 2016 | White | Male | 20-24 | 13203 | 211.4 |
| Gonorrhea | 2016 | White | Male | 25-29 | 14266 | 220.2 |
| Gonorrhea | 2016 | White | Male | 30-34 | 10314 | 165 |
| Gonorrhea | 2016 | White | Male | 35-39 | 6786 | 113.8 |
| Gonorrhea | 2016 | White | Male | 40-44 | 4288 | 75 |
| Gonorrhea | 2017 | American Indian/Alaska Native | Female | 0-14 | 45 | 17.8 |
| Gonorrhea | 2017 | American Indian/Alaska Native | Female | 15-19 | 721 | 812.5 |
| Gonorrhea | 2017 | American Indian/Alaska Native | Female | 20-24 | 1165 | 1264.1 |
| Gonorrhea | 2017 | American Indian/Alaska Native | Female | 25-29 | 1085 | 1127.8 |
| Gonorrhea | 2017 | American Indian/Alaska Native | Female | 30-34 | 675 | 807.9 |
| Gonorrhea | 2017 | American Indian/Alaska Native | Female | 35-39 | 341 | 442.4 |
| Gonorrhea | 2017 | American Indian/Alaska Native | Female | 40-44 | 213 | 298.9 |
| Gonorrhea | 2017 | American Indian/Alaska Native | Male | 0-14 | 7 | 2.7 |
| Gonorrhea | 2017 | American Indian/Alaska Native | Male | 15-19 | 300 | 326.7 |
| Gonorrhea | 2017 | American Indian/Alaska Native | Male | 20-24 | 632 | 658.9 |
| Gonorrhea | 2017 | American Indian/Alaska Native | Male | 25-29 | 671 | 667.3 |
| Gonorrhea | 2017 | American Indian/Alaska Native | Male | 30-34 | 482 | 573.9 |
| Gonorrhea | 2017 | American Indian/Alaska Native | Male | 35-39 | 336 | 440.8 |
| Gonorrhea | 2017 | American Indian/Alaska Native | Male | 40-44 | 160 | 231.5 |
| Gonorrhea | 2017 | Asian | Female | 0-14 | 14 | 0.9 |
| Gonorrhea | 2017 | Asian | Female | 15-19 | 272 | 50.8 |
| Gonorrhea | 2017 | Asian | Female | 20-24 | 447 | 70.09999999999999 |
| Gonorrhea | 2017 | Asian | Female | 25-29 | 293 | 36.4 |
| Gonorrhea | 2017 | Asian | Female | 30-34 | 214 | 25.8 |
| Gonorrhea | 2017 | Asian | Female | 35-39 | 138 | 17.2 |
| Gonorrhea | 2017 | Asian | Female | 40-44 | 78 | 10.2 |
| Gonorrhea | 2017 | Asian | Male | 0-14 | 0 | 0 |
| Gonorrhea | 2017 | Asian | Male | 15-19 | 187 | 34.6 |
| Gonorrhea | 2017 | Asian | Male | 20-24 | 986 | 151 |
| Gonorrhea | 2017 | Asian | Male | 25-29 | 1175 | 151 |
| Gonorrhea | 2017 | Asian | Male | 30-34 | 849 | 111.1 |
| Gonorrhea | 2017 | Asian | Male | 35-39 | 513 | 72.8 |
| Gonorrhea | 2017 | Asian | Male | 40-44 | 368 | 54.9 |
| Gonorrhea | 2017 | Black/African American | Female | 0-14 | 1177 | 28.5 |
| Gonorrhea | 2017 | Black/African American | Female | 15-19 | 27090 | 1854.3 |
| Gonorrhea | 2017 | Black/African American | Female | 20-24 | 33513 | 2120 |
| Gonorrhea | 2017 | Black/African American | Female | 25-29 | 18087 | 1065.3 |
| Gonorrhea | 2017 | Black/African American | Female | 30-34 | 7087 | 483.5 |
| Gonorrhea | 2017 | Black/African American | Female | 35-39 | 3436 | 240.4 |
| Gonorrhea | 2017 | Black/African American | Female | 40-44 | 1398 | 106.2 |
| Gonorrhea | 2017 | Black/African American | Male | 0-14 | 327 | 7.7 |
| Gonorrhea | 2017 | Black/African American | Male | 15-19 | 18077 | 1201 |
| Gonorrhea | 2017 | Black/African American | Male | 20-24 | 36136 | 2214 |
| Gonorrhea | 2017 | Black/African American | Male | 25-29 | 30162 | 1779.5 |
| Gonorrhea | 2017 | Black/African American | Male | 30-34 | 16494 | 1191.7 |
| Gonorrhea | 2017 | Black/African American | Male | 35-39 | 9726 | 750 |
| Gonorrhea | 2017 | Black/African American | Male | 40-44 | 5523 | 472.9 |
| Gonorrhea | 2017 | Hispanic/Latino | Female | 0-14 | 219 | 2.9 |
| Gonorrhea | 2017 | Hispanic/Latino | Female | 15-19 | 5801 | 242.1 |
| Gonorrhea | 2017 | Hispanic/Latino | Female | 20-24 | 7874 | 336.8 |
| Gonorrhea | 2017 | Hispanic/Latino | Female | 25-29 | 5031 | 220.5 |
| Gonorrhea | 2017 | Hispanic/Latino | Female | 30-34 | 2794 | 130 |
| Gonorrhea | 2017 | Hispanic/Latino | Female | 35-39 | 1694 | 79.5 |
| Gonorrhea | 2017 | Hispanic/Latino | Female | 40-44 | 734 | 36.8 |
| Gonorrhea | 2017 | Hispanic/Latino | Male | 0-14 | 37 | 0.5 |
| Gonorrhea | 2017 | Hispanic/Latino | Male | 15-19 | 3559 | 142.2 |
| Gonorrhea | 2017 | Hispanic/Latino | Male | 20-24 | 10199 | 408.3 |
| Gonorrhea | 2017 | Hispanic/Latino | Male | 25-29 | 10178 | 405.3 |
| Gonorrhea | 2017 | Hispanic/Latino | Male | 30-34 | 6691 | 281.4 |
| Gonorrhea | 2017 | Hispanic/Latino | Male | 35-39 | 4163 | 182 |
| Gonorrhea | 2017 | Hispanic/Latino | Male | 40-44 | 2384 | 115.7 |
| Gonorrhea | 2017 | Multiple races | Female | 0-14 | 26 | 2 |
| Gonorrhea | 2017 | Multiple races | Female | 15-19 | 595 | 167.9 |
| Gonorrhea | 2017 | Multiple races | Female | 20-24 | 826 | 262.5 |
| Gonorrhea | 2017 | Multiple races | Female | 25-29 | 411 | 152.9 |
| Gonorrhea | 2017 | Multiple races | Female | 30-34 | 217 | 101.7 |
| Gonorrhea | 2017 | Multiple races | Female | 35-39 | 85 | 45.5 |
| Gonorrhea | 2017 | Multiple races | Female | 40-44 | 45 | 29.5 |
| Gonorrhea | 2017 | Multiple races | Male | 0-14 | 2 | 0.1 |
| Gonorrhea | 2017 | Multiple races | Male | 15-19 | 225 | 61.8 |
| Gonorrhea | 2017 | Multiple races | Male | 20-24 | 626 | 194.8 |
| Gonorrhea | 2017 | Multiple races | Male | 25-29 | 693 | 269.5 |
| Gonorrhea | 2017 | Multiple races | Male | 30-34 | 571 | 296.7 |
| Gonorrhea | 2017 | Multiple races | Male | 35-39 | 326 | 196.4 |
| Gonorrhea | 2017 | Multiple races | Male | 40-44 | 193 | 142.5 |
| Gonorrhea | 2017 | Native Hawaiian/Other Pacific Islander | Female | 0-14 | 4 | 6.6 |
| Gonorrhea | 2017 | Native Hawaiian/Other Pacific Islander | Female | 15-19 | 98 | 494.3 |
| Gonorrhea | 2017 | Native Hawaiian/Other Pacific Islander | Female | 20-24 | 167 | 775.3 |
| Gonorrhea | 2017 | Native Hawaiian/Other Pacific Islander | Female | 25-29 | 98 | 392.8 |
| Gonorrhea | 2017 | Native Hawaiian/Other Pacific Islander | Female | 30-34 | 56 | 228.4 |
| Gonorrhea | 2017 | Native Hawaiian/Other Pacific Islander | Female | 35-39 | 48 | 215.8 |
| Gonorrhea | 2017 | Native Hawaiian/Other Pacific Islander | Female | 40-44 | 16 | 84.09999999999999 |
| Gonorrhea | 2017 | Native Hawaiian/Other Pacific Islander | Male | 0-14 | 5 | 8 |
| Gonorrhea | 2017 | Native Hawaiian/Other Pacific Islander | Male | 15-19 | 53 | 254 |
| Gonorrhea | 2017 | Native Hawaiian/Other Pacific Islander | Male | 20-24 | 117 | 521.8 |
| Gonorrhea | 2017 | Native Hawaiian/Other Pacific Islander | Male | 25-29 | 140 | 520.7 |
| Gonorrhea | 2017 | Native Hawaiian/Other Pacific Islander | Male | 30-34 | 97 | 377.6 |
| Gonorrhea | 2017 | Native Hawaiian/Other Pacific Islander | Male | 35-39 | 72 | 308.1 |
| Gonorrhea | 2017 | Native Hawaiian/Other Pacific Islander | Male | 40-44 | 31 | 157.5 |
| Gonorrhea | 2017 | Unknown | Female | 0-14 | 565 | NA |
| Gonorrhea | 2017 | Unknown | Female | 15-19 | 12055 | NA |
| Gonorrhea | 2017 | Unknown | Female | 20-24 | 14058 | NA |
| Gonorrhea | 2017 | Unknown | Female | 25-29 | 8654 | NA |
| Gonorrhea | 2017 | Unknown | Female | 30-34 | 4859 | NA |
| Gonorrhea | 2017 | Unknown | Female | 35-39 | 2923 | NA |
| Gonorrhea | 2017 | Unknown | Female | 40-44 | 1551 | NA |
| Gonorrhea | 2017 | Unknown | Male | 0-14 | 160 | NA |
| Gonorrhea | 2017 | Unknown | Male | 15-19 | 8314 | NA |
| Gonorrhea | 2017 | Unknown | Male | 20-24 | 17876 | NA |
| Gonorrhea | 2017 | Unknown | Male | 25-29 | 15644 | NA |
| Gonorrhea | 2017 | Unknown | Male | 30-34 | 9999 | NA |
| Gonorrhea | 2017 | Unknown | Male | 35-39 | 6685 | NA |
| Gonorrhea | 2017 | Unknown | Male | 40-44 | 4078 | NA |
| Gonorrhea | 2017 | White | Female | 0-14 | 396 | 2.7 |
| Gonorrhea | 2017 | White | Female | 15-19 | 10941 | 199.8 |
| Gonorrhea | 2017 | White | Female | 20-24 | 16528 | 285.7 |
| Gonorrhea | 2017 | White | Female | 25-29 | 12918 | 205.2 |
| Gonorrhea | 2017 | White | Female | 30-34 | 8255 | 135 |
| Gonorrhea | 2017 | White | Female | 35-39 | 4783 | 80.2 |
| Gonorrhea | 2017 | White | Female | 40-44 | 2296 | 41.2 |
| Gonorrhea | 2017 | White | Male | 0-14 | 44 | 0.3 |
| Gonorrhea | 2017 | White | Male | 15-19 | 4203 | 72.8 |
| Gonorrhea | 2017 | White | Male | 20-24 | 14464 | 236.1 |
| Gonorrhea | 2017 | White | Male | 25-29 | 16460 | 252 |
| Gonorrhea | 2017 | White | Male | 30-34 | 12159 | 194.2 |
| Gonorrhea | 2017 | White | Male | 35-39 | 8456 | 139.5 |
| Gonorrhea | 2017 | White | Male | 40-44 | 5016 | 89.09999999999999 |
# Here I read in all the CDC data for HIV/AIDS rates for females from 2008 to 2017. I have added an extra column to list what the sex is.
hiv_aids_f <- read_xlsx("Data_Sets/CDC_Data/Atlas_CDC_HIV:AIDS_Female.xlsx",
skip = 8) %>%
clean_names() %>%
mutate(sex = "F")
hiv_aids_f[hiv_aids_f == "Data not available"] <-NA
hiv_aids_f
## # A tibble: 2,100 x 7
## indicator year race_ethnicity age_group transmission_cat… cases sex
## <chr> <dbl> <chr> <chr> <chr> <dbl> <chr>
## 1 HIV diagno… 2008 American Indian/Al… 13-24 Heterosexual con… 4 F
## 2 HIV diagno… 2008 American Indian/Al… 13-24 Injection drug u… 0 F
## 3 HIV diagno… 2008 American Indian/Al… 13-24 Other 0 F
## 4 HIV diagno… 2008 American Indian/Al… 25-34 Heterosexual con… 6 F
## 5 HIV diagno… 2008 American Indian/Al… 25-34 Injection drug u… 3 F
## 6 HIV diagno… 2008 American Indian/Al… 25-34 Other 0 F
## 7 HIV diagno… 2008 American Indian/Al… 35-44 Heterosexual con… 4 F
## 8 HIV diagno… 2008 American Indian/Al… 35-44 Injection drug u… 4 F
## 9 HIV diagno… 2008 American Indian/Al… 35-44 Other 0 F
## 10 HIV diagno… 2008 American Indian/Al… 45-54 Heterosexual con… 3 F
## # … with 2,090 more rows
# Here I read in all the CDC data for HIV/AIDS rates for males from 2008 to 2017. I have added an extra column to list what the sex is.
hiv_aids_m <- read_xlsx("Data_Sets/CDC_Data/AtlasPlus_CDC_Male_HIV:AIDS.xlsx",
skip = 8) %>%
clean_names() %>%
mutate(sex = "M")
hiv_aids_m[hiv_aids_m == "Data not available"] <-NA
hiv_aids_m
## # A tibble: 3,500 x 7
## indicator year race_ethnicity age_group transmission_category cases sex
## <chr> <dbl> <chr> <chr> <chr> <dbl> <chr>
## 1 HIV diagn… 2008 American Indian… 13-24 Heterosexual contact 0 M
## 2 HIV diagn… 2008 American Indian… 13-24 Injection drug use 1 M
## 3 HIV diagn… 2008 American Indian… 13-24 Male-to-male sexual … 9 M
## 4 HIV diagn… 2008 American Indian… 13-24 Male-to-male sexual … 3 M
## 5 HIV diagn… 2008 American Indian… 13-24 Other 0 M
## 6 HIV diagn… 2008 American Indian… 25-34 Heterosexual contact 5 M
## 7 HIV diagn… 2008 American Indian… 25-34 Injection drug use 1 M
## 8 HIV diagn… 2008 American Indian… 25-34 Male-to-male sexual … 25 M
## 9 HIV diagn… 2008 American Indian… 25-34 Male-to-male sexual … 3 M
## 10 HIV diagn… 2008 American Indian… 25-34 Other 0 M
## # … with 3,490 more rows
# Here I merged the two HIV/AIDS datasets as the variables were the same for both the female and male tables.
hiv_aids_all <- rbind(hiv_aids_f, hiv_aids_m) %>%
gt()
hiv_aids_all
| indicator | year | race_ethnicity | age_group | transmission_category | cases | sex |
|---|---|---|---|---|---|---|
| HIV diagnoses | 2008 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 4 | F |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 13-24 | Injection drug use | 0 | F |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 13-24 | Other | 0 | F |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 6 | F |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 25-34 | Injection drug use | 3 | F |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 25-34 | Other | 0 | F |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 4 | F |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 35-44 | Injection drug use | 4 | F |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 35-44 | Other | 0 | F |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 45-54 | Injection drug use | 2 | F |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 55 | Heterosexual contact | 4 | F |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 55 | Injection drug use | 1 | F |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 55 | Other | 0 | F |
| HIV diagnoses | 2008 | Asian | 13-24 | Heterosexual contact | 15 | F |
| HIV diagnoses | 2008 | Asian | 13-24 | Injection drug use | 0 | F |
| HIV diagnoses | 2008 | Asian | 13-24 | Other | 0 | F |
| HIV diagnoses | 2008 | Asian | 25-34 | Heterosexual contact | 41 | F |
| HIV diagnoses | 2008 | Asian | 25-34 | Injection drug use | 4 | F |
| HIV diagnoses | 2008 | Asian | 25-34 | Other | 0 | F |
| HIV diagnoses | 2008 | Asian | 35-44 | Heterosexual contact | 22 | F |
| HIV diagnoses | 2008 | Asian | 35-44 | Injection drug use | 1 | F |
| HIV diagnoses | 2008 | Asian | 35-44 | Other | 0 | F |
| HIV diagnoses | 2008 | Asian | 45-54 | Heterosexual contact | 10 | F |
| HIV diagnoses | 2008 | Asian | 45-54 | Injection drug use | 1 | F |
| HIV diagnoses | 2008 | Asian | 45-54 | Other | 1 | F |
| HIV diagnoses | 2008 | Asian | 55 | Heterosexual contact | 4 | F |
| HIV diagnoses | 2008 | Asian | 55 | Injection drug use | 0 | F |
| HIV diagnoses | 2008 | Asian | 55 | Other | 0 | F |
| HIV diagnoses | 2008 | Black/African American | 13-24 | Heterosexual contact | 1041 | F |
| HIV diagnoses | 2008 | Black/African American | 13-24 | Injection drug use | 83 | F |
| HIV diagnoses | 2008 | Black/African American | 13-24 | Other | 18 | F |
| HIV diagnoses | 2008 | Black/African American | 25-34 | Heterosexual contact | 1649 | F |
| HIV diagnoses | 2008 | Black/African American | 25-34 | Injection drug use | 175 | F |
| HIV diagnoses | 2008 | Black/African American | 25-34 | Other | 1 | F |
| HIV diagnoses | 2008 | Black/African American | 35-44 | Heterosexual contact | 1640 | F |
| HIV diagnoses | 2008 | Black/African American | 35-44 | Injection drug use | 266 | F |
| HIV diagnoses | 2008 | Black/African American | 35-44 | Other | 1 | F |
| HIV diagnoses | 2008 | Black/African American | 45-54 | Heterosexual contact | 1284 | F |
| HIV diagnoses | 2008 | Black/African American | 45-54 | Injection drug use | 282 | F |
| HIV diagnoses | 2008 | Black/African American | 45-54 | Other | 2 | F |
| HIV diagnoses | 2008 | Black/African American | 55 | Heterosexual contact | 622 | F |
| HIV diagnoses | 2008 | Black/African American | 55 | Injection drug use | 146 | F |
| HIV diagnoses | 2008 | Black/African American | 55 | Other | 4 | F |
| HIV diagnoses | 2008 | Hispanic/Latino | 13-24 | Heterosexual contact | 236 | F |
| HIV diagnoses | 2008 | Hispanic/Latino | 13-24 | Injection drug use | 33 | F |
| HIV diagnoses | 2008 | Hispanic/Latino | 13-24 | Other | 2 | F |
| HIV diagnoses | 2008 | Hispanic/Latino | 25-34 | Heterosexual contact | 450 | F |
| HIV diagnoses | 2008 | Hispanic/Latino | 25-34 | Injection drug use | 74 | F |
| HIV diagnoses | 2008 | Hispanic/Latino | 25-34 | Other | 0 | F |
| HIV diagnoses | 2008 | Hispanic/Latino | 35-44 | Heterosexual contact | 338 | F |
| HIV diagnoses | 2008 | Hispanic/Latino | 35-44 | Injection drug use | 96 | F |
| HIV diagnoses | 2008 | Hispanic/Latino | 35-44 | Other | 1 | F |
| HIV diagnoses | 2008 | Hispanic/Latino | 45-54 | Heterosexual contact | 252 | F |
| HIV diagnoses | 2008 | Hispanic/Latino | 45-54 | Injection drug use | 79 | F |
| HIV diagnoses | 2008 | Hispanic/Latino | 45-54 | Other | 0 | F |
| HIV diagnoses | 2008 | Hispanic/Latino | 55 | Heterosexual contact | 108 | F |
| HIV diagnoses | 2008 | Hispanic/Latino | 55 | Injection drug use | 21 | F |
| HIV diagnoses | 2008 | Hispanic/Latino | 55 | Other | 1 | F |
| HIV diagnoses | 2008 | Multiple races | 13-24 | Heterosexual contact | 80 | F |
| HIV diagnoses | 2008 | Multiple races | 13-24 | Injection drug use | 12 | F |
| HIV diagnoses | 2008 | Multiple races | 13-24 | Other | 2 | F |
| HIV diagnoses | 2008 | Multiple races | 25-34 | Heterosexual contact | 136 | F |
| HIV diagnoses | 2008 | Multiple races | 25-34 | Injection drug use | 21 | F |
| HIV diagnoses | 2008 | Multiple races | 25-34 | Other | 0 | F |
| HIV diagnoses | 2008 | Multiple races | 35-44 | Heterosexual contact | 115 | F |
| HIV diagnoses | 2008 | Multiple races | 35-44 | Injection drug use | 35 | F |
| HIV diagnoses | 2008 | Multiple races | 35-44 | Other | 0 | F |
| HIV diagnoses | 2008 | Multiple races | 45-54 | Heterosexual contact | 82 | F |
| HIV diagnoses | 2008 | Multiple races | 45-54 | Injection drug use | 34 | F |
| HIV diagnoses | 2008 | Multiple races | 45-54 | Other | 0 | F |
| HIV diagnoses | 2008 | Multiple races | 55 | Heterosexual contact | 45 | F |
| HIV diagnoses | 2008 | Multiple races | 55 | Injection drug use | 11 | F |
| HIV diagnoses | 2008 | Multiple races | 55 | Other | 0 | F |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | F |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | F |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 4 | F |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | F |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 0 | F |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 1 | F |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 0 | F |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | F |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 0 | F |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | F |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | F |
| HIV diagnoses | 2008 | White | 13-24 | Heterosexual contact | 183 | F |
| HIV diagnoses | 2008 | White | 13-24 | Injection drug use | 67 | F |
| HIV diagnoses | 2008 | White | 13-24 | Other | 1 | F |
| HIV diagnoses | 2008 | White | 25-34 | Heterosexual contact | 326 | F |
| HIV diagnoses | 2008 | White | 25-34 | Injection drug use | 136 | F |
| HIV diagnoses | 2008 | White | 25-34 | Other | 1 | F |
| HIV diagnoses | 2008 | White | 35-44 | Heterosexual contact | 346 | F |
| HIV diagnoses | 2008 | White | 35-44 | Injection drug use | 137 | F |
| HIV diagnoses | 2008 | White | 35-44 | Other | 0 | F |
| HIV diagnoses | 2008 | White | 45-54 | Heterosexual contact | 281 | F |
| HIV diagnoses | 2008 | White | 45-54 | Injection drug use | 132 | F |
| HIV diagnoses | 2008 | White | 45-54 | Other | 3 | F |
| HIV diagnoses | 2008 | White | 55 | Heterosexual contact | 124 | F |
| HIV diagnoses | 2008 | White | 55 | Injection drug use | 39 | F |
| HIV diagnoses | 2008 | White | 55 | Other | 6 | F |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 13-24 | Injection drug use | 1 | F |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 13-24 | Other | 0 | F |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 7 | F |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 25-34 | Injection drug use | 6 | F |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 25-34 | Other | 0 | F |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 5 | F |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 35-44 | Injection drug use | 1 | F |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 35-44 | Other | 0 | F |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 9 | F |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 45-54 | Injection drug use | 5 | F |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 55 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 55 | Injection drug use | 1 | F |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 55 | Other | 0 | F |
| HIV diagnoses | 2009 | Asian | 13-24 | Heterosexual contact | 14 | F |
| HIV diagnoses | 2009 | Asian | 13-24 | Injection drug use | 0 | F |
| HIV diagnoses | 2009 | Asian | 13-24 | Other | 0 | F |
| HIV diagnoses | 2009 | Asian | 25-34 | Heterosexual contact | 47 | F |
| HIV diagnoses | 2009 | Asian | 25-34 | Injection drug use | 3 | F |
| HIV diagnoses | 2009 | Asian | 25-34 | Other | 1 | F |
| HIV diagnoses | 2009 | Asian | 35-44 | Heterosexual contact | 31 | F |
| HIV diagnoses | 2009 | Asian | 35-44 | Injection drug use | 4 | F |
| HIV diagnoses | 2009 | Asian | 35-44 | Other | 0 | F |
| HIV diagnoses | 2009 | Asian | 45-54 | Heterosexual contact | 13 | F |
| HIV diagnoses | 2009 | Asian | 45-54 | Injection drug use | 2 | F |
| HIV diagnoses | 2009 | Asian | 45-54 | Other | 1 | F |
| HIV diagnoses | 2009 | Asian | 55 | Heterosexual contact | 6 | F |
| HIV diagnoses | 2009 | Asian | 55 | Injection drug use | 1 | F |
| HIV diagnoses | 2009 | Asian | 55 | Other | 1 | F |
| HIV diagnoses | 2009 | Black/African American | 13-24 | Heterosexual contact | 968 | F |
| HIV diagnoses | 2009 | Black/African American | 13-24 | Injection drug use | 77 | F |
| HIV diagnoses | 2009 | Black/African American | 13-24 | Other | 15 | F |
| HIV diagnoses | 2009 | Black/African American | 25-34 | Heterosexual contact | 1410 | F |
| HIV diagnoses | 2009 | Black/African American | 25-34 | Injection drug use | 144 | F |
| HIV diagnoses | 2009 | Black/African American | 25-34 | Other | 1 | F |
| HIV diagnoses | 2009 | Black/African American | 35-44 | Heterosexual contact | 1488 | F |
| HIV diagnoses | 2009 | Black/African American | 35-44 | Injection drug use | 226 | F |
| HIV diagnoses | 2009 | Black/African American | 35-44 | Other | 0 | F |
| HIV diagnoses | 2009 | Black/African American | 45-54 | Heterosexual contact | 1188 | F |
| HIV diagnoses | 2009 | Black/African American | 45-54 | Injection drug use | 252 | F |
| HIV diagnoses | 2009 | Black/African American | 45-54 | Other | 2 | F |
| HIV diagnoses | 2009 | Black/African American | 55 | Heterosexual contact | 543 | F |
| HIV diagnoses | 2009 | Black/African American | 55 | Injection drug use | 109 | F |
| HIV diagnoses | 2009 | Black/African American | 55 | Other | 3 | F |
| HIV diagnoses | 2009 | Hispanic/Latino | 13-24 | Heterosexual contact | 188 | F |
| HIV diagnoses | 2009 | Hispanic/Latino | 13-24 | Injection drug use | 39 | F |
| HIV diagnoses | 2009 | Hispanic/Latino | 13-24 | Other | 3 | F |
| HIV diagnoses | 2009 | Hispanic/Latino | 25-34 | Heterosexual contact | 375 | F |
| HIV diagnoses | 2009 | Hispanic/Latino | 25-34 | Injection drug use | 69 | F |
| HIV diagnoses | 2009 | Hispanic/Latino | 25-34 | Other | 0 | F |
| HIV diagnoses | 2009 | Hispanic/Latino | 35-44 | Heterosexual contact | 357 | F |
| HIV diagnoses | 2009 | Hispanic/Latino | 35-44 | Injection drug use | 91 | F |
| HIV diagnoses | 2009 | Hispanic/Latino | 35-44 | Other | 2 | F |
| HIV diagnoses | 2009 | Hispanic/Latino | 45-54 | Heterosexual contact | 249 | F |
| HIV diagnoses | 2009 | Hispanic/Latino | 45-54 | Injection drug use | 56 | F |
| HIV diagnoses | 2009 | Hispanic/Latino | 45-54 | Other | 1 | F |
| HIV diagnoses | 2009 | Hispanic/Latino | 55 | Heterosexual contact | 134 | F |
| HIV diagnoses | 2009 | Hispanic/Latino | 55 | Injection drug use | 26 | F |
| HIV diagnoses | 2009 | Hispanic/Latino | 55 | Other | 1 | F |
| HIV diagnoses | 2009 | Multiple races | 13-24 | Heterosexual contact | 81 | F |
| HIV diagnoses | 2009 | Multiple races | 13-24 | Injection drug use | 13 | F |
| HIV diagnoses | 2009 | Multiple races | 13-24 | Other | 0 | F |
| HIV diagnoses | 2009 | Multiple races | 25-34 | Heterosexual contact | 106 | F |
| HIV diagnoses | 2009 | Multiple races | 25-34 | Injection drug use | 23 | F |
| HIV diagnoses | 2009 | Multiple races | 25-34 | Other | 0 | F |
| HIV diagnoses | 2009 | Multiple races | 35-44 | Heterosexual contact | 100 | F |
| HIV diagnoses | 2009 | Multiple races | 35-44 | Injection drug use | 28 | F |
| HIV diagnoses | 2009 | Multiple races | 35-44 | Other | 0 | F |
| HIV diagnoses | 2009 | Multiple races | 45-54 | Heterosexual contact | 66 | F |
| HIV diagnoses | 2009 | Multiple races | 45-54 | Injection drug use | 30 | F |
| HIV diagnoses | 2009 | Multiple races | 45-54 | Other | 0 | F |
| HIV diagnoses | 2009 | Multiple races | 55 | Heterosexual contact | 35 | F |
| HIV diagnoses | 2009 | Multiple races | 55 | Injection drug use | 10 | F |
| HIV diagnoses | 2009 | Multiple races | 55 | Other | 0 | F |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 2 | F |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 1 | F |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | F |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | F |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | F |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 2 | F |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 1 | F |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | F |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 0 | F |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | F |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | F |
| HIV diagnoses | 2009 | White | 13-24 | Heterosexual contact | 168 | F |
| HIV diagnoses | 2009 | White | 13-24 | Injection drug use | 61 | F |
| HIV diagnoses | 2009 | White | 13-24 | Other | 5 | F |
| HIV diagnoses | 2009 | White | 25-34 | Heterosexual contact | 269 | F |
| HIV diagnoses | 2009 | White | 25-34 | Injection drug use | 102 | F |
| HIV diagnoses | 2009 | White | 25-34 | Other | 0 | F |
| HIV diagnoses | 2009 | White | 35-44 | Heterosexual contact | 258 | F |
| HIV diagnoses | 2009 | White | 35-44 | Injection drug use | 112 | F |
| HIV diagnoses | 2009 | White | 35-44 | Other | 1 | F |
| HIV diagnoses | 2009 | White | 45-54 | Heterosexual contact | 267 | F |
| HIV diagnoses | 2009 | White | 45-54 | Injection drug use | 110 | F |
| HIV diagnoses | 2009 | White | 45-54 | Other | 2 | F |
| HIV diagnoses | 2009 | White | 55 | Heterosexual contact | 126 | F |
| HIV diagnoses | 2009 | White | 55 | Injection drug use | 40 | F |
| HIV diagnoses | 2009 | White | 55 | Other | 4 | F |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 4 | F |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 13-24 | Injection drug use | 1 | F |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 13-24 | Other | 0 | F |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 11 | F |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 25-34 | Injection drug use | 3 | F |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 25-34 | Other | 0 | F |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 10 | F |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 35-44 | Injection drug use | 2 | F |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 35-44 | Other | 0 | F |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 7 | F |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 45-54 | Injection drug use | 3 | F |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 55 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 55 | Injection drug use | 2 | F |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 55 | Other | 0 | F |
| HIV diagnoses | 2010 | Asian | 13-24 | Heterosexual contact | 11 | F |
| HIV diagnoses | 2010 | Asian | 13-24 | Injection drug use | 2 | F |
| HIV diagnoses | 2010 | Asian | 13-24 | Other | 0 | F |
| HIV diagnoses | 2010 | Asian | 25-34 | Heterosexual contact | 42 | F |
| HIV diagnoses | 2010 | Asian | 25-34 | Injection drug use | 2 | F |
| HIV diagnoses | 2010 | Asian | 25-34 | Other | 0 | F |
| HIV diagnoses | 2010 | Asian | 35-44 | Heterosexual contact | 29 | F |
| HIV diagnoses | 2010 | Asian | 35-44 | Injection drug use | 3 | F |
| HIV diagnoses | 2010 | Asian | 35-44 | Other | 0 | F |
| HIV diagnoses | 2010 | Asian | 45-54 | Heterosexual contact | 15 | F |
| HIV diagnoses | 2010 | Asian | 45-54 | Injection drug use | 2 | F |
| HIV diagnoses | 2010 | Asian | 45-54 | Other | 1 | F |
| HIV diagnoses | 2010 | Asian | 55 | Heterosexual contact | 5 | F |
| HIV diagnoses | 2010 | Asian | 55 | Injection drug use | 1 | F |
| HIV diagnoses | 2010 | Asian | 55 | Other | 0 | F |
| HIV diagnoses | 2010 | Black/African American | 13-24 | Heterosexual contact | 844 | F |
| HIV diagnoses | 2010 | Black/African American | 13-24 | Injection drug use | 61 | F |
| HIV diagnoses | 2010 | Black/African American | 13-24 | Other | 18 | F |
| HIV diagnoses | 2010 | Black/African American | 25-34 | Heterosexual contact | 1350 | F |
| HIV diagnoses | 2010 | Black/African American | 25-34 | Injection drug use | 122 | F |
| HIV diagnoses | 2010 | Black/African American | 25-34 | Other | 1 | F |
| HIV diagnoses | 2010 | Black/African American | 35-44 | Heterosexual contact | 1343 | F |
| HIV diagnoses | 2010 | Black/African American | 35-44 | Injection drug use | 175 | F |
| HIV diagnoses | 2010 | Black/African American | 35-44 | Other | 2 | F |
| HIV diagnoses | 2010 | Black/African American | 45-54 | Heterosexual contact | 1086 | F |
| HIV diagnoses | 2010 | Black/African American | 45-54 | Injection drug use | 235 | F |
| HIV diagnoses | 2010 | Black/African American | 45-54 | Other | 1 | F |
| HIV diagnoses | 2010 | Black/African American | 55 | Heterosexual contact | 597 | F |
| HIV diagnoses | 2010 | Black/African American | 55 | Injection drug use | 110 | F |
| HIV diagnoses | 2010 | Black/African American | 55 | Other | 2 | F |
| HIV diagnoses | 2010 | Hispanic/Latino | 13-24 | Heterosexual contact | 212 | F |
| HIV diagnoses | 2010 | Hispanic/Latino | 13-24 | Injection drug use | 27 | F |
| HIV diagnoses | 2010 | Hispanic/Latino | 13-24 | Other | 1 | F |
| HIV diagnoses | 2010 | Hispanic/Latino | 25-34 | Heterosexual contact | 369 | F |
| HIV diagnoses | 2010 | Hispanic/Latino | 25-34 | Injection drug use | 44 | F |
| HIV diagnoses | 2010 | Hispanic/Latino | 25-34 | Other | 0 | F |
| HIV diagnoses | 2010 | Hispanic/Latino | 35-44 | Heterosexual contact | 314 | F |
| HIV diagnoses | 2010 | Hispanic/Latino | 35-44 | Injection drug use | 53 | F |
| HIV diagnoses | 2010 | Hispanic/Latino | 35-44 | Other | 0 | F |
| HIV diagnoses | 2010 | Hispanic/Latino | 45-54 | Heterosexual contact | 237 | F |
| HIV diagnoses | 2010 | Hispanic/Latino | 45-54 | Injection drug use | 55 | F |
| HIV diagnoses | 2010 | Hispanic/Latino | 45-54 | Other | 1 | F |
| HIV diagnoses | 2010 | Hispanic/Latino | 55 | Heterosexual contact | 139 | F |
| HIV diagnoses | 2010 | Hispanic/Latino | 55 | Injection drug use | 26 | F |
| HIV diagnoses | 2010 | Hispanic/Latino | 55 | Other | 0 | F |
| HIV diagnoses | 2010 | Multiple races | 13-24 | Heterosexual contact | 75 | F |
| HIV diagnoses | 2010 | Multiple races | 13-24 | Injection drug use | 8 | F |
| HIV diagnoses | 2010 | Multiple races | 13-24 | Other | 1 | F |
| HIV diagnoses | 2010 | Multiple races | 25-34 | Heterosexual contact | 86 | F |
| HIV diagnoses | 2010 | Multiple races | 25-34 | Injection drug use | 18 | F |
| HIV diagnoses | 2010 | Multiple races | 25-34 | Other | 0 | F |
| HIV diagnoses | 2010 | Multiple races | 35-44 | Heterosexual contact | 79 | F |
| HIV diagnoses | 2010 | Multiple races | 35-44 | Injection drug use | 19 | F |
| HIV diagnoses | 2010 | Multiple races | 35-44 | Other | 0 | F |
| HIV diagnoses | 2010 | Multiple races | 45-54 | Heterosexual contact | 67 | F |
| HIV diagnoses | 2010 | Multiple races | 45-54 | Injection drug use | 28 | F |
| HIV diagnoses | 2010 | Multiple races | 45-54 | Other | 0 | F |
| HIV diagnoses | 2010 | Multiple races | 55 | Heterosexual contact | 41 | F |
| HIV diagnoses | 2010 | Multiple races | 55 | Injection drug use | 7 | F |
| HIV diagnoses | 2010 | Multiple races | 55 | Other | 0 | F |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | F |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 1 | F |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | F |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 2 | F |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 0 | F |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | F |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 0 | F |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | F |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | F |
| HIV diagnoses | 2010 | White | 13-24 | Heterosexual contact | 167 | F |
| HIV diagnoses | 2010 | White | 13-24 | Injection drug use | 51 | F |
| HIV diagnoses | 2010 | White | 13-24 | Other | 1 | F |
| HIV diagnoses | 2010 | White | 25-34 | Heterosexual contact | 251 | F |
| HIV diagnoses | 2010 | White | 25-34 | Injection drug use | 113 | F |
| HIV diagnoses | 2010 | White | 25-34 | Other | 0 | F |
| HIV diagnoses | 2010 | White | 35-44 | Heterosexual contact | 261 | F |
| HIV diagnoses | 2010 | White | 35-44 | Injection drug use | 100 | F |
| HIV diagnoses | 2010 | White | 35-44 | Other | 1 | F |
| HIV diagnoses | 2010 | White | 45-54 | Heterosexual contact | 222 | F |
| HIV diagnoses | 2010 | White | 45-54 | Injection drug use | 107 | F |
| HIV diagnoses | 2010 | White | 45-54 | Other | 2 | F |
| HIV diagnoses | 2010 | White | 55 | Heterosexual contact | 118 | F |
| HIV diagnoses | 2010 | White | 55 | Injection drug use | 38 | F |
| HIV diagnoses | 2010 | White | 55 | Other | 4 | F |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 13-24 | Injection drug use | 1 | F |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 13-24 | Other | 0 | F |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 6 | F |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 25-34 | Injection drug use | 8 | F |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 25-34 | Other | 0 | F |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 5 | F |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 35-44 | Injection drug use | 4 | F |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 35-44 | Other | 0 | F |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 5 | F |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 45-54 | Injection drug use | 2 | F |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 55 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 55 | Injection drug use | 2 | F |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 55 | Other | 0 | F |
| HIV diagnoses | 2011 | Asian | 13-24 | Heterosexual contact | 13 | F |
| HIV diagnoses | 2011 | Asian | 13-24 | Injection drug use | 1 | F |
| HIV diagnoses | 2011 | Asian | 13-24 | Other | 0 | F |
| HIV diagnoses | 2011 | Asian | 25-34 | Heterosexual contact | 36 | F |
| HIV diagnoses | 2011 | Asian | 25-34 | Injection drug use | 2 | F |
| HIV diagnoses | 2011 | Asian | 25-34 | Other | 0 | F |
| HIV diagnoses | 2011 | Asian | 35-44 | Heterosexual contact | 31 | F |
| HIV diagnoses | 2011 | Asian | 35-44 | Injection drug use | 3 | F |
| HIV diagnoses | 2011 | Asian | 35-44 | Other | 0 | F |
| HIV diagnoses | 2011 | Asian | 45-54 | Heterosexual contact | 16 | F |
| HIV diagnoses | 2011 | Asian | 45-54 | Injection drug use | 1 | F |
| HIV diagnoses | 2011 | Asian | 45-54 | Other | 0 | F |
| HIV diagnoses | 2011 | Asian | 55 | Heterosexual contact | 12 | F |
| HIV diagnoses | 2011 | Asian | 55 | Injection drug use | 0 | F |
| HIV diagnoses | 2011 | Asian | 55 | Other | 1 | F |
| HIV diagnoses | 2011 | Black/African American | 13-24 | Heterosexual contact | 871 | F |
| HIV diagnoses | 2011 | Black/African American | 13-24 | Injection drug use | 58 | F |
| HIV diagnoses | 2011 | Black/African American | 13-24 | Other | 22 | F |
| HIV diagnoses | 2011 | Black/African American | 25-34 | Heterosexual contact | 1214 | F |
| HIV diagnoses | 2011 | Black/African American | 25-34 | Injection drug use | 96 | F |
| HIV diagnoses | 2011 | Black/African American | 25-34 | Other | 1 | F |
| HIV diagnoses | 2011 | Black/African American | 35-44 | Heterosexual contact | 1150 | F |
| HIV diagnoses | 2011 | Black/African American | 35-44 | Injection drug use | 134 | F |
| HIV diagnoses | 2011 | Black/African American | 35-44 | Other | 1 | F |
| HIV diagnoses | 2011 | Black/African American | 45-54 | Heterosexual contact | 1023 | F |
| HIV diagnoses | 2011 | Black/African American | 45-54 | Injection drug use | 193 | F |
| HIV diagnoses | 2011 | Black/African American | 45-54 | Other | 1 | F |
| HIV diagnoses | 2011 | Black/African American | 55 | Heterosexual contact | 592 | F |
| HIV diagnoses | 2011 | Black/African American | 55 | Injection drug use | 100 | F |
| HIV diagnoses | 2011 | Black/African American | 55 | Other | 1 | F |
| HIV diagnoses | 2011 | Hispanic/Latino | 13-24 | Heterosexual contact | 183 | F |
| HIV diagnoses | 2011 | Hispanic/Latino | 13-24 | Injection drug use | 24 | F |
| HIV diagnoses | 2011 | Hispanic/Latino | 13-24 | Other | 0 | F |
| HIV diagnoses | 2011 | Hispanic/Latino | 25-34 | Heterosexual contact | 328 | F |
| HIV diagnoses | 2011 | Hispanic/Latino | 25-34 | Injection drug use | 53 | F |
| HIV diagnoses | 2011 | Hispanic/Latino | 25-34 | Other | 0 | F |
| HIV diagnoses | 2011 | Hispanic/Latino | 35-44 | Heterosexual contact | 281 | F |
| HIV diagnoses | 2011 | Hispanic/Latino | 35-44 | Injection drug use | 48 | F |
| HIV diagnoses | 2011 | Hispanic/Latino | 35-44 | Other | 0 | F |
| HIV diagnoses | 2011 | Hispanic/Latino | 45-54 | Heterosexual contact | 229 | F |
| HIV diagnoses | 2011 | Hispanic/Latino | 45-54 | Injection drug use | 58 | F |
| HIV diagnoses | 2011 | Hispanic/Latino | 45-54 | Other | 0 | F |
| HIV diagnoses | 2011 | Hispanic/Latino | 55 | Heterosexual contact | 128 | F |
| HIV diagnoses | 2011 | Hispanic/Latino | 55 | Injection drug use | 20 | F |
| HIV diagnoses | 2011 | Hispanic/Latino | 55 | Other | 0 | F |
| HIV diagnoses | 2011 | Multiple races | 13-24 | Heterosexual contact | 56 | F |
| HIV diagnoses | 2011 | Multiple races | 13-24 | Injection drug use | 10 | F |
| HIV diagnoses | 2011 | Multiple races | 13-24 | Other | 0 | F |
| HIV diagnoses | 2011 | Multiple races | 25-34 | Heterosexual contact | 79 | F |
| HIV diagnoses | 2011 | Multiple races | 25-34 | Injection drug use | 18 | F |
| HIV diagnoses | 2011 | Multiple races | 25-34 | Other | 0 | F |
| HIV diagnoses | 2011 | Multiple races | 35-44 | Heterosexual contact | 67 | F |
| HIV diagnoses | 2011 | Multiple races | 35-44 | Injection drug use | 10 | F |
| HIV diagnoses | 2011 | Multiple races | 35-44 | Other | 0 | F |
| HIV diagnoses | 2011 | Multiple races | 45-54 | Heterosexual contact | 64 | F |
| HIV diagnoses | 2011 | Multiple races | 45-54 | Injection drug use | 15 | F |
| HIV diagnoses | 2011 | Multiple races | 45-54 | Other | 0 | F |
| HIV diagnoses | 2011 | Multiple races | 55 | Heterosexual contact | 38 | F |
| HIV diagnoses | 2011 | Multiple races | 55 | Injection drug use | 8 | F |
| HIV diagnoses | 2011 | Multiple races | 55 | Other | 0 | F |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | F |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | F |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | F |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 2 | F |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | F |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 2 | F |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 0 | F |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | F |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 2 | F |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | F |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | F |
| HIV diagnoses | 2011 | White | 13-24 | Heterosexual contact | 141 | F |
| HIV diagnoses | 2011 | White | 13-24 | Injection drug use | 46 | F |
| HIV diagnoses | 2011 | White | 13-24 | Other | 2 | F |
| HIV diagnoses | 2011 | White | 25-34 | Heterosexual contact | 238 | F |
| HIV diagnoses | 2011 | White | 25-34 | Injection drug use | 118 | F |
| HIV diagnoses | 2011 | White | 25-34 | Other | 1 | F |
| HIV diagnoses | 2011 | White | 35-44 | Heterosexual contact | 256 | F |
| HIV diagnoses | 2011 | White | 35-44 | Injection drug use | 96 | F |
| HIV diagnoses | 2011 | White | 35-44 | Other | 0 | F |
| HIV diagnoses | 2011 | White | 45-54 | Heterosexual contact | 228 | F |
| HIV diagnoses | 2011 | White | 45-54 | Injection drug use | 110 | F |
| HIV diagnoses | 2011 | White | 45-54 | Other | 1 | F |
| HIV diagnoses | 2011 | White | 55 | Heterosexual contact | 108 | F |
| HIV diagnoses | 2011 | White | 55 | Injection drug use | 37 | F |
| HIV diagnoses | 2011 | White | 55 | Other | 3 | F |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 13-24 | Injection drug use | 1 | F |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 13-24 | Other | 0 | F |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 6 | F |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 25-34 | Injection drug use | 5 | F |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 25-34 | Other | 0 | F |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 8 | F |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 35-44 | Injection drug use | 3 | F |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 35-44 | Other | 0 | F |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 5 | F |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 45-54 | Injection drug use | 3 | F |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 55 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 55 | Injection drug use | 2 | F |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 55 | Other | 0 | F |
| HIV diagnoses | 2012 | Asian | 13-24 | Heterosexual contact | 15 | F |
| HIV diagnoses | 2012 | Asian | 13-24 | Injection drug use | 1 | F |
| HIV diagnoses | 2012 | Asian | 13-24 | Other | 0 | F |
| HIV diagnoses | 2012 | Asian | 25-34 | Heterosexual contact | 44 | F |
| HIV diagnoses | 2012 | Asian | 25-34 | Injection drug use | 3 | F |
| HIV diagnoses | 2012 | Asian | 25-34 | Other | 0 | F |
| HIV diagnoses | 2012 | Asian | 35-44 | Heterosexual contact | 35 | F |
| HIV diagnoses | 2012 | Asian | 35-44 | Injection drug use | 2 | F |
| HIV diagnoses | 2012 | Asian | 35-44 | Other | 0 | F |
| HIV diagnoses | 2012 | Asian | 45-54 | Heterosexual contact | 12 | F |
| HIV diagnoses | 2012 | Asian | 45-54 | Injection drug use | 1 | F |
| HIV diagnoses | 2012 | Asian | 45-54 | Other | 0 | F |
| HIV diagnoses | 2012 | Asian | 55 | Heterosexual contact | 10 | F |
| HIV diagnoses | 2012 | Asian | 55 | Injection drug use | 1 | F |
| HIV diagnoses | 2012 | Asian | 55 | Other | 0 | F |
| HIV diagnoses | 2012 | Black/African American | 13-24 | Heterosexual contact | 710 | F |
| HIV diagnoses | 2012 | Black/African American | 13-24 | Injection drug use | 60 | F |
| HIV diagnoses | 2012 | Black/African American | 13-24 | Other | 13 | F |
| HIV diagnoses | 2012 | Black/African American | 25-34 | Heterosexual contact | 1225 | F |
| HIV diagnoses | 2012 | Black/African American | 25-34 | Injection drug use | 96 | F |
| HIV diagnoses | 2012 | Black/African American | 25-34 | Other | 3 | F |
| HIV diagnoses | 2012 | Black/African American | 35-44 | Heterosexual contact | 1078 | F |
| HIV diagnoses | 2012 | Black/African American | 35-44 | Injection drug use | 119 | F |
| HIV diagnoses | 2012 | Black/African American | 35-44 | Other | 0 | F |
| HIV diagnoses | 2012 | Black/African American | 45-54 | Heterosexual contact | 988 | F |
| HIV diagnoses | 2012 | Black/African American | 45-54 | Injection drug use | 159 | F |
| HIV diagnoses | 2012 | Black/African American | 45-54 | Other | 2 | F |
| HIV diagnoses | 2012 | Black/African American | 55 | Heterosexual contact | 570 | F |
| HIV diagnoses | 2012 | Black/African American | 55 | Injection drug use | 98 | F |
| HIV diagnoses | 2012 | Black/African American | 55 | Other | 1 | F |
| HIV diagnoses | 2012 | Hispanic/Latino | 13-24 | Heterosexual contact | 151 | F |
| HIV diagnoses | 2012 | Hispanic/Latino | 13-24 | Injection drug use | 23 | F |
| HIV diagnoses | 2012 | Hispanic/Latino | 13-24 | Other | 3 | F |
| HIV diagnoses | 2012 | Hispanic/Latino | 25-34 | Heterosexual contact | 278 | F |
| HIV diagnoses | 2012 | Hispanic/Latino | 25-34 | Injection drug use | 51 | F |
| HIV diagnoses | 2012 | Hispanic/Latino | 25-34 | Other | 1 | F |
| HIV diagnoses | 2012 | Hispanic/Latino | 35-44 | Heterosexual contact | 262 | F |
| HIV diagnoses | 2012 | Hispanic/Latino | 35-44 | Injection drug use | 41 | F |
| HIV diagnoses | 2012 | Hispanic/Latino | 35-44 | Other | 0 | F |
| HIV diagnoses | 2012 | Hispanic/Latino | 45-54 | Heterosexual contact | 203 | F |
| HIV diagnoses | 2012 | Hispanic/Latino | 45-54 | Injection drug use | 43 | F |
| HIV diagnoses | 2012 | Hispanic/Latino | 45-54 | Other | 0 | F |
| HIV diagnoses | 2012 | Hispanic/Latino | 55 | Heterosexual contact | 130 | F |
| HIV diagnoses | 2012 | Hispanic/Latino | 55 | Injection drug use | 21 | F |
| HIV diagnoses | 2012 | Hispanic/Latino | 55 | Other | 1 | F |
| HIV diagnoses | 2012 | Multiple races | 13-24 | Heterosexual contact | 59 | F |
| HIV diagnoses | 2012 | Multiple races | 13-24 | Injection drug use | 7 | F |
| HIV diagnoses | 2012 | Multiple races | 13-24 | Other | 0 | F |
| HIV diagnoses | 2012 | Multiple races | 25-34 | Heterosexual contact | 63 | F |
| HIV diagnoses | 2012 | Multiple races | 25-34 | Injection drug use | 15 | F |
| HIV diagnoses | 2012 | Multiple races | 25-34 | Other | 0 | F |
| HIV diagnoses | 2012 | Multiple races | 35-44 | Heterosexual contact | 57 | F |
| HIV diagnoses | 2012 | Multiple races | 35-44 | Injection drug use | 17 | F |
| HIV diagnoses | 2012 | Multiple races | 35-44 | Other | 0 | F |
| HIV diagnoses | 2012 | Multiple races | 45-54 | Heterosexual contact | 51 | F |
| HIV diagnoses | 2012 | Multiple races | 45-54 | Injection drug use | 15 | F |
| HIV diagnoses | 2012 | Multiple races | 45-54 | Other | 0 | F |
| HIV diagnoses | 2012 | Multiple races | 55 | Heterosexual contact | 43 | F |
| HIV diagnoses | 2012 | Multiple races | 55 | Injection drug use | 10 | F |
| HIV diagnoses | 2012 | Multiple races | 55 | Other | 0 | F |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | F |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | F |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | F |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | F |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 0 | F |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | F |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 0 | F |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | F |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | F |
| HIV diagnoses | 2012 | White | 13-24 | Heterosexual contact | 142 | F |
| HIV diagnoses | 2012 | White | 13-24 | Injection drug use | 38 | F |
| HIV diagnoses | 2012 | White | 13-24 | Other | 1 | F |
| HIV diagnoses | 2012 | White | 25-34 | Heterosexual contact | 222 | F |
| HIV diagnoses | 2012 | White | 25-34 | Injection drug use | 103 | F |
| HIV diagnoses | 2012 | White | 25-34 | Other | 1 | F |
| HIV diagnoses | 2012 | White | 35-44 | Heterosexual contact | 232 | F |
| HIV diagnoses | 2012 | White | 35-44 | Injection drug use | 90 | F |
| HIV diagnoses | 2012 | White | 35-44 | Other | 1 | F |
| HIV diagnoses | 2012 | White | 45-54 | Heterosexual contact | 208 | F |
| HIV diagnoses | 2012 | White | 45-54 | Injection drug use | 83 | F |
| HIV diagnoses | 2012 | White | 45-54 | Other | 2 | F |
| HIV diagnoses | 2012 | White | 55 | Heterosexual contact | 121 | F |
| HIV diagnoses | 2012 | White | 55 | Injection drug use | 44 | F |
| HIV diagnoses | 2012 | White | 55 | Other | 2 | F |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 4 | F |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 13-24 | Injection drug use | 1 | F |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 13-24 | Other | 0 | F |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 25-34 | Injection drug use | 2 | F |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 25-34 | Other | 0 | F |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 4 | F |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 35-44 | Injection drug use | 3 | F |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 35-44 | Other | 0 | F |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 6 | F |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 45-54 | Injection drug use | 3 | F |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 55 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 55 | Injection drug use | 1 | F |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 55 | Other | 0 | F |
| HIV diagnoses | 2013 | Asian | 13-24 | Heterosexual contact | 11 | F |
| HIV diagnoses | 2013 | Asian | 13-24 | Injection drug use | 0 | F |
| HIV diagnoses | 2013 | Asian | 13-24 | Other | 0 | F |
| HIV diagnoses | 2013 | Asian | 25-34 | Heterosexual contact | 41 | F |
| HIV diagnoses | 2013 | Asian | 25-34 | Injection drug use | 1 | F |
| HIV diagnoses | 2013 | Asian | 25-34 | Other | 0 | F |
| HIV diagnoses | 2013 | Asian | 35-44 | Heterosexual contact | 38 | F |
| HIV diagnoses | 2013 | Asian | 35-44 | Injection drug use | 1 | F |
| HIV diagnoses | 2013 | Asian | 35-44 | Other | 0 | F |
| HIV diagnoses | 2013 | Asian | 45-54 | Heterosexual contact | 19 | F |
| HIV diagnoses | 2013 | Asian | 45-54 | Injection drug use | 3 | F |
| HIV diagnoses | 2013 | Asian | 45-54 | Other | 0 | F |
| HIV diagnoses | 2013 | Asian | 55 | Heterosexual contact | 12 | F |
| HIV diagnoses | 2013 | Asian | 55 | Injection drug use | 2 | F |
| HIV diagnoses | 2013 | Asian | 55 | Other | 1 | F |
| HIV diagnoses | 2013 | Black/African American | 13-24 | Heterosexual contact | 648 | F |
| HIV diagnoses | 2013 | Black/African American | 13-24 | Injection drug use | 39 | F |
| HIV diagnoses | 2013 | Black/African American | 13-24 | Other | 22 | F |
| HIV diagnoses | 2013 | Black/African American | 25-34 | Heterosexual contact | 1122 | F |
| HIV diagnoses | 2013 | Black/African American | 25-34 | Injection drug use | 70 | F |
| HIV diagnoses | 2013 | Black/African American | 25-34 | Other | 3 | F |
| HIV diagnoses | 2013 | Black/African American | 35-44 | Heterosexual contact | 984 | F |
| HIV diagnoses | 2013 | Black/African American | 35-44 | Injection drug use | 84 | F |
| HIV diagnoses | 2013 | Black/African American | 35-44 | Other | 1 | F |
| HIV diagnoses | 2013 | Black/African American | 45-54 | Heterosexual contact | 892 | F |
| HIV diagnoses | 2013 | Black/African American | 45-54 | Injection drug use | 114 | F |
| HIV diagnoses | 2013 | Black/African American | 45-54 | Other | 2 | F |
| HIV diagnoses | 2013 | Black/African American | 55 | Heterosexual contact | 579 | F |
| HIV diagnoses | 2013 | Black/African American | 55 | Injection drug use | 99 | F |
| HIV diagnoses | 2013 | Black/African American | 55 | Other | 3 | F |
| HIV diagnoses | 2013 | Hispanic/Latino | 13-24 | Heterosexual contact | 138 | F |
| HIV diagnoses | 2013 | Hispanic/Latino | 13-24 | Injection drug use | 18 | F |
| HIV diagnoses | 2013 | Hispanic/Latino | 13-24 | Other | 4 | F |
| HIV diagnoses | 2013 | Hispanic/Latino | 25-34 | Heterosexual contact | 276 | F |
| HIV diagnoses | 2013 | Hispanic/Latino | 25-34 | Injection drug use | 45 | F |
| HIV diagnoses | 2013 | Hispanic/Latino | 25-34 | Other | 0 | F |
| HIV diagnoses | 2013 | Hispanic/Latino | 35-44 | Heterosexual contact | 244 | F |
| HIV diagnoses | 2013 | Hispanic/Latino | 35-44 | Injection drug use | 39 | F |
| HIV diagnoses | 2013 | Hispanic/Latino | 35-44 | Other | 0 | F |
| HIV diagnoses | 2013 | Hispanic/Latino | 45-54 | Heterosexual contact | 236 | F |
| HIV diagnoses | 2013 | Hispanic/Latino | 45-54 | Injection drug use | 38 | F |
| HIV diagnoses | 2013 | Hispanic/Latino | 45-54 | Other | 0 | F |
| HIV diagnoses | 2013 | Hispanic/Latino | 55 | Heterosexual contact | 128 | F |
| HIV diagnoses | 2013 | Hispanic/Latino | 55 | Injection drug use | 22 | F |
| HIV diagnoses | 2013 | Hispanic/Latino | 55 | Other | 0 | F |
| HIV diagnoses | 2013 | Multiple races | 13-24 | Heterosexual contact | 56 | F |
| HIV diagnoses | 2013 | Multiple races | 13-24 | Injection drug use | 5 | F |
| HIV diagnoses | 2013 | Multiple races | 13-24 | Other | 3 | F |
| HIV diagnoses | 2013 | Multiple races | 25-34 | Heterosexual contact | 66 | F |
| HIV diagnoses | 2013 | Multiple races | 25-34 | Injection drug use | 10 | F |
| HIV diagnoses | 2013 | Multiple races | 25-34 | Other | 0 | F |
| HIV diagnoses | 2013 | Multiple races | 35-44 | Heterosexual contact | 61 | F |
| HIV diagnoses | 2013 | Multiple races | 35-44 | Injection drug use | 13 | F |
| HIV diagnoses | 2013 | Multiple races | 35-44 | Other | 0 | F |
| HIV diagnoses | 2013 | Multiple races | 45-54 | Heterosexual contact | 60 | F |
| HIV diagnoses | 2013 | Multiple races | 45-54 | Injection drug use | 9 | F |
| HIV diagnoses | 2013 | Multiple races | 45-54 | Other | 0 | F |
| HIV diagnoses | 2013 | Multiple races | 55 | Heterosexual contact | 34 | F |
| HIV diagnoses | 2013 | Multiple races | 55 | Injection drug use | 8 | F |
| HIV diagnoses | 2013 | Multiple races | 55 | Other | 0 | F |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | F |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | F |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 0 | F |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | F |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 4 | F |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 0 | F |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | F |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | F |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | F |
| HIV diagnoses | 2013 | White | 13-24 | Heterosexual contact | 121 | F |
| HIV diagnoses | 2013 | White | 13-24 | Injection drug use | 46 | F |
| HIV diagnoses | 2013 | White | 13-24 | Other | 2 | F |
| HIV diagnoses | 2013 | White | 25-34 | Heterosexual contact | 221 | F |
| HIV diagnoses | 2013 | White | 25-34 | Injection drug use | 110 | F |
| HIV diagnoses | 2013 | White | 25-34 | Other | 0 | F |
| HIV diagnoses | 2013 | White | 35-44 | Heterosexual contact | 201 | F |
| HIV diagnoses | 2013 | White | 35-44 | Injection drug use | 81 | F |
| HIV diagnoses | 2013 | White | 35-44 | Other | 0 | F |
| HIV diagnoses | 2013 | White | 45-54 | Heterosexual contact | 198 | F |
| HIV diagnoses | 2013 | White | 45-54 | Injection drug use | 92 | F |
| HIV diagnoses | 2013 | White | 45-54 | Other | 1 | F |
| HIV diagnoses | 2013 | White | 55 | Heterosexual contact | 150 | F |
| HIV diagnoses | 2013 | White | 55 | Injection drug use | 41 | F |
| HIV diagnoses | 2013 | White | 55 | Other | 2 | F |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 13-24 | Injection drug use | 0 | F |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 13-24 | Other | 0 | F |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 7 | F |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 25-34 | Injection drug use | 4 | F |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 25-34 | Other | 0 | F |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 5 | F |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 35-44 | Injection drug use | 3 | F |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 35-44 | Other | 0 | F |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 6 | F |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 45-54 | Injection drug use | 1 | F |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 55 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 55 | Injection drug use | 1 | F |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 55 | Other | 0 | F |
| HIV diagnoses | 2014 | Asian | 13-24 | Heterosexual contact | 10 | F |
| HIV diagnoses | 2014 | Asian | 13-24 | Injection drug use | 1 | F |
| HIV diagnoses | 2014 | Asian | 13-24 | Other | 0 | F |
| HIV diagnoses | 2014 | Asian | 25-34 | Heterosexual contact | 36 | F |
| HIV diagnoses | 2014 | Asian | 25-34 | Injection drug use | 1 | F |
| HIV diagnoses | 2014 | Asian | 25-34 | Other | 0 | F |
| HIV diagnoses | 2014 | Asian | 35-44 | Heterosexual contact | 44 | F |
| HIV diagnoses | 2014 | Asian | 35-44 | Injection drug use | 2 | F |
| HIV diagnoses | 2014 | Asian | 35-44 | Other | 0 | F |
| HIV diagnoses | 2014 | Asian | 45-54 | Heterosexual contact | 17 | F |
| HIV diagnoses | 2014 | Asian | 45-54 | Injection drug use | 1 | F |
| HIV diagnoses | 2014 | Asian | 45-54 | Other | 0 | F |
| HIV diagnoses | 2014 | Asian | 55 | Heterosexual contact | 14 | F |
| HIV diagnoses | 2014 | Asian | 55 | Injection drug use | 2 | F |
| HIV diagnoses | 2014 | Asian | 55 | Other | 0 | F |
| HIV diagnoses | 2014 | Black/African American | 13-24 | Heterosexual contact | 655 | F |
| HIV diagnoses | 2014 | Black/African American | 13-24 | Injection drug use | 41 | F |
| HIV diagnoses | 2014 | Black/African American | 13-24 | Other | 16 | F |
| HIV diagnoses | 2014 | Black/African American | 25-34 | Heterosexual contact | 1091 | F |
| HIV diagnoses | 2014 | Black/African American | 25-34 | Injection drug use | 73 | F |
| HIV diagnoses | 2014 | Black/African American | 25-34 | Other | 3 | F |
| HIV diagnoses | 2014 | Black/African American | 35-44 | Heterosexual contact | 1022 | F |
| HIV diagnoses | 2014 | Black/African American | 35-44 | Injection drug use | 80 | F |
| HIV diagnoses | 2014 | Black/African American | 35-44 | Other | 1 | F |
| HIV diagnoses | 2014 | Black/African American | 45-54 | Heterosexual contact | 799 | F |
| HIV diagnoses | 2014 | Black/African American | 45-54 | Injection drug use | 100 | F |
| HIV diagnoses | 2014 | Black/African American | 45-54 | Other | 0 | F |
| HIV diagnoses | 2014 | Black/African American | 55 | Heterosexual contact | 606 | F |
| HIV diagnoses | 2014 | Black/African American | 55 | Injection drug use | 84 | F |
| HIV diagnoses | 2014 | Black/African American | 55 | Other | 1 | F |
| HIV diagnoses | 2014 | Hispanic/Latino | 13-24 | Heterosexual contact | 172 | F |
| HIV diagnoses | 2014 | Hispanic/Latino | 13-24 | Injection drug use | 25 | F |
| HIV diagnoses | 2014 | Hispanic/Latino | 13-24 | Other | 4 | F |
| HIV diagnoses | 2014 | Hispanic/Latino | 25-34 | Heterosexual contact | 292 | F |
| HIV diagnoses | 2014 | Hispanic/Latino | 25-34 | Injection drug use | 40 | F |
| HIV diagnoses | 2014 | Hispanic/Latino | 25-34 | Other | 1 | F |
| HIV diagnoses | 2014 | Hispanic/Latino | 35-44 | Heterosexual contact | 277 | F |
| HIV diagnoses | 2014 | Hispanic/Latino | 35-44 | Injection drug use | 48 | F |
| HIV diagnoses | 2014 | Hispanic/Latino | 35-44 | Other | 0 | F |
| HIV diagnoses | 2014 | Hispanic/Latino | 45-54 | Heterosexual contact | 203 | F |
| HIV diagnoses | 2014 | Hispanic/Latino | 45-54 | Injection drug use | 32 | F |
| HIV diagnoses | 2014 | Hispanic/Latino | 45-54 | Other | 0 | F |
| HIV diagnoses | 2014 | Hispanic/Latino | 55 | Heterosexual contact | 133 | F |
| HIV diagnoses | 2014 | Hispanic/Latino | 55 | Injection drug use | 28 | F |
| HIV diagnoses | 2014 | Hispanic/Latino | 55 | Other | 1 | F |
| HIV diagnoses | 2014 | Multiple races | 13-24 | Heterosexual contact | 49 | F |
| HIV diagnoses | 2014 | Multiple races | 13-24 | Injection drug use | 6 | F |
| HIV diagnoses | 2014 | Multiple races | 13-24 | Other | 0 | F |
| HIV diagnoses | 2014 | Multiple races | 25-34 | Heterosexual contact | 76 | F |
| HIV diagnoses | 2014 | Multiple races | 25-34 | Injection drug use | 11 | F |
| HIV diagnoses | 2014 | Multiple races | 25-34 | Other | 0 | F |
| HIV diagnoses | 2014 | Multiple races | 35-44 | Heterosexual contact | 61 | F |
| HIV diagnoses | 2014 | Multiple races | 35-44 | Injection drug use | 13 | F |
| HIV diagnoses | 2014 | Multiple races | 35-44 | Other | 0 | F |
| HIV diagnoses | 2014 | Multiple races | 45-54 | Heterosexual contact | 31 | F |
| HIV diagnoses | 2014 | Multiple races | 45-54 | Injection drug use | 14 | F |
| HIV diagnoses | 2014 | Multiple races | 45-54 | Other | 0 | F |
| HIV diagnoses | 2014 | Multiple races | 55 | Heterosexual contact | 23 | F |
| HIV diagnoses | 2014 | Multiple races | 55 | Injection drug use | 7 | F |
| HIV diagnoses | 2014 | Multiple races | 55 | Other | 0 | F |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 2 | F |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | F |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | F |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 2 | F |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | F |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 0 | F |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | F |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 2 | F |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | F |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | F |
| HIV diagnoses | 2014 | White | 13-24 | Heterosexual contact | 139 | F |
| HIV diagnoses | 2014 | White | 13-24 | Injection drug use | 53 | F |
| HIV diagnoses | 2014 | White | 13-24 | Other | 2 | F |
| HIV diagnoses | 2014 | White | 25-34 | Heterosexual contact | 254 | F |
| HIV diagnoses | 2014 | White | 25-34 | Injection drug use | 117 | F |
| HIV diagnoses | 2014 | White | 25-34 | Other | 1 | F |
| HIV diagnoses | 2014 | White | 35-44 | Heterosexual contact | 215 | F |
| HIV diagnoses | 2014 | White | 35-44 | Injection drug use | 83 | F |
| HIV diagnoses | 2014 | White | 35-44 | Other | 0 | F |
| HIV diagnoses | 2014 | White | 45-54 | Heterosexual contact | 213 | F |
| HIV diagnoses | 2014 | White | 45-54 | Injection drug use | 65 | F |
| HIV diagnoses | 2014 | White | 45-54 | Other | 1 | F |
| HIV diagnoses | 2014 | White | 55 | Heterosexual contact | 120 | F |
| HIV diagnoses | 2014 | White | 55 | Injection drug use | 31 | F |
| HIV diagnoses | 2014 | White | 55 | Other | 1 | F |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 13-24 | Injection drug use | 1 | F |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 13-24 | Other | 0 | F |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 13 | F |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 25-34 | Injection drug use | 3 | F |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 25-34 | Other | 0 | F |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 9 | F |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 35-44 | Injection drug use | 3 | F |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 35-44 | Other | 0 | F |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 6 | F |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 45-54 | Injection drug use | 3 | F |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 55 | Heterosexual contact | 4 | F |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 55 | Injection drug use | 3 | F |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 55 | Other | 0 | F |
| HIV diagnoses | 2015 | Asian | 13-24 | Heterosexual contact | 16 | F |
| HIV diagnoses | 2015 | Asian | 13-24 | Injection drug use | 1 | F |
| HIV diagnoses | 2015 | Asian | 13-24 | Other | 0 | F |
| HIV diagnoses | 2015 | Asian | 25-34 | Heterosexual contact | 36 | F |
| HIV diagnoses | 2015 | Asian | 25-34 | Injection drug use | 2 | F |
| HIV diagnoses | 2015 | Asian | 25-34 | Other | 0 | F |
| HIV diagnoses | 2015 | Asian | 35-44 | Heterosexual contact | 34 | F |
| HIV diagnoses | 2015 | Asian | 35-44 | Injection drug use | 1 | F |
| HIV diagnoses | 2015 | Asian | 35-44 | Other | 0 | F |
| HIV diagnoses | 2015 | Asian | 45-54 | Heterosexual contact | 18 | F |
| HIV diagnoses | 2015 | Asian | 45-54 | Injection drug use | 0 | F |
| HIV diagnoses | 2015 | Asian | 45-54 | Other | 0 | F |
| HIV diagnoses | 2015 | Asian | 55 | Heterosexual contact | 15 | F |
| HIV diagnoses | 2015 | Asian | 55 | Injection drug use | 2 | F |
| HIV diagnoses | 2015 | Asian | 55 | Other | 1 | F |
| HIV diagnoses | 2015 | Black/African American | 13-24 | Heterosexual contact | 628 | F |
| HIV diagnoses | 2015 | Black/African American | 13-24 | Injection drug use | 36 | F |
| HIV diagnoses | 2015 | Black/African American | 13-24 | Other | 10 | F |
| HIV diagnoses | 2015 | Black/African American | 25-34 | Heterosexual contact | 1065 | F |
| HIV diagnoses | 2015 | Black/African American | 25-34 | Injection drug use | 75 | F |
| HIV diagnoses | 2015 | Black/African American | 25-34 | Other | 4 | F |
| HIV diagnoses | 2015 | Black/African American | 35-44 | Heterosexual contact | 977 | F |
| HIV diagnoses | 2015 | Black/African American | 35-44 | Injection drug use | 66 | F |
| HIV diagnoses | 2015 | Black/African American | 35-44 | Other | 1 | F |
| HIV diagnoses | 2015 | Black/African American | 45-54 | Heterosexual contact | 785 | F |
| HIV diagnoses | 2015 | Black/African American | 45-54 | Injection drug use | 85 | F |
| HIV diagnoses | 2015 | Black/African American | 45-54 | Other | 1 | F |
| HIV diagnoses | 2015 | Black/African American | 55 | Heterosexual contact | 592 | F |
| HIV diagnoses | 2015 | Black/African American | 55 | Injection drug use | 76 | F |
| HIV diagnoses | 2015 | Black/African American | 55 | Other | 2 | F |
| HIV diagnoses | 2015 | Hispanic/Latino | 13-24 | Heterosexual contact | 160 | F |
| HIV diagnoses | 2015 | Hispanic/Latino | 13-24 | Injection drug use | 30 | F |
| HIV diagnoses | 2015 | Hispanic/Latino | 13-24 | Other | 4 | F |
| HIV diagnoses | 2015 | Hispanic/Latino | 25-34 | Heterosexual contact | 266 | F |
| HIV diagnoses | 2015 | Hispanic/Latino | 25-34 | Injection drug use | 30 | F |
| HIV diagnoses | 2015 | Hispanic/Latino | 25-34 | Other | 0 | F |
| HIV diagnoses | 2015 | Hispanic/Latino | 35-44 | Heterosexual contact | 263 | F |
| HIV diagnoses | 2015 | Hispanic/Latino | 35-44 | Injection drug use | 36 | F |
| HIV diagnoses | 2015 | Hispanic/Latino | 35-44 | Other | 0 | F |
| HIV diagnoses | 2015 | Hispanic/Latino | 45-54 | Heterosexual contact | 215 | F |
| HIV diagnoses | 2015 | Hispanic/Latino | 45-54 | Injection drug use | 33 | F |
| HIV diagnoses | 2015 | Hispanic/Latino | 45-54 | Other | 0 | F |
| HIV diagnoses | 2015 | Hispanic/Latino | 55 | Heterosexual contact | 122 | F |
| HIV diagnoses | 2015 | Hispanic/Latino | 55 | Injection drug use | 18 | F |
| HIV diagnoses | 2015 | Hispanic/Latino | 55 | Other | 0 | F |
| HIV diagnoses | 2015 | Multiple races | 13-24 | Heterosexual contact | 31 | F |
| HIV diagnoses | 2015 | Multiple races | 13-24 | Injection drug use | 3 | F |
| HIV diagnoses | 2015 | Multiple races | 13-24 | Other | 0 | F |
| HIV diagnoses | 2015 | Multiple races | 25-34 | Heterosexual contact | 57 | F |
| HIV diagnoses | 2015 | Multiple races | 25-34 | Injection drug use | 11 | F |
| HIV diagnoses | 2015 | Multiple races | 25-34 | Other | 0 | F |
| HIV diagnoses | 2015 | Multiple races | 35-44 | Heterosexual contact | 42 | F |
| HIV diagnoses | 2015 | Multiple races | 35-44 | Injection drug use | 6 | F |
| HIV diagnoses | 2015 | Multiple races | 35-44 | Other | 0 | F |
| HIV diagnoses | 2015 | Multiple races | 45-54 | Heterosexual contact | 43 | F |
| HIV diagnoses | 2015 | Multiple races | 45-54 | Injection drug use | 9 | F |
| HIV diagnoses | 2015 | Multiple races | 45-54 | Other | 0 | F |
| HIV diagnoses | 2015 | Multiple races | 55 | Heterosexual contact | 22 | F |
| HIV diagnoses | 2015 | Multiple races | 55 | Injection drug use | 10 | F |
| HIV diagnoses | 2015 | Multiple races | 55 | Other | 0 | F |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | F |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 1 | F |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 0 | F |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | F |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 0 | F |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | F |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | F |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | F |
| HIV diagnoses | 2015 | White | 13-24 | Heterosexual contact | 110 | F |
| HIV diagnoses | 2015 | White | 13-24 | Injection drug use | 61 | F |
| HIV diagnoses | 2015 | White | 13-24 | Other | 1 | F |
| HIV diagnoses | 2015 | White | 25-34 | Heterosexual contact | 229 | F |
| HIV diagnoses | 2015 | White | 25-34 | Injection drug use | 178 | F |
| HIV diagnoses | 2015 | White | 25-34 | Other | 1 | F |
| HIV diagnoses | 2015 | White | 35-44 | Heterosexual contact | 208 | F |
| HIV diagnoses | 2015 | White | 35-44 | Injection drug use | 114 | F |
| HIV diagnoses | 2015 | White | 35-44 | Other | 1 | F |
| HIV diagnoses | 2015 | White | 45-54 | Heterosexual contact | 214 | F |
| HIV diagnoses | 2015 | White | 45-54 | Injection drug use | 90 | F |
| HIV diagnoses | 2015 | White | 45-54 | Other | 0 | F |
| HIV diagnoses | 2015 | White | 55 | Heterosexual contact | 149 | F |
| HIV diagnoses | 2015 | White | 55 | Injection drug use | 39 | F |
| HIV diagnoses | 2015 | White | 55 | Other | 2 | F |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 0 | F |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 13-24 | Injection drug use | 1 | F |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 13-24 | Other | 0 | F |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 7 | F |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 25-34 | Injection drug use | 4 | F |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 25-34 | Other | 0 | F |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 12 | F |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 35-44 | Injection drug use | 3 | F |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 35-44 | Other | 0 | F |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 5 | F |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 45-54 | Injection drug use | 5 | F |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 55 | Heterosexual contact | 4 | F |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 55 | Injection drug use | 1 | F |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 55 | Other | 0 | F |
| HIV diagnoses | 2016 | Asian | 13-24 | Heterosexual contact | 10 | F |
| HIV diagnoses | 2016 | Asian | 13-24 | Injection drug use | 1 | F |
| HIV diagnoses | 2016 | Asian | 13-24 | Other | 1 | F |
| HIV diagnoses | 2016 | Asian | 25-34 | Heterosexual contact | 52 | F |
| HIV diagnoses | 2016 | Asian | 25-34 | Injection drug use | 2 | F |
| HIV diagnoses | 2016 | Asian | 25-34 | Other | 0 | F |
| HIV diagnoses | 2016 | Asian | 35-44 | Heterosexual contact | 38 | F |
| HIV diagnoses | 2016 | Asian | 35-44 | Injection drug use | 2 | F |
| HIV diagnoses | 2016 | Asian | 35-44 | Other | 0 | F |
| HIV diagnoses | 2016 | Asian | 45-54 | Heterosexual contact | 20 | F |
| HIV diagnoses | 2016 | Asian | 45-54 | Injection drug use | 1 | F |
| HIV diagnoses | 2016 | Asian | 45-54 | Other | 0 | F |
| HIV diagnoses | 2016 | Asian | 55 | Heterosexual contact | 16 | F |
| HIV diagnoses | 2016 | Asian | 55 | Injection drug use | 1 | F |
| HIV diagnoses | 2016 | Asian | 55 | Other | 0 | F |
| HIV diagnoses | 2016 | Black/African American | 13-24 | Heterosexual contact | 558 | F |
| HIV diagnoses | 2016 | Black/African American | 13-24 | Injection drug use | 27 | F |
| HIV diagnoses | 2016 | Black/African American | 13-24 | Other | 25 | F |
| HIV diagnoses | 2016 | Black/African American | 25-34 | Heterosexual contact | 1114 | F |
| HIV diagnoses | 2016 | Black/African American | 25-34 | Injection drug use | 80 | F |
| HIV diagnoses | 2016 | Black/African American | 25-34 | Other | 3 | F |
| HIV diagnoses | 2016 | Black/African American | 35-44 | Heterosexual contact | 984 | F |
| HIV diagnoses | 2016 | Black/African American | 35-44 | Injection drug use | 58 | F |
| HIV diagnoses | 2016 | Black/African American | 35-44 | Other | 1 | F |
| HIV diagnoses | 2016 | Black/African American | 45-54 | Heterosexual contact | 819 | F |
| HIV diagnoses | 2016 | Black/African American | 45-54 | Injection drug use | 87 | F |
| HIV diagnoses | 2016 | Black/African American | 45-54 | Other | 0 | F |
| HIV diagnoses | 2016 | Black/African American | 55 | Heterosexual contact | 614 | F |
| HIV diagnoses | 2016 | Black/African American | 55 | Injection drug use | 83 | F |
| HIV diagnoses | 2016 | Black/African American | 55 | Other | 2 | F |
| HIV diagnoses | 2016 | Hispanic/Latino | 13-24 | Heterosexual contact | 134 | F |
| HIV diagnoses | 2016 | Hispanic/Latino | 13-24 | Injection drug use | 17 | F |
| HIV diagnoses | 2016 | Hispanic/Latino | 13-24 | Other | 1 | F |
| HIV diagnoses | 2016 | Hispanic/Latino | 25-34 | Heterosexual contact | 289 | F |
| HIV diagnoses | 2016 | Hispanic/Latino | 25-34 | Injection drug use | 57 | F |
| HIV diagnoses | 2016 | Hispanic/Latino | 25-34 | Other | 1 | F |
| HIV diagnoses | 2016 | Hispanic/Latino | 35-44 | Heterosexual contact | 242 | F |
| HIV diagnoses | 2016 | Hispanic/Latino | 35-44 | Injection drug use | 29 | F |
| HIV diagnoses | 2016 | Hispanic/Latino | 35-44 | Other | 0 | F |
| HIV diagnoses | 2016 | Hispanic/Latino | 45-54 | Heterosexual contact | 204 | F |
| HIV diagnoses | 2016 | Hispanic/Latino | 45-54 | Injection drug use | 29 | F |
| HIV diagnoses | 2016 | Hispanic/Latino | 45-54 | Other | 0 | F |
| HIV diagnoses | 2016 | Hispanic/Latino | 55 | Heterosexual contact | 146 | F |
| HIV diagnoses | 2016 | Hispanic/Latino | 55 | Injection drug use | 25 | F |
| HIV diagnoses | 2016 | Hispanic/Latino | 55 | Other | 0 | F |
| HIV diagnoses | 2016 | Multiple races | 13-24 | Heterosexual contact | 37 | F |
| HIV diagnoses | 2016 | Multiple races | 13-24 | Injection drug use | 4 | F |
| HIV diagnoses | 2016 | Multiple races | 13-24 | Other | 2 | F |
| HIV diagnoses | 2016 | Multiple races | 25-34 | Heterosexual contact | 46 | F |
| HIV diagnoses | 2016 | Multiple races | 25-34 | Injection drug use | 8 | F |
| HIV diagnoses | 2016 | Multiple races | 25-34 | Other | 0 | F |
| HIV diagnoses | 2016 | Multiple races | 35-44 | Heterosexual contact | 39 | F |
| HIV diagnoses | 2016 | Multiple races | 35-44 | Injection drug use | 12 | F |
| HIV diagnoses | 2016 | Multiple races | 35-44 | Other | 0 | F |
| HIV diagnoses | 2016 | Multiple races | 45-54 | Heterosexual contact | 34 | F |
| HIV diagnoses | 2016 | Multiple races | 45-54 | Injection drug use | 9 | F |
| HIV diagnoses | 2016 | Multiple races | 45-54 | Other | 0 | F |
| HIV diagnoses | 2016 | Multiple races | 55 | Heterosexual contact | 27 | F |
| HIV diagnoses | 2016 | Multiple races | 55 | Injection drug use | 5 | F |
| HIV diagnoses | 2016 | Multiple races | 55 | Other | 0 | F |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | F |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | F |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 2 | F |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | F |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 2 | F |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 2 | F |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | F |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 0 | F |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | F |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | F |
| HIV diagnoses | 2016 | White | 13-24 | Heterosexual contact | 138 | F |
| HIV diagnoses | 2016 | White | 13-24 | Injection drug use | 48 | F |
| HIV diagnoses | 2016 | White | 13-24 | Other | 3 | F |
| HIV diagnoses | 2016 | White | 25-34 | Heterosexual contact | 283 | F |
| HIV diagnoses | 2016 | White | 25-34 | Injection drug use | 159 | F |
| HIV diagnoses | 2016 | White | 25-34 | Other | 1 | F |
| HIV diagnoses | 2016 | White | 35-44 | Heterosexual contact | 210 | F |
| HIV diagnoses | 2016 | White | 35-44 | Injection drug use | 102 | F |
| HIV diagnoses | 2016 | White | 35-44 | Other | 0 | F |
| HIV diagnoses | 2016 | White | 45-54 | Heterosexual contact | 209 | F |
| HIV diagnoses | 2016 | White | 45-54 | Injection drug use | 83 | F |
| HIV diagnoses | 2016 | White | 45-54 | Other | 1 | F |
| HIV diagnoses | 2016 | White | 55 | Heterosexual contact | 169 | F |
| HIV diagnoses | 2016 | White | 55 | Injection drug use | 43 | F |
| HIV diagnoses | 2016 | White | 55 | Other | 2 | F |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 2 | F |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 13-24 | Injection drug use | 2 | F |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 13-24 | Other | 0 | F |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 7 | F |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 25-34 | Injection drug use | 4 | F |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 25-34 | Other | 0 | F |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 9 | F |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 35-44 | Injection drug use | 4 | F |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 35-44 | Other | 0 | F |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 10 | F |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 45-54 | Injection drug use | 5 | F |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 55 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 55 | Injection drug use | 2 | F |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 55 | Other | 0 | F |
| HIV diagnoses | 2017 | Asian | 13-24 | Heterosexual contact | 7 | F |
| HIV diagnoses | 2017 | Asian | 13-24 | Injection drug use | 1 | F |
| HIV diagnoses | 2017 | Asian | 13-24 | Other | 0 | F |
| HIV diagnoses | 2017 | Asian | 25-34 | Heterosexual contact | 27 | F |
| HIV diagnoses | 2017 | Asian | 25-34 | Injection drug use | 2 | F |
| HIV diagnoses | 2017 | Asian | 25-34 | Other | 0 | F |
| HIV diagnoses | 2017 | Asian | 35-44 | Heterosexual contact | 34 | F |
| HIV diagnoses | 2017 | Asian | 35-44 | Injection drug use | 2 | F |
| HIV diagnoses | 2017 | Asian | 35-44 | Other | 0 | F |
| HIV diagnoses | 2017 | Asian | 45-54 | Heterosexual contact | 25 | F |
| HIV diagnoses | 2017 | Asian | 45-54 | Injection drug use | 1 | F |
| HIV diagnoses | 2017 | Asian | 45-54 | Other | 0 | F |
| HIV diagnoses | 2017 | Asian | 55 | Heterosexual contact | 19 | F |
| HIV diagnoses | 2017 | Asian | 55 | Injection drug use | 1 | F |
| HIV diagnoses | 2017 | Asian | 55 | Other | 1 | F |
| HIV diagnoses | 2017 | Black/African American | 13-24 | Heterosexual contact | 563 | F |
| HIV diagnoses | 2017 | Black/African American | 13-24 | Injection drug use | 39 | F |
| HIV diagnoses | 2017 | Black/African American | 13-24 | Other | 22 | F |
| HIV diagnoses | 2017 | Black/African American | 25-34 | Heterosexual contact | 1068 | F |
| HIV diagnoses | 2017 | Black/African American | 25-34 | Injection drug use | 78 | F |
| HIV diagnoses | 2017 | Black/African American | 25-34 | Other | 7 | F |
| HIV diagnoses | 2017 | Black/African American | 35-44 | Heterosexual contact | 912 | F |
| HIV diagnoses | 2017 | Black/African American | 35-44 | Injection drug use | 77 | F |
| HIV diagnoses | 2017 | Black/African American | 35-44 | Other | 1 | F |
| HIV diagnoses | 2017 | Black/African American | 45-54 | Heterosexual contact | 744 | F |
| HIV diagnoses | 2017 | Black/African American | 45-54 | Injection drug use | 77 | F |
| HIV diagnoses | 2017 | Black/African American | 45-54 | Other | 0 | F |
| HIV diagnoses | 2017 | Black/African American | 55 | Heterosexual contact | 668 | F |
| HIV diagnoses | 2017 | Black/African American | 55 | Injection drug use | 73 | F |
| HIV diagnoses | 2017 | Black/African American | 55 | Other | 1 | F |
| HIV diagnoses | 2017 | Hispanic/Latino | 13-24 | Heterosexual contact | 153 | F |
| HIV diagnoses | 2017 | Hispanic/Latino | 13-24 | Injection drug use | 20 | F |
| HIV diagnoses | 2017 | Hispanic/Latino | 13-24 | Other | 2 | F |
| HIV diagnoses | 2017 | Hispanic/Latino | 25-34 | Heterosexual contact | 265 | F |
| HIV diagnoses | 2017 | Hispanic/Latino | 25-34 | Injection drug use | 44 | F |
| HIV diagnoses | 2017 | Hispanic/Latino | 25-34 | Other | 1 | F |
| HIV diagnoses | 2017 | Hispanic/Latino | 35-44 | Heterosexual contact | 224 | F |
| HIV diagnoses | 2017 | Hispanic/Latino | 35-44 | Injection drug use | 36 | F |
| HIV diagnoses | 2017 | Hispanic/Latino | 35-44 | Other | 0 | F |
| HIV diagnoses | 2017 | Hispanic/Latino | 45-54 | Heterosexual contact | 208 | F |
| HIV diagnoses | 2017 | Hispanic/Latino | 45-54 | Injection drug use | 26 | F |
| HIV diagnoses | 2017 | Hispanic/Latino | 45-54 | Other | 0 | F |
| HIV diagnoses | 2017 | Hispanic/Latino | 55 | Heterosexual contact | 149 | F |
| HIV diagnoses | 2017 | Hispanic/Latino | 55 | Injection drug use | 15 | F |
| HIV diagnoses | 2017 | Hispanic/Latino | 55 | Other | 0 | F |
| HIV diagnoses | 2017 | Multiple races | 13-24 | Heterosexual contact | 30 | F |
| HIV diagnoses | 2017 | Multiple races | 13-24 | Injection drug use | 7 | F |
| HIV diagnoses | 2017 | Multiple races | 13-24 | Other | 3 | F |
| HIV diagnoses | 2017 | Multiple races | 25-34 | Heterosexual contact | 41 | F |
| HIV diagnoses | 2017 | Multiple races | 25-34 | Injection drug use | 9 | F |
| HIV diagnoses | 2017 | Multiple races | 25-34 | Other | 0 | F |
| HIV diagnoses | 2017 | Multiple races | 35-44 | Heterosexual contact | 29 | F |
| HIV diagnoses | 2017 | Multiple races | 35-44 | Injection drug use | 10 | F |
| HIV diagnoses | 2017 | Multiple races | 35-44 | Other | 0 | F |
| HIV diagnoses | 2017 | Multiple races | 45-54 | Heterosexual contact | 34 | F |
| HIV diagnoses | 2017 | Multiple races | 45-54 | Injection drug use | 9 | F |
| HIV diagnoses | 2017 | Multiple races | 45-54 | Other | 0 | F |
| HIV diagnoses | 2017 | Multiple races | 55 | Heterosexual contact | 18 | F |
| HIV diagnoses | 2017 | Multiple races | 55 | Injection drug use | 3 | F |
| HIV diagnoses | 2017 | Multiple races | 55 | Other | 0 | F |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | F |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | F |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 5 | F |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | F |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 3 | F |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | F |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 0 | F |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 0 | F |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | F |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 1 | F |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | F |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | F |
| HIV diagnoses | 2017 | White | 13-24 | Heterosexual contact | 133 | F |
| HIV diagnoses | 2017 | White | 13-24 | Injection drug use | 59 | F |
| HIV diagnoses | 2017 | White | 13-24 | Other | 1 | F |
| HIV diagnoses | 2017 | White | 25-34 | Heterosexual contact | 242 | F |
| HIV diagnoses | 2017 | White | 25-34 | Injection drug use | 182 | F |
| HIV diagnoses | 2017 | White | 25-34 | Other | 1 | F |
| HIV diagnoses | 2017 | White | 35-44 | Heterosexual contact | 198 | F |
| HIV diagnoses | 2017 | White | 35-44 | Injection drug use | 133 | F |
| HIV diagnoses | 2017 | White | 35-44 | Other | 0 | F |
| HIV diagnoses | 2017 | White | 45-54 | Heterosexual contact | 210 | F |
| HIV diagnoses | 2017 | White | 45-54 | Injection drug use | 75 | F |
| HIV diagnoses | 2017 | White | 45-54 | Other | 1 | F |
| HIV diagnoses | 2017 | White | 55 | Heterosexual contact | 166 | F |
| HIV diagnoses | 2017 | White | 55 | Injection drug use | 42 | F |
| HIV diagnoses | 2017 | White | 55 | Other | 2 | F |
| HIV prevalence | 2008 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 18 | F |
| HIV prevalence | 2008 | American Indian/Alaska Native | 13-24 | Injection drug use | 6 | F |
| HIV prevalence | 2008 | American Indian/Alaska Native | 13-24 | Other | 9 | F |
| HIV prevalence | 2008 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 81 | F |
| HIV prevalence | 2008 | American Indian/Alaska Native | 25-34 | Injection drug use | 33 | F |
| HIV prevalence | 2008 | American Indian/Alaska Native | 25-34 | Other | 2 | F |
| HIV prevalence | 2008 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 111 | F |
| HIV prevalence | 2008 | American Indian/Alaska Native | 35-44 | Injection drug use | 75 | F |
| HIV prevalence | 2008 | American Indian/Alaska Native | 35-44 | Other | 1 | F |
| HIV prevalence | 2008 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 95 | F |
| HIV prevalence | 2008 | American Indian/Alaska Native | 45-54 | Injection drug use | 62 | F |
| HIV prevalence | 2008 | American Indian/Alaska Native | 45-54 | Other | 1 | F |
| HIV prevalence | 2008 | American Indian/Alaska Native | 55 | Heterosexual contact | 56 | F |
| HIV prevalence | 2008 | American Indian/Alaska Native | 55 | Injection drug use | 24 | F |
| HIV prevalence | 2008 | American Indian/Alaska Native | 55 | Other | 4 | F |
| HIV prevalence | 2008 | Asian | 13-24 | Heterosexual contact | 35 | F |
| HIV prevalence | 2008 | Asian | 13-24 | Injection drug use | 2 | F |
| HIV prevalence | 2008 | Asian | 13-24 | Other | 15 | F |
| HIV prevalence | 2008 | Asian | 25-34 | Heterosexual contact | 270 | F |
| HIV prevalence | 2008 | Asian | 25-34 | Injection drug use | 19 | F |
| HIV prevalence | 2008 | Asian | 25-34 | Other | 6 | F |
| HIV prevalence | 2008 | Asian | 35-44 | Heterosexual contact | 428 | F |
| HIV prevalence | 2008 | Asian | 35-44 | Injection drug use | 38 | F |
| HIV prevalence | 2008 | Asian | 35-44 | Other | 8 | F |
| HIV prevalence | 2008 | Asian | 45-54 | Heterosexual contact | 251 | F |
| HIV prevalence | 2008 | Asian | 45-54 | Injection drug use | 37 | F |
| HIV prevalence | 2008 | Asian | 45-54 | Other | 18 | F |
| HIV prevalence | 2008 | Asian | 55 | Heterosexual contact | 155 | F |
| HIV prevalence | 2008 | Asian | 55 | Injection drug use | 19 | F |
| HIV prevalence | 2008 | Asian | 55 | Other | 20 | F |
| HIV prevalence | 2008 | Black/African American | 13-24 | Heterosexual contact | 4080 | F |
| HIV prevalence | 2008 | Black/African American | 13-24 | Injection drug use | 372 | F |
| HIV prevalence | 2008 | Black/African American | 13-24 | Other | 2222 | F |
| HIV prevalence | 2008 | Black/African American | 25-34 | Heterosexual contact | 18930 | F |
| HIV prevalence | 2008 | Black/African American | 25-34 | Injection drug use | 2364 | F |
| HIV prevalence | 2008 | Black/African American | 25-34 | Other | 145 | F |
| HIV prevalence | 2008 | Black/African American | 35-44 | Heterosexual contact | 28968 | F |
| HIV prevalence | 2008 | Black/African American | 35-44 | Injection drug use | 8020 | F |
| HIV prevalence | 2008 | Black/African American | 35-44 | Other | 113 | F |
| HIV prevalence | 2008 | Black/African American | 45-54 | Heterosexual contact | 22802 | F |
| HIV prevalence | 2008 | Black/African American | 45-54 | Injection drug use | 11196 | F |
| HIV prevalence | 2008 | Black/African American | 45-54 | Other | 191 | F |
| HIV prevalence | 2008 | Black/African American | 55 | Heterosexual contact | 10574 | F |
| HIV prevalence | 2008 | Black/African American | 55 | Injection drug use | 4556 | F |
| HIV prevalence | 2008 | Black/African American | 55 | Other | 182 | F |
| HIV prevalence | 2008 | Hispanic/Latino | 13-24 | Heterosexual contact | 977 | F |
| HIV prevalence | 2008 | Hispanic/Latino | 13-24 | Injection drug use | 147 | F |
| HIV prevalence | 2008 | Hispanic/Latino | 13-24 | Other | 900 | F |
| HIV prevalence | 2008 | Hispanic/Latino | 25-34 | Heterosexual contact | 4842 | F |
| HIV prevalence | 2008 | Hispanic/Latino | 25-34 | Injection drug use | 1064 | F |
| HIV prevalence | 2008 | Hispanic/Latino | 25-34 | Other | 74 | F |
| HIV prevalence | 2008 | Hispanic/Latino | 35-44 | Heterosexual contact | 7860 | F |
| HIV prevalence | 2008 | Hispanic/Latino | 35-44 | Injection drug use | 3210 | F |
| HIV prevalence | 2008 | Hispanic/Latino | 35-44 | Other | 32 | F |
| HIV prevalence | 2008 | Hispanic/Latino | 45-54 | Heterosexual contact | 6745 | F |
| HIV prevalence | 2008 | Hispanic/Latino | 45-54 | Injection drug use | 3792 | F |
| HIV prevalence | 2008 | Hispanic/Latino | 45-54 | Other | 66 | F |
| HIV prevalence | 2008 | Hispanic/Latino | 55 | Heterosexual contact | 3601 | F |
| HIV prevalence | 2008 | Hispanic/Latino | 55 | Injection drug use | 1473 | F |
| HIV prevalence | 2008 | Hispanic/Latino | 55 | Other | 76 | F |
| HIV prevalence | 2008 | Multiple races | 13-24 | Heterosexual contact | 358 | F |
| HIV prevalence | 2008 | Multiple races | 13-24 | Injection drug use | 55 | F |
| HIV prevalence | 2008 | Multiple races | 13-24 | Other | 237 | F |
| HIV prevalence | 2008 | Multiple races | 25-34 | Heterosexual contact | 1434 | F |
| HIV prevalence | 2008 | Multiple races | 25-34 | Injection drug use | 356 | F |
| HIV prevalence | 2008 | Multiple races | 25-34 | Other | 21 | F |
| HIV prevalence | 2008 | Multiple races | 35-44 | Heterosexual contact | 2164 | F |
| HIV prevalence | 2008 | Multiple races | 35-44 | Injection drug use | 1075 | F |
| HIV prevalence | 2008 | Multiple races | 35-44 | Other | 9 | F |
| HIV prevalence | 2008 | Multiple races | 45-54 | Heterosexual contact | 1716 | F |
| HIV prevalence | 2008 | Multiple races | 45-54 | Injection drug use | 1315 | F |
| HIV prevalence | 2008 | Multiple races | 45-54 | Other | 19 | F |
| HIV prevalence | 2008 | Multiple races | 55 | Heterosexual contact | 798 | F |
| HIV prevalence | 2008 | Multiple races | 55 | Injection drug use | 517 | F |
| HIV prevalence | 2008 | Multiple races | 55 | Other | 20 | F |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 2 | F |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 1 | F |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 19 | F |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 1 | F |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 24 | F |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 7 | F |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 14 | F |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 8 | F |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | F |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 11 | F |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | F |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | F |
| HIV prevalence | 2008 | White | 13-24 | Heterosexual contact | 725 | F |
| HIV prevalence | 2008 | White | 13-24 | Injection drug use | 248 | F |
| HIV prevalence | 2008 | White | 13-24 | Other | 451 | F |
| HIV prevalence | 2008 | White | 25-34 | Heterosexual contact | 3630 | F |
| HIV prevalence | 2008 | White | 25-34 | Injection drug use | 1458 | F |
| HIV prevalence | 2008 | White | 25-34 | Other | 65 | F |
| HIV prevalence | 2008 | White | 35-44 | Heterosexual contact | 6900 | F |
| HIV prevalence | 2008 | White | 35-44 | Injection drug use | 3981 | F |
| HIV prevalence | 2008 | White | 35-44 | Other | 70 | F |
| HIV prevalence | 2008 | White | 45-54 | Heterosexual contact | 6249 | F |
| HIV prevalence | 2008 | White | 45-54 | Injection drug use | 4714 | F |
| HIV prevalence | 2008 | White | 45-54 | Other | 153 | F |
| HIV prevalence | 2008 | White | 55 | Heterosexual contact | 3086 | F |
| HIV prevalence | 2008 | White | 55 | Injection drug use | 1443 | F |
| HIV prevalence | 2008 | White | 55 | Other | 200 | F |
| HIV prevalence | 2009 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 19 | F |
| HIV prevalence | 2009 | American Indian/Alaska Native | 13-24 | Injection drug use | 6 | F |
| HIV prevalence | 2009 | American Indian/Alaska Native | 13-24 | Other | 9 | F |
| HIV prevalence | 2009 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 76 | F |
| HIV prevalence | 2009 | American Indian/Alaska Native | 25-34 | Injection drug use | 33 | F |
| HIV prevalence | 2009 | American Indian/Alaska Native | 25-34 | Other | 2 | F |
| HIV prevalence | 2009 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 116 | F |
| HIV prevalence | 2009 | American Indian/Alaska Native | 35-44 | Injection drug use | 71 | F |
| HIV prevalence | 2009 | American Indian/Alaska Native | 35-44 | Other | 1 | F |
| HIV prevalence | 2009 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 103 | F |
| HIV prevalence | 2009 | American Indian/Alaska Native | 45-54 | Injection drug use | 69 | F |
| HIV prevalence | 2009 | American Indian/Alaska Native | 45-54 | Other | 1 | F |
| HIV prevalence | 2009 | American Indian/Alaska Native | 55 | Heterosexual contact | 61 | F |
| HIV prevalence | 2009 | American Indian/Alaska Native | 55 | Injection drug use | 25 | F |
| HIV prevalence | 2009 | American Indian/Alaska Native | 55 | Other | 4 | F |
| HIV prevalence | 2009 | Asian | 13-24 | Heterosexual contact | 39 | F |
| HIV prevalence | 2009 | Asian | 13-24 | Injection drug use | 2 | F |
| HIV prevalence | 2009 | Asian | 13-24 | Other | 15 | F |
| HIV prevalence | 2009 | Asian | 25-34 | Heterosexual contact | 287 | F |
| HIV prevalence | 2009 | Asian | 25-34 | Injection drug use | 20 | F |
| HIV prevalence | 2009 | Asian | 25-34 | Other | 7 | F |
| HIV prevalence | 2009 | Asian | 35-44 | Heterosexual contact | 443 | F |
| HIV prevalence | 2009 | Asian | 35-44 | Injection drug use | 40 | F |
| HIV prevalence | 2009 | Asian | 35-44 | Other | 7 | F |
| HIV prevalence | 2009 | Asian | 45-54 | Heterosexual contact | 278 | F |
| HIV prevalence | 2009 | Asian | 45-54 | Injection drug use | 41 | F |
| HIV prevalence | 2009 | Asian | 45-54 | Other | 19 | F |
| HIV prevalence | 2009 | Asian | 55 | Heterosexual contact | 186 | F |
| HIV prevalence | 2009 | Asian | 55 | Injection drug use | 22 | F |
| HIV prevalence | 2009 | Asian | 55 | Other | 20 | F |
| HIV prevalence | 2009 | Black/African American | 13-24 | Heterosexual contact | 4000 | F |
| HIV prevalence | 2009 | Black/African American | 13-24 | Injection drug use | 347 | F |
| HIV prevalence | 2009 | Black/African American | 13-24 | Other | 2347 | F |
| HIV prevalence | 2009 | Black/African American | 25-34 | Heterosexual contact | 18386 | F |
| HIV prevalence | 2009 | Black/African American | 25-34 | Injection drug use | 2188 | F |
| HIV prevalence | 2009 | Black/African American | 25-34 | Other | 177 | F |
| HIV prevalence | 2009 | Black/African American | 35-44 | Heterosexual contact | 29409 | F |
| HIV prevalence | 2009 | Black/African American | 35-44 | Injection drug use | 7280 | F |
| HIV prevalence | 2009 | Black/African American | 35-44 | Other | 103 | F |
| HIV prevalence | 2009 | Black/African American | 45-54 | Heterosexual contact | 24969 | F |
| HIV prevalence | 2009 | Black/African American | 45-54 | Injection drug use | 11218 | F |
| HIV prevalence | 2009 | Black/African American | 45-54 | Other | 192 | F |
| HIV prevalence | 2009 | Black/African American | 55 | Heterosexual contact | 12187 | F |
| HIV prevalence | 2009 | Black/African American | 55 | Injection drug use | 5266 | F |
| HIV prevalence | 2009 | Black/African American | 55 | Other | 194 | F |
| HIV prevalence | 2009 | Hispanic/Latino | 13-24 | Heterosexual contact | 911 | F |
| HIV prevalence | 2009 | Hispanic/Latino | 13-24 | Injection drug use | 148 | F |
| HIV prevalence | 2009 | Hispanic/Latino | 13-24 | Other | 931 | F |
| HIV prevalence | 2009 | Hispanic/Latino | 25-34 | Heterosexual contact | 4764 | F |
| HIV prevalence | 2009 | Hispanic/Latino | 25-34 | Injection drug use | 1008 | F |
| HIV prevalence | 2009 | Hispanic/Latino | 25-34 | Other | 106 | F |
| HIV prevalence | 2009 | Hispanic/Latino | 35-44 | Heterosexual contact | 7891 | F |
| HIV prevalence | 2009 | Hispanic/Latino | 35-44 | Injection drug use | 2907 | F |
| HIV prevalence | 2009 | Hispanic/Latino | 35-44 | Other | 31 | F |
| HIV prevalence | 2009 | Hispanic/Latino | 45-54 | Heterosexual contact | 7310 | F |
| HIV prevalence | 2009 | Hispanic/Latino | 45-54 | Injection drug use | 3919 | F |
| HIV prevalence | 2009 | Hispanic/Latino | 45-54 | Other | 65 | F |
| HIV prevalence | 2009 | Hispanic/Latino | 55 | Heterosexual contact | 4074 | F |
| HIV prevalence | 2009 | Hispanic/Latino | 55 | Injection drug use | 1706 | F |
| HIV prevalence | 2009 | Hispanic/Latino | 55 | Other | 82 | F |
| HIV prevalence | 2009 | Multiple races | 13-24 | Heterosexual contact | 354 | F |
| HIV prevalence | 2009 | Multiple races | 13-24 | Injection drug use | 57 | F |
| HIV prevalence | 2009 | Multiple races | 13-24 | Other | 252 | F |
| HIV prevalence | 2009 | Multiple races | 25-34 | Heterosexual contact | 1418 | F |
| HIV prevalence | 2009 | Multiple races | 25-34 | Injection drug use | 337 | F |
| HIV prevalence | 2009 | Multiple races | 25-34 | Other | 28 | F |
| HIV prevalence | 2009 | Multiple races | 35-44 | Heterosexual contact | 2195 | F |
| HIV prevalence | 2009 | Multiple races | 35-44 | Injection drug use | 974 | F |
| HIV prevalence | 2009 | Multiple races | 35-44 | Other | 7 | F |
| HIV prevalence | 2009 | Multiple races | 45-54 | Heterosexual contact | 1871 | F |
| HIV prevalence | 2009 | Multiple races | 45-54 | Injection drug use | 1351 | F |
| HIV prevalence | 2009 | Multiple races | 45-54 | Other | 19 | F |
| HIV prevalence | 2009 | Multiple races | 55 | Heterosexual contact | 921 | F |
| HIV prevalence | 2009 | Multiple races | 55 | Injection drug use | 599 | F |
| HIV prevalence | 2009 | Multiple races | 55 | Other | 23 | F |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 3 | F |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 1 | F |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 1 | F |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 19 | F |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 1 | F |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 27 | F |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 6 | F |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 16 | F |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 10 | F |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | F |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 13 | F |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 1 | F |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Other | 1 | F |
| HIV prevalence | 2009 | White | 13-24 | Heterosexual contact | 713 | F |
| HIV prevalence | 2009 | White | 13-24 | Injection drug use | 231 | F |
| HIV prevalence | 2009 | White | 13-24 | Other | 470 | F |
| HIV prevalence | 2009 | White | 25-34 | Heterosexual contact | 3566 | F |
| HIV prevalence | 2009 | White | 25-34 | Injection drug use | 1418 | F |
| HIV prevalence | 2009 | White | 25-34 | Other | 80 | F |
| HIV prevalence | 2009 | White | 35-44 | Heterosexual contact | 6714 | F |
| HIV prevalence | 2009 | White | 35-44 | Injection drug use | 3602 | F |
| HIV prevalence | 2009 | White | 35-44 | Other | 62 | F |
| HIV prevalence | 2009 | White | 45-54 | Heterosexual contact | 6793 | F |
| HIV prevalence | 2009 | White | 45-54 | Injection drug use | 4882 | F |
| HIV prevalence | 2009 | White | 45-54 | Other | 154 | F |
| HIV prevalence | 2009 | White | 55 | Heterosexual contact | 3513 | F |
| HIV prevalence | 2009 | White | 55 | Injection drug use | 1735 | F |
| HIV prevalence | 2009 | White | 55 | Other | 207 | F |
| HIV prevalence | 2010 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 16 | F |
| HIV prevalence | 2010 | American Indian/Alaska Native | 13-24 | Injection drug use | 4 | F |
| HIV prevalence | 2010 | American Indian/Alaska Native | 13-24 | Other | 9 | F |
| HIV prevalence | 2010 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 81 | F |
| HIV prevalence | 2010 | American Indian/Alaska Native | 25-34 | Injection drug use | 33 | F |
| HIV prevalence | 2010 | American Indian/Alaska Native | 25-34 | Other | 2 | F |
| HIV prevalence | 2010 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 123 | F |
| HIV prevalence | 2010 | American Indian/Alaska Native | 35-44 | Injection drug use | 63 | F |
| HIV prevalence | 2010 | American Indian/Alaska Native | 35-44 | Other | 2 | F |
| HIV prevalence | 2010 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 112 | F |
| HIV prevalence | 2010 | American Indian/Alaska Native | 45-54 | Injection drug use | 72 | F |
| HIV prevalence | 2010 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV prevalence | 2010 | American Indian/Alaska Native | 55 | Heterosexual contact | 67 | F |
| HIV prevalence | 2010 | American Indian/Alaska Native | 55 | Injection drug use | 33 | F |
| HIV prevalence | 2010 | American Indian/Alaska Native | 55 | Other | 5 | F |
| HIV prevalence | 2010 | Asian | 13-24 | Heterosexual contact | 34 | F |
| HIV prevalence | 2010 | Asian | 13-24 | Injection drug use | 4 | F |
| HIV prevalence | 2010 | Asian | 13-24 | Other | 18 | F |
| HIV prevalence | 2010 | Asian | 25-34 | Heterosexual contact | 320 | F |
| HIV prevalence | 2010 | Asian | 25-34 | Injection drug use | 23 | F |
| HIV prevalence | 2010 | Asian | 25-34 | Other | 6 | F |
| HIV prevalence | 2010 | Asian | 35-44 | Heterosexual contact | 493 | F |
| HIV prevalence | 2010 | Asian | 35-44 | Injection drug use | 42 | F |
| HIV prevalence | 2010 | Asian | 35-44 | Other | 6 | F |
| HIV prevalence | 2010 | Asian | 45-54 | Heterosexual contact | 305 | F |
| HIV prevalence | 2010 | Asian | 45-54 | Injection drug use | 39 | F |
| HIV prevalence | 2010 | Asian | 45-54 | Other | 20 | F |
| HIV prevalence | 2010 | Asian | 55 | Heterosexual contact | 199 | F |
| HIV prevalence | 2010 | Asian | 55 | Injection drug use | 28 | F |
| HIV prevalence | 2010 | Asian | 55 | Other | 18 | F |
| HIV prevalence | 2010 | Black/African American | 13-24 | Heterosexual contact | 3815 | F |
| HIV prevalence | 2010 | Black/African American | 13-24 | Injection drug use | 313 | F |
| HIV prevalence | 2010 | Black/African American | 13-24 | Other | 2485 | F |
| HIV prevalence | 2010 | Black/African American | 25-34 | Heterosexual contact | 18091 | F |
| HIV prevalence | 2010 | Black/African American | 25-34 | Injection drug use | 2055 | F |
| HIV prevalence | 2010 | Black/African American | 25-34 | Other | 235 | F |
| HIV prevalence | 2010 | Black/African American | 35-44 | Heterosexual contact | 29669 | F |
| HIV prevalence | 2010 | Black/African American | 35-44 | Injection drug use | 6491 | F |
| HIV prevalence | 2010 | Black/African American | 35-44 | Other | 93 | F |
| HIV prevalence | 2010 | Black/African American | 45-54 | Heterosexual contact | 26961 | F |
| HIV prevalence | 2010 | Black/African American | 45-54 | Injection drug use | 11232 | F |
| HIV prevalence | 2010 | Black/African American | 45-54 | Other | 194 | F |
| HIV prevalence | 2010 | Black/African American | 55 | Heterosexual contact | 14074 | F |
| HIV prevalence | 2010 | Black/African American | 55 | Injection drug use | 6057 | F |
| HIV prevalence | 2010 | Black/African American | 55 | Other | 205 | F |
| HIV prevalence | 2010 | Hispanic/Latino | 13-24 | Heterosexual contact | 883 | F |
| HIV prevalence | 2010 | Hispanic/Latino | 13-24 | Injection drug use | 134 | F |
| HIV prevalence | 2010 | Hispanic/Latino | 13-24 | Other | 970 | F |
| HIV prevalence | 2010 | Hispanic/Latino | 25-34 | Heterosexual contact | 4725 | F |
| HIV prevalence | 2010 | Hispanic/Latino | 25-34 | Injection drug use | 961 | F |
| HIV prevalence | 2010 | Hispanic/Latino | 25-34 | Other | 152 | F |
| HIV prevalence | 2010 | Hispanic/Latino | 35-44 | Heterosexual contact | 7941 | F |
| HIV prevalence | 2010 | Hispanic/Latino | 35-44 | Injection drug use | 2726 | F |
| HIV prevalence | 2010 | Hispanic/Latino | 35-44 | Other | 26 | F |
| HIV prevalence | 2010 | Hispanic/Latino | 45-54 | Heterosexual contact | 7914 | F |
| HIV prevalence | 2010 | Hispanic/Latino | 45-54 | Injection drug use | 4043 | F |
| HIV prevalence | 2010 | Hispanic/Latino | 45-54 | Other | 68 | F |
| HIV prevalence | 2010 | Hispanic/Latino | 55 | Heterosexual contact | 4724 | F |
| HIV prevalence | 2010 | Hispanic/Latino | 55 | Injection drug use | 1951 | F |
| HIV prevalence | 2010 | Hispanic/Latino | 55 | Other | 81 | F |
| HIV prevalence | 2010 | Multiple races | 13-24 | Heterosexual contact | 346 | F |
| HIV prevalence | 2010 | Multiple races | 13-24 | Injection drug use | 50 | F |
| HIV prevalence | 2010 | Multiple races | 13-24 | Other | 256 | F |
| HIV prevalence | 2010 | Multiple races | 25-34 | Heterosexual contact | 1369 | F |
| HIV prevalence | 2010 | Multiple races | 25-34 | Injection drug use | 318 | F |
| HIV prevalence | 2010 | Multiple races | 25-34 | Other | 36 | F |
| HIV prevalence | 2010 | Multiple races | 35-44 | Heterosexual contact | 2214 | F |
| HIV prevalence | 2010 | Multiple races | 35-44 | Injection drug use | 867 | F |
| HIV prevalence | 2010 | Multiple races | 35-44 | Other | 6 | F |
| HIV prevalence | 2010 | Multiple races | 45-54 | Heterosexual contact | 2021 | F |
| HIV prevalence | 2010 | Multiple races | 45-54 | Injection drug use | 1384 | F |
| HIV prevalence | 2010 | Multiple races | 45-54 | Other | 22 | F |
| HIV prevalence | 2010 | Multiple races | 55 | Heterosexual contact | 1056 | F |
| HIV prevalence | 2010 | Multiple races | 55 | Injection drug use | 685 | F |
| HIV prevalence | 2010 | Multiple races | 55 | Other | 23 | F |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 3 | F |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 1 | F |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 1 | F |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 19 | F |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 2 | F |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 27 | F |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 5 | F |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 17 | F |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 10 | F |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 1 | F |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 15 | F |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 3 | F |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Other | 1 | F |
| HIV prevalence | 2010 | White | 13-24 | Heterosexual contact | 709 | F |
| HIV prevalence | 2010 | White | 13-24 | Injection drug use | 218 | F |
| HIV prevalence | 2010 | White | 13-24 | Other | 467 | F |
| HIV prevalence | 2010 | White | 25-34 | Heterosexual contact | 3472 | F |
| HIV prevalence | 2010 | White | 25-34 | Injection drug use | 1375 | F |
| HIV prevalence | 2010 | White | 25-34 | Other | 101 | F |
| HIV prevalence | 2010 | White | 35-44 | Heterosexual contact | 6610 | F |
| HIV prevalence | 2010 | White | 35-44 | Injection drug use | 3302 | F |
| HIV prevalence | 2010 | White | 35-44 | Other | 55 | F |
| HIV prevalence | 2010 | White | 45-54 | Heterosexual contact | 7150 | F |
| HIV prevalence | 2010 | White | 45-54 | Injection drug use | 5028 | F |
| HIV prevalence | 2010 | White | 45-54 | Other | 148 | F |
| HIV prevalence | 2010 | White | 55 | Heterosexual contact | 4025 | F |
| HIV prevalence | 2010 | White | 55 | Injection drug use | 2007 | F |
| HIV prevalence | 2010 | White | 55 | Other | 221 | F |
| HIV prevalence | 2011 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 14 | F |
| HIV prevalence | 2011 | American Indian/Alaska Native | 13-24 | Injection drug use | 5 | F |
| HIV prevalence | 2011 | American Indian/Alaska Native | 13-24 | Other | 9 | F |
| HIV prevalence | 2011 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 77 | F |
| HIV prevalence | 2011 | American Indian/Alaska Native | 25-34 | Injection drug use | 39 | F |
| HIV prevalence | 2011 | American Indian/Alaska Native | 25-34 | Other | 2 | F |
| HIV prevalence | 2011 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 129 | F |
| HIV prevalence | 2011 | American Indian/Alaska Native | 35-44 | Injection drug use | 61 | F |
| HIV prevalence | 2011 | American Indian/Alaska Native | 35-44 | Other | 2 | F |
| HIV prevalence | 2011 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 114 | F |
| HIV prevalence | 2011 | American Indian/Alaska Native | 45-54 | Injection drug use | 74 | F |
| HIV prevalence | 2011 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV prevalence | 2011 | American Indian/Alaska Native | 55 | Heterosexual contact | 77 | F |
| HIV prevalence | 2011 | American Indian/Alaska Native | 55 | Injection drug use | 37 | F |
| HIV prevalence | 2011 | American Indian/Alaska Native | 55 | Other | 5 | F |
| HIV prevalence | 2011 | Asian | 13-24 | Heterosexual contact | 34 | F |
| HIV prevalence | 2011 | Asian | 13-24 | Injection drug use | 3 | F |
| HIV prevalence | 2011 | Asian | 13-24 | Other | 20 | F |
| HIV prevalence | 2011 | Asian | 25-34 | Heterosexual contact | 322 | F |
| HIV prevalence | 2011 | Asian | 25-34 | Injection drug use | 22 | F |
| HIV prevalence | 2011 | Asian | 25-34 | Other | 6 | F |
| HIV prevalence | 2011 | Asian | 35-44 | Heterosexual contact | 526 | F |
| HIV prevalence | 2011 | Asian | 35-44 | Injection drug use | 44 | F |
| HIV prevalence | 2011 | Asian | 35-44 | Other | 6 | F |
| HIV prevalence | 2011 | Asian | 45-54 | Heterosexual contact | 337 | F |
| HIV prevalence | 2011 | Asian | 45-54 | Injection drug use | 40 | F |
| HIV prevalence | 2011 | Asian | 45-54 | Other | 18 | F |
| HIV prevalence | 2011 | Asian | 55 | Heterosexual contact | 235 | F |
| HIV prevalence | 2011 | Asian | 55 | Injection drug use | 31 | F |
| HIV prevalence | 2011 | Asian | 55 | Other | 21 | F |
| HIV prevalence | 2011 | Black/African American | 13-24 | Heterosexual contact | 3710 | F |
| HIV prevalence | 2011 | Black/African American | 13-24 | Injection drug use | 282 | F |
| HIV prevalence | 2011 | Black/African American | 13-24 | Other | 2567 | F |
| HIV prevalence | 2011 | Black/African American | 25-34 | Heterosexual contact | 17633 | F |
| HIV prevalence | 2011 | Black/African American | 25-34 | Injection drug use | 1890 | F |
| HIV prevalence | 2011 | Black/African American | 25-34 | Other | 317 | F |
| HIV prevalence | 2011 | Black/African American | 35-44 | Heterosexual contact | 29645 | F |
| HIV prevalence | 2011 | Black/African American | 35-44 | Injection drug use | 5823 | F |
| HIV prevalence | 2011 | Black/African American | 35-44 | Other | 79 | F |
| HIV prevalence | 2011 | Black/African American | 45-54 | Heterosexual contact | 28661 | F |
| HIV prevalence | 2011 | Black/African American | 45-54 | Injection drug use | 11088 | F |
| HIV prevalence | 2011 | Black/African American | 45-54 | Other | 187 | F |
| HIV prevalence | 2011 | Black/African American | 55 | Heterosexual contact | 16131 | F |
| HIV prevalence | 2011 | Black/African American | 55 | Injection drug use | 6825 | F |
| HIV prevalence | 2011 | Black/African American | 55 | Other | 217 | F |
| HIV prevalence | 2011 | Hispanic/Latino | 13-24 | Heterosexual contact | 837 | F |
| HIV prevalence | 2011 | Hispanic/Latino | 13-24 | Injection drug use | 117 | F |
| HIV prevalence | 2011 | Hispanic/Latino | 13-24 | Other | 967 | F |
| HIV prevalence | 2011 | Hispanic/Latino | 25-34 | Heterosexual contact | 4562 | F |
| HIV prevalence | 2011 | Hispanic/Latino | 25-34 | Injection drug use | 904 | F |
| HIV prevalence | 2011 | Hispanic/Latino | 25-34 | Other | 190 | F |
| HIV prevalence | 2011 | Hispanic/Latino | 35-44 | Heterosexual contact | 7974 | F |
| HIV prevalence | 2011 | Hispanic/Latino | 35-44 | Injection drug use | 2442 | F |
| HIV prevalence | 2011 | Hispanic/Latino | 35-44 | Other | 23 | F |
| HIV prevalence | 2011 | Hispanic/Latino | 45-54 | Heterosexual contact | 8371 | F |
| HIV prevalence | 2011 | Hispanic/Latino | 45-54 | Injection drug use | 4073 | F |
| HIV prevalence | 2011 | Hispanic/Latino | 45-54 | Other | 63 | F |
| HIV prevalence | 2011 | Hispanic/Latino | 55 | Heterosexual contact | 5302 | F |
| HIV prevalence | 2011 | Hispanic/Latino | 55 | Injection drug use | 2232 | F |
| HIV prevalence | 2011 | Hispanic/Latino | 55 | Other | 88 | F |
| HIV prevalence | 2011 | Multiple races | 13-24 | Heterosexual contact | 319 | F |
| HIV prevalence | 2011 | Multiple races | 13-24 | Injection drug use | 47 | F |
| HIV prevalence | 2011 | Multiple races | 13-24 | Other | 259 | F |
| HIV prevalence | 2011 | Multiple races | 25-34 | Heterosexual contact | 1336 | F |
| HIV prevalence | 2011 | Multiple races | 25-34 | Injection drug use | 300 | F |
| HIV prevalence | 2011 | Multiple races | 25-34 | Other | 40 | F |
| HIV prevalence | 2011 | Multiple races | 35-44 | Heterosexual contact | 2212 | F |
| HIV prevalence | 2011 | Multiple races | 35-44 | Injection drug use | 775 | F |
| HIV prevalence | 2011 | Multiple races | 35-44 | Other | 6 | F |
| HIV prevalence | 2011 | Multiple races | 45-54 | Heterosexual contact | 2145 | F |
| HIV prevalence | 2011 | Multiple races | 45-54 | Injection drug use | 1375 | F |
| HIV prevalence | 2011 | Multiple races | 45-54 | Other | 21 | F |
| HIV prevalence | 2011 | Multiple races | 55 | Heterosexual contact | 1198 | F |
| HIV prevalence | 2011 | Multiple races | 55 | Injection drug use | 772 | F |
| HIV prevalence | 2011 | Multiple races | 55 | Other | 25 | F |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 3 | F |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 1 | F |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 17 | F |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 2 | F |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 27 | F |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 5 | F |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 23 | F |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 7 | F |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 1 | F |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 17 | F |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 5 | F |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Other | 1 | F |
| HIV prevalence | 2011 | White | 13-24 | Heterosexual contact | 629 | F |
| HIV prevalence | 2011 | White | 13-24 | Injection drug use | 189 | F |
| HIV prevalence | 2011 | White | 13-24 | Other | 460 | F |
| HIV prevalence | 2011 | White | 25-34 | Heterosexual contact | 3399 | F |
| HIV prevalence | 2011 | White | 25-34 | Injection drug use | 1342 | F |
| HIV prevalence | 2011 | White | 25-34 | Other | 124 | F |
| HIV prevalence | 2011 | White | 35-44 | Heterosexual contact | 6477 | F |
| HIV prevalence | 2011 | White | 35-44 | Injection drug use | 3058 | F |
| HIV prevalence | 2011 | White | 35-44 | Other | 45 | F |
| HIV prevalence | 2011 | White | 45-54 | Heterosexual contact | 7487 | F |
| HIV prevalence | 2011 | White | 45-54 | Injection drug use | 5072 | F |
| HIV prevalence | 2011 | White | 45-54 | Other | 147 | F |
| HIV prevalence | 2011 | White | 55 | Heterosexual contact | 4580 | F |
| HIV prevalence | 2011 | White | 55 | Injection drug use | 2309 | F |
| HIV prevalence | 2011 | White | 55 | Other | 225 | F |
| HIV prevalence | 2012 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 13 | F |
| HIV prevalence | 2012 | American Indian/Alaska Native | 13-24 | Injection drug use | 6 | F |
| HIV prevalence | 2012 | American Indian/Alaska Native | 13-24 | Other | 9 | F |
| HIV prevalence | 2012 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 74 | F |
| HIV prevalence | 2012 | American Indian/Alaska Native | 25-34 | Injection drug use | 38 | F |
| HIV prevalence | 2012 | American Indian/Alaska Native | 25-34 | Other | 2 | F |
| HIV prevalence | 2012 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 134 | F |
| HIV prevalence | 2012 | American Indian/Alaska Native | 35-44 | Injection drug use | 59 | F |
| HIV prevalence | 2012 | American Indian/Alaska Native | 35-44 | Other | 2 | F |
| HIV prevalence | 2012 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 126 | F |
| HIV prevalence | 2012 | American Indian/Alaska Native | 45-54 | Injection drug use | 76 | F |
| HIV prevalence | 2012 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV prevalence | 2012 | American Indian/Alaska Native | 55 | Heterosexual contact | 82 | F |
| HIV prevalence | 2012 | American Indian/Alaska Native | 55 | Injection drug use | 41 | F |
| HIV prevalence | 2012 | American Indian/Alaska Native | 55 | Other | 5 | F |
| HIV prevalence | 2012 | Asian | 13-24 | Heterosexual contact | 34 | F |
| HIV prevalence | 2012 | Asian | 13-24 | Injection drug use | 3 | F |
| HIV prevalence | 2012 | Asian | 13-24 | Other | 19 | F |
| HIV prevalence | 2012 | Asian | 25-34 | Heterosexual contact | 332 | F |
| HIV prevalence | 2012 | Asian | 25-34 | Injection drug use | 22 | F |
| HIV prevalence | 2012 | Asian | 25-34 | Other | 5 | F |
| HIV prevalence | 2012 | Asian | 35-44 | Heterosexual contact | 571 | F |
| HIV prevalence | 2012 | Asian | 35-44 | Injection drug use | 46 | F |
| HIV prevalence | 2012 | Asian | 35-44 | Other | 7 | F |
| HIV prevalence | 2012 | Asian | 45-54 | Heterosexual contact | 363 | F |
| HIV prevalence | 2012 | Asian | 45-54 | Injection drug use | 41 | F |
| HIV prevalence | 2012 | Asian | 45-54 | Other | 19 | F |
| HIV prevalence | 2012 | Asian | 55 | Heterosexual contact | 268 | F |
| HIV prevalence | 2012 | Asian | 55 | Injection drug use | 35 | F |
| HIV prevalence | 2012 | Asian | 55 | Other | 22 | F |
| HIV prevalence | 2012 | Black/African American | 13-24 | Heterosexual contact | 3426 | F |
| HIV prevalence | 2012 | Black/African American | 13-24 | Injection drug use | 261 | F |
| HIV prevalence | 2012 | Black/African American | 13-24 | Other | 2566 | F |
| HIV prevalence | 2012 | Black/African American | 25-34 | Heterosexual contact | 17169 | F |
| HIV prevalence | 2012 | Black/African American | 25-34 | Injection drug use | 1719 | F |
| HIV prevalence | 2012 | Black/African American | 25-34 | Other | 425 | F |
| HIV prevalence | 2012 | Black/African American | 35-44 | Heterosexual contact | 29650 | F |
| HIV prevalence | 2012 | Black/African American | 35-44 | Injection drug use | 5251 | F |
| HIV prevalence | 2012 | Black/African American | 35-44 | Other | 76 | F |
| HIV prevalence | 2012 | Black/African American | 45-54 | Heterosexual contact | 30003 | F |
| HIV prevalence | 2012 | Black/African American | 45-54 | Injection drug use | 10788 | F |
| HIV prevalence | 2012 | Black/African American | 45-54 | Other | 182 | F |
| HIV prevalence | 2012 | Black/African American | 55 | Heterosexual contact | 18393 | F |
| HIV prevalence | 2012 | Black/African American | 55 | Injection drug use | 7669 | F |
| HIV prevalence | 2012 | Black/African American | 55 | Other | 226 | F |
| HIV prevalence | 2012 | Hispanic/Latino | 13-24 | Heterosexual contact | 755 | F |
| HIV prevalence | 2012 | Hispanic/Latino | 13-24 | Injection drug use | 101 | F |
| HIV prevalence | 2012 | Hispanic/Latino | 13-24 | Other | 952 | F |
| HIV prevalence | 2012 | Hispanic/Latino | 25-34 | Heterosexual contact | 4385 | F |
| HIV prevalence | 2012 | Hispanic/Latino | 25-34 | Injection drug use | 834 | F |
| HIV prevalence | 2012 | Hispanic/Latino | 25-34 | Other | 241 | F |
| HIV prevalence | 2012 | Hispanic/Latino | 35-44 | Heterosexual contact | 7996 | F |
| HIV prevalence | 2012 | Hispanic/Latino | 35-44 | Injection drug use | 2249 | F |
| HIV prevalence | 2012 | Hispanic/Latino | 35-44 | Other | 24 | F |
| HIV prevalence | 2012 | Hispanic/Latino | 45-54 | Heterosexual contact | 8682 | F |
| HIV prevalence | 2012 | Hispanic/Latino | 45-54 | Injection drug use | 4051 | F |
| HIV prevalence | 2012 | Hispanic/Latino | 45-54 | Other | 57 | F |
| HIV prevalence | 2012 | Hispanic/Latino | 55 | Heterosexual contact | 5990 | F |
| HIV prevalence | 2012 | Hispanic/Latino | 55 | Injection drug use | 2492 | F |
| HIV prevalence | 2012 | Hispanic/Latino | 55 | Other | 94 | F |
| HIV prevalence | 2012 | Multiple races | 13-24 | Heterosexual contact | 295 | F |
| HIV prevalence | 2012 | Multiple races | 13-24 | Injection drug use | 44 | F |
| HIV prevalence | 2012 | Multiple races | 13-24 | Other | 255 | F |
| HIV prevalence | 2012 | Multiple races | 25-34 | Heterosexual contact | 1284 | F |
| HIV prevalence | 2012 | Multiple races | 25-34 | Injection drug use | 274 | F |
| HIV prevalence | 2012 | Multiple races | 25-34 | Other | 55 | F |
| HIV prevalence | 2012 | Multiple races | 35-44 | Heterosexual contact | 2174 | F |
| HIV prevalence | 2012 | Multiple races | 35-44 | Injection drug use | 713 | F |
| HIV prevalence | 2012 | Multiple races | 35-44 | Other | 5 | F |
| HIV prevalence | 2012 | Multiple races | 45-54 | Heterosexual contact | 2252 | F |
| HIV prevalence | 2012 | Multiple races | 45-54 | Injection drug use | 1354 | F |
| HIV prevalence | 2012 | Multiple races | 45-54 | Other | 19 | F |
| HIV prevalence | 2012 | Multiple races | 55 | Heterosexual contact | 1352 | F |
| HIV prevalence | 2012 | Multiple races | 55 | Injection drug use | 848 | F |
| HIV prevalence | 2012 | Multiple races | 55 | Other | 24 | F |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 3 | F |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 1 | F |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 16 | F |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 2 | F |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 29 | F |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 5 | F |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 23 | F |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 6 | F |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 1 | F |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 19 | F |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 6 | F |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Other | 1 | F |
| HIV prevalence | 2012 | White | 13-24 | Heterosexual contact | 608 | F |
| HIV prevalence | 2012 | White | 13-24 | Injection drug use | 166 | F |
| HIV prevalence | 2012 | White | 13-24 | Other | 451 | F |
| HIV prevalence | 2012 | White | 25-34 | Heterosexual contact | 3297 | F |
| HIV prevalence | 2012 | White | 25-34 | Injection drug use | 1294 | F |
| HIV prevalence | 2012 | White | 25-34 | Other | 142 | F |
| HIV prevalence | 2012 | White | 35-44 | Heterosexual contact | 6365 | F |
| HIV prevalence | 2012 | White | 35-44 | Injection drug use | 2850 | F |
| HIV prevalence | 2012 | White | 35-44 | Other | 41 | F |
| HIV prevalence | 2012 | White | 45-54 | Heterosexual contact | 7712 | F |
| HIV prevalence | 2012 | White | 45-54 | Injection drug use | 4997 | F |
| HIV prevalence | 2012 | White | 45-54 | Other | 134 | F |
| HIV prevalence | 2012 | White | 55 | Heterosexual contact | 5115 | F |
| HIV prevalence | 2012 | White | 55 | Injection drug use | 2648 | F |
| HIV prevalence | 2012 | White | 55 | Other | 241 | F |
| HIV prevalence | 2013 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 11 | F |
| HIV prevalence | 2013 | American Indian/Alaska Native | 13-24 | Injection drug use | 4 | F |
| HIV prevalence | 2013 | American Indian/Alaska Native | 13-24 | Other | 9 | F |
| HIV prevalence | 2013 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 71 | F |
| HIV prevalence | 2013 | American Indian/Alaska Native | 25-34 | Injection drug use | 36 | F |
| HIV prevalence | 2013 | American Indian/Alaska Native | 25-34 | Other | 2 | F |
| HIV prevalence | 2013 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 129 | F |
| HIV prevalence | 2013 | American Indian/Alaska Native | 35-44 | Injection drug use | 62 | F |
| HIV prevalence | 2013 | American Indian/Alaska Native | 35-44 | Other | 2 | F |
| HIV prevalence | 2013 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 133 | F |
| HIV prevalence | 2013 | American Indian/Alaska Native | 45-54 | Injection drug use | 77 | F |
| HIV prevalence | 2013 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV prevalence | 2013 | American Indian/Alaska Native | 55 | Heterosexual contact | 93 | F |
| HIV prevalence | 2013 | American Indian/Alaska Native | 55 | Injection drug use | 46 | F |
| HIV prevalence | 2013 | American Indian/Alaska Native | 55 | Other | 5 | F |
| HIV prevalence | 2013 | Asian | 13-24 | Heterosexual contact | 39 | F |
| HIV prevalence | 2013 | Asian | 13-24 | Injection drug use | 2 | F |
| HIV prevalence | 2013 | Asian | 13-24 | Other | 21 | F |
| HIV prevalence | 2013 | Asian | 25-34 | Heterosexual contact | 335 | F |
| HIV prevalence | 2013 | Asian | 25-34 | Injection drug use | 23 | F |
| HIV prevalence | 2013 | Asian | 25-34 | Other | 6 | F |
| HIV prevalence | 2013 | Asian | 35-44 | Heterosexual contact | 617 | F |
| HIV prevalence | 2013 | Asian | 35-44 | Injection drug use | 46 | F |
| HIV prevalence | 2013 | Asian | 35-44 | Other | 7 | F |
| HIV prevalence | 2013 | Asian | 45-54 | Heterosexual contact | 389 | F |
| HIV prevalence | 2013 | Asian | 45-54 | Injection drug use | 40 | F |
| HIV prevalence | 2013 | Asian | 45-54 | Other | 16 | F |
| HIV prevalence | 2013 | Asian | 55 | Heterosexual contact | 310 | F |
| HIV prevalence | 2013 | Asian | 55 | Injection drug use | 44 | F |
| HIV prevalence | 2013 | Asian | 55 | Other | 26 | F |
| HIV prevalence | 2013 | Black/African American | 13-24 | Heterosexual contact | 3149 | F |
| HIV prevalence | 2013 | Black/African American | 13-24 | Injection drug use | 226 | F |
| HIV prevalence | 2013 | Black/African American | 13-24 | Other | 2537 | F |
| HIV prevalence | 2013 | Black/African American | 25-34 | Heterosexual contact | 16543 | F |
| HIV prevalence | 2013 | Black/African American | 25-34 | Injection drug use | 1570 | F |
| HIV prevalence | 2013 | Black/African American | 25-34 | Other | 559 | F |
| HIV prevalence | 2013 | Black/African American | 35-44 | Heterosexual contact | 29595 | F |
| HIV prevalence | 2013 | Black/African American | 35-44 | Injection drug use | 4684 | F |
| HIV prevalence | 2013 | Black/African American | 35-44 | Other | 74 | F |
| HIV prevalence | 2013 | Black/African American | 45-54 | Heterosexual contact | 31188 | F |
| HIV prevalence | 2013 | Black/African American | 45-54 | Injection drug use | 10378 | F |
| HIV prevalence | 2013 | Black/African American | 45-54 | Other | 171 | F |
| HIV prevalence | 2013 | Black/African American | 55 | Heterosexual contact | 20831 | F |
| HIV prevalence | 2013 | Black/African American | 55 | Injection drug use | 8437 | F |
| HIV prevalence | 2013 | Black/African American | 55 | Other | 246 | F |
| HIV prevalence | 2013 | Hispanic/Latino | 13-24 | Heterosexual contact | 681 | F |
| HIV prevalence | 2013 | Hispanic/Latino | 13-24 | Injection drug use | 94 | F |
| HIV prevalence | 2013 | Hispanic/Latino | 13-24 | Other | 924 | F |
| HIV prevalence | 2013 | Hispanic/Latino | 25-34 | Heterosexual contact | 4228 | F |
| HIV prevalence | 2013 | Hispanic/Latino | 25-34 | Injection drug use | 762 | F |
| HIV prevalence | 2013 | Hispanic/Latino | 25-34 | Other | 316 | F |
| HIV prevalence | 2013 | Hispanic/Latino | 35-44 | Heterosexual contact | 7911 | F |
| HIV prevalence | 2013 | Hispanic/Latino | 35-44 | Injection drug use | 2063 | F |
| HIV prevalence | 2013 | Hispanic/Latino | 35-44 | Other | 23 | F |
| HIV prevalence | 2013 | Hispanic/Latino | 45-54 | Heterosexual contact | 9101 | F |
| HIV prevalence | 2013 | Hispanic/Latino | 45-54 | Injection drug use | 3992 | F |
| HIV prevalence | 2013 | Hispanic/Latino | 45-54 | Other | 53 | F |
| HIV prevalence | 2013 | Hispanic/Latino | 55 | Heterosexual contact | 6659 | F |
| HIV prevalence | 2013 | Hispanic/Latino | 55 | Injection drug use | 2736 | F |
| HIV prevalence | 2013 | Hispanic/Latino | 55 | Other | 96 | F |
| HIV prevalence | 2013 | Multiple races | 13-24 | Heterosexual contact | 282 | F |
| HIV prevalence | 2013 | Multiple races | 13-24 | Injection drug use | 37 | F |
| HIV prevalence | 2013 | Multiple races | 13-24 | Other | 249 | F |
| HIV prevalence | 2013 | Multiple races | 25-34 | Heterosexual contact | 1214 | F |
| HIV prevalence | 2013 | Multiple races | 25-34 | Injection drug use | 248 | F |
| HIV prevalence | 2013 | Multiple races | 25-34 | Other | 66 | F |
| HIV prevalence | 2013 | Multiple races | 35-44 | Heterosexual contact | 2142 | F |
| HIV prevalence | 2013 | Multiple races | 35-44 | Injection drug use | 656 | F |
| HIV prevalence | 2013 | Multiple races | 35-44 | Other | 7 | F |
| HIV prevalence | 2013 | Multiple races | 45-54 | Heterosexual contact | 2347 | F |
| HIV prevalence | 2013 | Multiple races | 45-54 | Injection drug use | 1292 | F |
| HIV prevalence | 2013 | Multiple races | 45-54 | Other | 14 | F |
| HIV prevalence | 2013 | Multiple races | 55 | Heterosexual contact | 1490 | F |
| HIV prevalence | 2013 | Multiple races | 55 | Injection drug use | 940 | F |
| HIV prevalence | 2013 | Multiple races | 55 | Other | 27 | F |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 5 | F |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 1 | F |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 17 | F |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 2 | F |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 28 | F |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 5 | F |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 25 | F |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 5 | F |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 1 | F |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 21 | F |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 6 | F |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Other | 1 | F |
| HIV prevalence | 2013 | White | 13-24 | Heterosexual contact | 547 | F |
| HIV prevalence | 2013 | White | 13-24 | Injection drug use | 158 | F |
| HIV prevalence | 2013 | White | 13-24 | Other | 444 | F |
| HIV prevalence | 2013 | White | 25-34 | Heterosexual contact | 3165 | F |
| HIV prevalence | 2013 | White | 25-34 | Injection drug use | 1241 | F |
| HIV prevalence | 2013 | White | 25-34 | Other | 174 | F |
| HIV prevalence | 2013 | White | 35-44 | Heterosexual contact | 6182 | F |
| HIV prevalence | 2013 | White | 35-44 | Injection drug use | 2677 | F |
| HIV prevalence | 2013 | White | 35-44 | Other | 37 | F |
| HIV prevalence | 2013 | White | 45-54 | Heterosexual contact | 7958 | F |
| HIV prevalence | 2013 | White | 45-54 | Injection drug use | 4955 | F |
| HIV prevalence | 2013 | White | 45-54 | Other | 121 | F |
| HIV prevalence | 2013 | White | 55 | Heterosexual contact | 5779 | F |
| HIV prevalence | 2013 | White | 55 | Injection drug use | 2959 | F |
| HIV prevalence | 2013 | White | 55 | Other | 252 | F |
| HIV prevalence | 2014 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 11 | F |
| HIV prevalence | 2014 | American Indian/Alaska Native | 13-24 | Injection drug use | 3 | F |
| HIV prevalence | 2014 | American Indian/Alaska Native | 13-24 | Other | 9 | F |
| HIV prevalence | 2014 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 72 | F |
| HIV prevalence | 2014 | American Indian/Alaska Native | 25-34 | Injection drug use | 35 | F |
| HIV prevalence | 2014 | American Indian/Alaska Native | 25-34 | Other | 2 | F |
| HIV prevalence | 2014 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 123 | F |
| HIV prevalence | 2014 | American Indian/Alaska Native | 35-44 | Injection drug use | 64 | F |
| HIV prevalence | 2014 | American Indian/Alaska Native | 35-44 | Other | 2 | F |
| HIV prevalence | 2014 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 137 | F |
| HIV prevalence | 2014 | American Indian/Alaska Native | 45-54 | Injection drug use | 74 | F |
| HIV prevalence | 2014 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV prevalence | 2014 | American Indian/Alaska Native | 55 | Heterosexual contact | 101 | F |
| HIV prevalence | 2014 | American Indian/Alaska Native | 55 | Injection drug use | 51 | F |
| HIV prevalence | 2014 | American Indian/Alaska Native | 55 | Other | 5 | F |
| HIV prevalence | 2014 | Asian | 13-24 | Heterosexual contact | 37 | F |
| HIV prevalence | 2014 | Asian | 13-24 | Injection drug use | 2 | F |
| HIV prevalence | 2014 | Asian | 13-24 | Other | 28 | F |
| HIV prevalence | 2014 | Asian | 25-34 | Heterosexual contact | 329 | F |
| HIV prevalence | 2014 | Asian | 25-34 | Injection drug use | 20 | F |
| HIV prevalence | 2014 | Asian | 25-34 | Other | 6 | F |
| HIV prevalence | 2014 | Asian | 35-44 | Heterosexual contact | 667 | F |
| HIV prevalence | 2014 | Asian | 35-44 | Injection drug use | 47 | F |
| HIV prevalence | 2014 | Asian | 35-44 | Other | 7 | F |
| HIV prevalence | 2014 | Asian | 45-54 | Heterosexual contact | 432 | F |
| HIV prevalence | 2014 | Asian | 45-54 | Injection drug use | 39 | F |
| HIV prevalence | 2014 | Asian | 45-54 | Other | 14 | F |
| HIV prevalence | 2014 | Asian | 55 | Heterosexual contact | 350 | F |
| HIV prevalence | 2014 | Asian | 55 | Injection drug use | 51 | F |
| HIV prevalence | 2014 | Asian | 55 | Other | 29 | F |
| HIV prevalence | 2014 | Black/African American | 13-24 | Heterosexual contact | 2893 | F |
| HIV prevalence | 2014 | Black/African American | 13-24 | Injection drug use | 193 | F |
| HIV prevalence | 2014 | Black/African American | 13-24 | Other | 2460 | F |
| HIV prevalence | 2014 | Black/African American | 25-34 | Heterosexual contact | 16011 | F |
| HIV prevalence | 2014 | Black/African American | 25-34 | Injection drug use | 1442 | F |
| HIV prevalence | 2014 | Black/African American | 25-34 | Other | 746 | F |
| HIV prevalence | 2014 | Black/African American | 35-44 | Heterosexual contact | 29413 | F |
| HIV prevalence | 2014 | Black/African American | 35-44 | Injection drug use | 4204 | F |
| HIV prevalence | 2014 | Black/African American | 35-44 | Other | 75 | F |
| HIV prevalence | 2014 | Black/African American | 45-54 | Heterosexual contact | 32172 | F |
| HIV prevalence | 2014 | Black/African American | 45-54 | Injection drug use | 9914 | F |
| HIV prevalence | 2014 | Black/African American | 45-54 | Other | 155 | F |
| HIV prevalence | 2014 | Black/African American | 55 | Heterosexual contact | 23369 | F |
| HIV prevalence | 2014 | Black/African American | 55 | Injection drug use | 9194 | F |
| HIV prevalence | 2014 | Black/African American | 55 | Other | 262 | F |
| HIV prevalence | 2014 | Hispanic/Latino | 13-24 | Heterosexual contact | 643 | F |
| HIV prevalence | 2014 | Hispanic/Latino | 13-24 | Injection drug use | 89 | F |
| HIV prevalence | 2014 | Hispanic/Latino | 13-24 | Other | 880 | F |
| HIV prevalence | 2014 | Hispanic/Latino | 25-34 | Heterosexual contact | 4131 | F |
| HIV prevalence | 2014 | Hispanic/Latino | 25-34 | Injection drug use | 682 | F |
| HIV prevalence | 2014 | Hispanic/Latino | 25-34 | Other | 399 | F |
| HIV prevalence | 2014 | Hispanic/Latino | 35-44 | Heterosexual contact | 7835 | F |
| HIV prevalence | 2014 | Hispanic/Latino | 35-44 | Injection drug use | 1898 | F |
| HIV prevalence | 2014 | Hispanic/Latino | 35-44 | Other | 21 | F |
| HIV prevalence | 2014 | Hispanic/Latino | 45-54 | Heterosexual contact | 9343 | F |
| HIV prevalence | 2014 | Hispanic/Latino | 45-54 | Injection drug use | 3857 | F |
| HIV prevalence | 2014 | Hispanic/Latino | 45-54 | Other | 52 | F |
| HIV prevalence | 2014 | Hispanic/Latino | 55 | Heterosexual contact | 7472 | F |
| HIV prevalence | 2014 | Hispanic/Latino | 55 | Injection drug use | 3058 | F |
| HIV prevalence | 2014 | Hispanic/Latino | 55 | Other | 100 | F |
| HIV prevalence | 2014 | Multiple races | 13-24 | Heterosexual contact | 245 | F |
| HIV prevalence | 2014 | Multiple races | 13-24 | Injection drug use | 30 | F |
| HIV prevalence | 2014 | Multiple races | 13-24 | Other | 245 | F |
| HIV prevalence | 2014 | Multiple races | 25-34 | Heterosexual contact | 1199 | F |
| HIV prevalence | 2014 | Multiple races | 25-34 | Injection drug use | 226 | F |
| HIV prevalence | 2014 | Multiple races | 25-34 | Other | 84 | F |
| HIV prevalence | 2014 | Multiple races | 35-44 | Heterosexual contact | 2090 | F |
| HIV prevalence | 2014 | Multiple races | 35-44 | Injection drug use | 613 | F |
| HIV prevalence | 2014 | Multiple races | 35-44 | Other | 6 | F |
| HIV prevalence | 2014 | Multiple races | 45-54 | Heterosexual contact | 2393 | F |
| HIV prevalence | 2014 | Multiple races | 45-54 | Injection drug use | 1238 | F |
| HIV prevalence | 2014 | Multiple races | 45-54 | Other | 14 | F |
| HIV prevalence | 2014 | Multiple races | 55 | Heterosexual contact | 1623 | F |
| HIV prevalence | 2014 | Multiple races | 55 | Injection drug use | 1002 | F |
| HIV prevalence | 2014 | Multiple races | 55 | Other | 26 | F |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 6 | F |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 1 | F |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 17 | F |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 1 | F |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 29 | F |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 6 | F |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 24 | F |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 5 | F |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 1 | F |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 25 | F |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 8 | F |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Other | 1 | F |
| HIV prevalence | 2014 | White | 13-24 | Heterosexual contact | 510 | F |
| HIV prevalence | 2014 | White | 13-24 | Injection drug use | 151 | F |
| HIV prevalence | 2014 | White | 13-24 | Other | 424 | F |
| HIV prevalence | 2014 | White | 25-34 | Heterosexual contact | 3119 | F |
| HIV prevalence | 2014 | White | 25-34 | Injection drug use | 1208 | F |
| HIV prevalence | 2014 | White | 25-34 | Other | 212 | F |
| HIV prevalence | 2014 | White | 35-44 | Heterosexual contact | 5962 | F |
| HIV prevalence | 2014 | White | 35-44 | Injection drug use | 2518 | F |
| HIV prevalence | 2014 | White | 35-44 | Other | 30 | F |
| HIV prevalence | 2014 | White | 45-54 | Heterosexual contact | 8152 | F |
| HIV prevalence | 2014 | White | 45-54 | Injection drug use | 4780 | F |
| HIV prevalence | 2014 | White | 45-54 | Other | 111 | F |
| HIV prevalence | 2014 | White | 55 | Heterosexual contact | 6423 | F |
| HIV prevalence | 2014 | White | 55 | Injection drug use | 3329 | F |
| HIV prevalence | 2014 | White | 55 | Other | 265 | F |
| HIV prevalence | 2015 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 10 | F |
| HIV prevalence | 2015 | American Indian/Alaska Native | 13-24 | Injection drug use | 3 | F |
| HIV prevalence | 2015 | American Indian/Alaska Native | 13-24 | Other | 9 | F |
| HIV prevalence | 2015 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 74 | F |
| HIV prevalence | 2015 | American Indian/Alaska Native | 25-34 | Injection drug use | 32 | F |
| HIV prevalence | 2015 | American Indian/Alaska Native | 25-34 | Other | 2 | F |
| HIV prevalence | 2015 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 128 | F |
| HIV prevalence | 2015 | American Indian/Alaska Native | 35-44 | Injection drug use | 60 | F |
| HIV prevalence | 2015 | American Indian/Alaska Native | 35-44 | Other | 3 | F |
| HIV prevalence | 2015 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 142 | F |
| HIV prevalence | 2015 | American Indian/Alaska Native | 45-54 | Injection drug use | 75 | F |
| HIV prevalence | 2015 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV prevalence | 2015 | American Indian/Alaska Native | 55 | Heterosexual contact | 118 | F |
| HIV prevalence | 2015 | American Indian/Alaska Native | 55 | Injection drug use | 60 | F |
| HIV prevalence | 2015 | American Indian/Alaska Native | 55 | Other | 5 | F |
| HIV prevalence | 2015 | Asian | 13-24 | Heterosexual contact | 45 | F |
| HIV prevalence | 2015 | Asian | 13-24 | Injection drug use | 2 | F |
| HIV prevalence | 2015 | Asian | 13-24 | Other | 28 | F |
| HIV prevalence | 2015 | Asian | 25-34 | Heterosexual contact | 328 | F |
| HIV prevalence | 2015 | Asian | 25-34 | Injection drug use | 21 | F |
| HIV prevalence | 2015 | Asian | 25-34 | Other | 6 | F |
| HIV prevalence | 2015 | Asian | 35-44 | Heterosexual contact | 690 | F |
| HIV prevalence | 2015 | Asian | 35-44 | Injection drug use | 42 | F |
| HIV prevalence | 2015 | Asian | 35-44 | Other | 7 | F |
| HIV prevalence | 2015 | Asian | 45-54 | Heterosexual contact | 480 | F |
| HIV prevalence | 2015 | Asian | 45-54 | Injection drug use | 44 | F |
| HIV prevalence | 2015 | Asian | 45-54 | Other | 12 | F |
| HIV prevalence | 2015 | Asian | 55 | Heterosexual contact | 405 | F |
| HIV prevalence | 2015 | Asian | 55 | Injection drug use | 57 | F |
| HIV prevalence | 2015 | Asian | 55 | Other | 32 | F |
| HIV prevalence | 2015 | Black/African American | 13-24 | Heterosexual contact | 2657 | F |
| HIV prevalence | 2015 | Black/African American | 13-24 | Injection drug use | 168 | F |
| HIV prevalence | 2015 | Black/African American | 13-24 | Other | 2341 | F |
| HIV prevalence | 2015 | Black/African American | 25-34 | Heterosexual contact | 15348 | F |
| HIV prevalence | 2015 | Black/African American | 25-34 | Injection drug use | 1321 | F |
| HIV prevalence | 2015 | Black/African American | 25-34 | Other | 959 | F |
| HIV prevalence | 2015 | Black/African American | 35-44 | Heterosexual contact | 29014 | F |
| HIV prevalence | 2015 | Black/African American | 35-44 | Injection drug use | 3753 | F |
| HIV prevalence | 2015 | Black/African American | 35-44 | Other | 87 | F |
| HIV prevalence | 2015 | Black/African American | 45-54 | Heterosexual contact | 33242 | F |
| HIV prevalence | 2015 | Black/African American | 45-54 | Injection drug use | 9426 | F |
| HIV prevalence | 2015 | Black/African American | 45-54 | Other | 146 | F |
| HIV prevalence | 2015 | Black/African American | 55 | Heterosexual contact | 26129 | F |
| HIV prevalence | 2015 | Black/African American | 55 | Injection drug use | 9983 | F |
| HIV prevalence | 2015 | Black/African American | 55 | Other | 274 | F |
| HIV prevalence | 2015 | Hispanic/Latino | 13-24 | Heterosexual contact | 608 | F |
| HIV prevalence | 2015 | Hispanic/Latino | 13-24 | Injection drug use | 90 | F |
| HIV prevalence | 2015 | Hispanic/Latino | 13-24 | Other | 806 | F |
| HIV prevalence | 2015 | Hispanic/Latino | 25-34 | Heterosexual contact | 3948 | F |
| HIV prevalence | 2015 | Hispanic/Latino | 25-34 | Injection drug use | 609 | F |
| HIV prevalence | 2015 | Hispanic/Latino | 25-34 | Other | 481 | F |
| HIV prevalence | 2015 | Hispanic/Latino | 35-44 | Heterosexual contact | 7810 | F |
| HIV prevalence | 2015 | Hispanic/Latino | 35-44 | Injection drug use | 1741 | F |
| HIV prevalence | 2015 | Hispanic/Latino | 35-44 | Other | 27 | F |
| HIV prevalence | 2015 | Hispanic/Latino | 45-54 | Heterosexual contact | 9606 | F |
| HIV prevalence | 2015 | Hispanic/Latino | 45-54 | Injection drug use | 3697 | F |
| HIV prevalence | 2015 | Hispanic/Latino | 45-54 | Other | 49 | F |
| HIV prevalence | 2015 | Hispanic/Latino | 55 | Heterosexual contact | 8275 | F |
| HIV prevalence | 2015 | Hispanic/Latino | 55 | Injection drug use | 3394 | F |
| HIV prevalence | 2015 | Hispanic/Latino | 55 | Other | 104 | F |
| HIV prevalence | 2015 | Multiple races | 13-24 | Heterosexual contact | 208 | F |
| HIV prevalence | 2015 | Multiple races | 13-24 | Injection drug use | 26 | F |
| HIV prevalence | 2015 | Multiple races | 13-24 | Other | 233 | F |
| HIV prevalence | 2015 | Multiple races | 25-34 | Heterosexual contact | 1132 | F |
| HIV prevalence | 2015 | Multiple races | 25-34 | Injection drug use | 200 | F |
| HIV prevalence | 2015 | Multiple races | 25-34 | Other | 103 | F |
| HIV prevalence | 2015 | Multiple races | 35-44 | Heterosexual contact | 2051 | F |
| HIV prevalence | 2015 | Multiple races | 35-44 | Injection drug use | 544 | F |
| HIV prevalence | 2015 | Multiple races | 35-44 | Other | 6 | F |
| HIV prevalence | 2015 | Multiple races | 45-54 | Heterosexual contact | 2417 | F |
| HIV prevalence | 2015 | Multiple races | 45-54 | Injection drug use | 1190 | F |
| HIV prevalence | 2015 | Multiple races | 45-54 | Other | 13 | F |
| HIV prevalence | 2015 | Multiple races | 55 | Heterosexual contact | 1818 | F |
| HIV prevalence | 2015 | Multiple races | 55 | Injection drug use | 1072 | F |
| HIV prevalence | 2015 | Multiple races | 55 | Other | 27 | F |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 7 | F |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 1 | F |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 12 | F |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 2 | F |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 35 | F |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 5 | F |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 27 | F |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 5 | F |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 1 | F |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 26 | F |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 9 | F |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Other | 1 | F |
| HIV prevalence | 2015 | White | 13-24 | Heterosexual contact | 460 | F |
| HIV prevalence | 2015 | White | 13-24 | Injection drug use | 155 | F |
| HIV prevalence | 2015 | White | 13-24 | Other | 393 | F |
| HIV prevalence | 2015 | White | 25-34 | Heterosexual contact | 3017 | F |
| HIV prevalence | 2015 | White | 25-34 | Injection drug use | 1221 | F |
| HIV prevalence | 2015 | White | 25-34 | Other | 255 | F |
| HIV prevalence | 2015 | White | 35-44 | Heterosexual contact | 5739 | F |
| HIV prevalence | 2015 | White | 35-44 | Injection drug use | 2391 | F |
| HIV prevalence | 2015 | White | 35-44 | Other | 32 | F |
| HIV prevalence | 2015 | White | 45-54 | Heterosexual contact | 8310 | F |
| HIV prevalence | 2015 | White | 45-54 | Injection drug use | 4634 | F |
| HIV prevalence | 2015 | White | 45-54 | Other | 99 | F |
| HIV prevalence | 2015 | White | 55 | Heterosexual contact | 7176 | F |
| HIV prevalence | 2015 | White | 55 | Injection drug use | 3713 | F |
| HIV prevalence | 2015 | White | 55 | Other | 275 | F |
| HIV prevalence | 2016 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 9 | F |
| HIV prevalence | 2016 | American Indian/Alaska Native | 13-24 | Injection drug use | 3 | F |
| HIV prevalence | 2016 | American Indian/Alaska Native | 13-24 | Other | 7 | F |
| HIV prevalence | 2016 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 70 | F |
| HIV prevalence | 2016 | American Indian/Alaska Native | 25-34 | Injection drug use | 32 | F |
| HIV prevalence | 2016 | American Indian/Alaska Native | 25-34 | Other | 5 | F |
| HIV prevalence | 2016 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 135 | F |
| HIV prevalence | 2016 | American Indian/Alaska Native | 35-44 | Injection drug use | 61 | F |
| HIV prevalence | 2016 | American Indian/Alaska Native | 35-44 | Other | 3 | F |
| HIV prevalence | 2016 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 139 | F |
| HIV prevalence | 2016 | American Indian/Alaska Native | 45-54 | Injection drug use | 82 | F |
| HIV prevalence | 2016 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV prevalence | 2016 | American Indian/Alaska Native | 55 | Heterosexual contact | 142 | F |
| HIV prevalence | 2016 | American Indian/Alaska Native | 55 | Injection drug use | 64 | F |
| HIV prevalence | 2016 | American Indian/Alaska Native | 55 | Other | 5 | F |
| HIV prevalence | 2016 | Asian | 13-24 | Heterosexual contact | 42 | F |
| HIV prevalence | 2016 | Asian | 13-24 | Injection drug use | 3 | F |
| HIV prevalence | 2016 | Asian | 13-24 | Other | 39 | F |
| HIV prevalence | 2016 | Asian | 25-34 | Heterosexual contact | 344 | F |
| HIV prevalence | 2016 | Asian | 25-34 | Injection drug use | 20 | F |
| HIV prevalence | 2016 | Asian | 25-34 | Other | 6 | F |
| HIV prevalence | 2016 | Asian | 35-44 | Heterosexual contact | 728 | F |
| HIV prevalence | 2016 | Asian | 35-44 | Injection drug use | 44 | F |
| HIV prevalence | 2016 | Asian | 35-44 | Other | 9 | F |
| HIV prevalence | 2016 | Asian | 45-54 | Heterosexual contact | 524 | F |
| HIV prevalence | 2016 | Asian | 45-54 | Injection drug use | 46 | F |
| HIV prevalence | 2016 | Asian | 45-54 | Other | 9 | F |
| HIV prevalence | 2016 | Asian | 55 | Heterosexual contact | 453 | F |
| HIV prevalence | 2016 | Asian | 55 | Injection drug use | 61 | F |
| HIV prevalence | 2016 | Asian | 55 | Other | 36 | F |
| HIV prevalence | 2016 | Black/African American | 13-24 | Heterosexual contact | 2460 | F |
| HIV prevalence | 2016 | Black/African American | 13-24 | Injection drug use | 150 | F |
| HIV prevalence | 2016 | Black/African American | 13-24 | Other | 2203 | F |
| HIV prevalence | 2016 | Black/African American | 25-34 | Heterosexual contact | 14857 | F |
| HIV prevalence | 2016 | Black/African American | 25-34 | Injection drug use | 1221 | F |
| HIV prevalence | 2016 | Black/African American | 25-34 | Other | 1201 | F |
| HIV prevalence | 2016 | Black/African American | 35-44 | Heterosexual contact | 28816 | F |
| HIV prevalence | 2016 | Black/African American | 35-44 | Injection drug use | 3422 | F |
| HIV prevalence | 2016 | Black/African American | 35-44 | Other | 94 | F |
| HIV prevalence | 2016 | Black/African American | 45-54 | Heterosexual contact | 33973 | F |
| HIV prevalence | 2016 | Black/African American | 45-54 | Injection drug use | 8820 | F |
| HIV prevalence | 2016 | Black/African American | 45-54 | Other | 139 | F |
| HIV prevalence | 2016 | Black/African American | 55 | Heterosexual contact | 28974 | F |
| HIV prevalence | 2016 | Black/African American | 55 | Injection drug use | 10735 | F |
| HIV prevalence | 2016 | Black/African American | 55 | Other | 276 | F |
| HIV prevalence | 2016 | Hispanic/Latino | 13-24 | Heterosexual contact | 570 | F |
| HIV prevalence | 2016 | Hispanic/Latino | 13-24 | Injection drug use | 81 | F |
| HIV prevalence | 2016 | Hispanic/Latino | 13-24 | Other | 712 | F |
| HIV prevalence | 2016 | Hispanic/Latino | 25-34 | Heterosexual contact | 3800 | F |
| HIV prevalence | 2016 | Hispanic/Latino | 25-34 | Injection drug use | 580 | F |
| HIV prevalence | 2016 | Hispanic/Latino | 25-34 | Other | 587 | F |
| HIV prevalence | 2016 | Hispanic/Latino | 35-44 | Heterosexual contact | 7794 | F |
| HIV prevalence | 2016 | Hispanic/Latino | 35-44 | Injection drug use | 1597 | F |
| HIV prevalence | 2016 | Hispanic/Latino | 35-44 | Other | 27 | F |
| HIV prevalence | 2016 | Hispanic/Latino | 45-54 | Heterosexual contact | 9701 | F |
| HIV prevalence | 2016 | Hispanic/Latino | 45-54 | Injection drug use | 3502 | F |
| HIV prevalence | 2016 | Hispanic/Latino | 45-54 | Other | 41 | F |
| HIV prevalence | 2016 | Hispanic/Latino | 55 | Heterosexual contact | 9194 | F |
| HIV prevalence | 2016 | Hispanic/Latino | 55 | Injection drug use | 3699 | F |
| HIV prevalence | 2016 | Hispanic/Latino | 55 | Other | 111 | F |
| HIV prevalence | 2016 | Multiple races | 13-24 | Heterosexual contact | 181 | F |
| HIV prevalence | 2016 | Multiple races | 13-24 | Injection drug use | 25 | F |
| HIV prevalence | 2016 | Multiple races | 13-24 | Other | 214 | F |
| HIV prevalence | 2016 | Multiple races | 25-34 | Heterosexual contact | 1047 | F |
| HIV prevalence | 2016 | Multiple races | 25-34 | Injection drug use | 176 | F |
| HIV prevalence | 2016 | Multiple races | 25-34 | Other | 123 | F |
| HIV prevalence | 2016 | Multiple races | 35-44 | Heterosexual contact | 2026 | F |
| HIV prevalence | 2016 | Multiple races | 35-44 | Injection drug use | 492 | F |
| HIV prevalence | 2016 | Multiple races | 35-44 | Other | 10 | F |
| HIV prevalence | 2016 | Multiple races | 45-54 | Heterosexual contact | 2384 | F |
| HIV prevalence | 2016 | Multiple races | 45-54 | Injection drug use | 1109 | F |
| HIV prevalence | 2016 | Multiple races | 45-54 | Other | 11 | F |
| HIV prevalence | 2016 | Multiple races | 55 | Heterosexual contact | 2031 | F |
| HIV prevalence | 2016 | Multiple races | 55 | Injection drug use | 1157 | F |
| HIV prevalence | 2016 | Multiple races | 55 | Other | 27 | F |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 6 | F |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 1 | F |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 13 | F |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 2 | F |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 33 | F |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 4 | F |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 32 | F |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 7 | F |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 1 | F |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 26 | F |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 7 | F |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Other | 1 | F |
| HIV prevalence | 2016 | White | 13-24 | Heterosexual contact | 445 | F |
| HIV prevalence | 2016 | White | 13-24 | Injection drug use | 147 | F |
| HIV prevalence | 2016 | White | 13-24 | Other | 366 | F |
| HIV prevalence | 2016 | White | 25-34 | Heterosexual contact | 2964 | F |
| HIV prevalence | 2016 | White | 25-34 | Injection drug use | 1229 | F |
| HIV prevalence | 2016 | White | 25-34 | Other | 284 | F |
| HIV prevalence | 2016 | White | 35-44 | Heterosexual contact | 5605 | F |
| HIV prevalence | 2016 | White | 35-44 | Injection drug use | 2279 | F |
| HIV prevalence | 2016 | White | 35-44 | Other | 47 | F |
| HIV prevalence | 2016 | White | 45-54 | Heterosexual contact | 8357 | F |
| HIV prevalence | 2016 | White | 45-54 | Injection drug use | 4444 | F |
| HIV prevalence | 2016 | White | 45-54 | Other | 92 | F |
| HIV prevalence | 2016 | White | 55 | Heterosexual contact | 7945 | F |
| HIV prevalence | 2016 | White | 55 | Injection drug use | 4116 | F |
| HIV prevalence | 2016 | White | 55 | Other | 284 | F |
| HIV prevalence | 2017 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 8 | F |
| HIV prevalence | 2017 | American Indian/Alaska Native | 13-24 | Injection drug use | 2 | F |
| HIV prevalence | 2017 | American Indian/Alaska Native | 13-24 | Other | 4 | F |
| HIV prevalence | 2017 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 71 | F |
| HIV prevalence | 2017 | American Indian/Alaska Native | 25-34 | Injection drug use | 30 | F |
| HIV prevalence | 2017 | American Indian/Alaska Native | 25-34 | Other | 8 | F |
| HIV prevalence | 2017 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 141 | F |
| HIV prevalence | 2017 | American Indian/Alaska Native | 35-44 | Injection drug use | 69 | F |
| HIV prevalence | 2017 | American Indian/Alaska Native | 35-44 | Other | 3 | F |
| HIV prevalence | 2017 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 144 | F |
| HIV prevalence | 2017 | American Indian/Alaska Native | 45-54 | Injection drug use | 84 | F |
| HIV prevalence | 2017 | American Indian/Alaska Native | 45-54 | Other | 0 | F |
| HIV prevalence | 2017 | American Indian/Alaska Native | 55 | Heterosexual contact | 154 | F |
| HIV prevalence | 2017 | American Indian/Alaska Native | 55 | Injection drug use | 71 | F |
| HIV prevalence | 2017 | American Indian/Alaska Native | 55 | Other | 5 | F |
| HIV prevalence | 2017 | Asian | 13-24 | Heterosexual contact | 35 | F |
| HIV prevalence | 2017 | Asian | 13-24 | Injection drug use | 1 | F |
| HIV prevalence | 2017 | Asian | 13-24 | Other | 44 | F |
| HIV prevalence | 2017 | Asian | 25-34 | Heterosexual contact | 335 | F |
| HIV prevalence | 2017 | Asian | 25-34 | Injection drug use | 22 | F |
| HIV prevalence | 2017 | Asian | 25-34 | Other | 10 | F |
| HIV prevalence | 2017 | Asian | 35-44 | Heterosexual contact | 749 | F |
| HIV prevalence | 2017 | Asian | 35-44 | Injection drug use | 46 | F |
| HIV prevalence | 2017 | Asian | 35-44 | Other | 9 | F |
| HIV prevalence | 2017 | Asian | 45-54 | Heterosexual contact | 588 | F |
| HIV prevalence | 2017 | Asian | 45-54 | Injection drug use | 50 | F |
| HIV prevalence | 2017 | Asian | 45-54 | Other | 9 | F |
| HIV prevalence | 2017 | Asian | 55 | Heterosexual contact | 505 | F |
| HIV prevalence | 2017 | Asian | 55 | Injection drug use | 62 | F |
| HIV prevalence | 2017 | Asian | 55 | Other | 36 | F |
| HIV prevalence | 2017 | Black/African American | 13-24 | Heterosexual contact | 2310 | F |
| HIV prevalence | 2017 | Black/African American | 13-24 | Injection drug use | 142 | F |
| HIV prevalence | 2017 | Black/African American | 13-24 | Other | 2090 | F |
| HIV prevalence | 2017 | Black/African American | 25-34 | Heterosexual contact | 14431 | F |
| HIV prevalence | 2017 | Black/African American | 25-34 | Injection drug use | 1126 | F |
| HIV prevalence | 2017 | Black/African American | 25-34 | Other | 1413 | F |
| HIV prevalence | 2017 | Black/African American | 35-44 | Heterosexual contact | 28298 | F |
| HIV prevalence | 2017 | Black/African American | 35-44 | Injection drug use | 3124 | F |
| HIV prevalence | 2017 | Black/African American | 35-44 | Other | 111 | F |
| HIV prevalence | 2017 | Black/African American | 45-54 | Heterosexual contact | 34468 | F |
| HIV prevalence | 2017 | Black/African American | 45-54 | Injection drug use | 8150 | F |
| HIV prevalence | 2017 | Black/African American | 45-54 | Other | 121 | F |
| HIV prevalence | 2017 | Black/African American | 55 | Heterosexual contact | 32237 | F |
| HIV prevalence | 2017 | Black/African American | 55 | Injection drug use | 11551 | F |
| HIV prevalence | 2017 | Black/African American | 55 | Other | 295 | F |
| HIV prevalence | 2017 | Hispanic/Latino | 13-24 | Heterosexual contact | 562 | F |
| HIV prevalence | 2017 | Hispanic/Latino | 13-24 | Injection drug use | 66 | F |
| HIV prevalence | 2017 | Hispanic/Latino | 13-24 | Other | 653 | F |
| HIV prevalence | 2017 | Hispanic/Latino | 25-34 | Heterosexual contact | 3568 | F |
| HIV prevalence | 2017 | Hispanic/Latino | 25-34 | Injection drug use | 552 | F |
| HIV prevalence | 2017 | Hispanic/Latino | 25-34 | Other | 660 | F |
| HIV prevalence | 2017 | Hispanic/Latino | 35-44 | Heterosexual contact | 7768 | F |
| HIV prevalence | 2017 | Hispanic/Latino | 35-44 | Injection drug use | 1497 | F |
| HIV prevalence | 2017 | Hispanic/Latino | 35-44 | Other | 39 | F |
| HIV prevalence | 2017 | Hispanic/Latino | 45-54 | Heterosexual contact | 9754 | F |
| HIV prevalence | 2017 | Hispanic/Latino | 45-54 | Injection drug use | 3312 | F |
| HIV prevalence | 2017 | Hispanic/Latino | 45-54 | Other | 34 | F |
| HIV prevalence | 2017 | Hispanic/Latino | 55 | Heterosexual contact | 10240 | F |
| HIV prevalence | 2017 | Hispanic/Latino | 55 | Injection drug use | 3982 | F |
| HIV prevalence | 2017 | Hispanic/Latino | 55 | Other | 118 | F |
| HIV prevalence | 2017 | Multiple races | 13-24 | Heterosexual contact | 156 | F |
| HIV prevalence | 2017 | Multiple races | 13-24 | Injection drug use | 23 | F |
| HIV prevalence | 2017 | Multiple races | 13-24 | Other | 194 | F |
| HIV prevalence | 2017 | Multiple races | 25-34 | Heterosexual contact | 997 | F |
| HIV prevalence | 2017 | Multiple races | 25-34 | Injection drug use | 155 | F |
| HIV prevalence | 2017 | Multiple races | 25-34 | Other | 147 | F |
| HIV prevalence | 2017 | Multiple races | 35-44 | Heterosexual contact | 1938 | F |
| HIV prevalence | 2017 | Multiple races | 35-44 | Injection drug use | 462 | F |
| HIV prevalence | 2017 | Multiple races | 35-44 | Other | 13 | F |
| HIV prevalence | 2017 | Multiple races | 45-54 | Heterosexual contact | 2395 | F |
| HIV prevalence | 2017 | Multiple races | 45-54 | Injection drug use | 1023 | F |
| HIV prevalence | 2017 | Multiple races | 45-54 | Other | 9 | F |
| HIV prevalence | 2017 | Multiple races | 55 | Heterosexual contact | 2184 | F |
| HIV prevalence | 2017 | Multiple races | 55 | Injection drug use | 1232 | F |
| HIV prevalence | 2017 | Multiple races | 55 | Other | 28 | F |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 6 | F |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | F |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | F |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 15 | F |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 2 | F |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | F |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 36 | F |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 2 | F |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | F |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 30 | F |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 8 | F |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | F |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 30 | F |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 8 | F |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Other | 1 | F |
| HIV prevalence | 2017 | White | 13-24 | Heterosexual contact | 422 | F |
| HIV prevalence | 2017 | White | 13-24 | Injection drug use | 153 | F |
| HIV prevalence | 2017 | White | 13-24 | Other | 350 | F |
| HIV prevalence | 2017 | White | 25-34 | Heterosexual contact | 2932 | F |
| HIV prevalence | 2017 | White | 25-34 | Injection drug use | 1266 | F |
| HIV prevalence | 2017 | White | 25-34 | Other | 323 | F |
| HIV prevalence | 2017 | White | 35-44 | Heterosexual contact | 5505 | F |
| HIV prevalence | 2017 | White | 35-44 | Injection drug use | 2243 | F |
| HIV prevalence | 2017 | White | 35-44 | Other | 51 | F |
| HIV prevalence | 2017 | White | 45-54 | Heterosexual contact | 8297 | F |
| HIV prevalence | 2017 | White | 45-54 | Injection drug use | 4195 | F |
| HIV prevalence | 2017 | White | 45-54 | Other | 79 | F |
| HIV prevalence | 2017 | White | 55 | Heterosexual contact | 8697 | F |
| HIV prevalence | 2017 | White | 55 | Injection drug use | 4498 | F |
| HIV prevalence | 2017 | White | 55 | Other | 293 | F |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 13-24 | Injection drug use | 1 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 9 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 13-24 | Other | 0 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 5 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 25-34 | Injection drug use | 1 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 25 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 25-34 | Other | 0 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 35-44 | Injection drug use | 4 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 30 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 35-44 | Other | 0 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 4 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 45-54 | Injection drug use | 7 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 13 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 45-54 | Other | 0 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 55 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 55 | Injection drug use | 0 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 3 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2008 | American Indian/Alaska Native | 55 | Other | 0 | M |
| HIV diagnoses | 2008 | Asian | 13-24 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2008 | Asian | 13-24 | Injection drug use | 1 | M |
| HIV diagnoses | 2008 | Asian | 13-24 | Male-to-male sexual contact | 63 | M |
| HIV diagnoses | 2008 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2008 | Asian | 13-24 | Other | 0 | M |
| HIV diagnoses | 2008 | Asian | 25-34 | Heterosexual contact | 11 | M |
| HIV diagnoses | 2008 | Asian | 25-34 | Injection drug use | 12 | M |
| HIV diagnoses | 2008 | Asian | 25-34 | Male-to-male sexual contact | 177 | M |
| HIV diagnoses | 2008 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 5 | M |
| HIV diagnoses | 2008 | Asian | 25-34 | Other | 1 | M |
| HIV diagnoses | 2008 | Asian | 35-44 | Heterosexual contact | 21 | M |
| HIV diagnoses | 2008 | Asian | 35-44 | Injection drug use | 2 | M |
| HIV diagnoses | 2008 | Asian | 35-44 | Male-to-male sexual contact | 161 | M |
| HIV diagnoses | 2008 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 5 | M |
| HIV diagnoses | 2008 | Asian | 35-44 | Other | 0 | M |
| HIV diagnoses | 2008 | Asian | 45-54 | Heterosexual contact | 7 | M |
| HIV diagnoses | 2008 | Asian | 45-54 | Injection drug use | 5 | M |
| HIV diagnoses | 2008 | Asian | 45-54 | Male-to-male sexual contact | 59 | M |
| HIV diagnoses | 2008 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2008 | Asian | 45-54 | Other | 0 | M |
| HIV diagnoses | 2008 | Asian | 55 | Heterosexual contact | 6 | M |
| HIV diagnoses | 2008 | Asian | 55 | Injection drug use | 1 | M |
| HIV diagnoses | 2008 | Asian | 55 | Male-to-male sexual contact | 21 | M |
| HIV diagnoses | 2008 | Asian | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2008 | Asian | 55 | Other | 1 | M |
| HIV diagnoses | 2008 | Black/African American | 13-24 | Heterosexual contact | 210 | M |
| HIV diagnoses | 2008 | Black/African American | 13-24 | Injection drug use | 49 | M |
| HIV diagnoses | 2008 | Black/African American | 13-24 | Male-to-male sexual contact | 3346 | M |
| HIV diagnoses | 2008 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 114 | M |
| HIV diagnoses | 2008 | Black/African American | 13-24 | Other | 6 | M |
| HIV diagnoses | 2008 | Black/African American | 25-34 | Heterosexual contact | 530 | M |
| HIV diagnoses | 2008 | Black/African American | 25-34 | Injection drug use | 140 | M |
| HIV diagnoses | 2008 | Black/African American | 25-34 | Male-to-male sexual contact | 2650 | M |
| HIV diagnoses | 2008 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 133 | M |
| HIV diagnoses | 2008 | Black/African American | 25-34 | Other | 3 | M |
| HIV diagnoses | 2008 | Black/African American | 35-44 | Heterosexual contact | 885 | M |
| HIV diagnoses | 2008 | Black/African American | 35-44 | Injection drug use | 305 | M |
| HIV diagnoses | 2008 | Black/African American | 35-44 | Male-to-male sexual contact | 1929 | M |
| HIV diagnoses | 2008 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 140 | M |
| HIV diagnoses | 2008 | Black/African American | 35-44 | Other | 2 | M |
| HIV diagnoses | 2008 | Black/African American | 45-54 | Heterosexual contact | 937 | M |
| HIV diagnoses | 2008 | Black/African American | 45-54 | Injection drug use | 519 | M |
| HIV diagnoses | 2008 | Black/African American | 45-54 | Male-to-male sexual contact | 1203 | M |
| HIV diagnoses | 2008 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 115 | M |
| HIV diagnoses | 2008 | Black/African American | 45-54 | Other | 3 | M |
| HIV diagnoses | 2008 | Black/African American | 55 | Heterosexual contact | 551 | M |
| HIV diagnoses | 2008 | Black/African American | 55 | Injection drug use | 282 | M |
| HIV diagnoses | 2008 | Black/African American | 55 | Male-to-male sexual contact | 408 | M |
| HIV diagnoses | 2008 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 44 | M |
| HIV diagnoses | 2008 | Black/African American | 55 | Other | 6 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 13-24 | Heterosexual contact | 69 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 13-24 | Injection drug use | 45 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 1295 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 100 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 13-24 | Other | 1 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 25-34 | Heterosexual contact | 240 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 25-34 | Injection drug use | 151 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 2237 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 173 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 25-34 | Other | 1 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 35-44 | Heterosexual contact | 250 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 35-44 | Injection drug use | 173 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 1690 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 151 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 35-44 | Other | 1 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 45-54 | Heterosexual contact | 177 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 45-54 | Injection drug use | 168 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 741 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 63 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 45-54 | Other | 2 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 55 | Heterosexual contact | 108 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 55 | Injection drug use | 64 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 55 | Male-to-male sexual contact | 206 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 19 | M |
| HIV diagnoses | 2008 | Hispanic/Latino | 55 | Other | 4 | M |
| HIV diagnoses | 2008 | Multiple races | 13-24 | Heterosexual contact | 13 | M |
| HIV diagnoses | 2008 | Multiple races | 13-24 | Injection drug use | 4 | M |
| HIV diagnoses | 2008 | Multiple races | 13-24 | Male-to-male sexual contact | 344 | M |
| HIV diagnoses | 2008 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 32 | M |
| HIV diagnoses | 2008 | Multiple races | 13-24 | Other | 0 | M |
| HIV diagnoses | 2008 | Multiple races | 25-34 | Heterosexual contact | 40 | M |
| HIV diagnoses | 2008 | Multiple races | 25-34 | Injection drug use | 20 | M |
| HIV diagnoses | 2008 | Multiple races | 25-34 | Male-to-male sexual contact | 396 | M |
| HIV diagnoses | 2008 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 38 | M |
| HIV diagnoses | 2008 | Multiple races | 25-34 | Other | 0 | M |
| HIV diagnoses | 2008 | Multiple races | 35-44 | Heterosexual contact | 44 | M |
| HIV diagnoses | 2008 | Multiple races | 35-44 | Injection drug use | 25 | M |
| HIV diagnoses | 2008 | Multiple races | 35-44 | Male-to-male sexual contact | 337 | M |
| HIV diagnoses | 2008 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 40 | M |
| HIV diagnoses | 2008 | Multiple races | 35-44 | Other | 0 | M |
| HIV diagnoses | 2008 | Multiple races | 45-54 | Heterosexual contact | 46 | M |
| HIV diagnoses | 2008 | Multiple races | 45-54 | Injection drug use | 47 | M |
| HIV diagnoses | 2008 | Multiple races | 45-54 | Male-to-male sexual contact | 188 | M |
| HIV diagnoses | 2008 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 21 | M |
| HIV diagnoses | 2008 | Multiple races | 45-54 | Other | 0 | M |
| HIV diagnoses | 2008 | Multiple races | 55 | Heterosexual contact | 26 | M |
| HIV diagnoses | 2008 | Multiple races | 55 | Injection drug use | 19 | M |
| HIV diagnoses | 2008 | Multiple races | 55 | Male-to-male sexual contact | 68 | M |
| HIV diagnoses | 2008 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 6 | M |
| HIV diagnoses | 2008 | Multiple races | 55 | Other | 1 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 6 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 10 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 12 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 6 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV diagnoses | 2008 | White | 13-24 | Heterosexual contact | 23 | M |
| HIV diagnoses | 2008 | White | 13-24 | Injection drug use | 22 | M |
| HIV diagnoses | 2008 | White | 13-24 | Male-to-male sexual contact | 947 | M |
| HIV diagnoses | 2008 | White | 13-24 | Male-to-male sexual contact and injection drug use | 96 | M |
| HIV diagnoses | 2008 | White | 13-24 | Other | 2 | M |
| HIV diagnoses | 2008 | White | 25-34 | Heterosexual contact | 73 | M |
| HIV diagnoses | 2008 | White | 25-34 | Injection drug use | 92 | M |
| HIV diagnoses | 2008 | White | 25-34 | Male-to-male sexual contact | 2078 | M |
| HIV diagnoses | 2008 | White | 25-34 | Male-to-male sexual contact and injection drug use | 266 | M |
| HIV diagnoses | 2008 | White | 25-34 | Other | 2 | M |
| HIV diagnoses | 2008 | White | 35-44 | Heterosexual contact | 148 | M |
| HIV diagnoses | 2008 | White | 35-44 | Injection drug use | 165 | M |
| HIV diagnoses | 2008 | White | 35-44 | Male-to-male sexual contact | 2841 | M |
| HIV diagnoses | 2008 | White | 35-44 | Male-to-male sexual contact and injection drug use | 251 | M |
| HIV diagnoses | 2008 | White | 35-44 | Other | 2 | M |
| HIV diagnoses | 2008 | White | 45-54 | Heterosexual contact | 157 | M |
| HIV diagnoses | 2008 | White | 45-54 | Injection drug use | 164 | M |
| HIV diagnoses | 2008 | White | 45-54 | Male-to-male sexual contact | 2134 | M |
| HIV diagnoses | 2008 | White | 45-54 | Male-to-male sexual contact and injection drug use | 146 | M |
| HIV diagnoses | 2008 | White | 45-54 | Other | 2 | M |
| HIV diagnoses | 2008 | White | 55 | Heterosexual contact | 148 | M |
| HIV diagnoses | 2008 | White | 55 | Injection drug use | 72 | M |
| HIV diagnoses | 2008 | White | 55 | Male-to-male sexual contact | 906 | M |
| HIV diagnoses | 2008 | White | 55 | Male-to-male sexual contact and injection drug use | 44 | M |
| HIV diagnoses | 2008 | White | 55 | Other | 9 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 13-24 | Injection drug use | 1 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 9 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 13-24 | Other | 0 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 25-34 | Injection drug use | 5 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 27 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 25-34 | Other | 0 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 5 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 35-44 | Injection drug use | 4 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 21 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 35-44 | Other | 0 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 45-54 | Injection drug use | 4 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 10 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 45-54 | Other | 0 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 55 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 55 | Injection drug use | 0 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 4 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2009 | American Indian/Alaska Native | 55 | Other | 0 | M |
| HIV diagnoses | 2009 | Asian | 13-24 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2009 | Asian | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2009 | Asian | 13-24 | Male-to-male sexual contact | 58 | M |
| HIV diagnoses | 2009 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 6 | M |
| HIV diagnoses | 2009 | Asian | 13-24 | Other | 0 | M |
| HIV diagnoses | 2009 | Asian | 25-34 | Heterosexual contact | 7 | M |
| HIV diagnoses | 2009 | Asian | 25-34 | Injection drug use | 3 | M |
| HIV diagnoses | 2009 | Asian | 25-34 | Male-to-male sexual contact | 152 | M |
| HIV diagnoses | 2009 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 10 | M |
| HIV diagnoses | 2009 | Asian | 25-34 | Other | 0 | M |
| HIV diagnoses | 2009 | Asian | 35-44 | Heterosexual contact | 21 | M |
| HIV diagnoses | 2009 | Asian | 35-44 | Injection drug use | 8 | M |
| HIV diagnoses | 2009 | Asian | 35-44 | Male-to-male sexual contact | 141 | M |
| HIV diagnoses | 2009 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 6 | M |
| HIV diagnoses | 2009 | Asian | 35-44 | Other | 0 | M |
| HIV diagnoses | 2009 | Asian | 45-54 | Heterosexual contact | 7 | M |
| HIV diagnoses | 2009 | Asian | 45-54 | Injection drug use | 4 | M |
| HIV diagnoses | 2009 | Asian | 45-54 | Male-to-male sexual contact | 59 | M |
| HIV diagnoses | 2009 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV diagnoses | 2009 | Asian | 45-54 | Other | 0 | M |
| HIV diagnoses | 2009 | Asian | 55 | Heterosexual contact | 10 | M |
| HIV diagnoses | 2009 | Asian | 55 | Injection drug use | 2 | M |
| HIV diagnoses | 2009 | Asian | 55 | Male-to-male sexual contact | 22 | M |
| HIV diagnoses | 2009 | Asian | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2009 | Asian | 55 | Other | 1 | M |
| HIV diagnoses | 2009 | Black/African American | 13-24 | Heterosexual contact | 219 | M |
| HIV diagnoses | 2009 | Black/African American | 13-24 | Injection drug use | 45 | M |
| HIV diagnoses | 2009 | Black/African American | 13-24 | Male-to-male sexual contact | 3552 | M |
| HIV diagnoses | 2009 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 120 | M |
| HIV diagnoses | 2009 | Black/African American | 13-24 | Other | 6 | M |
| HIV diagnoses | 2009 | Black/African American | 25-34 | Heterosexual contact | 502 | M |
| HIV diagnoses | 2009 | Black/African American | 25-34 | Injection drug use | 124 | M |
| HIV diagnoses | 2009 | Black/African American | 25-34 | Male-to-male sexual contact | 2726 | M |
| HIV diagnoses | 2009 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 132 | M |
| HIV diagnoses | 2009 | Black/African American | 25-34 | Other | 1 | M |
| HIV diagnoses | 2009 | Black/African American | 35-44 | Heterosexual contact | 733 | M |
| HIV diagnoses | 2009 | Black/African American | 35-44 | Injection drug use | 243 | M |
| HIV diagnoses | 2009 | Black/African American | 35-44 | Male-to-male sexual contact | 1761 | M |
| HIV diagnoses | 2009 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 101 | M |
| HIV diagnoses | 2009 | Black/African American | 35-44 | Other | 2 | M |
| HIV diagnoses | 2009 | Black/African American | 45-54 | Heterosexual contact | 867 | M |
| HIV diagnoses | 2009 | Black/African American | 45-54 | Injection drug use | 394 | M |
| HIV diagnoses | 2009 | Black/African American | 45-54 | Male-to-male sexual contact | 1090 | M |
| HIV diagnoses | 2009 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 92 | M |
| HIV diagnoses | 2009 | Black/African American | 45-54 | Other | 3 | M |
| HIV diagnoses | 2009 | Black/African American | 55 | Heterosexual contact | 521 | M |
| HIV diagnoses | 2009 | Black/African American | 55 | Injection drug use | 253 | M |
| HIV diagnoses | 2009 | Black/African American | 55 | Male-to-male sexual contact | 398 | M |
| HIV diagnoses | 2009 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 33 | M |
| HIV diagnoses | 2009 | Black/African American | 55 | Other | 6 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 13-24 | Heterosexual contact | 66 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 13-24 | Injection drug use | 32 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 1332 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 95 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 13-24 | Other | 6 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 25-34 | Heterosexual contact | 250 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 25-34 | Injection drug use | 118 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 2232 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 173 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 25-34 | Other | 2 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 35-44 | Heterosexual contact | 242 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 35-44 | Injection drug use | 166 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 1635 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 110 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 35-44 | Other | 1 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 45-54 | Heterosexual contact | 161 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 45-54 | Injection drug use | 130 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 702 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 54 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 45-54 | Other | 1 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 55 | Heterosexual contact | 96 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 55 | Injection drug use | 70 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 55 | Male-to-male sexual contact | 243 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 14 | M |
| HIV diagnoses | 2009 | Hispanic/Latino | 55 | Other | 2 | M |
| HIV diagnoses | 2009 | Multiple races | 13-24 | Heterosexual contact | 17 | M |
| HIV diagnoses | 2009 | Multiple races | 13-24 | Injection drug use | 4 | M |
| HIV diagnoses | 2009 | Multiple races | 13-24 | Male-to-male sexual contact | 396 | M |
| HIV diagnoses | 2009 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 31 | M |
| HIV diagnoses | 2009 | Multiple races | 13-24 | Other | 2 | M |
| HIV diagnoses | 2009 | Multiple races | 25-34 | Heterosexual contact | 40 | M |
| HIV diagnoses | 2009 | Multiple races | 25-34 | Injection drug use | 4 | M |
| HIV diagnoses | 2009 | Multiple races | 25-34 | Male-to-male sexual contact | 370 | M |
| HIV diagnoses | 2009 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 48 | M |
| HIV diagnoses | 2009 | Multiple races | 25-34 | Other | 0 | M |
| HIV diagnoses | 2009 | Multiple races | 35-44 | Heterosexual contact | 54 | M |
| HIV diagnoses | 2009 | Multiple races | 35-44 | Injection drug use | 25 | M |
| HIV diagnoses | 2009 | Multiple races | 35-44 | Male-to-male sexual contact | 289 | M |
| HIV diagnoses | 2009 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 33 | M |
| HIV diagnoses | 2009 | Multiple races | 35-44 | Other | 0 | M |
| HIV diagnoses | 2009 | Multiple races | 45-54 | Heterosexual contact | 59 | M |
| HIV diagnoses | 2009 | Multiple races | 45-54 | Injection drug use | 27 | M |
| HIV diagnoses | 2009 | Multiple races | 45-54 | Male-to-male sexual contact | 177 | M |
| HIV diagnoses | 2009 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 22 | M |
| HIV diagnoses | 2009 | Multiple races | 45-54 | Other | 0 | M |
| HIV diagnoses | 2009 | Multiple races | 55 | Heterosexual contact | 30 | M |
| HIV diagnoses | 2009 | Multiple races | 55 | Injection drug use | 20 | M |
| HIV diagnoses | 2009 | Multiple races | 55 | Male-to-male sexual contact | 59 | M |
| HIV diagnoses | 2009 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 6 | M |
| HIV diagnoses | 2009 | Multiple races | 55 | Other | 1 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 4 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 1 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 9 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 9 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 0 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 6 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 4 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV diagnoses | 2009 | White | 13-24 | Heterosexual contact | 16 | M |
| HIV diagnoses | 2009 | White | 13-24 | Injection drug use | 23 | M |
| HIV diagnoses | 2009 | White | 13-24 | Male-to-male sexual contact | 989 | M |
| HIV diagnoses | 2009 | White | 13-24 | Male-to-male sexual contact and injection drug use | 127 | M |
| HIV diagnoses | 2009 | White | 13-24 | Other | 3 | M |
| HIV diagnoses | 2009 | White | 25-34 | Heterosexual contact | 81 | M |
| HIV diagnoses | 2009 | White | 25-34 | Injection drug use | 88 | M |
| HIV diagnoses | 2009 | White | 25-34 | Male-to-male sexual contact | 2067 | M |
| HIV diagnoses | 2009 | White | 25-34 | Male-to-male sexual contact and injection drug use | 244 | M |
| HIV diagnoses | 2009 | White | 25-34 | Other | 0 | M |
| HIV diagnoses | 2009 | White | 35-44 | Heterosexual contact | 133 | M |
| HIV diagnoses | 2009 | White | 35-44 | Injection drug use | 144 | M |
| HIV diagnoses | 2009 | White | 35-44 | Male-to-male sexual contact | 2573 | M |
| HIV diagnoses | 2009 | White | 35-44 | Male-to-male sexual contact and injection drug use | 222 | M |
| HIV diagnoses | 2009 | White | 35-44 | Other | 2 | M |
| HIV diagnoses | 2009 | White | 45-54 | Heterosexual contact | 153 | M |
| HIV diagnoses | 2009 | White | 45-54 | Injection drug use | 146 | M |
| HIV diagnoses | 2009 | White | 45-54 | Male-to-male sexual contact | 2085 | M |
| HIV diagnoses | 2009 | White | 45-54 | Male-to-male sexual contact and injection drug use | 138 | M |
| HIV diagnoses | 2009 | White | 45-54 | Other | 1 | M |
| HIV diagnoses | 2009 | White | 55 | Heterosexual contact | 111 | M |
| HIV diagnoses | 2009 | White | 55 | Injection drug use | 64 | M |
| HIV diagnoses | 2009 | White | 55 | Male-to-male sexual contact | 863 | M |
| HIV diagnoses | 2009 | White | 55 | Male-to-male sexual contact and injection drug use | 43 | M |
| HIV diagnoses | 2009 | White | 55 | Other | 5 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 18 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 13-24 | Other | 0 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 3 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 25-34 | Injection drug use | 2 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 29 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 6 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 25-34 | Other | 0 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 35-44 | Injection drug use | 0 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 13 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 35-44 | Other | 0 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 4 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 45-54 | Injection drug use | 2 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 8 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 45-54 | Other | 0 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 55 | Heterosexual contact | 3 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 55 | Injection drug use | 3 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 6 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2010 | American Indian/Alaska Native | 55 | Other | 0 | M |
| HIV diagnoses | 2010 | Asian | 13-24 | Heterosexual contact | 3 | M |
| HIV diagnoses | 2010 | Asian | 13-24 | Injection drug use | 1 | M |
| HIV diagnoses | 2010 | Asian | 13-24 | Male-to-male sexual contact | 70 | M |
| HIV diagnoses | 2010 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2010 | Asian | 13-24 | Other | 0 | M |
| HIV diagnoses | 2010 | Asian | 25-34 | Heterosexual contact | 11 | M |
| HIV diagnoses | 2010 | Asian | 25-34 | Injection drug use | 4 | M |
| HIV diagnoses | 2010 | Asian | 25-34 | Male-to-male sexual contact | 153 | M |
| HIV diagnoses | 2010 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 7 | M |
| HIV diagnoses | 2010 | Asian | 25-34 | Other | 0 | M |
| HIV diagnoses | 2010 | Asian | 35-44 | Heterosexual contact | 18 | M |
| HIV diagnoses | 2010 | Asian | 35-44 | Injection drug use | 7 | M |
| HIV diagnoses | 2010 | Asian | 35-44 | Male-to-male sexual contact | 150 | M |
| HIV diagnoses | 2010 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 6 | M |
| HIV diagnoses | 2010 | Asian | 35-44 | Other | 0 | M |
| HIV diagnoses | 2010 | Asian | 45-54 | Heterosexual contact | 14 | M |
| HIV diagnoses | 2010 | Asian | 45-54 | Injection drug use | 3 | M |
| HIV diagnoses | 2010 | Asian | 45-54 | Male-to-male sexual contact | 65 | M |
| HIV diagnoses | 2010 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 5 | M |
| HIV diagnoses | 2010 | Asian | 45-54 | Other | 0 | M |
| HIV diagnoses | 2010 | Asian | 55 | Heterosexual contact | 6 | M |
| HIV diagnoses | 2010 | Asian | 55 | Injection drug use | 0 | M |
| HIV diagnoses | 2010 | Asian | 55 | Male-to-male sexual contact | 27 | M |
| HIV diagnoses | 2010 | Asian | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2010 | Asian | 55 | Other | 1 | M |
| HIV diagnoses | 2010 | Black/African American | 13-24 | Heterosexual contact | 215 | M |
| HIV diagnoses | 2010 | Black/African American | 13-24 | Injection drug use | 40 | M |
| HIV diagnoses | 2010 | Black/African American | 13-24 | Male-to-male sexual contact | 3770 | M |
| HIV diagnoses | 2010 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 116 | M |
| HIV diagnoses | 2010 | Black/African American | 13-24 | Other | 16 | M |
| HIV diagnoses | 2010 | Black/African American | 25-34 | Heterosexual contact | 470 | M |
| HIV diagnoses | 2010 | Black/African American | 25-34 | Injection drug use | 115 | M |
| HIV diagnoses | 2010 | Black/African American | 25-34 | Male-to-male sexual contact | 2701 | M |
| HIV diagnoses | 2010 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 126 | M |
| HIV diagnoses | 2010 | Black/African American | 25-34 | Other | 2 | M |
| HIV diagnoses | 2010 | Black/African American | 35-44 | Heterosexual contact | 699 | M |
| HIV diagnoses | 2010 | Black/African American | 35-44 | Injection drug use | 187 | M |
| HIV diagnoses | 2010 | Black/African American | 35-44 | Male-to-male sexual contact | 1521 | M |
| HIV diagnoses | 2010 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 95 | M |
| HIV diagnoses | 2010 | Black/African American | 35-44 | Other | 1 | M |
| HIV diagnoses | 2010 | Black/African American | 45-54 | Heterosexual contact | 771 | M |
| HIV diagnoses | 2010 | Black/African American | 45-54 | Injection drug use | 338 | M |
| HIV diagnoses | 2010 | Black/African American | 45-54 | Male-to-male sexual contact | 1074 | M |
| HIV diagnoses | 2010 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 80 | M |
| HIV diagnoses | 2010 | Black/African American | 45-54 | Other | 2 | M |
| HIV diagnoses | 2010 | Black/African American | 55 | Heterosexual contact | 470 | M |
| HIV diagnoses | 2010 | Black/African American | 55 | Injection drug use | 231 | M |
| HIV diagnoses | 2010 | Black/African American | 55 | Male-to-male sexual contact | 361 | M |
| HIV diagnoses | 2010 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 31 | M |
| HIV diagnoses | 2010 | Black/African American | 55 | Other | 6 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 13-24 | Heterosexual contact | 43 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 13-24 | Injection drug use | 26 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 1458 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 87 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 13-24 | Other | 0 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 25-34 | Heterosexual contact | 190 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 25-34 | Injection drug use | 104 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 2253 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 172 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 25-34 | Other | 0 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 35-44 | Heterosexual contact | 234 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 35-44 | Injection drug use | 148 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 1526 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 82 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 35-44 | Other | 1 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 45-54 | Heterosexual contact | 169 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 45-54 | Injection drug use | 128 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 709 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 55 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 45-54 | Other | 2 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 55 | Heterosexual contact | 92 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 55 | Injection drug use | 63 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 55 | Male-to-male sexual contact | 248 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 18 | M |
| HIV diagnoses | 2010 | Hispanic/Latino | 55 | Other | 2 | M |
| HIV diagnoses | 2010 | Multiple races | 13-24 | Heterosexual contact | 8 | M |
| HIV diagnoses | 2010 | Multiple races | 13-24 | Injection drug use | 6 | M |
| HIV diagnoses | 2010 | Multiple races | 13-24 | Male-to-male sexual contact | 427 | M |
| HIV diagnoses | 2010 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 35 | M |
| HIV diagnoses | 2010 | Multiple races | 13-24 | Other | 1 | M |
| HIV diagnoses | 2010 | Multiple races | 25-34 | Heterosexual contact | 26 | M |
| HIV diagnoses | 2010 | Multiple races | 25-34 | Injection drug use | 18 | M |
| HIV diagnoses | 2010 | Multiple races | 25-34 | Male-to-male sexual contact | 380 | M |
| HIV diagnoses | 2010 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 45 | M |
| HIV diagnoses | 2010 | Multiple races | 25-34 | Other | 1 | M |
| HIV diagnoses | 2010 | Multiple races | 35-44 | Heterosexual contact | 43 | M |
| HIV diagnoses | 2010 | Multiple races | 35-44 | Injection drug use | 12 | M |
| HIV diagnoses | 2010 | Multiple races | 35-44 | Male-to-male sexual contact | 262 | M |
| HIV diagnoses | 2010 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 42 | M |
| HIV diagnoses | 2010 | Multiple races | 35-44 | Other | 0 | M |
| HIV diagnoses | 2010 | Multiple races | 45-54 | Heterosexual contact | 41 | M |
| HIV diagnoses | 2010 | Multiple races | 45-54 | Injection drug use | 25 | M |
| HIV diagnoses | 2010 | Multiple races | 45-54 | Male-to-male sexual contact | 178 | M |
| HIV diagnoses | 2010 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 17 | M |
| HIV diagnoses | 2010 | Multiple races | 45-54 | Other | 0 | M |
| HIV diagnoses | 2010 | Multiple races | 55 | Heterosexual contact | 28 | M |
| HIV diagnoses | 2010 | Multiple races | 55 | Injection drug use | 14 | M |
| HIV diagnoses | 2010 | Multiple races | 55 | Male-to-male sexual contact | 64 | M |
| HIV diagnoses | 2010 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 9 | M |
| HIV diagnoses | 2010 | Multiple races | 55 | Other | 1 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 5 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 2 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 12 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 1 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 7 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 1 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 5 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 0 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV diagnoses | 2010 | White | 13-24 | Heterosexual contact | 23 | M |
| HIV diagnoses | 2010 | White | 13-24 | Injection drug use | 22 | M |
| HIV diagnoses | 2010 | White | 13-24 | Male-to-male sexual contact | 1108 | M |
| HIV diagnoses | 2010 | White | 13-24 | Male-to-male sexual contact and injection drug use | 133 | M |
| HIV diagnoses | 2010 | White | 13-24 | Other | 1 | M |
| HIV diagnoses | 2010 | White | 25-34 | Heterosexual contact | 64 | M |
| HIV diagnoses | 2010 | White | 25-34 | Injection drug use | 69 | M |
| HIV diagnoses | 2010 | White | 25-34 | Male-to-male sexual contact | 2102 | M |
| HIV diagnoses | 2010 | White | 25-34 | Male-to-male sexual contact and injection drug use | 220 | M |
| HIV diagnoses | 2010 | White | 25-34 | Other | 1 | M |
| HIV diagnoses | 2010 | White | 35-44 | Heterosexual contact | 112 | M |
| HIV diagnoses | 2010 | White | 35-44 | Injection drug use | 121 | M |
| HIV diagnoses | 2010 | White | 35-44 | Male-to-male sexual contact | 2263 | M |
| HIV diagnoses | 2010 | White | 35-44 | Male-to-male sexual contact and injection drug use | 184 | M |
| HIV diagnoses | 2010 | White | 35-44 | Other | 2 | M |
| HIV diagnoses | 2010 | White | 45-54 | Heterosexual contact | 136 | M |
| HIV diagnoses | 2010 | White | 45-54 | Injection drug use | 130 | M |
| HIV diagnoses | 2010 | White | 45-54 | Male-to-male sexual contact | 2062 | M |
| HIV diagnoses | 2010 | White | 45-54 | Male-to-male sexual contact and injection drug use | 129 | M |
| HIV diagnoses | 2010 | White | 45-54 | Other | 1 | M |
| HIV diagnoses | 2010 | White | 55 | Heterosexual contact | 132 | M |
| HIV diagnoses | 2010 | White | 55 | Injection drug use | 68 | M |
| HIV diagnoses | 2010 | White | 55 | Male-to-male sexual contact | 861 | M |
| HIV diagnoses | 2010 | White | 55 | Male-to-male sexual contact and injection drug use | 40 | M |
| HIV diagnoses | 2010 | White | 55 | Other | 6 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 3 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 16 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 13-24 | Other | 0 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 25-34 | Injection drug use | 2 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 21 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 25-34 | Other | 0 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 4 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 35-44 | Injection drug use | 3 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 18 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 35-44 | Other | 0 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 45-54 | Injection drug use | 3 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 8 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 45-54 | Other | 0 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 55 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 55 | Injection drug use | 2 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 4 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2011 | American Indian/Alaska Native | 55 | Other | 0 | M |
| HIV diagnoses | 2011 | Asian | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2011 | Asian | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2011 | Asian | 13-24 | Male-to-male sexual contact | 93 | M |
| HIV diagnoses | 2011 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV diagnoses | 2011 | Asian | 13-24 | Other | 0 | M |
| HIV diagnoses | 2011 | Asian | 25-34 | Heterosexual contact | 8 | M |
| HIV diagnoses | 2011 | Asian | 25-34 | Injection drug use | 3 | M |
| HIV diagnoses | 2011 | Asian | 25-34 | Male-to-male sexual contact | 163 | M |
| HIV diagnoses | 2011 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 8 | M |
| HIV diagnoses | 2011 | Asian | 25-34 | Other | 0 | M |
| HIV diagnoses | 2011 | Asian | 35-44 | Heterosexual contact | 16 | M |
| HIV diagnoses | 2011 | Asian | 35-44 | Injection drug use | 6 | M |
| HIV diagnoses | 2011 | Asian | 35-44 | Male-to-male sexual contact | 156 | M |
| HIV diagnoses | 2011 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 9 | M |
| HIV diagnoses | 2011 | Asian | 35-44 | Other | 0 | M |
| HIV diagnoses | 2011 | Asian | 45-54 | Heterosexual contact | 13 | M |
| HIV diagnoses | 2011 | Asian | 45-54 | Injection drug use | 3 | M |
| HIV diagnoses | 2011 | Asian | 45-54 | Male-to-male sexual contact | 73 | M |
| HIV diagnoses | 2011 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2011 | Asian | 45-54 | Other | 0 | M |
| HIV diagnoses | 2011 | Asian | 55 | Heterosexual contact | 9 | M |
| HIV diagnoses | 2011 | Asian | 55 | Injection drug use | 1 | M |
| HIV diagnoses | 2011 | Asian | 55 | Male-to-male sexual contact | 21 | M |
| HIV diagnoses | 2011 | Asian | 55 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2011 | Asian | 55 | Other | 1 | M |
| HIV diagnoses | 2011 | Black/African American | 13-24 | Heterosexual contact | 182 | M |
| HIV diagnoses | 2011 | Black/African American | 13-24 | Injection drug use | 31 | M |
| HIV diagnoses | 2011 | Black/African American | 13-24 | Male-to-male sexual contact | 3800 | M |
| HIV diagnoses | 2011 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 103 | M |
| HIV diagnoses | 2011 | Black/African American | 13-24 | Other | 14 | M |
| HIV diagnoses | 2011 | Black/African American | 25-34 | Heterosexual contact | 453 | M |
| HIV diagnoses | 2011 | Black/African American | 25-34 | Injection drug use | 85 | M |
| HIV diagnoses | 2011 | Black/African American | 25-34 | Male-to-male sexual contact | 2816 | M |
| HIV diagnoses | 2011 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 104 | M |
| HIV diagnoses | 2011 | Black/African American | 25-34 | Other | 2 | M |
| HIV diagnoses | 2011 | Black/African American | 35-44 | Heterosexual contact | 642 | M |
| HIV diagnoses | 2011 | Black/African American | 35-44 | Injection drug use | 148 | M |
| HIV diagnoses | 2011 | Black/African American | 35-44 | Male-to-male sexual contact | 1377 | M |
| HIV diagnoses | 2011 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 70 | M |
| HIV diagnoses | 2011 | Black/African American | 35-44 | Other | 1 | M |
| HIV diagnoses | 2011 | Black/African American | 45-54 | Heterosexual contact | 742 | M |
| HIV diagnoses | 2011 | Black/African American | 45-54 | Injection drug use | 238 | M |
| HIV diagnoses | 2011 | Black/African American | 45-54 | Male-to-male sexual contact | 1049 | M |
| HIV diagnoses | 2011 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 71 | M |
| HIV diagnoses | 2011 | Black/African American | 45-54 | Other | 2 | M |
| HIV diagnoses | 2011 | Black/African American | 55 | Heterosexual contact | 461 | M |
| HIV diagnoses | 2011 | Black/African American | 55 | Injection drug use | 187 | M |
| HIV diagnoses | 2011 | Black/African American | 55 | Male-to-male sexual contact | 389 | M |
| HIV diagnoses | 2011 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 35 | M |
| HIV diagnoses | 2011 | Black/African American | 55 | Other | 5 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 13-24 | Heterosexual contact | 42 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 13-24 | Injection drug use | 27 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 1458 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 101 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 13-24 | Other | 2 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 25-34 | Heterosexual contact | 182 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 25-34 | Injection drug use | 103 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 2247 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 168 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 25-34 | Other | 0 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 35-44 | Heterosexual contact | 200 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 35-44 | Injection drug use | 119 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 1511 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 76 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 35-44 | Other | 1 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 45-54 | Heterosexual contact | 152 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 45-54 | Injection drug use | 107 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 788 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 47 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 45-54 | Other | 2 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 55 | Heterosexual contact | 91 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 55 | Injection drug use | 56 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 55 | Male-to-male sexual contact | 245 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 13 | M |
| HIV diagnoses | 2011 | Hispanic/Latino | 55 | Other | 2 | M |
| HIV diagnoses | 2011 | Multiple races | 13-24 | Heterosexual contact | 13 | M |
| HIV diagnoses | 2011 | Multiple races | 13-24 | Injection drug use | 1 | M |
| HIV diagnoses | 2011 | Multiple races | 13-24 | Male-to-male sexual contact | 421 | M |
| HIV diagnoses | 2011 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 30 | M |
| HIV diagnoses | 2011 | Multiple races | 13-24 | Other | 1 | M |
| HIV diagnoses | 2011 | Multiple races | 25-34 | Heterosexual contact | 19 | M |
| HIV diagnoses | 2011 | Multiple races | 25-34 | Injection drug use | 9 | M |
| HIV diagnoses | 2011 | Multiple races | 25-34 | Male-to-male sexual contact | 396 | M |
| HIV diagnoses | 2011 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 44 | M |
| HIV diagnoses | 2011 | Multiple races | 25-34 | Other | 0 | M |
| HIV diagnoses | 2011 | Multiple races | 35-44 | Heterosexual contact | 35 | M |
| HIV diagnoses | 2011 | Multiple races | 35-44 | Injection drug use | 13 | M |
| HIV diagnoses | 2011 | Multiple races | 35-44 | Male-to-male sexual contact | 235 | M |
| HIV diagnoses | 2011 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 22 | M |
| HIV diagnoses | 2011 | Multiple races | 35-44 | Other | 0 | M |
| HIV diagnoses | 2011 | Multiple races | 45-54 | Heterosexual contact | 28 | M |
| HIV diagnoses | 2011 | Multiple races | 45-54 | Injection drug use | 17 | M |
| HIV diagnoses | 2011 | Multiple races | 45-54 | Male-to-male sexual contact | 168 | M |
| HIV diagnoses | 2011 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 20 | M |
| HIV diagnoses | 2011 | Multiple races | 45-54 | Other | 0 | M |
| HIV diagnoses | 2011 | Multiple races | 55 | Heterosexual contact | 20 | M |
| HIV diagnoses | 2011 | Multiple races | 55 | Injection drug use | 20 | M |
| HIV diagnoses | 2011 | Multiple races | 55 | Male-to-male sexual contact | 68 | M |
| HIV diagnoses | 2011 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 7 | M |
| HIV diagnoses | 2011 | Multiple races | 55 | Other | 1 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 10 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 14 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 1 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 13 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 1 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 1 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 1 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 1 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV diagnoses | 2011 | White | 13-24 | Heterosexual contact | 17 | M |
| HIV diagnoses | 2011 | White | 13-24 | Injection drug use | 23 | M |
| HIV diagnoses | 2011 | White | 13-24 | Male-to-male sexual contact | 1122 | M |
| HIV diagnoses | 2011 | White | 13-24 | Male-to-male sexual contact and injection drug use | 110 | M |
| HIV diagnoses | 2011 | White | 13-24 | Other | 1 | M |
| HIV diagnoses | 2011 | White | 25-34 | Heterosexual contact | 65 | M |
| HIV diagnoses | 2011 | White | 25-34 | Injection drug use | 73 | M |
| HIV diagnoses | 2011 | White | 25-34 | Male-to-male sexual contact | 2088 | M |
| HIV diagnoses | 2011 | White | 25-34 | Male-to-male sexual contact and injection drug use | 231 | M |
| HIV diagnoses | 2011 | White | 25-34 | Other | 1 | M |
| HIV diagnoses | 2011 | White | 35-44 | Heterosexual contact | 97 | M |
| HIV diagnoses | 2011 | White | 35-44 | Injection drug use | 97 | M |
| HIV diagnoses | 2011 | White | 35-44 | Male-to-male sexual contact | 1990 | M |
| HIV diagnoses | 2011 | White | 35-44 | Male-to-male sexual contact and injection drug use | 174 | M |
| HIV diagnoses | 2011 | White | 35-44 | Other | 0 | M |
| HIV diagnoses | 2011 | White | 45-54 | Heterosexual contact | 137 | M |
| HIV diagnoses | 2011 | White | 45-54 | Injection drug use | 117 | M |
| HIV diagnoses | 2011 | White | 45-54 | Male-to-male sexual contact | 1941 | M |
| HIV diagnoses | 2011 | White | 45-54 | Male-to-male sexual contact and injection drug use | 116 | M |
| HIV diagnoses | 2011 | White | 45-54 | Other | 1 | M |
| HIV diagnoses | 2011 | White | 55 | Heterosexual contact | 126 | M |
| HIV diagnoses | 2011 | White | 55 | Injection drug use | 60 | M |
| HIV diagnoses | 2011 | White | 55 | Male-to-male sexual contact | 898 | M |
| HIV diagnoses | 2011 | White | 55 | Male-to-male sexual contact and injection drug use | 39 | M |
| HIV diagnoses | 2011 | White | 55 | Other | 4 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 13-24 | Injection drug use | 2 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 23 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 13-24 | Other | 0 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 25-34 | Injection drug use | 3 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 25 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 9 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 25-34 | Other | 0 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 35-44 | Injection drug use | 5 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 22 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 35-44 | Other | 0 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 5 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 45-54 | Injection drug use | 1 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 15 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 45-54 | Other | 0 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 55 | Heterosexual contact | 3 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 55 | Injection drug use | 2 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 2 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2012 | American Indian/Alaska Native | 55 | Other | 0 | M |
| HIV diagnoses | 2012 | Asian | 13-24 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2012 | Asian | 13-24 | Injection drug use | 1 | M |
| HIV diagnoses | 2012 | Asian | 13-24 | Male-to-male sexual contact | 94 | M |
| HIV diagnoses | 2012 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2012 | Asian | 13-24 | Other | 0 | M |
| HIV diagnoses | 2012 | Asian | 25-34 | Heterosexual contact | 9 | M |
| HIV diagnoses | 2012 | Asian | 25-34 | Injection drug use | 3 | M |
| HIV diagnoses | 2012 | Asian | 25-34 | Male-to-male sexual contact | 206 | M |
| HIV diagnoses | 2012 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 6 | M |
| HIV diagnoses | 2012 | Asian | 25-34 | Other | 0 | M |
| HIV diagnoses | 2012 | Asian | 35-44 | Heterosexual contact | 17 | M |
| HIV diagnoses | 2012 | Asian | 35-44 | Injection drug use | 11 | M |
| HIV diagnoses | 2012 | Asian | 35-44 | Male-to-male sexual contact | 159 | M |
| HIV diagnoses | 2012 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 6 | M |
| HIV diagnoses | 2012 | Asian | 35-44 | Other | 1 | M |
| HIV diagnoses | 2012 | Asian | 45-54 | Heterosexual contact | 11 | M |
| HIV diagnoses | 2012 | Asian | 45-54 | Injection drug use | 2 | M |
| HIV diagnoses | 2012 | Asian | 45-54 | Male-to-male sexual contact | 76 | M |
| HIV diagnoses | 2012 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2012 | Asian | 45-54 | Other | 0 | M |
| HIV diagnoses | 2012 | Asian | 55 | Heterosexual contact | 10 | M |
| HIV diagnoses | 2012 | Asian | 55 | Injection drug use | 2 | M |
| HIV diagnoses | 2012 | Asian | 55 | Male-to-male sexual contact | 19 | M |
| HIV diagnoses | 2012 | Asian | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2012 | Asian | 55 | Other | 0 | M |
| HIV diagnoses | 2012 | Black/African American | 13-24 | Heterosexual contact | 205 | M |
| HIV diagnoses | 2012 | Black/African American | 13-24 | Injection drug use | 35 | M |
| HIV diagnoses | 2012 | Black/African American | 13-24 | Male-to-male sexual contact | 3822 | M |
| HIV diagnoses | 2012 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 77 | M |
| HIV diagnoses | 2012 | Black/African American | 13-24 | Other | 14 | M |
| HIV diagnoses | 2012 | Black/African American | 25-34 | Heterosexual contact | 409 | M |
| HIV diagnoses | 2012 | Black/African American | 25-34 | Injection drug use | 94 | M |
| HIV diagnoses | 2012 | Black/African American | 25-34 | Male-to-male sexual contact | 2828 | M |
| HIV diagnoses | 2012 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 90 | M |
| HIV diagnoses | 2012 | Black/African American | 25-34 | Other | 1 | M |
| HIV diagnoses | 2012 | Black/African American | 35-44 | Heterosexual contact | 541 | M |
| HIV diagnoses | 2012 | Black/African American | 35-44 | Injection drug use | 119 | M |
| HIV diagnoses | 2012 | Black/African American | 35-44 | Male-to-male sexual contact | 1338 | M |
| HIV diagnoses | 2012 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 62 | M |
| HIV diagnoses | 2012 | Black/African American | 35-44 | Other | 2 | M |
| HIV diagnoses | 2012 | Black/African American | 45-54 | Heterosexual contact | 657 | M |
| HIV diagnoses | 2012 | Black/African American | 45-54 | Injection drug use | 200 | M |
| HIV diagnoses | 2012 | Black/African American | 45-54 | Male-to-male sexual contact | 970 | M |
| HIV diagnoses | 2012 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 55 | M |
| HIV diagnoses | 2012 | Black/African American | 45-54 | Other | 2 | M |
| HIV diagnoses | 2012 | Black/African American | 55 | Heterosexual contact | 468 | M |
| HIV diagnoses | 2012 | Black/African American | 55 | Injection drug use | 165 | M |
| HIV diagnoses | 2012 | Black/African American | 55 | Male-to-male sexual contact | 389 | M |
| HIV diagnoses | 2012 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 27 | M |
| HIV diagnoses | 2012 | Black/African American | 55 | Other | 4 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 13-24 | Heterosexual contact | 43 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 13-24 | Injection drug use | 14 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 1641 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 92 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 13-24 | Other | 0 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 25-34 | Heterosexual contact | 145 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 25-34 | Injection drug use | 83 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 2490 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 160 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 25-34 | Other | 2 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 35-44 | Heterosexual contact | 166 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 35-44 | Injection drug use | 106 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 1410 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 95 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 35-44 | Other | 1 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 45-54 | Heterosexual contact | 136 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 45-54 | Injection drug use | 96 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 808 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 44 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 45-54 | Other | 1 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 55 | Heterosexual contact | 104 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 55 | Injection drug use | 58 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 55 | Male-to-male sexual contact | 236 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 8 | M |
| HIV diagnoses | 2012 | Hispanic/Latino | 55 | Other | 1 | M |
| HIV diagnoses | 2012 | Multiple races | 13-24 | Heterosexual contact | 9 | M |
| HIV diagnoses | 2012 | Multiple races | 13-24 | Injection drug use | 3 | M |
| HIV diagnoses | 2012 | Multiple races | 13-24 | Male-to-male sexual contact | 440 | M |
| HIV diagnoses | 2012 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 32 | M |
| HIV diagnoses | 2012 | Multiple races | 13-24 | Other | 1 | M |
| HIV diagnoses | 2012 | Multiple races | 25-34 | Heterosexual contact | 17 | M |
| HIV diagnoses | 2012 | Multiple races | 25-34 | Injection drug use | 6 | M |
| HIV diagnoses | 2012 | Multiple races | 25-34 | Male-to-male sexual contact | 411 | M |
| HIV diagnoses | 2012 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 39 | M |
| HIV diagnoses | 2012 | Multiple races | 25-34 | Other | 0 | M |
| HIV diagnoses | 2012 | Multiple races | 35-44 | Heterosexual contact | 34 | M |
| HIV diagnoses | 2012 | Multiple races | 35-44 | Injection drug use | 8 | M |
| HIV diagnoses | 2012 | Multiple races | 35-44 | Male-to-male sexual contact | 237 | M |
| HIV diagnoses | 2012 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 20 | M |
| HIV diagnoses | 2012 | Multiple races | 35-44 | Other | 0 | M |
| HIV diagnoses | 2012 | Multiple races | 45-54 | Heterosexual contact | 23 | M |
| HIV diagnoses | 2012 | Multiple races | 45-54 | Injection drug use | 18 | M |
| HIV diagnoses | 2012 | Multiple races | 45-54 | Male-to-male sexual contact | 136 | M |
| HIV diagnoses | 2012 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 16 | M |
| HIV diagnoses | 2012 | Multiple races | 45-54 | Other | 0 | M |
| HIV diagnoses | 2012 | Multiple races | 55 | Heterosexual contact | 18 | M |
| HIV diagnoses | 2012 | Multiple races | 55 | Injection drug use | 11 | M |
| HIV diagnoses | 2012 | Multiple races | 55 | Male-to-male sexual contact | 64 | M |
| HIV diagnoses | 2012 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 11 | M |
| HIV diagnoses | 2012 | Multiple races | 55 | Other | 1 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 9 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 13 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 4 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 7 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 4 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV diagnoses | 2012 | White | 13-24 | Heterosexual contact | 24 | M |
| HIV diagnoses | 2012 | White | 13-24 | Injection drug use | 41 | M |
| HIV diagnoses | 2012 | White | 13-24 | Male-to-male sexual contact | 1090 | M |
| HIV diagnoses | 2012 | White | 13-24 | Male-to-male sexual contact and injection drug use | 110 | M |
| HIV diagnoses | 2012 | White | 13-24 | Other | 3 | M |
| HIV diagnoses | 2012 | White | 25-34 | Heterosexual contact | 78 | M |
| HIV diagnoses | 2012 | White | 25-34 | Injection drug use | 84 | M |
| HIV diagnoses | 2012 | White | 25-34 | Male-to-male sexual contact | 2234 | M |
| HIV diagnoses | 2012 | White | 25-34 | Male-to-male sexual contact and injection drug use | 247 | M |
| HIV diagnoses | 2012 | White | 25-34 | Other | 2 | M |
| HIV diagnoses | 2012 | White | 35-44 | Heterosexual contact | 109 | M |
| HIV diagnoses | 2012 | White | 35-44 | Injection drug use | 74 | M |
| HIV diagnoses | 2012 | White | 35-44 | Male-to-male sexual contact | 1833 | M |
| HIV diagnoses | 2012 | White | 35-44 | Male-to-male sexual contact and injection drug use | 180 | M |
| HIV diagnoses | 2012 | White | 35-44 | Other | 2 | M |
| HIV diagnoses | 2012 | White | 45-54 | Heterosexual contact | 135 | M |
| HIV diagnoses | 2012 | White | 45-54 | Injection drug use | 112 | M |
| HIV diagnoses | 2012 | White | 45-54 | Male-to-male sexual contact | 1956 | M |
| HIV diagnoses | 2012 | White | 45-54 | Male-to-male sexual contact and injection drug use | 129 | M |
| HIV diagnoses | 2012 | White | 45-54 | Other | 3 | M |
| HIV diagnoses | 2012 | White | 55 | Heterosexual contact | 101 | M |
| HIV diagnoses | 2012 | White | 55 | Injection drug use | 38 | M |
| HIV diagnoses | 2012 | White | 55 | Male-to-male sexual contact | 904 | M |
| HIV diagnoses | 2012 | White | 55 | Male-to-male sexual contact and injection drug use | 37 | M |
| HIV diagnoses | 2012 | White | 55 | Other | 5 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 13-24 | Injection drug use | 2 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 18 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 13-24 | Other | 0 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 5 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 25-34 | Injection drug use | 4 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 33 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 25-34 | Other | 0 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 35-44 | Injection drug use | 2 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 14 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 35-44 | Other | 0 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 3 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 45-54 | Injection drug use | 4 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 12 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 45-54 | Other | 0 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 55 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 55 | Injection drug use | 2 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 3 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2013 | American Indian/Alaska Native | 55 | Other | 0 | M |
| HIV diagnoses | 2013 | Asian | 13-24 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2013 | Asian | 13-24 | Injection drug use | 2 | M |
| HIV diagnoses | 2013 | Asian | 13-24 | Male-to-male sexual contact | 99 | M |
| HIV diagnoses | 2013 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2013 | Asian | 13-24 | Other | 0 | M |
| HIV diagnoses | 2013 | Asian | 25-34 | Heterosexual contact | 12 | M |
| HIV diagnoses | 2013 | Asian | 25-34 | Injection drug use | 5 | M |
| HIV diagnoses | 2013 | Asian | 25-34 | Male-to-male sexual contact | 204 | M |
| HIV diagnoses | 2013 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2013 | Asian | 25-34 | Other | 0 | M |
| HIV diagnoses | 2013 | Asian | 35-44 | Heterosexual contact | 15 | M |
| HIV diagnoses | 2013 | Asian | 35-44 | Injection drug use | 8 | M |
| HIV diagnoses | 2013 | Asian | 35-44 | Male-to-male sexual contact | 167 | M |
| HIV diagnoses | 2013 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV diagnoses | 2013 | Asian | 35-44 | Other | 0 | M |
| HIV diagnoses | 2013 | Asian | 45-54 | Heterosexual contact | 14 | M |
| HIV diagnoses | 2013 | Asian | 45-54 | Injection drug use | 3 | M |
| HIV diagnoses | 2013 | Asian | 45-54 | Male-to-male sexual contact | 71 | M |
| HIV diagnoses | 2013 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2013 | Asian | 45-54 | Other | 0 | M |
| HIV diagnoses | 2013 | Asian | 55 | Heterosexual contact | 8 | M |
| HIV diagnoses | 2013 | Asian | 55 | Injection drug use | 3 | M |
| HIV diagnoses | 2013 | Asian | 55 | Male-to-male sexual contact | 21 | M |
| HIV diagnoses | 2013 | Asian | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2013 | Asian | 55 | Other | 0 | M |
| HIV diagnoses | 2013 | Black/African American | 13-24 | Heterosexual contact | 168 | M |
| HIV diagnoses | 2013 | Black/African American | 13-24 | Injection drug use | 34 | M |
| HIV diagnoses | 2013 | Black/African American | 13-24 | Male-to-male sexual contact | 3780 | M |
| HIV diagnoses | 2013 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 99 | M |
| HIV diagnoses | 2013 | Black/African American | 13-24 | Other | 9 | M |
| HIV diagnoses | 2013 | Black/African American | 25-34 | Heterosexual contact | 417 | M |
| HIV diagnoses | 2013 | Black/African American | 25-34 | Injection drug use | 80 | M |
| HIV diagnoses | 2013 | Black/African American | 25-34 | Male-to-male sexual contact | 3059 | M |
| HIV diagnoses | 2013 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 107 | M |
| HIV diagnoses | 2013 | Black/African American | 25-34 | Other | 5 | M |
| HIV diagnoses | 2013 | Black/African American | 35-44 | Heterosexual contact | 465 | M |
| HIV diagnoses | 2013 | Black/African American | 35-44 | Injection drug use | 98 | M |
| HIV diagnoses | 2013 | Black/African American | 35-44 | Male-to-male sexual contact | 1232 | M |
| HIV diagnoses | 2013 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 47 | M |
| HIV diagnoses | 2013 | Black/African American | 35-44 | Other | 1 | M |
| HIV diagnoses | 2013 | Black/African American | 45-54 | Heterosexual contact | 564 | M |
| HIV diagnoses | 2013 | Black/African American | 45-54 | Injection drug use | 178 | M |
| HIV diagnoses | 2013 | Black/African American | 45-54 | Male-to-male sexual contact | 884 | M |
| HIV diagnoses | 2013 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 49 | M |
| HIV diagnoses | 2013 | Black/African American | 45-54 | Other | 1 | M |
| HIV diagnoses | 2013 | Black/African American | 55 | Heterosexual contact | 465 | M |
| HIV diagnoses | 2013 | Black/African American | 55 | Injection drug use | 154 | M |
| HIV diagnoses | 2013 | Black/African American | 55 | Male-to-male sexual contact | 343 | M |
| HIV diagnoses | 2013 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 29 | M |
| HIV diagnoses | 2013 | Black/African American | 55 | Other | 4 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 13-24 | Heterosexual contact | 42 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 13-24 | Injection drug use | 22 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 1555 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 79 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 13-24 | Other | 2 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 25-34 | Heterosexual contact | 179 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 25-34 | Injection drug use | 83 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 2503 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 143 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 25-34 | Other | 1 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 35-44 | Heterosexual contact | 175 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 35-44 | Injection drug use | 90 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 1416 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 78 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 35-44 | Other | 1 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 45-54 | Heterosexual contact | 142 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 45-54 | Injection drug use | 86 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 822 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 33 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 45-54 | Other | 1 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 55 | Heterosexual contact | 93 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 55 | Injection drug use | 58 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 55 | Male-to-male sexual contact | 262 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 11 | M |
| HIV diagnoses | 2013 | Hispanic/Latino | 55 | Other | 2 | M |
| HIV diagnoses | 2013 | Multiple races | 13-24 | Heterosexual contact | 12 | M |
| HIV diagnoses | 2013 | Multiple races | 13-24 | Injection drug use | 2 | M |
| HIV diagnoses | 2013 | Multiple races | 13-24 | Male-to-male sexual contact | 417 | M |
| HIV diagnoses | 2013 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 35 | M |
| HIV diagnoses | 2013 | Multiple races | 13-24 | Other | 1 | M |
| HIV diagnoses | 2013 | Multiple races | 25-34 | Heterosexual contact | 26 | M |
| HIV diagnoses | 2013 | Multiple races | 25-34 | Injection drug use | 10 | M |
| HIV diagnoses | 2013 | Multiple races | 25-34 | Male-to-male sexual contact | 410 | M |
| HIV diagnoses | 2013 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 34 | M |
| HIV diagnoses | 2013 | Multiple races | 25-34 | Other | 0 | M |
| HIV diagnoses | 2013 | Multiple races | 35-44 | Heterosexual contact | 26 | M |
| HIV diagnoses | 2013 | Multiple races | 35-44 | Injection drug use | 14 | M |
| HIV diagnoses | 2013 | Multiple races | 35-44 | Male-to-male sexual contact | 191 | M |
| HIV diagnoses | 2013 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 15 | M |
| HIV diagnoses | 2013 | Multiple races | 35-44 | Other | 0 | M |
| HIV diagnoses | 2013 | Multiple races | 45-54 | Heterosexual contact | 31 | M |
| HIV diagnoses | 2013 | Multiple races | 45-54 | Injection drug use | 18 | M |
| HIV diagnoses | 2013 | Multiple races | 45-54 | Male-to-male sexual contact | 133 | M |
| HIV diagnoses | 2013 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 15 | M |
| HIV diagnoses | 2013 | Multiple races | 45-54 | Other | 0 | M |
| HIV diagnoses | 2013 | Multiple races | 55 | Heterosexual contact | 23 | M |
| HIV diagnoses | 2013 | Multiple races | 55 | Injection drug use | 8 | M |
| HIV diagnoses | 2013 | Multiple races | 55 | Male-to-male sexual contact | 63 | M |
| HIV diagnoses | 2013 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2013 | Multiple races | 55 | Other | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 3 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 17 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 7 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 1 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 6 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV diagnoses | 2013 | White | 13-24 | Heterosexual contact | 19 | M |
| HIV diagnoses | 2013 | White | 13-24 | Injection drug use | 28 | M |
| HIV diagnoses | 2013 | White | 13-24 | Male-to-male sexual contact | 1090 | M |
| HIV diagnoses | 2013 | White | 13-24 | Male-to-male sexual contact and injection drug use | 113 | M |
| HIV diagnoses | 2013 | White | 13-24 | Other | 1 | M |
| HIV diagnoses | 2013 | White | 25-34 | Heterosexual contact | 68 | M |
| HIV diagnoses | 2013 | White | 25-34 | Injection drug use | 83 | M |
| HIV diagnoses | 2013 | White | 25-34 | Male-to-male sexual contact | 2113 | M |
| HIV diagnoses | 2013 | White | 25-34 | Male-to-male sexual contact and injection drug use | 238 | M |
| HIV diagnoses | 2013 | White | 25-34 | Other | 3 | M |
| HIV diagnoses | 2013 | White | 35-44 | Heterosexual contact | 119 | M |
| HIV diagnoses | 2013 | White | 35-44 | Injection drug use | 79 | M |
| HIV diagnoses | 2013 | White | 35-44 | Male-to-male sexual contact | 1703 | M |
| HIV diagnoses | 2013 | White | 35-44 | Male-to-male sexual contact and injection drug use | 149 | M |
| HIV diagnoses | 2013 | White | 35-44 | Other | 1 | M |
| HIV diagnoses | 2013 | White | 45-54 | Heterosexual contact | 121 | M |
| HIV diagnoses | 2013 | White | 45-54 | Injection drug use | 105 | M |
| HIV diagnoses | 2013 | White | 45-54 | Male-to-male sexual contact | 1785 | M |
| HIV diagnoses | 2013 | White | 45-54 | Male-to-male sexual contact and injection drug use | 91 | M |
| HIV diagnoses | 2013 | White | 45-54 | Other | 1 | M |
| HIV diagnoses | 2013 | White | 55 | Heterosexual contact | 136 | M |
| HIV diagnoses | 2013 | White | 55 | Injection drug use | 68 | M |
| HIV diagnoses | 2013 | White | 55 | Male-to-male sexual contact | 1028 | M |
| HIV diagnoses | 2013 | White | 55 | Male-to-male sexual contact and injection drug use | 46 | M |
| HIV diagnoses | 2013 | White | 55 | Other | 6 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 13-24 | Injection drug use | 1 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 32 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 13-24 | Other | 0 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 3 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 25-34 | Injection drug use | 2 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 46 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 25-34 | Other | 0 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 35-44 | Injection drug use | 3 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 16 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 35-44 | Other | 0 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 4 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 45-54 | Injection drug use | 4 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 17 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 5 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 45-54 | Other | 0 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 55 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 55 | Injection drug use | 0 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 2 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2014 | American Indian/Alaska Native | 55 | Other | 0 | M |
| HIV diagnoses | 2014 | Asian | 13-24 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2014 | Asian | 13-24 | Injection drug use | 2 | M |
| HIV diagnoses | 2014 | Asian | 13-24 | Male-to-male sexual contact | 141 | M |
| HIV diagnoses | 2014 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2014 | Asian | 13-24 | Other | 0 | M |
| HIV diagnoses | 2014 | Asian | 25-34 | Heterosexual contact | 18 | M |
| HIV diagnoses | 2014 | Asian | 25-34 | Injection drug use | 4 | M |
| HIV diagnoses | 2014 | Asian | 25-34 | Male-to-male sexual contact | 256 | M |
| HIV diagnoses | 2014 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV diagnoses | 2014 | Asian | 25-34 | Other | 0 | M |
| HIV diagnoses | 2014 | Asian | 35-44 | Heterosexual contact | 11 | M |
| HIV diagnoses | 2014 | Asian | 35-44 | Injection drug use | 7 | M |
| HIV diagnoses | 2014 | Asian | 35-44 | Male-to-male sexual contact | 166 | M |
| HIV diagnoses | 2014 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 8 | M |
| HIV diagnoses | 2014 | Asian | 35-44 | Other | 0 | M |
| HIV diagnoses | 2014 | Asian | 45-54 | Heterosexual contact | 12 | M |
| HIV diagnoses | 2014 | Asian | 45-54 | Injection drug use | 3 | M |
| HIV diagnoses | 2014 | Asian | 45-54 | Male-to-male sexual contact | 91 | M |
| HIV diagnoses | 2014 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2014 | Asian | 45-54 | Other | 0 | M |
| HIV diagnoses | 2014 | Asian | 55 | Heterosexual contact | 9 | M |
| HIV diagnoses | 2014 | Asian | 55 | Injection drug use | 2 | M |
| HIV diagnoses | 2014 | Asian | 55 | Male-to-male sexual contact | 25 | M |
| HIV diagnoses | 2014 | Asian | 55 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2014 | Asian | 55 | Other | 0 | M |
| HIV diagnoses | 2014 | Black/African American | 13-24 | Heterosexual contact | 191 | M |
| HIV diagnoses | 2014 | Black/African American | 13-24 | Injection drug use | 38 | M |
| HIV diagnoses | 2014 | Black/African American | 13-24 | Male-to-male sexual contact | 3934 | M |
| HIV diagnoses | 2014 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 66 | M |
| HIV diagnoses | 2014 | Black/African American | 13-24 | Other | 9 | M |
| HIV diagnoses | 2014 | Black/African American | 25-34 | Heterosexual contact | 414 | M |
| HIV diagnoses | 2014 | Black/African American | 25-34 | Injection drug use | 72 | M |
| HIV diagnoses | 2014 | Black/African American | 25-34 | Male-to-male sexual contact | 3482 | M |
| HIV diagnoses | 2014 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 92 | M |
| HIV diagnoses | 2014 | Black/African American | 25-34 | Other | 2 | M |
| HIV diagnoses | 2014 | Black/African American | 35-44 | Heterosexual contact | 492 | M |
| HIV diagnoses | 2014 | Black/African American | 35-44 | Injection drug use | 86 | M |
| HIV diagnoses | 2014 | Black/African American | 35-44 | Male-to-male sexual contact | 1184 | M |
| HIV diagnoses | 2014 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 53 | M |
| HIV diagnoses | 2014 | Black/African American | 35-44 | Other | 1 | M |
| HIV diagnoses | 2014 | Black/African American | 45-54 | Heterosexual contact | 505 | M |
| HIV diagnoses | 2014 | Black/African American | 45-54 | Injection drug use | 133 | M |
| HIV diagnoses | 2014 | Black/African American | 45-54 | Male-to-male sexual contact | 810 | M |
| HIV diagnoses | 2014 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 37 | M |
| HIV diagnoses | 2014 | Black/African American | 45-54 | Other | 2 | M |
| HIV diagnoses | 2014 | Black/African American | 55 | Heterosexual contact | 434 | M |
| HIV diagnoses | 2014 | Black/African American | 55 | Injection drug use | 157 | M |
| HIV diagnoses | 2014 | Black/African American | 55 | Male-to-male sexual contact | 407 | M |
| HIV diagnoses | 2014 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 28 | M |
| HIV diagnoses | 2014 | Black/African American | 55 | Other | 4 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 13-24 | Heterosexual contact | 46 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 13-24 | Injection drug use | 20 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 1745 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 71 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 13-24 | Other | 4 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 25-34 | Heterosexual contact | 156 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 25-34 | Injection drug use | 72 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 2699 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 129 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 25-34 | Other | 1 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 35-44 | Heterosexual contact | 200 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 35-44 | Injection drug use | 85 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 1538 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 76 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 35-44 | Other | 0 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 45-54 | Heterosexual contact | 154 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 45-54 | Injection drug use | 83 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 840 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 39 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 45-54 | Other | 0 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 55 | Heterosexual contact | 90 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 55 | Injection drug use | 47 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 55 | Male-to-male sexual contact | 266 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 13 | M |
| HIV diagnoses | 2014 | Hispanic/Latino | 55 | Other | 1 | M |
| HIV diagnoses | 2014 | Multiple races | 13-24 | Heterosexual contact | 6 | M |
| HIV diagnoses | 2014 | Multiple races | 13-24 | Injection drug use | 2 | M |
| HIV diagnoses | 2014 | Multiple races | 13-24 | Male-to-male sexual contact | 340 | M |
| HIV diagnoses | 2014 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 29 | M |
| HIV diagnoses | 2014 | Multiple races | 13-24 | Other | 0 | M |
| HIV diagnoses | 2014 | Multiple races | 25-34 | Heterosexual contact | 16 | M |
| HIV diagnoses | 2014 | Multiple races | 25-34 | Injection drug use | 16 | M |
| HIV diagnoses | 2014 | Multiple races | 25-34 | Male-to-male sexual contact | 380 | M |
| HIV diagnoses | 2014 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 28 | M |
| HIV diagnoses | 2014 | Multiple races | 25-34 | Other | 0 | M |
| HIV diagnoses | 2014 | Multiple races | 35-44 | Heterosexual contact | 27 | M |
| HIV diagnoses | 2014 | Multiple races | 35-44 | Injection drug use | 9 | M |
| HIV diagnoses | 2014 | Multiple races | 35-44 | Male-to-male sexual contact | 180 | M |
| HIV diagnoses | 2014 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 18 | M |
| HIV diagnoses | 2014 | Multiple races | 35-44 | Other | 0 | M |
| HIV diagnoses | 2014 | Multiple races | 45-54 | Heterosexual contact | 31 | M |
| HIV diagnoses | 2014 | Multiple races | 45-54 | Injection drug use | 10 | M |
| HIV diagnoses | 2014 | Multiple races | 45-54 | Male-to-male sexual contact | 124 | M |
| HIV diagnoses | 2014 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 13 | M |
| HIV diagnoses | 2014 | Multiple races | 45-54 | Other | 0 | M |
| HIV diagnoses | 2014 | Multiple races | 55 | Heterosexual contact | 16 | M |
| HIV diagnoses | 2014 | Multiple races | 55 | Injection drug use | 8 | M |
| HIV diagnoses | 2014 | Multiple races | 55 | Male-to-male sexual contact | 45 | M |
| HIV diagnoses | 2014 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2014 | Multiple races | 55 | Other | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 6 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 9 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 10 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 4 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 1 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 2 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV diagnoses | 2014 | White | 13-24 | Heterosexual contact | 22 | M |
| HIV diagnoses | 2014 | White | 13-24 | Injection drug use | 27 | M |
| HIV diagnoses | 2014 | White | 13-24 | Male-to-male sexual contact | 1113 | M |
| HIV diagnoses | 2014 | White | 13-24 | Male-to-male sexual contact and injection drug use | 93 | M |
| HIV diagnoses | 2014 | White | 13-24 | Other | 2 | M |
| HIV diagnoses | 2014 | White | 25-34 | Heterosexual contact | 79 | M |
| HIV diagnoses | 2014 | White | 25-34 | Injection drug use | 95 | M |
| HIV diagnoses | 2014 | White | 25-34 | Male-to-male sexual contact | 2273 | M |
| HIV diagnoses | 2014 | White | 25-34 | Male-to-male sexual contact and injection drug use | 267 | M |
| HIV diagnoses | 2014 | White | 25-34 | Other | 1 | M |
| HIV diagnoses | 2014 | White | 35-44 | Heterosexual contact | 87 | M |
| HIV diagnoses | 2014 | White | 35-44 | Injection drug use | 101 | M |
| HIV diagnoses | 2014 | White | 35-44 | Male-to-male sexual contact | 1615 | M |
| HIV diagnoses | 2014 | White | 35-44 | Male-to-male sexual contact and injection drug use | 167 | M |
| HIV diagnoses | 2014 | White | 35-44 | Other | 1 | M |
| HIV diagnoses | 2014 | White | 45-54 | Heterosexual contact | 134 | M |
| HIV diagnoses | 2014 | White | 45-54 | Injection drug use | 105 | M |
| HIV diagnoses | 2014 | White | 45-54 | Male-to-male sexual contact | 1737 | M |
| HIV diagnoses | 2014 | White | 45-54 | Male-to-male sexual contact and injection drug use | 113 | M |
| HIV diagnoses | 2014 | White | 45-54 | Other | 0 | M |
| HIV diagnoses | 2014 | White | 55 | Heterosexual contact | 110 | M |
| HIV diagnoses | 2014 | White | 55 | Injection drug use | 59 | M |
| HIV diagnoses | 2014 | White | 55 | Male-to-male sexual contact | 892 | M |
| HIV diagnoses | 2014 | White | 55 | Male-to-male sexual contact and injection drug use | 34 | M |
| HIV diagnoses | 2014 | White | 55 | Other | 4 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 35 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 13-24 | Other | 0 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 25-34 | Injection drug use | 4 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 40 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 25-34 | Other | 0 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 35-44 | Injection drug use | 1 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 19 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 35-44 | Other | 0 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 5 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 45-54 | Injection drug use | 1 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 11 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 45-54 | Other | 0 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 55 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 55 | Injection drug use | 1 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 3 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2015 | American Indian/Alaska Native | 55 | Other | 0 | M |
| HIV diagnoses | 2015 | Asian | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2015 | Asian | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2015 | Asian | 13-24 | Male-to-male sexual contact | 144 | M |
| HIV diagnoses | 2015 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV diagnoses | 2015 | Asian | 13-24 | Other | 1 | M |
| HIV diagnoses | 2015 | Asian | 25-34 | Heterosexual contact | 10 | M |
| HIV diagnoses | 2015 | Asian | 25-34 | Injection drug use | 8 | M |
| HIV diagnoses | 2015 | Asian | 25-34 | Male-to-male sexual contact | 271 | M |
| HIV diagnoses | 2015 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 6 | M |
| HIV diagnoses | 2015 | Asian | 25-34 | Other | 0 | M |
| HIV diagnoses | 2015 | Asian | 35-44 | Heterosexual contact | 28 | M |
| HIV diagnoses | 2015 | Asian | 35-44 | Injection drug use | 4 | M |
| HIV diagnoses | 2015 | Asian | 35-44 | Male-to-male sexual contact | 154 | M |
| HIV diagnoses | 2015 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 7 | M |
| HIV diagnoses | 2015 | Asian | 35-44 | Other | 0 | M |
| HIV diagnoses | 2015 | Asian | 45-54 | Heterosexual contact | 15 | M |
| HIV diagnoses | 2015 | Asian | 45-54 | Injection drug use | 3 | M |
| HIV diagnoses | 2015 | Asian | 45-54 | Male-to-male sexual contact | 97 | M |
| HIV diagnoses | 2015 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2015 | Asian | 45-54 | Other | 0 | M |
| HIV diagnoses | 2015 | Asian | 55 | Heterosexual contact | 9 | M |
| HIV diagnoses | 2015 | Asian | 55 | Injection drug use | 3 | M |
| HIV diagnoses | 2015 | Asian | 55 | Male-to-male sexual contact | 23 | M |
| HIV diagnoses | 2015 | Asian | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2015 | Asian | 55 | Other | 1 | M |
| HIV diagnoses | 2015 | Black/African American | 13-24 | Heterosexual contact | 196 | M |
| HIV diagnoses | 2015 | Black/African American | 13-24 | Injection drug use | 33 | M |
| HIV diagnoses | 2015 | Black/African American | 13-24 | Male-to-male sexual contact | 3870 | M |
| HIV diagnoses | 2015 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 74 | M |
| HIV diagnoses | 2015 | Black/African American | 13-24 | Other | 7 | M |
| HIV diagnoses | 2015 | Black/African American | 25-34 | Heterosexual contact | 457 | M |
| HIV diagnoses | 2015 | Black/African American | 25-34 | Injection drug use | 76 | M |
| HIV diagnoses | 2015 | Black/African American | 25-34 | Male-to-male sexual contact | 3684 | M |
| HIV diagnoses | 2015 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 85 | M |
| HIV diagnoses | 2015 | Black/African American | 25-34 | Other | 2 | M |
| HIV diagnoses | 2015 | Black/African American | 35-44 | Heterosexual contact | 477 | M |
| HIV diagnoses | 2015 | Black/African American | 35-44 | Injection drug use | 90 | M |
| HIV diagnoses | 2015 | Black/African American | 35-44 | Male-to-male sexual contact | 1224 | M |
| HIV diagnoses | 2015 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 51 | M |
| HIV diagnoses | 2015 | Black/African American | 35-44 | Other | 1 | M |
| HIV diagnoses | 2015 | Black/African American | 45-54 | Heterosexual contact | 514 | M |
| HIV diagnoses | 2015 | Black/African American | 45-54 | Injection drug use | 111 | M |
| HIV diagnoses | 2015 | Black/African American | 45-54 | Male-to-male sexual contact | 827 | M |
| HIV diagnoses | 2015 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 31 | M |
| HIV diagnoses | 2015 | Black/African American | 45-54 | Other | 3 | M |
| HIV diagnoses | 2015 | Black/African American | 55 | Heterosexual contact | 443 | M |
| HIV diagnoses | 2015 | Black/African American | 55 | Injection drug use | 121 | M |
| HIV diagnoses | 2015 | Black/African American | 55 | Male-to-male sexual contact | 375 | M |
| HIV diagnoses | 2015 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 23 | M |
| HIV diagnoses | 2015 | Black/African American | 55 | Other | 2 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 13-24 | Heterosexual contact | 37 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 13-24 | Injection drug use | 23 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 1813 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 85 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 13-24 | Other | 3 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 25-34 | Heterosexual contact | 138 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 25-34 | Injection drug use | 80 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 2782 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 150 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 25-34 | Other | 2 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 35-44 | Heterosexual contact | 181 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 35-44 | Injection drug use | 86 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 1524 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 69 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 35-44 | Other | 2 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 45-54 | Heterosexual contact | 132 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 45-54 | Injection drug use | 71 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 896 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 33 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 45-54 | Other | 1 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 55 | Heterosexual contact | 108 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 55 | Injection drug use | 51 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 55 | Male-to-male sexual contact | 290 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 8 | M |
| HIV diagnoses | 2015 | Hispanic/Latino | 55 | Other | 1 | M |
| HIV diagnoses | 2015 | Multiple races | 13-24 | Heterosexual contact | 10 | M |
| HIV diagnoses | 2015 | Multiple races | 13-24 | Injection drug use | 3 | M |
| HIV diagnoses | 2015 | Multiple races | 13-24 | Male-to-male sexual contact | 314 | M |
| HIV diagnoses | 2015 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 17 | M |
| HIV diagnoses | 2015 | Multiple races | 13-24 | Other | 1 | M |
| HIV diagnoses | 2015 | Multiple races | 25-34 | Heterosexual contact | 19 | M |
| HIV diagnoses | 2015 | Multiple races | 25-34 | Injection drug use | 14 | M |
| HIV diagnoses | 2015 | Multiple races | 25-34 | Male-to-male sexual contact | 391 | M |
| HIV diagnoses | 2015 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 43 | M |
| HIV diagnoses | 2015 | Multiple races | 25-34 | Other | 0 | M |
| HIV diagnoses | 2015 | Multiple races | 35-44 | Heterosexual contact | 13 | M |
| HIV diagnoses | 2015 | Multiple races | 35-44 | Injection drug use | 3 | M |
| HIV diagnoses | 2015 | Multiple races | 35-44 | Male-to-male sexual contact | 150 | M |
| HIV diagnoses | 2015 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 11 | M |
| HIV diagnoses | 2015 | Multiple races | 35-44 | Other | 0 | M |
| HIV diagnoses | 2015 | Multiple races | 45-54 | Heterosexual contact | 21 | M |
| HIV diagnoses | 2015 | Multiple races | 45-54 | Injection drug use | 7 | M |
| HIV diagnoses | 2015 | Multiple races | 45-54 | Male-to-male sexual contact | 100 | M |
| HIV diagnoses | 2015 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 6 | M |
| HIV diagnoses | 2015 | Multiple races | 45-54 | Other | 0 | M |
| HIV diagnoses | 2015 | Multiple races | 55 | Heterosexual contact | 18 | M |
| HIV diagnoses | 2015 | Multiple races | 55 | Injection drug use | 11 | M |
| HIV diagnoses | 2015 | Multiple races | 55 | Male-to-male sexual contact | 55 | M |
| HIV diagnoses | 2015 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2015 | Multiple races | 55 | Other | 0 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 11 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 22 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 2 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 10 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 0 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 11 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 2 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV diagnoses | 2015 | White | 13-24 | Heterosexual contact | 16 | M |
| HIV diagnoses | 2015 | White | 13-24 | Injection drug use | 44 | M |
| HIV diagnoses | 2015 | White | 13-24 | Male-to-male sexual contact | 1095 | M |
| HIV diagnoses | 2015 | White | 13-24 | Male-to-male sexual contact and injection drug use | 119 | M |
| HIV diagnoses | 2015 | White | 13-24 | Other | 1 | M |
| HIV diagnoses | 2015 | White | 25-34 | Heterosexual contact | 70 | M |
| HIV diagnoses | 2015 | White | 25-34 | Injection drug use | 161 | M |
| HIV diagnoses | 2015 | White | 25-34 | Male-to-male sexual contact | 2265 | M |
| HIV diagnoses | 2015 | White | 25-34 | Male-to-male sexual contact and injection drug use | 285 | M |
| HIV diagnoses | 2015 | White | 25-34 | Other | 1 | M |
| HIV diagnoses | 2015 | White | 35-44 | Heterosexual contact | 83 | M |
| HIV diagnoses | 2015 | White | 35-44 | Injection drug use | 108 | M |
| HIV diagnoses | 2015 | White | 35-44 | Male-to-male sexual contact | 1446 | M |
| HIV diagnoses | 2015 | White | 35-44 | Male-to-male sexual contact and injection drug use | 152 | M |
| HIV diagnoses | 2015 | White | 35-44 | Other | 1 | M |
| HIV diagnoses | 2015 | White | 45-54 | Heterosexual contact | 108 | M |
| HIV diagnoses | 2015 | White | 45-54 | Injection drug use | 122 | M |
| HIV diagnoses | 2015 | White | 45-54 | Male-to-male sexual contact | 1565 | M |
| HIV diagnoses | 2015 | White | 45-54 | Male-to-male sexual contact and injection drug use | 108 | M |
| HIV diagnoses | 2015 | White | 45-54 | Other | 1 | M |
| HIV diagnoses | 2015 | White | 55 | Heterosexual contact | 130 | M |
| HIV diagnoses | 2015 | White | 55 | Injection drug use | 61 | M |
| HIV diagnoses | 2015 | White | 55 | Male-to-male sexual contact | 868 | M |
| HIV diagnoses | 2015 | White | 55 | Male-to-male sexual contact and injection drug use | 48 | M |
| HIV diagnoses | 2015 | White | 55 | Other | 5 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 13-24 | Injection drug use | 3 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 27 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 13-24 | Other | 0 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 25-34 | Injection drug use | 4 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 68 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 10 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 25-34 | Other | 0 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 35-44 | Injection drug use | 3 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 25 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 35-44 | Other | 0 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 45-54 | Injection drug use | 2 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 11 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 45-54 | Other | 0 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 55 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 55 | Injection drug use | 3 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 6 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2016 | American Indian/Alaska Native | 55 | Other | 0 | M |
| HIV diagnoses | 2016 | Asian | 13-24 | Heterosexual contact | 3 | M |
| HIV diagnoses | 2016 | Asian | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2016 | Asian | 13-24 | Male-to-male sexual contact | 133 | M |
| HIV diagnoses | 2016 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 5 | M |
| HIV diagnoses | 2016 | Asian | 13-24 | Other | 1 | M |
| HIV diagnoses | 2016 | Asian | 25-34 | Heterosexual contact | 14 | M |
| HIV diagnoses | 2016 | Asian | 25-34 | Injection drug use | 3 | M |
| HIV diagnoses | 2016 | Asian | 25-34 | Male-to-male sexual contact | 291 | M |
| HIV diagnoses | 2016 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2016 | Asian | 25-34 | Other | 0 | M |
| HIV diagnoses | 2016 | Asian | 35-44 | Heterosexual contact | 17 | M |
| HIV diagnoses | 2016 | Asian | 35-44 | Injection drug use | 4 | M |
| HIV diagnoses | 2016 | Asian | 35-44 | Male-to-male sexual contact | 170 | M |
| HIV diagnoses | 2016 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2016 | Asian | 35-44 | Other | 0 | M |
| HIV diagnoses | 2016 | Asian | 45-54 | Heterosexual contact | 11 | M |
| HIV diagnoses | 2016 | Asian | 45-54 | Injection drug use | 5 | M |
| HIV diagnoses | 2016 | Asian | 45-54 | Male-to-male sexual contact | 85 | M |
| HIV diagnoses | 2016 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2016 | Asian | 45-54 | Other | 0 | M |
| HIV diagnoses | 2016 | Asian | 55 | Heterosexual contact | 14 | M |
| HIV diagnoses | 2016 | Asian | 55 | Injection drug use | 3 | M |
| HIV diagnoses | 2016 | Asian | 55 | Male-to-male sexual contact | 39 | M |
| HIV diagnoses | 2016 | Asian | 55 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2016 | Asian | 55 | Other | 1 | M |
| HIV diagnoses | 2016 | Black/African American | 13-24 | Heterosexual contact | 202 | M |
| HIV diagnoses | 2016 | Black/African American | 13-24 | Injection drug use | 23 | M |
| HIV diagnoses | 2016 | Black/African American | 13-24 | Male-to-male sexual contact | 3684 | M |
| HIV diagnoses | 2016 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 68 | M |
| HIV diagnoses | 2016 | Black/African American | 13-24 | Other | 5 | M |
| HIV diagnoses | 2016 | Black/African American | 25-34 | Heterosexual contact | 490 | M |
| HIV diagnoses | 2016 | Black/African American | 25-34 | Injection drug use | 67 | M |
| HIV diagnoses | 2016 | Black/African American | 25-34 | Male-to-male sexual contact | 3820 | M |
| HIV diagnoses | 2016 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 110 | M |
| HIV diagnoses | 2016 | Black/African American | 25-34 | Other | 2 | M |
| HIV diagnoses | 2016 | Black/African American | 35-44 | Heterosexual contact | 460 | M |
| HIV diagnoses | 2016 | Black/African American | 35-44 | Injection drug use | 93 | M |
| HIV diagnoses | 2016 | Black/African American | 35-44 | Male-to-male sexual contact | 1194 | M |
| HIV diagnoses | 2016 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 48 | M |
| HIV diagnoses | 2016 | Black/African American | 35-44 | Other | 2 | M |
| HIV diagnoses | 2016 | Black/African American | 45-54 | Heterosexual contact | 469 | M |
| HIV diagnoses | 2016 | Black/African American | 45-54 | Injection drug use | 102 | M |
| HIV diagnoses | 2016 | Black/African American | 45-54 | Male-to-male sexual contact | 754 | M |
| HIV diagnoses | 2016 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 31 | M |
| HIV diagnoses | 2016 | Black/African American | 45-54 | Other | 2 | M |
| HIV diagnoses | 2016 | Black/African American | 55 | Heterosexual contact | 434 | M |
| HIV diagnoses | 2016 | Black/African American | 55 | Injection drug use | 109 | M |
| HIV diagnoses | 2016 | Black/African American | 55 | Male-to-male sexual contact | 387 | M |
| HIV diagnoses | 2016 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 21 | M |
| HIV diagnoses | 2016 | Black/African American | 55 | Other | 2 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 13-24 | Heterosexual contact | 57 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 13-24 | Injection drug use | 22 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 1767 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 83 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 13-24 | Other | 1 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 25-34 | Heterosexual contact | 164 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 25-34 | Injection drug use | 83 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 3090 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 145 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 25-34 | Other | 1 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 35-44 | Heterosexual contact | 168 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 35-44 | Injection drug use | 68 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 1569 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 76 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 35-44 | Other | 0 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 45-54 | Heterosexual contact | 134 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 45-54 | Injection drug use | 71 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 830 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 30 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 45-54 | Other | 1 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 55 | Heterosexual contact | 91 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 55 | Injection drug use | 49 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 55 | Male-to-male sexual contact | 287 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 12 | M |
| HIV diagnoses | 2016 | Hispanic/Latino | 55 | Other | 2 | M |
| HIV diagnoses | 2016 | Multiple races | 13-24 | Heterosexual contact | 9 | M |
| HIV diagnoses | 2016 | Multiple races | 13-24 | Injection drug use | 3 | M |
| HIV diagnoses | 2016 | Multiple races | 13-24 | Male-to-male sexual contact | 276 | M |
| HIV diagnoses | 2016 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 19 | M |
| HIV diagnoses | 2016 | Multiple races | 13-24 | Other | 1 | M |
| HIV diagnoses | 2016 | Multiple races | 25-34 | Heterosexual contact | 16 | M |
| HIV diagnoses | 2016 | Multiple races | 25-34 | Injection drug use | 5 | M |
| HIV diagnoses | 2016 | Multiple races | 25-34 | Male-to-male sexual contact | 348 | M |
| HIV diagnoses | 2016 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 31 | M |
| HIV diagnoses | 2016 | Multiple races | 25-34 | Other | 0 | M |
| HIV diagnoses | 2016 | Multiple races | 35-44 | Heterosexual contact | 29 | M |
| HIV diagnoses | 2016 | Multiple races | 35-44 | Injection drug use | 11 | M |
| HIV diagnoses | 2016 | Multiple races | 35-44 | Male-to-male sexual contact | 125 | M |
| HIV diagnoses | 2016 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 9 | M |
| HIV diagnoses | 2016 | Multiple races | 35-44 | Other | 0 | M |
| HIV diagnoses | 2016 | Multiple races | 45-54 | Heterosexual contact | 17 | M |
| HIV diagnoses | 2016 | Multiple races | 45-54 | Injection drug use | 10 | M |
| HIV diagnoses | 2016 | Multiple races | 45-54 | Male-to-male sexual contact | 87 | M |
| HIV diagnoses | 2016 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 11 | M |
| HIV diagnoses | 2016 | Multiple races | 45-54 | Other | 0 | M |
| HIV diagnoses | 2016 | Multiple races | 55 | Heterosexual contact | 14 | M |
| HIV diagnoses | 2016 | Multiple races | 55 | Injection drug use | 5 | M |
| HIV diagnoses | 2016 | Multiple races | 55 | Male-to-male sexual contact | 55 | M |
| HIV diagnoses | 2016 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV diagnoses | 2016 | Multiple races | 55 | Other | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 2 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 10 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 10 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 3 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 1 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV diagnoses | 2016 | White | 13-24 | Heterosexual contact | 36 | M |
| HIV diagnoses | 2016 | White | 13-24 | Injection drug use | 34 | M |
| HIV diagnoses | 2016 | White | 13-24 | Male-to-male sexual contact | 1054 | M |
| HIV diagnoses | 2016 | White | 13-24 | Male-to-male sexual contact and injection drug use | 111 | M |
| HIV diagnoses | 2016 | White | 13-24 | Other | 0 | M |
| HIV diagnoses | 2016 | White | 25-34 | Heterosexual contact | 87 | M |
| HIV diagnoses | 2016 | White | 25-34 | Injection drug use | 141 | M |
| HIV diagnoses | 2016 | White | 25-34 | Male-to-male sexual contact | 2208 | M |
| HIV diagnoses | 2016 | White | 25-34 | Male-to-male sexual contact and injection drug use | 270 | M |
| HIV diagnoses | 2016 | White | 25-34 | Other | 0 | M |
| HIV diagnoses | 2016 | White | 35-44 | Heterosexual contact | 98 | M |
| HIV diagnoses | 2016 | White | 35-44 | Injection drug use | 115 | M |
| HIV diagnoses | 2016 | White | 35-44 | Male-to-male sexual contact | 1315 | M |
| HIV diagnoses | 2016 | White | 35-44 | Male-to-male sexual contact and injection drug use | 150 | M |
| HIV diagnoses | 2016 | White | 35-44 | Other | 0 | M |
| HIV diagnoses | 2016 | White | 45-54 | Heterosexual contact | 123 | M |
| HIV diagnoses | 2016 | White | 45-54 | Injection drug use | 100 | M |
| HIV diagnoses | 2016 | White | 45-54 | Male-to-male sexual contact | 1469 | M |
| HIV diagnoses | 2016 | White | 45-54 | Male-to-male sexual contact and injection drug use | 95 | M |
| HIV diagnoses | 2016 | White | 45-54 | Other | 1 | M |
| HIV diagnoses | 2016 | White | 55 | Heterosexual contact | 125 | M |
| HIV diagnoses | 2016 | White | 55 | Injection drug use | 64 | M |
| HIV diagnoses | 2016 | White | 55 | Male-to-male sexual contact | 894 | M |
| HIV diagnoses | 2016 | White | 55 | Male-to-male sexual contact and injection drug use | 51 | M |
| HIV diagnoses | 2016 | White | 55 | Other | 4 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 13-24 | Injection drug use | 1 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 20 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 13-24 | Other | 0 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 3 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 25-34 | Injection drug use | 10 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 53 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 13 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 25-34 | Other | 0 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 3 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 35-44 | Injection drug use | 1 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 27 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 35-44 | Other | 0 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 45-54 | Injection drug use | 3 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 14 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 45-54 | Other | 0 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 55 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 55 | Injection drug use | 2 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 4 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV diagnoses | 2017 | American Indian/Alaska Native | 55 | Other | 0 | M |
| HIV diagnoses | 2017 | Asian | 13-24 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2017 | Asian | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2017 | Asian | 13-24 | Male-to-male sexual contact | 177 | M |
| HIV diagnoses | 2017 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2017 | Asian | 13-24 | Other | 1 | M |
| HIV diagnoses | 2017 | Asian | 25-34 | Heterosexual contact | 7 | M |
| HIV diagnoses | 2017 | Asian | 25-34 | Injection drug use | 2 | M |
| HIV diagnoses | 2017 | Asian | 25-34 | Male-to-male sexual contact | 267 | M |
| HIV diagnoses | 2017 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 9 | M |
| HIV diagnoses | 2017 | Asian | 25-34 | Other | 0 | M |
| HIV diagnoses | 2017 | Asian | 35-44 | Heterosexual contact | 12 | M |
| HIV diagnoses | 2017 | Asian | 35-44 | Injection drug use | 5 | M |
| HIV diagnoses | 2017 | Asian | 35-44 | Male-to-male sexual contact | 163 | M |
| HIV diagnoses | 2017 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV diagnoses | 2017 | Asian | 35-44 | Other | 0 | M |
| HIV diagnoses | 2017 | Asian | 45-54 | Heterosexual contact | 8 | M |
| HIV diagnoses | 2017 | Asian | 45-54 | Injection drug use | 4 | M |
| HIV diagnoses | 2017 | Asian | 45-54 | Male-to-male sexual contact | 101 | M |
| HIV diagnoses | 2017 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV diagnoses | 2017 | Asian | 45-54 | Other | 0 | M |
| HIV diagnoses | 2017 | Asian | 55 | Heterosexual contact | 10 | M |
| HIV diagnoses | 2017 | Asian | 55 | Injection drug use | 0 | M |
| HIV diagnoses | 2017 | Asian | 55 | Male-to-male sexual contact | 34 | M |
| HIV diagnoses | 2017 | Asian | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2017 | Asian | 55 | Other | 1 | M |
| HIV diagnoses | 2017 | Black/African American | 13-24 | Heterosexual contact | 157 | M |
| HIV diagnoses | 2017 | Black/African American | 13-24 | Injection drug use | 27 | M |
| HIV diagnoses | 2017 | Black/African American | 13-24 | Male-to-male sexual contact | 3429 | M |
| HIV diagnoses | 2017 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 46 | M |
| HIV diagnoses | 2017 | Black/African American | 13-24 | Other | 8 | M |
| HIV diagnoses | 2017 | Black/African American | 25-34 | Heterosexual contact | 410 | M |
| HIV diagnoses | 2017 | Black/African American | 25-34 | Injection drug use | 94 | M |
| HIV diagnoses | 2017 | Black/African American | 25-34 | Male-to-male sexual contact | 3899 | M |
| HIV diagnoses | 2017 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 106 | M |
| HIV diagnoses | 2017 | Black/African American | 25-34 | Other | 2 | M |
| HIV diagnoses | 2017 | Black/African American | 35-44 | Heterosexual contact | 405 | M |
| HIV diagnoses | 2017 | Black/African American | 35-44 | Injection drug use | 78 | M |
| HIV diagnoses | 2017 | Black/African American | 35-44 | Male-to-male sexual contact | 1220 | M |
| HIV diagnoses | 2017 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 54 | M |
| HIV diagnoses | 2017 | Black/African American | 35-44 | Other | 1 | M |
| HIV diagnoses | 2017 | Black/African American | 45-54 | Heterosexual contact | 384 | M |
| HIV diagnoses | 2017 | Black/African American | 45-54 | Injection drug use | 96 | M |
| HIV diagnoses | 2017 | Black/African American | 45-54 | Male-to-male sexual contact | 709 | M |
| HIV diagnoses | 2017 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 35 | M |
| HIV diagnoses | 2017 | Black/African American | 45-54 | Other | 2 | M |
| HIV diagnoses | 2017 | Black/African American | 55 | Heterosexual contact | 418 | M |
| HIV diagnoses | 2017 | Black/African American | 55 | Injection drug use | 120 | M |
| HIV diagnoses | 2017 | Black/African American | 55 | Male-to-male sexual contact | 383 | M |
| HIV diagnoses | 2017 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 20 | M |
| HIV diagnoses | 2017 | Black/African American | 55 | Other | 5 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 13-24 | Heterosexual contact | 36 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 13-24 | Injection drug use | 23 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 1670 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 71 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 13-24 | Other | 1 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 25-34 | Heterosexual contact | 131 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 25-34 | Injection drug use | 96 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 3026 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 146 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 25-34 | Other | 2 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 35-44 | Heterosexual contact | 155 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 35-44 | Injection drug use | 84 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 1498 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 69 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 35-44 | Other | 2 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 45-54 | Heterosexual contact | 108 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 45-54 | Injection drug use | 76 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 859 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 34 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 45-54 | Other | 0 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 55 | Heterosexual contact | 91 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 55 | Injection drug use | 51 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 55 | Male-to-male sexual contact | 313 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 12 | M |
| HIV diagnoses | 2017 | Hispanic/Latino | 55 | Other | 2 | M |
| HIV diagnoses | 2017 | Multiple races | 13-24 | Heterosexual contact | 5 | M |
| HIV diagnoses | 2017 | Multiple races | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2017 | Multiple races | 13-24 | Male-to-male sexual contact | 220 | M |
| HIV diagnoses | 2017 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 11 | M |
| HIV diagnoses | 2017 | Multiple races | 13-24 | Other | 0 | M |
| HIV diagnoses | 2017 | Multiple races | 25-34 | Heterosexual contact | 14 | M |
| HIV diagnoses | 2017 | Multiple races | 25-34 | Injection drug use | 9 | M |
| HIV diagnoses | 2017 | Multiple races | 25-34 | Male-to-male sexual contact | 314 | M |
| HIV diagnoses | 2017 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 16 | M |
| HIV diagnoses | 2017 | Multiple races | 25-34 | Other | 0 | M |
| HIV diagnoses | 2017 | Multiple races | 35-44 | Heterosexual contact | 13 | M |
| HIV diagnoses | 2017 | Multiple races | 35-44 | Injection drug use | 7 | M |
| HIV diagnoses | 2017 | Multiple races | 35-44 | Male-to-male sexual contact | 114 | M |
| HIV diagnoses | 2017 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 11 | M |
| HIV diagnoses | 2017 | Multiple races | 35-44 | Other | 0 | M |
| HIV diagnoses | 2017 | Multiple races | 45-54 | Heterosexual contact | 11 | M |
| HIV diagnoses | 2017 | Multiple races | 45-54 | Injection drug use | 6 | M |
| HIV diagnoses | 2017 | Multiple races | 45-54 | Male-to-male sexual contact | 80 | M |
| HIV diagnoses | 2017 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 8 | M |
| HIV diagnoses | 2017 | Multiple races | 45-54 | Other | 0 | M |
| HIV diagnoses | 2017 | Multiple races | 55 | Heterosexual contact | 14 | M |
| HIV diagnoses | 2017 | Multiple races | 55 | Injection drug use | 4 | M |
| HIV diagnoses | 2017 | Multiple races | 55 | Male-to-male sexual contact | 37 | M |
| HIV diagnoses | 2017 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV diagnoses | 2017 | Multiple races | 55 | Other | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 10 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 2 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 19 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 7 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 1 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 2 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 1 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV diagnoses | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV diagnoses | 2017 | White | 13-24 | Heterosexual contact | 21 | M |
| HIV diagnoses | 2017 | White | 13-24 | Injection drug use | 40 | M |
| HIV diagnoses | 2017 | White | 13-24 | Male-to-male sexual contact | 1124 | M |
| HIV diagnoses | 2017 | White | 13-24 | Male-to-male sexual contact and injection drug use | 94 | M |
| HIV diagnoses | 2017 | White | 13-24 | Other | 2 | M |
| HIV diagnoses | 2017 | White | 25-34 | Heterosexual contact | 92 | M |
| HIV diagnoses | 2017 | White | 25-34 | Injection drug use | 176 | M |
| HIV diagnoses | 2017 | White | 25-34 | Male-to-male sexual contact | 2170 | M |
| HIV diagnoses | 2017 | White | 25-34 | Male-to-male sexual contact and injection drug use | 278 | M |
| HIV diagnoses | 2017 | White | 25-34 | Other | 0 | M |
| HIV diagnoses | 2017 | White | 35-44 | Heterosexual contact | 104 | M |
| HIV diagnoses | 2017 | White | 35-44 | Injection drug use | 126 | M |
| HIV diagnoses | 2017 | White | 35-44 | Male-to-male sexual contact | 1257 | M |
| HIV diagnoses | 2017 | White | 35-44 | Male-to-male sexual contact and injection drug use | 150 | M |
| HIV diagnoses | 2017 | White | 35-44 | Other | 1 | M |
| HIV diagnoses | 2017 | White | 45-54 | Heterosexual contact | 114 | M |
| HIV diagnoses | 2017 | White | 45-54 | Injection drug use | 93 | M |
| HIV diagnoses | 2017 | White | 45-54 | Male-to-male sexual contact | 1323 | M |
| HIV diagnoses | 2017 | White | 45-54 | Male-to-male sexual contact and injection drug use | 92 | M |
| HIV diagnoses | 2017 | White | 45-54 | Other | 1 | M |
| HIV diagnoses | 2017 | White | 55 | Heterosexual contact | 117 | M |
| HIV diagnoses | 2017 | White | 55 | Injection drug use | 72 | M |
| HIV diagnoses | 2017 | White | 55 | Male-to-male sexual contact | 863 | M |
| HIV diagnoses | 2017 | White | 55 | Male-to-male sexual contact and injection drug use | 50 | M |
| HIV diagnoses | 2017 | White | 55 | Other | 3 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 0 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 13-24 | Injection drug use | 2 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 31 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 13-24 | Other | 2 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 15 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 25-34 | Injection drug use | 14 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 157 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 34 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 25-34 | Other | 2 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 33 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 35-44 | Injection drug use | 49 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 326 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 93 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 35-44 | Other | 6 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 35 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 45-54 | Injection drug use | 80 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 283 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 88 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 45-54 | Other | 3 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 55 | Heterosexual contact | 27 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 55 | Injection drug use | 22 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 92 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 22 | M |
| HIV prevalence | 2008 | American Indian/Alaska Native | 55 | Other | 0 | M |
| HIV prevalence | 2008 | Asian | 13-24 | Heterosexual contact | 9 | M |
| HIV prevalence | 2008 | Asian | 13-24 | Injection drug use | 6 | M |
| HIV prevalence | 2008 | Asian | 13-24 | Male-to-male sexual contact | 128 | M |
| HIV prevalence | 2008 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 6 | M |
| HIV prevalence | 2008 | Asian | 13-24 | Other | 15 | M |
| HIV prevalence | 2008 | Asian | 25-34 | Heterosexual contact | 72 | M |
| HIV prevalence | 2008 | Asian | 25-34 | Injection drug use | 43 | M |
| HIV prevalence | 2008 | Asian | 25-34 | Male-to-male sexual contact | 840 | M |
| HIV prevalence | 2008 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 43 | M |
| HIV prevalence | 2008 | Asian | 25-34 | Other | 17 | M |
| HIV prevalence | 2008 | Asian | 35-44 | Heterosexual contact | 209 | M |
| HIV prevalence | 2008 | Asian | 35-44 | Injection drug use | 80 | M |
| HIV prevalence | 2008 | Asian | 35-44 | Male-to-male sexual contact | 1849 | M |
| HIV prevalence | 2008 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 109 | M |
| HIV prevalence | 2008 | Asian | 35-44 | Other | 14 | M |
| HIV prevalence | 2008 | Asian | 45-54 | Heterosexual contact | 146 | M |
| HIV prevalence | 2008 | Asian | 45-54 | Injection drug use | 94 | M |
| HIV prevalence | 2008 | Asian | 45-54 | Male-to-male sexual contact | 1223 | M |
| HIV prevalence | 2008 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 54 | M |
| HIV prevalence | 2008 | Asian | 45-54 | Other | 12 | M |
| HIV prevalence | 2008 | Asian | 55 | Heterosexual contact | 112 | M |
| HIV prevalence | 2008 | Asian | 55 | Injection drug use | 53 | M |
| HIV prevalence | 2008 | Asian | 55 | Male-to-male sexual contact | 572 | M |
| HIV prevalence | 2008 | Asian | 55 | Male-to-male sexual contact and injection drug use | 25 | M |
| HIV prevalence | 2008 | Asian | 55 | Other | 12 | M |
| HIV prevalence | 2008 | Black/African American | 13-24 | Heterosexual contact | 627 | M |
| HIV prevalence | 2008 | Black/African American | 13-24 | Injection drug use | 171 | M |
| HIV prevalence | 2008 | Black/African American | 13-24 | Male-to-male sexual contact | 9135 | M |
| HIV prevalence | 2008 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 396 | M |
| HIV prevalence | 2008 | Black/African American | 13-24 | Other | 2004 | M |
| HIV prevalence | 2008 | Black/African American | 25-34 | Heterosexual contact | 4038 | M |
| HIV prevalence | 2008 | Black/African American | 25-34 | Injection drug use | 1472 | M |
| HIV prevalence | 2008 | Black/African American | 25-34 | Male-to-male sexual contact | 20994 | M |
| HIV prevalence | 2008 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 1665 | M |
| HIV prevalence | 2008 | Black/African American | 25-34 | Other | 165 | M |
| HIV prevalence | 2008 | Black/African American | 35-44 | Heterosexual contact | 11666 | M |
| HIV prevalence | 2008 | Black/African American | 35-44 | Injection drug use | 6995 | M |
| HIV prevalence | 2008 | Black/African American | 35-44 | Male-to-male sexual contact | 33410 | M |
| HIV prevalence | 2008 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 4919 | M |
| HIV prevalence | 2008 | Black/African American | 35-44 | Other | 159 | M |
| HIV prevalence | 2008 | Black/African American | 45-54 | Heterosexual contact | 14100 | M |
| HIV prevalence | 2008 | Black/African American | 45-54 | Injection drug use | 17906 | M |
| HIV prevalence | 2008 | Black/African American | 45-54 | Male-to-male sexual contact | 29460 | M |
| HIV prevalence | 2008 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 7035 | M |
| HIV prevalence | 2008 | Black/African American | 45-54 | Other | 175 | M |
| HIV prevalence | 2008 | Black/African American | 55 | Heterosexual contact | 8376 | M |
| HIV prevalence | 2008 | Black/African American | 55 | Injection drug use | 12803 | M |
| HIV prevalence | 2008 | Black/African American | 55 | Male-to-male sexual contact | 11006 | M |
| HIV prevalence | 2008 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 2625 | M |
| HIV prevalence | 2008 | Black/African American | 55 | Other | 159 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 13-24 | Heterosexual contact | 217 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 13-24 | Injection drug use | 108 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 3358 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 293 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 13-24 | Other | 913 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 25-34 | Heterosexual contact | 1731 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 25-34 | Injection drug use | 1404 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 15710 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 1840 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 25-34 | Other | 129 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 35-44 | Heterosexual contact | 3684 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 35-44 | Injection drug use | 5326 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 29664 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 3959 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 35-44 | Other | 101 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 45-54 | Heterosexual contact | 3465 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 45-54 | Injection drug use | 8908 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 21291 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 3709 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 45-54 | Other | 92 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 55 | Heterosexual contact | 2165 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 55 | Injection drug use | 4775 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 55 | Male-to-male sexual contact | 7743 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 1105 | M |
| HIV prevalence | 2008 | Hispanic/Latino | 55 | Other | 76 | M |
| HIV prevalence | 2008 | Multiple races | 13-24 | Heterosexual contact | 45 | M |
| HIV prevalence | 2008 | Multiple races | 13-24 | Injection drug use | 16 | M |
| HIV prevalence | 2008 | Multiple races | 13-24 | Male-to-male sexual contact | 1033 | M |
| HIV prevalence | 2008 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 107 | M |
| HIV prevalence | 2008 | Multiple races | 13-24 | Other | 230 | M |
| HIV prevalence | 2008 | Multiple races | 25-34 | Heterosexual contact | 253 | M |
| HIV prevalence | 2008 | Multiple races | 25-34 | Injection drug use | 131 | M |
| HIV prevalence | 2008 | Multiple races | 25-34 | Male-to-male sexual contact | 3386 | M |
| HIV prevalence | 2008 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 578 | M |
| HIV prevalence | 2008 | Multiple races | 25-34 | Other | 46 | M |
| HIV prevalence | 2008 | Multiple races | 35-44 | Heterosexual contact | 742 | M |
| HIV prevalence | 2008 | Multiple races | 35-44 | Injection drug use | 705 | M |
| HIV prevalence | 2008 | Multiple races | 35-44 | Male-to-male sexual contact | 6351 | M |
| HIV prevalence | 2008 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 1446 | M |
| HIV prevalence | 2008 | Multiple races | 35-44 | Other | 34 | M |
| HIV prevalence | 2008 | Multiple races | 45-54 | Heterosexual contact | 902 | M |
| HIV prevalence | 2008 | Multiple races | 45-54 | Injection drug use | 1690 | M |
| HIV prevalence | 2008 | Multiple races | 45-54 | Male-to-male sexual contact | 5760 | M |
| HIV prevalence | 2008 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 1578 | M |
| HIV prevalence | 2008 | Multiple races | 45-54 | Other | 36 | M |
| HIV prevalence | 2008 | Multiple races | 55 | Heterosexual contact | 492 | M |
| HIV prevalence | 2008 | Multiple races | 55 | Injection drug use | 1065 | M |
| HIV prevalence | 2008 | Multiple races | 55 | Male-to-male sexual contact | 2200 | M |
| HIV prevalence | 2008 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 505 | M |
| HIV prevalence | 2008 | Multiple races | 55 | Other | 22 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 8 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 0 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 1 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 60 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 1 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 12 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 2 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 118 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 10 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 0 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 6 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 6 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 97 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 9 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 5 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 4 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 33 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV prevalence | 2008 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV prevalence | 2008 | White | 13-24 | Heterosexual contact | 64 | M |
| HIV prevalence | 2008 | White | 13-24 | Injection drug use | 71 | M |
| HIV prevalence | 2008 | White | 13-24 | Male-to-male sexual contact | 2291 | M |
| HIV prevalence | 2008 | White | 13-24 | Male-to-male sexual contact and injection drug use | 316 | M |
| HIV prevalence | 2008 | White | 13-24 | Other | 454 | M |
| HIV prevalence | 2008 | White | 25-34 | Heterosexual contact | 540 | M |
| HIV prevalence | 2008 | White | 25-34 | Injection drug use | 812 | M |
| HIV prevalence | 2008 | White | 25-34 | Male-to-male sexual contact | 14545 | M |
| HIV prevalence | 2008 | White | 25-34 | Male-to-male sexual contact and injection drug use | 2459 | M |
| HIV prevalence | 2008 | White | 25-34 | Other | 322 | M |
| HIV prevalence | 2008 | White | 35-44 | Heterosexual contact | 2054 | M |
| HIV prevalence | 2008 | White | 35-44 | Injection drug use | 3511 | M |
| HIV prevalence | 2008 | White | 35-44 | Male-to-male sexual contact | 51305 | M |
| HIV prevalence | 2008 | White | 35-44 | Male-to-male sexual contact and injection drug use | 7346 | M |
| HIV prevalence | 2008 | White | 35-44 | Other | 496 | M |
| HIV prevalence | 2008 | White | 45-54 | Heterosexual contact | 2907 | M |
| HIV prevalence | 2008 | White | 45-54 | Injection drug use | 6539 | M |
| HIV prevalence | 2008 | White | 45-54 | Male-to-male sexual contact | 67299 | M |
| HIV prevalence | 2008 | White | 45-54 | Male-to-male sexual contact and injection drug use | 8361 | M |
| HIV prevalence | 2008 | White | 45-54 | Other | 471 | M |
| HIV prevalence | 2008 | White | 55 | Heterosexual contact | 2064 | M |
| HIV prevalence | 2008 | White | 55 | Injection drug use | 2966 | M |
| HIV prevalence | 2008 | White | 55 | Male-to-male sexual contact | 34897 | M |
| HIV prevalence | 2008 | White | 55 | Male-to-male sexual contact and injection drug use | 2673 | M |
| HIV prevalence | 2008 | White | 55 | Other | 318 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 1 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 13-24 | Injection drug use | 1 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 28 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 13-24 | Other | 3 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 14 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 25-34 | Injection drug use | 19 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 181 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 31 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 25-34 | Other | 2 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 37 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 35-44 | Injection drug use | 33 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 319 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 88 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 35-44 | Other | 6 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 36 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 45-54 | Injection drug use | 92 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 301 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 95 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 45-54 | Other | 3 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 55 | Heterosexual contact | 29 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 55 | Injection drug use | 25 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 105 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 26 | M |
| HIV prevalence | 2009 | American Indian/Alaska Native | 55 | Other | 0 | M |
| HIV prevalence | 2009 | Asian | 13-24 | Heterosexual contact | 7 | M |
| HIV prevalence | 2009 | Asian | 13-24 | Injection drug use | 5 | M |
| HIV prevalence | 2009 | Asian | 13-24 | Male-to-male sexual contact | 150 | M |
| HIV prevalence | 2009 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 9 | M |
| HIV prevalence | 2009 | Asian | 13-24 | Other | 15 | M |
| HIV prevalence | 2009 | Asian | 25-34 | Heterosexual contact | 66 | M |
| HIV prevalence | 2009 | Asian | 25-34 | Injection drug use | 39 | M |
| HIV prevalence | 2009 | Asian | 25-34 | Male-to-male sexual contact | 883 | M |
| HIV prevalence | 2009 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 49 | M |
| HIV prevalence | 2009 | Asian | 25-34 | Other | 18 | M |
| HIV prevalence | 2009 | Asian | 35-44 | Heterosexual contact | 222 | M |
| HIV prevalence | 2009 | Asian | 35-44 | Injection drug use | 86 | M |
| HIV prevalence | 2009 | Asian | 35-44 | Male-to-male sexual contact | 1958 | M |
| HIV prevalence | 2009 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 109 | M |
| HIV prevalence | 2009 | Asian | 35-44 | Other | 12 | M |
| HIV prevalence | 2009 | Asian | 45-54 | Heterosexual contact | 158 | M |
| HIV prevalence | 2009 | Asian | 45-54 | Injection drug use | 97 | M |
| HIV prevalence | 2009 | Asian | 45-54 | Male-to-male sexual contact | 1346 | M |
| HIV prevalence | 2009 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 68 | M |
| HIV prevalence | 2009 | Asian | 45-54 | Other | 12 | M |
| HIV prevalence | 2009 | Asian | 55 | Heterosexual contact | 131 | M |
| HIV prevalence | 2009 | Asian | 55 | Injection drug use | 63 | M |
| HIV prevalence | 2009 | Asian | 55 | Male-to-male sexual contact | 670 | M |
| HIV prevalence | 2009 | Asian | 55 | Male-to-male sexual contact and injection drug use | 28 | M |
| HIV prevalence | 2009 | Asian | 55 | Other | 14 | M |
| HIV prevalence | 2009 | Black/African American | 13-24 | Heterosexual contact | 661 | M |
| HIV prevalence | 2009 | Black/African American | 13-24 | Injection drug use | 152 | M |
| HIV prevalence | 2009 | Black/African American | 13-24 | Male-to-male sexual contact | 10579 | M |
| HIV prevalence | 2009 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 401 | M |
| HIV prevalence | 2009 | Black/African American | 13-24 | Other | 2109 | M |
| HIV prevalence | 2009 | Black/African American | 25-34 | Heterosexual contact | 3993 | M |
| HIV prevalence | 2009 | Black/African American | 25-34 | Injection drug use | 1395 | M |
| HIV prevalence | 2009 | Black/African American | 25-34 | Male-to-male sexual contact | 23232 | M |
| HIV prevalence | 2009 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 1659 | M |
| HIV prevalence | 2009 | Black/African American | 25-34 | Other | 209 | M |
| HIV prevalence | 2009 | Black/African American | 35-44 | Heterosexual contact | 11134 | M |
| HIV prevalence | 2009 | Black/African American | 35-44 | Injection drug use | 6018 | M |
| HIV prevalence | 2009 | Black/African American | 35-44 | Male-to-male sexual contact | 32566 | M |
| HIV prevalence | 2009 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 4350 | M |
| HIV prevalence | 2009 | Black/African American | 35-44 | Other | 144 | M |
| HIV prevalence | 2009 | Black/African American | 45-54 | Heterosexual contact | 15081 | M |
| HIV prevalence | 2009 | Black/African American | 45-54 | Injection drug use | 16998 | M |
| HIV prevalence | 2009 | Black/African American | 45-54 | Male-to-male sexual contact | 32175 | M |
| HIV prevalence | 2009 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 7142 | M |
| HIV prevalence | 2009 | Black/African American | 45-54 | Other | 176 | M |
| HIV prevalence | 2009 | Black/African American | 55 | Heterosexual contact | 9489 | M |
| HIV prevalence | 2009 | Black/African American | 55 | Injection drug use | 14108 | M |
| HIV prevalence | 2009 | Black/African American | 55 | Male-to-male sexual contact | 12658 | M |
| HIV prevalence | 2009 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 2985 | M |
| HIV prevalence | 2009 | Black/African American | 55 | Other | 165 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 13-24 | Heterosexual contact | 197 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 13-24 | Injection drug use | 106 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 3679 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 296 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 13-24 | Other | 924 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 25-34 | Heterosexual contact | 1785 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 25-34 | Injection drug use | 1279 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 16702 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 1868 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 25-34 | Other | 155 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 35-44 | Heterosexual contact | 3679 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 35-44 | Injection drug use | 4829 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 29550 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 3694 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 35-44 | Other | 102 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 45-54 | Heterosexual contact | 3780 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 45-54 | Injection drug use | 8848 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 23954 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 3930 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 45-54 | Other | 92 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 55 | Heterosexual contact | 2409 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 55 | Injection drug use | 5333 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 55 | Male-to-male sexual contact | 9015 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 1309 | M |
| HIV prevalence | 2009 | Hispanic/Latino | 55 | Other | 82 | M |
| HIV prevalence | 2009 | Multiple races | 13-24 | Heterosexual contact | 47 | M |
| HIV prevalence | 2009 | Multiple races | 13-24 | Injection drug use | 13 | M |
| HIV prevalence | 2009 | Multiple races | 13-24 | Male-to-male sexual contact | 1179 | M |
| HIV prevalence | 2009 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 107 | M |
| HIV prevalence | 2009 | Multiple races | 13-24 | Other | 245 | M |
| HIV prevalence | 2009 | Multiple races | 25-34 | Heterosexual contact | 261 | M |
| HIV prevalence | 2009 | Multiple races | 25-34 | Injection drug use | 114 | M |
| HIV prevalence | 2009 | Multiple races | 25-34 | Male-to-male sexual contact | 3569 | M |
| HIV prevalence | 2009 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 580 | M |
| HIV prevalence | 2009 | Multiple races | 25-34 | Other | 51 | M |
| HIV prevalence | 2009 | Multiple races | 35-44 | Heterosexual contact | 722 | M |
| HIV prevalence | 2009 | Multiple races | 35-44 | Injection drug use | 601 | M |
| HIV prevalence | 2009 | Multiple races | 35-44 | Male-to-male sexual contact | 6083 | M |
| HIV prevalence | 2009 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 1317 | M |
| HIV prevalence | 2009 | Multiple races | 35-44 | Other | 32 | M |
| HIV prevalence | 2009 | Multiple races | 45-54 | Heterosexual contact | 956 | M |
| HIV prevalence | 2009 | Multiple races | 45-54 | Injection drug use | 1598 | M |
| HIV prevalence | 2009 | Multiple races | 45-54 | Male-to-male sexual contact | 6371 | M |
| HIV prevalence | 2009 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 1663 | M |
| HIV prevalence | 2009 | Multiple races | 45-54 | Other | 36 | M |
| HIV prevalence | 2009 | Multiple races | 55 | Heterosexual contact | 569 | M |
| HIV prevalence | 2009 | Multiple races | 55 | Injection drug use | 1198 | M |
| HIV prevalence | 2009 | Multiple races | 55 | Male-to-male sexual contact | 2484 | M |
| HIV prevalence | 2009 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 588 | M |
| HIV prevalence | 2009 | Multiple races | 55 | Other | 25 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 10 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 0 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 2 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 65 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 11 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 2 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 118 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 9 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 1 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 9 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 5 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 105 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 11 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 5 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 5 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 44 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV prevalence | 2009 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV prevalence | 2009 | White | 13-24 | Heterosexual contact | 62 | M |
| HIV prevalence | 2009 | White | 13-24 | Injection drug use | 65 | M |
| HIV prevalence | 2009 | White | 13-24 | Male-to-male sexual contact | 2501 | M |
| HIV prevalence | 2009 | White | 13-24 | Male-to-male sexual contact and injection drug use | 328 | M |
| HIV prevalence | 2009 | White | 13-24 | Other | 467 | M |
| HIV prevalence | 2009 | White | 25-34 | Heterosexual contact | 537 | M |
| HIV prevalence | 2009 | White | 25-34 | Injection drug use | 781 | M |
| HIV prevalence | 2009 | White | 25-34 | Male-to-male sexual contact | 15107 | M |
| HIV prevalence | 2009 | White | 25-34 | Male-to-male sexual contact and injection drug use | 2423 | M |
| HIV prevalence | 2009 | White | 25-34 | Other | 304 | M |
| HIV prevalence | 2009 | White | 35-44 | Heterosexual contact | 1928 | M |
| HIV prevalence | 2009 | White | 35-44 | Injection drug use | 3126 | M |
| HIV prevalence | 2009 | White | 35-44 | Male-to-male sexual contact | 46965 | M |
| HIV prevalence | 2009 | White | 35-44 | Male-to-male sexual contact and injection drug use | 6676 | M |
| HIV prevalence | 2009 | White | 35-44 | Other | 448 | M |
| HIV prevalence | 2009 | White | 45-54 | Heterosexual contact | 3079 | M |
| HIV prevalence | 2009 | White | 45-54 | Injection drug use | 6468 | M |
| HIV prevalence | 2009 | White | 45-54 | Male-to-male sexual contact | 71894 | M |
| HIV prevalence | 2009 | White | 45-54 | Male-to-male sexual contact and injection drug use | 8886 | M |
| HIV prevalence | 2009 | White | 45-54 | Other | 493 | M |
| HIV prevalence | 2009 | White | 55 | Heterosexual contact | 2299 | M |
| HIV prevalence | 2009 | White | 55 | Injection drug use | 3357 | M |
| HIV prevalence | 2009 | White | 55 | Male-to-male sexual contact | 39470 | M |
| HIV prevalence | 2009 | White | 55 | Male-to-male sexual contact and injection drug use | 3057 | M |
| HIV prevalence | 2009 | White | 55 | Other | 335 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 1 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 13-24 | Injection drug use | 0 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 35 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 7 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 13-24 | Other | 3 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 13 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 25-34 | Injection drug use | 21 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 197 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 26 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 25-34 | Other | 2 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 40 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 35-44 | Injection drug use | 30 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 307 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 81 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 35-44 | Other | 6 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 38 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 45-54 | Injection drug use | 88 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 307 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 100 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 45-54 | Other | 3 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 55 | Heterosexual contact | 32 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 55 | Injection drug use | 35 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 132 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 32 | M |
| HIV prevalence | 2010 | American Indian/Alaska Native | 55 | Other | 0 | M |
| HIV prevalence | 2010 | Asian | 13-24 | Heterosexual contact | 5 | M |
| HIV prevalence | 2010 | Asian | 13-24 | Injection drug use | 4 | M |
| HIV prevalence | 2010 | Asian | 13-24 | Male-to-male sexual contact | 172 | M |
| HIV prevalence | 2010 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 8 | M |
| HIV prevalence | 2010 | Asian | 13-24 | Other | 18 | M |
| HIV prevalence | 2010 | Asian | 25-34 | Heterosexual contact | 71 | M |
| HIV prevalence | 2010 | Asian | 25-34 | Injection drug use | 40 | M |
| HIV prevalence | 2010 | Asian | 25-34 | Male-to-male sexual contact | 957 | M |
| HIV prevalence | 2010 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 47 | M |
| HIV prevalence | 2010 | Asian | 25-34 | Other | 16 | M |
| HIV prevalence | 2010 | Asian | 35-44 | Heterosexual contact | 245 | M |
| HIV prevalence | 2010 | Asian | 35-44 | Injection drug use | 89 | M |
| HIV prevalence | 2010 | Asian | 35-44 | Male-to-male sexual contact | 2034 | M |
| HIV prevalence | 2010 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 114 | M |
| HIV prevalence | 2010 | Asian | 35-44 | Other | 15 | M |
| HIV prevalence | 2010 | Asian | 45-54 | Heterosexual contact | 176 | M |
| HIV prevalence | 2010 | Asian | 45-54 | Injection drug use | 107 | M |
| HIV prevalence | 2010 | Asian | 45-54 | Male-to-male sexual contact | 1515 | M |
| HIV prevalence | 2010 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 86 | M |
| HIV prevalence | 2010 | Asian | 45-54 | Other | 13 | M |
| HIV prevalence | 2010 | Asian | 55 | Heterosexual contact | 150 | M |
| HIV prevalence | 2010 | Asian | 55 | Injection drug use | 69 | M |
| HIV prevalence | 2010 | Asian | 55 | Male-to-male sexual contact | 771 | M |
| HIV prevalence | 2010 | Asian | 55 | Male-to-male sexual contact and injection drug use | 29 | M |
| HIV prevalence | 2010 | Asian | 55 | Other | 15 | M |
| HIV prevalence | 2010 | Black/African American | 13-24 | Heterosexual contact | 664 | M |
| HIV prevalence | 2010 | Black/African American | 13-24 | Injection drug use | 144 | M |
| HIV prevalence | 2010 | Black/African American | 13-24 | Male-to-male sexual contact | 11769 | M |
| HIV prevalence | 2010 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 414 | M |
| HIV prevalence | 2010 | Black/African American | 13-24 | Other | 2201 | M |
| HIV prevalence | 2010 | Black/African American | 25-34 | Heterosexual contact | 4010 | M |
| HIV prevalence | 2010 | Black/African American | 25-34 | Injection drug use | 1329 | M |
| HIV prevalence | 2010 | Black/African American | 25-34 | Male-to-male sexual contact | 25937 | M |
| HIV prevalence | 2010 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 1663 | M |
| HIV prevalence | 2010 | Black/African American | 25-34 | Other | 263 | M |
| HIV prevalence | 2010 | Black/African American | 35-44 | Heterosexual contact | 10721 | M |
| HIV prevalence | 2010 | Black/African American | 35-44 | Injection drug use | 5242 | M |
| HIV prevalence | 2010 | Black/African American | 35-44 | Male-to-male sexual contact | 31665 | M |
| HIV prevalence | 2010 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 3831 | M |
| HIV prevalence | 2010 | Black/African American | 35-44 | Other | 120 | M |
| HIV prevalence | 2010 | Black/African American | 45-54 | Heterosexual contact | 15854 | M |
| HIV prevalence | 2010 | Black/African American | 45-54 | Injection drug use | 16085 | M |
| HIV prevalence | 2010 | Black/African American | 45-54 | Male-to-male sexual contact | 34838 | M |
| HIV prevalence | 2010 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 7224 | M |
| HIV prevalence | 2010 | Black/African American | 45-54 | Other | 183 | M |
| HIV prevalence | 2010 | Black/African American | 55 | Heterosexual contact | 10638 | M |
| HIV prevalence | 2010 | Black/African American | 55 | Injection drug use | 15463 | M |
| HIV prevalence | 2010 | Black/African American | 55 | Male-to-male sexual contact | 14490 | M |
| HIV prevalence | 2010 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 3399 | M |
| HIV prevalence | 2010 | Black/African American | 55 | Other | 175 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 13-24 | Heterosexual contact | 172 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 13-24 | Injection drug use | 99 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 4051 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 298 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 13-24 | Other | 955 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 25-34 | Heterosexual contact | 1771 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 25-34 | Injection drug use | 1210 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 17854 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 1859 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 25-34 | Other | 201 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 35-44 | Heterosexual contact | 3707 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 35-44 | Injection drug use | 4498 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 29291 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 3562 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 35-44 | Other | 99 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 45-54 | Heterosexual contact | 4052 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 45-54 | Injection drug use | 8785 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 26585 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 4187 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 45-54 | Other | 96 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 55 | Heterosexual contact | 2671 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 55 | Injection drug use | 5960 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 55 | Male-to-male sexual contact | 10377 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 1505 | M |
| HIV prevalence | 2010 | Hispanic/Latino | 55 | Other | 86 | M |
| HIV prevalence | 2010 | Multiple races | 13-24 | Heterosexual contact | 43 | M |
| HIV prevalence | 2010 | Multiple races | 13-24 | Injection drug use | 12 | M |
| HIV prevalence | 2010 | Multiple races | 13-24 | Male-to-male sexual contact | 1287 | M |
| HIV prevalence | 2010 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 109 | M |
| HIV prevalence | 2010 | Multiple races | 13-24 | Other | 244 | M |
| HIV prevalence | 2010 | Multiple races | 25-34 | Heterosexual contact | 260 | M |
| HIV prevalence | 2010 | Multiple races | 25-34 | Injection drug use | 117 | M |
| HIV prevalence | 2010 | Multiple races | 25-34 | Male-to-male sexual contact | 3843 | M |
| HIV prevalence | 2010 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 578 | M |
| HIV prevalence | 2010 | Multiple races | 25-34 | Other | 58 | M |
| HIV prevalence | 2010 | Multiple races | 35-44 | Heterosexual contact | 689 | M |
| HIV prevalence | 2010 | Multiple races | 35-44 | Injection drug use | 514 | M |
| HIV prevalence | 2010 | Multiple races | 35-44 | Male-to-male sexual contact | 5865 | M |
| HIV prevalence | 2010 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 1213 | M |
| HIV prevalence | 2010 | Multiple races | 35-44 | Other | 31 | M |
| HIV prevalence | 2010 | Multiple races | 45-54 | Heterosexual contact | 1003 | M |
| HIV prevalence | 2010 | Multiple races | 45-54 | Injection drug use | 1501 | M |
| HIV prevalence | 2010 | Multiple races | 45-54 | Male-to-male sexual contact | 6875 | M |
| HIV prevalence | 2010 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 1724 | M |
| HIV prevalence | 2010 | Multiple races | 45-54 | Other | 41 | M |
| HIV prevalence | 2010 | Multiple races | 55 | Heterosexual contact | 642 | M |
| HIV prevalence | 2010 | Multiple races | 55 | Injection drug use | 1319 | M |
| HIV prevalence | 2010 | Multiple races | 55 | Male-to-male sexual contact | 2824 | M |
| HIV prevalence | 2010 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 664 | M |
| HIV prevalence | 2010 | Multiple races | 55 | Other | 27 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 12 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 1 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 4 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 74 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 5 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 11 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 3 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 118 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 7 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 1 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 9 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 6 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 110 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 11 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 6 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 5 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 55 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV prevalence | 2010 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV prevalence | 2010 | White | 13-24 | Heterosexual contact | 60 | M |
| HIV prevalence | 2010 | White | 13-24 | Injection drug use | 63 | M |
| HIV prevalence | 2010 | White | 13-24 | Male-to-male sexual contact | 2735 | M |
| HIV prevalence | 2010 | White | 13-24 | Male-to-male sexual contact and injection drug use | 346 | M |
| HIV prevalence | 2010 | White | 13-24 | Other | 475 | M |
| HIV prevalence | 2010 | White | 25-34 | Heterosexual contact | 537 | M |
| HIV prevalence | 2010 | White | 25-34 | Injection drug use | 752 | M |
| HIV prevalence | 2010 | White | 25-34 | Male-to-male sexual contact | 15886 | M |
| HIV prevalence | 2010 | White | 25-34 | Male-to-male sexual contact and injection drug use | 2402 | M |
| HIV prevalence | 2010 | White | 25-34 | Other | 287 | M |
| HIV prevalence | 2010 | White | 35-44 | Heterosexual contact | 1831 | M |
| HIV prevalence | 2010 | White | 35-44 | Injection drug use | 2760 | M |
| HIV prevalence | 2010 | White | 35-44 | Male-to-male sexual contact | 43314 | M |
| HIV prevalence | 2010 | White | 35-44 | Male-to-male sexual contact and injection drug use | 6123 | M |
| HIV prevalence | 2010 | White | 35-44 | Other | 426 | M |
| HIV prevalence | 2010 | White | 45-54 | Heterosexual contact | 3157 | M |
| HIV prevalence | 2010 | White | 45-54 | Injection drug use | 6352 | M |
| HIV prevalence | 2010 | White | 45-54 | Male-to-male sexual contact | 75366 | M |
| HIV prevalence | 2010 | White | 45-54 | Male-to-male sexual contact and injection drug use | 9156 | M |
| HIV prevalence | 2010 | White | 45-54 | Other | 502 | M |
| HIV prevalence | 2010 | White | 55 | Heterosexual contact | 2574 | M |
| HIV prevalence | 2010 | White | 55 | Injection drug use | 3765 | M |
| HIV prevalence | 2010 | White | 55 | Male-to-male sexual contact | 44378 | M |
| HIV prevalence | 2010 | White | 55 | Male-to-male sexual contact and injection drug use | 3525 | M |
| HIV prevalence | 2010 | White | 55 | Other | 350 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 4 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 13-24 | Injection drug use | 0 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 42 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 9 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 13-24 | Other | 3 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 11 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 25-34 | Injection drug use | 22 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 197 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 25 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 25-34 | Other | 2 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 40 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 35-44 | Injection drug use | 30 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 308 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 71 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 35-44 | Other | 6 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 40 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 45-54 | Injection drug use | 87 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 328 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 108 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 45-54 | Other | 3 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 55 | Heterosexual contact | 33 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 55 | Injection drug use | 36 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 150 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 36 | M |
| HIV prevalence | 2011 | American Indian/Alaska Native | 55 | Other | 0 | M |
| HIV prevalence | 2011 | Asian | 13-24 | Heterosexual contact | 4 | M |
| HIV prevalence | 2011 | Asian | 13-24 | Injection drug use | 3 | M |
| HIV prevalence | 2011 | Asian | 13-24 | Male-to-male sexual contact | 207 | M |
| HIV prevalence | 2011 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 7 | M |
| HIV prevalence | 2011 | Asian | 13-24 | Other | 18 | M |
| HIV prevalence | 2011 | Asian | 25-34 | Heterosexual contact | 74 | M |
| HIV prevalence | 2011 | Asian | 25-34 | Injection drug use | 36 | M |
| HIV prevalence | 2011 | Asian | 25-34 | Male-to-male sexual contact | 1032 | M |
| HIV prevalence | 2011 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 58 | M |
| HIV prevalence | 2011 | Asian | 25-34 | Other | 17 | M |
| HIV prevalence | 2011 | Asian | 35-44 | Heterosexual contact | 249 | M |
| HIV prevalence | 2011 | Asian | 35-44 | Injection drug use | 96 | M |
| HIV prevalence | 2011 | Asian | 35-44 | Male-to-male sexual contact | 2123 | M |
| HIV prevalence | 2011 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 117 | M |
| HIV prevalence | 2011 | Asian | 35-44 | Other | 15 | M |
| HIV prevalence | 2011 | Asian | 45-54 | Heterosexual contact | 196 | M |
| HIV prevalence | 2011 | Asian | 45-54 | Injection drug use | 112 | M |
| HIV prevalence | 2011 | Asian | 45-54 | Male-to-male sexual contact | 1655 | M |
| HIV prevalence | 2011 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 91 | M |
| HIV prevalence | 2011 | Asian | 45-54 | Other | 13 | M |
| HIV prevalence | 2011 | Asian | 55 | Heterosexual contact | 166 | M |
| HIV prevalence | 2011 | Asian | 55 | Injection drug use | 74 | M |
| HIV prevalence | 2011 | Asian | 55 | Male-to-male sexual contact | 901 | M |
| HIV prevalence | 2011 | Asian | 55 | Male-to-male sexual contact and injection drug use | 34 | M |
| HIV prevalence | 2011 | Asian | 55 | Other | 13 | M |
| HIV prevalence | 2011 | Black/African American | 13-24 | Heterosexual contact | 648 | M |
| HIV prevalence | 2011 | Black/African American | 13-24 | Injection drug use | 131 | M |
| HIV prevalence | 2011 | Black/African American | 13-24 | Male-to-male sexual contact | 12587 | M |
| HIV prevalence | 2011 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 395 | M |
| HIV prevalence | 2011 | Black/African American | 13-24 | Other | 2248 | M |
| HIV prevalence | 2011 | Black/African American | 25-34 | Heterosexual contact | 3983 | M |
| HIV prevalence | 2011 | Black/African American | 25-34 | Injection drug use | 1239 | M |
| HIV prevalence | 2011 | Black/African American | 25-34 | Male-to-male sexual contact | 29056 | M |
| HIV prevalence | 2011 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 1673 | M |
| HIV prevalence | 2011 | Black/African American | 25-34 | Other | 333 | M |
| HIV prevalence | 2011 | Black/African American | 35-44 | Heterosexual contact | 10253 | M |
| HIV prevalence | 2011 | Black/African American | 35-44 | Injection drug use | 4540 | M |
| HIV prevalence | 2011 | Black/African American | 35-44 | Male-to-male sexual contact | 30743 | M |
| HIV prevalence | 2011 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 3383 | M |
| HIV prevalence | 2011 | Black/African American | 35-44 | Other | 109 | M |
| HIV prevalence | 2011 | Black/African American | 45-54 | Heterosexual contact | 16363 | M |
| HIV prevalence | 2011 | Black/African American | 45-54 | Injection drug use | 14946 | M |
| HIV prevalence | 2011 | Black/African American | 45-54 | Male-to-male sexual contact | 37022 | M |
| HIV prevalence | 2011 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 7133 | M |
| HIV prevalence | 2011 | Black/African American | 45-54 | Other | 178 | M |
| HIV prevalence | 2011 | Black/African American | 55 | Heterosexual contact | 11932 | M |
| HIV prevalence | 2011 | Black/African American | 55 | Injection drug use | 16730 | M |
| HIV prevalence | 2011 | Black/African American | 55 | Male-to-male sexual contact | 16641 | M |
| HIV prevalence | 2011 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 3880 | M |
| HIV prevalence | 2011 | Black/African American | 55 | Other | 186 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 13-24 | Heterosexual contact | 150 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 13-24 | Injection drug use | 87 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 4249 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 303 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 13-24 | Other | 937 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 25-34 | Heterosexual contact | 1697 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 25-34 | Injection drug use | 1136 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 18927 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 1882 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 25-34 | Other | 252 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 35-44 | Heterosexual contact | 3719 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 35-44 | Injection drug use | 4045 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 29309 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 3353 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 35-44 | Other | 96 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 45-54 | Heterosexual contact | 4263 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 45-54 | Injection drug use | 8612 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 28995 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 4325 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 45-54 | Other | 101 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 55 | Heterosexual contact | 3010 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 55 | Injection drug use | 6565 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 55 | Male-to-male sexual contact | 11937 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 1732 | M |
| HIV prevalence | 2011 | Hispanic/Latino | 55 | Other | 92 | M |
| HIV prevalence | 2011 | Multiple races | 13-24 | Heterosexual contact | 46 | M |
| HIV prevalence | 2011 | Multiple races | 13-24 | Injection drug use | 10 | M |
| HIV prevalence | 2011 | Multiple races | 13-24 | Male-to-male sexual contact | 1357 | M |
| HIV prevalence | 2011 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 111 | M |
| HIV prevalence | 2011 | Multiple races | 13-24 | Other | 251 | M |
| HIV prevalence | 2011 | Multiple races | 25-34 | Heterosexual contact | 246 | M |
| HIV prevalence | 2011 | Multiple races | 25-34 | Injection drug use | 113 | M |
| HIV prevalence | 2011 | Multiple races | 25-34 | Male-to-male sexual contact | 4178 | M |
| HIV prevalence | 2011 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 580 | M |
| HIV prevalence | 2011 | Multiple races | 25-34 | Other | 65 | M |
| HIV prevalence | 2011 | Multiple races | 35-44 | Heterosexual contact | 660 | M |
| HIV prevalence | 2011 | Multiple races | 35-44 | Injection drug use | 434 | M |
| HIV prevalence | 2011 | Multiple races | 35-44 | Male-to-male sexual contact | 5642 | M |
| HIV prevalence | 2011 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 1131 | M |
| HIV prevalence | 2011 | Multiple races | 35-44 | Other | 29 | M |
| HIV prevalence | 2011 | Multiple races | 45-54 | Heterosexual contact | 1009 | M |
| HIV prevalence | 2011 | Multiple races | 45-54 | Injection drug use | 1391 | M |
| HIV prevalence | 2011 | Multiple races | 45-54 | Male-to-male sexual contact | 7243 | M |
| HIV prevalence | 2011 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 1735 | M |
| HIV prevalence | 2011 | Multiple races | 45-54 | Other | 37 | M |
| HIV prevalence | 2011 | Multiple races | 55 | Heterosexual contact | 719 | M |
| HIV prevalence | 2011 | Multiple races | 55 | Injection drug use | 1445 | M |
| HIV prevalence | 2011 | Multiple races | 55 | Male-to-male sexual contact | 3248 | M |
| HIV prevalence | 2011 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 746 | M |
| HIV prevalence | 2011 | Multiple races | 55 | Other | 29 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 17 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 1 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 3 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 79 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 5 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 10 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 5 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 131 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 7 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 1 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 10 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 7 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 115 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 11 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 6 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 5 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 65 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV prevalence | 2011 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV prevalence | 2011 | White | 13-24 | Heterosexual contact | 55 | M |
| HIV prevalence | 2011 | White | 13-24 | Injection drug use | 59 | M |
| HIV prevalence | 2011 | White | 13-24 | Male-to-male sexual contact | 2948 | M |
| HIV prevalence | 2011 | White | 13-24 | Male-to-male sexual contact and injection drug use | 346 | M |
| HIV prevalence | 2011 | White | 13-24 | Other | 485 | M |
| HIV prevalence | 2011 | White | 25-34 | Heterosexual contact | 520 | M |
| HIV prevalence | 2011 | White | 25-34 | Injection drug use | 697 | M |
| HIV prevalence | 2011 | White | 25-34 | Male-to-male sexual contact | 16640 | M |
| HIV prevalence | 2011 | White | 25-34 | Male-to-male sexual contact and injection drug use | 2399 | M |
| HIV prevalence | 2011 | White | 25-34 | Other | 254 | M |
| HIV prevalence | 2011 | White | 35-44 | Heterosexual contact | 1707 | M |
| HIV prevalence | 2011 | White | 35-44 | Injection drug use | 2469 | M |
| HIV prevalence | 2011 | White | 35-44 | Male-to-male sexual contact | 40098 | M |
| HIV prevalence | 2011 | White | 35-44 | Male-to-male sexual contact and injection drug use | 5615 | M |
| HIV prevalence | 2011 | White | 35-44 | Other | 405 | M |
| HIV prevalence | 2011 | White | 45-54 | Heterosexual contact | 3252 | M |
| HIV prevalence | 2011 | White | 45-54 | Injection drug use | 6130 | M |
| HIV prevalence | 2011 | White | 45-54 | Male-to-male sexual contact | 77429 | M |
| HIV prevalence | 2011 | White | 45-54 | Male-to-male sexual contact and injection drug use | 9313 | M |
| HIV prevalence | 2011 | White | 45-54 | Other | 518 | M |
| HIV prevalence | 2011 | White | 55 | Heterosexual contact | 2855 | M |
| HIV prevalence | 2011 | White | 55 | Injection drug use | 4214 | M |
| HIV prevalence | 2011 | White | 55 | Male-to-male sexual contact | 49792 | M |
| HIV prevalence | 2011 | White | 55 | Male-to-male sexual contact and injection drug use | 4025 | M |
| HIV prevalence | 2011 | White | 55 | Other | 365 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 4 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 13-24 | Injection drug use | 2 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 52 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 8 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 13-24 | Other | 3 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 12 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 25-34 | Injection drug use | 20 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 208 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 32 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 25-34 | Other | 2 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 38 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 35-44 | Injection drug use | 33 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 303 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 72 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 35-44 | Other | 5 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 44 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 45-54 | Injection drug use | 84 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 368 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 106 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 45-54 | Other | 4 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 55 | Heterosexual contact | 38 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 55 | Injection drug use | 44 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 161 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 40 | M |
| HIV prevalence | 2012 | American Indian/Alaska Native | 55 | Other | 0 | M |
| HIV prevalence | 2012 | Asian | 13-24 | Heterosexual contact | 4 | M |
| HIV prevalence | 2012 | Asian | 13-24 | Injection drug use | 3 | M |
| HIV prevalence | 2012 | Asian | 13-24 | Male-to-male sexual contact | 237 | M |
| HIV prevalence | 2012 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 8 | M |
| HIV prevalence | 2012 | Asian | 13-24 | Other | 21 | M |
| HIV prevalence | 2012 | Asian | 25-34 | Heterosexual contact | 71 | M |
| HIV prevalence | 2012 | Asian | 25-34 | Injection drug use | 32 | M |
| HIV prevalence | 2012 | Asian | 25-34 | Male-to-male sexual contact | 1131 | M |
| HIV prevalence | 2012 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 60 | M |
| HIV prevalence | 2012 | Asian | 25-34 | Other | 18 | M |
| HIV prevalence | 2012 | Asian | 35-44 | Heterosexual contact | 250 | M |
| HIV prevalence | 2012 | Asian | 35-44 | Injection drug use | 104 | M |
| HIV prevalence | 2012 | Asian | 35-44 | Male-to-male sexual contact | 2190 | M |
| HIV prevalence | 2012 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 117 | M |
| HIV prevalence | 2012 | Asian | 35-44 | Other | 16 | M |
| HIV prevalence | 2012 | Asian | 45-54 | Heterosexual contact | 221 | M |
| HIV prevalence | 2012 | Asian | 45-54 | Injection drug use | 112 | M |
| HIV prevalence | 2012 | Asian | 45-54 | Male-to-male sexual contact | 1839 | M |
| HIV prevalence | 2012 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 98 | M |
| HIV prevalence | 2012 | Asian | 45-54 | Other | 14 | M |
| HIV prevalence | 2012 | Asian | 55 | Heterosexual contact | 182 | M |
| HIV prevalence | 2012 | Asian | 55 | Injection drug use | 84 | M |
| HIV prevalence | 2012 | Asian | 55 | Male-to-male sexual contact | 1036 | M |
| HIV prevalence | 2012 | Asian | 55 | Male-to-male sexual contact and injection drug use | 38 | M |
| HIV prevalence | 2012 | Asian | 55 | Other | 12 | M |
| HIV prevalence | 2012 | Black/African American | 13-24 | Heterosexual contact | 651 | M |
| HIV prevalence | 2012 | Black/African American | 13-24 | Injection drug use | 124 | M |
| HIV prevalence | 2012 | Black/African American | 13-24 | Male-to-male sexual contact | 13276 | M |
| HIV prevalence | 2012 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 368 | M |
| HIV prevalence | 2012 | Black/African American | 13-24 | Other | 2231 | M |
| HIV prevalence | 2012 | Black/African American | 25-34 | Heterosexual contact | 3906 | M |
| HIV prevalence | 2012 | Black/African American | 25-34 | Injection drug use | 1149 | M |
| HIV prevalence | 2012 | Black/African American | 25-34 | Male-to-male sexual contact | 31955 | M |
| HIV prevalence | 2012 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 1641 | M |
| HIV prevalence | 2012 | Black/African American | 25-34 | Other | 429 | M |
| HIV prevalence | 2012 | Black/African American | 35-44 | Heterosexual contact | 9850 | M |
| HIV prevalence | 2012 | Black/African American | 35-44 | Injection drug use | 3981 | M |
| HIV prevalence | 2012 | Black/African American | 35-44 | Male-to-male sexual contact | 30390 | M |
| HIV prevalence | 2012 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 3003 | M |
| HIV prevalence | 2012 | Black/African American | 35-44 | Other | 105 | M |
| HIV prevalence | 2012 | Black/African American | 45-54 | Heterosexual contact | 16620 | M |
| HIV prevalence | 2012 | Black/African American | 45-54 | Injection drug use | 13668 | M |
| HIV prevalence | 2012 | Black/African American | 45-54 | Male-to-male sexual contact | 38640 | M |
| HIV prevalence | 2012 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 6947 | M |
| HIV prevalence | 2012 | Black/African American | 45-54 | Other | 179 | M |
| HIV prevalence | 2012 | Black/African American | 55 | Heterosexual contact | 13302 | M |
| HIV prevalence | 2012 | Black/African American | 55 | Injection drug use | 17998 | M |
| HIV prevalence | 2012 | Black/African American | 55 | Male-to-male sexual contact | 19100 | M |
| HIV prevalence | 2012 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 4374 | M |
| HIV prevalence | 2012 | Black/African American | 55 | Other | 195 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 13-24 | Heterosexual contact | 136 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 13-24 | Injection drug use | 63 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 4607 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 313 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 13-24 | Other | 909 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 25-34 | Heterosexual contact | 1598 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 25-34 | Injection drug use | 1043 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 20207 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 1856 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 25-34 | Other | 312 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 35-44 | Heterosexual contact | 3682 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 35-44 | Injection drug use | 3657 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 29405 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 3228 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 35-44 | Other | 97 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 45-54 | Heterosexual contact | 4470 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 45-54 | Injection drug use | 8338 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 31205 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 4447 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 45-54 | Other | 101 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 55 | Heterosexual contact | 3355 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 55 | Injection drug use | 7207 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 55 | Male-to-male sexual contact | 13765 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 1966 | M |
| HIV prevalence | 2012 | Hispanic/Latino | 55 | Other | 96 | M |
| HIV prevalence | 2012 | Multiple races | 13-24 | Heterosexual contact | 47 | M |
| HIV prevalence | 2012 | Multiple races | 13-24 | Injection drug use | 10 | M |
| HIV prevalence | 2012 | Multiple races | 13-24 | Male-to-male sexual contact | 1427 | M |
| HIV prevalence | 2012 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 109 | M |
| HIV prevalence | 2012 | Multiple races | 13-24 | Other | 244 | M |
| HIV prevalence | 2012 | Multiple races | 25-34 | Heterosexual contact | 222 | M |
| HIV prevalence | 2012 | Multiple races | 25-34 | Injection drug use | 107 | M |
| HIV prevalence | 2012 | Multiple races | 25-34 | Male-to-male sexual contact | 4486 | M |
| HIV prevalence | 2012 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 576 | M |
| HIV prevalence | 2012 | Multiple races | 25-34 | Other | 74 | M |
| HIV prevalence | 2012 | Multiple races | 35-44 | Heterosexual contact | 644 | M |
| HIV prevalence | 2012 | Multiple races | 35-44 | Injection drug use | 376 | M |
| HIV prevalence | 2012 | Multiple races | 35-44 | Male-to-male sexual contact | 5549 | M |
| HIV prevalence | 2012 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 1041 | M |
| HIV prevalence | 2012 | Multiple races | 35-44 | Other | 28 | M |
| HIV prevalence | 2012 | Multiple races | 45-54 | Heterosexual contact | 1008 | M |
| HIV prevalence | 2012 | Multiple races | 45-54 | Injection drug use | 1303 | M |
| HIV prevalence | 2012 | Multiple races | 45-54 | Male-to-male sexual contact | 7496 | M |
| HIV prevalence | 2012 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 1748 | M |
| HIV prevalence | 2012 | Multiple races | 45-54 | Other | 36 | M |
| HIV prevalence | 2012 | Multiple races | 55 | Heterosexual contact | 802 | M |
| HIV prevalence | 2012 | Multiple races | 55 | Injection drug use | 1498 | M |
| HIV prevalence | 2012 | Multiple races | 55 | Male-to-male sexual contact | 3679 | M |
| HIV prevalence | 2012 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 838 | M |
| HIV prevalence | 2012 | Multiple races | 55 | Other | 31 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 18 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 3 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 1 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 3 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 91 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 6 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 7 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 5 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 129 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 5 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 1 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 12 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 6 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 127 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 12 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 8 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 6 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 75 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV prevalence | 2012 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV prevalence | 2012 | White | 13-24 | Heterosexual contact | 57 | M |
| HIV prevalence | 2012 | White | 13-24 | Injection drug use | 76 | M |
| HIV prevalence | 2012 | White | 13-24 | Male-to-male sexual contact | 3035 | M |
| HIV prevalence | 2012 | White | 13-24 | Male-to-male sexual contact and injection drug use | 321 | M |
| HIV prevalence | 2012 | White | 13-24 | Other | 479 | M |
| HIV prevalence | 2012 | White | 25-34 | Heterosexual contact | 522 | M |
| HIV prevalence | 2012 | White | 25-34 | Injection drug use | 678 | M |
| HIV prevalence | 2012 | White | 25-34 | Male-to-male sexual contact | 17464 | M |
| HIV prevalence | 2012 | White | 25-34 | Male-to-male sexual contact and injection drug use | 2401 | M |
| HIV prevalence | 2012 | White | 25-34 | Other | 244 | M |
| HIV prevalence | 2012 | White | 35-44 | Heterosexual contact | 1614 | M |
| HIV prevalence | 2012 | White | 35-44 | Injection drug use | 2200 | M |
| HIV prevalence | 2012 | White | 35-44 | Male-to-male sexual contact | 37555 | M |
| HIV prevalence | 2012 | White | 35-44 | Male-to-male sexual contact and injection drug use | 5182 | M |
| HIV prevalence | 2012 | White | 35-44 | Other | 377 | M |
| HIV prevalence | 2012 | White | 45-54 | Heterosexual contact | 3302 | M |
| HIV prevalence | 2012 | White | 45-54 | Injection drug use | 5791 | M |
| HIV prevalence | 2012 | White | 45-54 | Male-to-male sexual contact | 78413 | M |
| HIV prevalence | 2012 | White | 45-54 | Male-to-male sexual contact and injection drug use | 9354 | M |
| HIV prevalence | 2012 | White | 45-54 | Other | 531 | M |
| HIV prevalence | 2012 | White | 55 | Heterosexual contact | 3107 | M |
| HIV prevalence | 2012 | White | 55 | Injection drug use | 4700 | M |
| HIV prevalence | 2012 | White | 55 | Male-to-male sexual contact | 55563 | M |
| HIV prevalence | 2012 | White | 55 | Male-to-male sexual contact and injection drug use | 4635 | M |
| HIV prevalence | 2012 | White | 55 | Other | 380 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 4 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 13-24 | Injection drug use | 4 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 54 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 8 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 13-24 | Other | 3 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 13 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 25-34 | Injection drug use | 24 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 227 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 32 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 25-34 | Other | 2 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 40 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 35-44 | Injection drug use | 34 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 289 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 66 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 35-44 | Other | 3 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 46 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 45-54 | Injection drug use | 79 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 387 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 105 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 45-54 | Other | 4 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 55 | Heterosexual contact | 39 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 55 | Injection drug use | 50 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 185 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 49 | M |
| HIV prevalence | 2013 | American Indian/Alaska Native | 55 | Other | 2 | M |
| HIV prevalence | 2013 | Asian | 13-24 | Heterosexual contact | 4 | M |
| HIV prevalence | 2013 | Asian | 13-24 | Injection drug use | 4 | M |
| HIV prevalence | 2013 | Asian | 13-24 | Male-to-male sexual contact | 258 | M |
| HIV prevalence | 2013 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 10 | M |
| HIV prevalence | 2013 | Asian | 13-24 | Other | 25 | M |
| HIV prevalence | 2013 | Asian | 25-34 | Heterosexual contact | 68 | M |
| HIV prevalence | 2013 | Asian | 25-34 | Injection drug use | 31 | M |
| HIV prevalence | 2013 | Asian | 25-34 | Male-to-male sexual contact | 1253 | M |
| HIV prevalence | 2013 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 55 | M |
| HIV prevalence | 2013 | Asian | 25-34 | Other | 16 | M |
| HIV prevalence | 2013 | Asian | 35-44 | Heterosexual contact | 252 | M |
| HIV prevalence | 2013 | Asian | 35-44 | Injection drug use | 110 | M |
| HIV prevalence | 2013 | Asian | 35-44 | Male-to-male sexual contact | 2274 | M |
| HIV prevalence | 2013 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 117 | M |
| HIV prevalence | 2013 | Asian | 35-44 | Other | 16 | M |
| HIV prevalence | 2013 | Asian | 45-54 | Heterosexual contact | 251 | M |
| HIV prevalence | 2013 | Asian | 45-54 | Injection drug use | 110 | M |
| HIV prevalence | 2013 | Asian | 45-54 | Male-to-male sexual contact | 2003 | M |
| HIV prevalence | 2013 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 105 | M |
| HIV prevalence | 2013 | Asian | 45-54 | Other | 16 | M |
| HIV prevalence | 2013 | Asian | 55 | Heterosexual contact | 200 | M |
| HIV prevalence | 2013 | Asian | 55 | Injection drug use | 99 | M |
| HIV prevalence | 2013 | Asian | 55 | Male-to-male sexual contact | 1174 | M |
| HIV prevalence | 2013 | Asian | 55 | Male-to-male sexual contact and injection drug use | 42 | M |
| HIV prevalence | 2013 | Asian | 55 | Other | 14 | M |
| HIV prevalence | 2013 | Black/African American | 13-24 | Heterosexual contact | 621 | M |
| HIV prevalence | 2013 | Black/African American | 13-24 | Injection drug use | 120 | M |
| HIV prevalence | 2013 | Black/African American | 13-24 | Male-to-male sexual contact | 13348 | M |
| HIV prevalence | 2013 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 360 | M |
| HIV prevalence | 2013 | Black/African American | 13-24 | Other | 2178 | M |
| HIV prevalence | 2013 | Black/African American | 25-34 | Heterosexual contact | 3917 | M |
| HIV prevalence | 2013 | Black/African American | 25-34 | Injection drug use | 1075 | M |
| HIV prevalence | 2013 | Black/African American | 25-34 | Male-to-male sexual contact | 35306 | M |
| HIV prevalence | 2013 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 1626 | M |
| HIV prevalence | 2013 | Black/African American | 25-34 | Other | 558 | M |
| HIV prevalence | 2013 | Black/African American | 35-44 | Heterosexual contact | 9315 | M |
| HIV prevalence | 2013 | Black/African American | 35-44 | Injection drug use | 3481 | M |
| HIV prevalence | 2013 | Black/African American | 35-44 | Male-to-male sexual contact | 30587 | M |
| HIV prevalence | 2013 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 2733 | M |
| HIV prevalence | 2013 | Black/African American | 35-44 | Other | 101 | M |
| HIV prevalence | 2013 | Black/African American | 45-54 | Heterosexual contact | 16747 | M |
| HIV prevalence | 2013 | Black/African American | 45-54 | Injection drug use | 12466 | M |
| HIV prevalence | 2013 | Black/African American | 45-54 | Male-to-male sexual contact | 39857 | M |
| HIV prevalence | 2013 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 6681 | M |
| HIV prevalence | 2013 | Black/African American | 45-54 | Other | 171 | M |
| HIV prevalence | 2013 | Black/African American | 55 | Heterosexual contact | 14694 | M |
| HIV prevalence | 2013 | Black/African American | 55 | Injection drug use | 19097 | M |
| HIV prevalence | 2013 | Black/African American | 55 | Male-to-male sexual contact | 21554 | M |
| HIV prevalence | 2013 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 4824 | M |
| HIV prevalence | 2013 | Black/African American | 55 | Other | 209 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 13-24 | Heterosexual contact | 129 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 13-24 | Injection drug use | 64 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 4696 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 288 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 13-24 | Other | 862 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 25-34 | Heterosexual contact | 1568 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 25-34 | Injection drug use | 954 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 21546 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 1817 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 25-34 | Other | 374 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 35-44 | Heterosexual contact | 3624 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 35-44 | Injection drug use | 3286 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 29507 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 3103 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 35-44 | Other | 95 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 45-54 | Heterosexual contact | 4642 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 45-54 | Injection drug use | 8028 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 33379 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 4491 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 45-54 | Other | 104 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 55 | Heterosexual contact | 3698 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 55 | Injection drug use | 7833 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 55 | Male-to-male sexual contact | 15685 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 2203 | M |
| HIV prevalence | 2013 | Hispanic/Latino | 55 | Other | 103 | M |
| HIV prevalence | 2013 | Multiple races | 13-24 | Heterosexual contact | 43 | M |
| HIV prevalence | 2013 | Multiple races | 13-24 | Injection drug use | 9 | M |
| HIV prevalence | 2013 | Multiple races | 13-24 | Male-to-male sexual contact | 1434 | M |
| HIV prevalence | 2013 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 112 | M |
| HIV prevalence | 2013 | Multiple races | 13-24 | Other | 225 | M |
| HIV prevalence | 2013 | Multiple races | 25-34 | Heterosexual contact | 228 | M |
| HIV prevalence | 2013 | Multiple races | 25-34 | Injection drug use | 101 | M |
| HIV prevalence | 2013 | Multiple races | 25-34 | Male-to-male sexual contact | 4810 | M |
| HIV prevalence | 2013 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 553 | M |
| HIV prevalence | 2013 | Multiple races | 25-34 | Other | 90 | M |
| HIV prevalence | 2013 | Multiple races | 35-44 | Heterosexual contact | 584 | M |
| HIV prevalence | 2013 | Multiple races | 35-44 | Injection drug use | 323 | M |
| HIV prevalence | 2013 | Multiple races | 35-44 | Male-to-male sexual contact | 5397 | M |
| HIV prevalence | 2013 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 969 | M |
| HIV prevalence | 2013 | Multiple races | 35-44 | Other | 31 | M |
| HIV prevalence | 2013 | Multiple races | 45-54 | Heterosexual contact | 1035 | M |
| HIV prevalence | 2013 | Multiple races | 45-54 | Injection drug use | 1191 | M |
| HIV prevalence | 2013 | Multiple races | 45-54 | Male-to-male sexual contact | 7685 | M |
| HIV prevalence | 2013 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 1716 | M |
| HIV prevalence | 2013 | Multiple races | 45-54 | Other | 36 | M |
| HIV prevalence | 2013 | Multiple races | 55 | Heterosexual contact | 886 | M |
| HIV prevalence | 2013 | Multiple races | 55 | Injection drug use | 1591 | M |
| HIV prevalence | 2013 | Multiple races | 55 | Male-to-male sexual contact | 4165 | M |
| HIV prevalence | 2013 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 943 | M |
| HIV prevalence | 2013 | Multiple races | 55 | Other | 32 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 17 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 0 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 3 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 98 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 8 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 7 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 5 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 136 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 5 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 1 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 12 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 6 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 131 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 11 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 9 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 6 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 86 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 5 | M |
| HIV prevalence | 2013 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV prevalence | 2013 | White | 13-24 | Heterosexual contact | 59 | M |
| HIV prevalence | 2013 | White | 13-24 | Injection drug use | 83 | M |
| HIV prevalence | 2013 | White | 13-24 | Male-to-male sexual contact | 3064 | M |
| HIV prevalence | 2013 | White | 13-24 | Male-to-male sexual contact and injection drug use | 317 | M |
| HIV prevalence | 2013 | White | 13-24 | Other | 442 | M |
| HIV prevalence | 2013 | White | 25-34 | Heterosexual contact | 522 | M |
| HIV prevalence | 2013 | White | 25-34 | Injection drug use | 634 | M |
| HIV prevalence | 2013 | White | 25-34 | Male-to-male sexual contact | 18243 | M |
| HIV prevalence | 2013 | White | 25-34 | Male-to-male sexual contact and injection drug use | 2371 | M |
| HIV prevalence | 2013 | White | 25-34 | Other | 268 | M |
| HIV prevalence | 2013 | White | 35-44 | Heterosexual contact | 1542 | M |
| HIV prevalence | 2013 | White | 35-44 | Injection drug use | 1993 | M |
| HIV prevalence | 2013 | White | 35-44 | Male-to-male sexual contact | 35366 | M |
| HIV prevalence | 2013 | White | 35-44 | Male-to-male sexual contact and injection drug use | 4861 | M |
| HIV prevalence | 2013 | White | 35-44 | Other | 353 | M |
| HIV prevalence | 2013 | White | 45-54 | Heterosexual contact | 3311 | M |
| HIV prevalence | 2013 | White | 45-54 | Injection drug use | 5514 | M |
| HIV prevalence | 2013 | White | 45-54 | Male-to-male sexual contact | 78510 | M |
| HIV prevalence | 2013 | White | 45-54 | Male-to-male sexual contact and injection drug use | 9246 | M |
| HIV prevalence | 2013 | White | 45-54 | Other | 524 | M |
| HIV prevalence | 2013 | White | 55 | Heterosexual contact | 3430 | M |
| HIV prevalence | 2013 | White | 55 | Injection drug use | 5129 | M |
| HIV prevalence | 2013 | White | 55 | Male-to-male sexual contact | 61675 | M |
| HIV prevalence | 2013 | White | 55 | Male-to-male sexual contact and injection drug use | 5220 | M |
| HIV prevalence | 2013 | White | 55 | Other | 406 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 3 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 13-24 | Injection drug use | 5 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 59 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 7 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 13-24 | Other | 5 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 15 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 25-34 | Injection drug use | 25 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 267 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 34 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 25-34 | Other | 2 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 35 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 35-44 | Injection drug use | 30 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 296 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 54 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 35-44 | Other | 3 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 52 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 45-54 | Injection drug use | 81 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 408 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 106 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 45-54 | Other | 4 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 55 | Heterosexual contact | 44 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 55 | Injection drug use | 57 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 209 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 53 | M |
| HIV prevalence | 2014 | American Indian/Alaska Native | 55 | Other | 2 | M |
| HIV prevalence | 2014 | Asian | 13-24 | Heterosexual contact | 6 | M |
| HIV prevalence | 2014 | Asian | 13-24 | Injection drug use | 5 | M |
| HIV prevalence | 2014 | Asian | 13-24 | Male-to-male sexual contact | 291 | M |
| HIV prevalence | 2014 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 11 | M |
| HIV prevalence | 2014 | Asian | 13-24 | Other | 25 | M |
| HIV prevalence | 2014 | Asian | 25-34 | Heterosexual contact | 75 | M |
| HIV prevalence | 2014 | Asian | 25-34 | Injection drug use | 30 | M |
| HIV prevalence | 2014 | Asian | 25-34 | Male-to-male sexual contact | 1457 | M |
| HIV prevalence | 2014 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 51 | M |
| HIV prevalence | 2014 | Asian | 25-34 | Other | 16 | M |
| HIV prevalence | 2014 | Asian | 35-44 | Heterosexual contact | 245 | M |
| HIV prevalence | 2014 | Asian | 35-44 | Injection drug use | 108 | M |
| HIV prevalence | 2014 | Asian | 35-44 | Male-to-male sexual contact | 2346 | M |
| HIV prevalence | 2014 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 122 | M |
| HIV prevalence | 2014 | Asian | 35-44 | Other | 16 | M |
| HIV prevalence | 2014 | Asian | 45-54 | Heterosexual contact | 265 | M |
| HIV prevalence | 2014 | Asian | 45-54 | Injection drug use | 120 | M |
| HIV prevalence | 2014 | Asian | 45-54 | Male-to-male sexual contact | 2205 | M |
| HIV prevalence | 2014 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 112 | M |
| HIV prevalence | 2014 | Asian | 45-54 | Other | 15 | M |
| HIV prevalence | 2014 | Asian | 55 | Heterosexual contact | 233 | M |
| HIV prevalence | 2014 | Asian | 55 | Injection drug use | 108 | M |
| HIV prevalence | 2014 | Asian | 55 | Male-to-male sexual contact | 1318 | M |
| HIV prevalence | 2014 | Asian | 55 | Male-to-male sexual contact and injection drug use | 50 | M |
| HIV prevalence | 2014 | Asian | 55 | Other | 16 | M |
| HIV prevalence | 2014 | Black/African American | 13-24 | Heterosexual contact | 619 | M |
| HIV prevalence | 2014 | Black/African American | 13-24 | Injection drug use | 115 | M |
| HIV prevalence | 2014 | Black/African American | 13-24 | Male-to-male sexual contact | 13250 | M |
| HIV prevalence | 2014 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 310 | M |
| HIV prevalence | 2014 | Black/African American | 13-24 | Other | 2127 | M |
| HIV prevalence | 2014 | Black/African American | 25-34 | Heterosexual contact | 3852 | M |
| HIV prevalence | 2014 | Black/African American | 25-34 | Injection drug use | 979 | M |
| HIV prevalence | 2014 | Black/African American | 25-34 | Male-to-male sexual contact | 39461 | M |
| HIV prevalence | 2014 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 1632 | M |
| HIV prevalence | 2014 | Black/African American | 25-34 | Other | 697 | M |
| HIV prevalence | 2014 | Black/African American | 35-44 | Heterosexual contact | 8951 | M |
| HIV prevalence | 2014 | Black/African American | 35-44 | Injection drug use | 3102 | M |
| HIV prevalence | 2014 | Black/African American | 35-44 | Male-to-male sexual contact | 30797 | M |
| HIV prevalence | 2014 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 2528 | M |
| HIV prevalence | 2014 | Black/African American | 35-44 | Other | 107 | M |
| HIV prevalence | 2014 | Black/African American | 45-54 | Heterosexual contact | 16660 | M |
| HIV prevalence | 2014 | Black/African American | 45-54 | Injection drug use | 11279 | M |
| HIV prevalence | 2014 | Black/African American | 45-54 | Male-to-male sexual contact | 40593 | M |
| HIV prevalence | 2014 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 6306 | M |
| HIV prevalence | 2014 | Black/African American | 45-54 | Other | 168 | M |
| HIV prevalence | 2014 | Black/African American | 55 | Heterosexual contact | 16218 | M |
| HIV prevalence | 2014 | Black/African American | 55 | Injection drug use | 20036 | M |
| HIV prevalence | 2014 | Black/African American | 55 | Male-to-male sexual contact | 24360 | M |
| HIV prevalence | 2014 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 5282 | M |
| HIV prevalence | 2014 | Black/African American | 55 | Other | 221 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 13-24 | Heterosexual contact | 122 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 13-24 | Injection drug use | 58 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 4975 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 268 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 13-24 | Other | 802 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 25-34 | Heterosexual contact | 1494 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 25-34 | Injection drug use | 851 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 22982 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 1749 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 25-34 | Other | 454 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 35-44 | Heterosexual contact | 3625 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 35-44 | Injection drug use | 3009 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 29900 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 3008 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 35-44 | Other | 86 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 45-54 | Heterosexual contact | 4791 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 45-54 | Injection drug use | 7617 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 35216 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 4484 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 45-54 | Other | 99 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 55 | Heterosexual contact | 4057 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 55 | Injection drug use | 8431 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 55 | Male-to-male sexual contact | 17867 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 2481 | M |
| HIV prevalence | 2014 | Hispanic/Latino | 55 | Other | 115 | M |
| HIV prevalence | 2014 | Multiple races | 13-24 | Heterosexual contact | 36 | M |
| HIV prevalence | 2014 | Multiple races | 13-24 | Injection drug use | 9 | M |
| HIV prevalence | 2014 | Multiple races | 13-24 | Male-to-male sexual contact | 1339 | M |
| HIV prevalence | 2014 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 96 | M |
| HIV prevalence | 2014 | Multiple races | 13-24 | Other | 221 | M |
| HIV prevalence | 2014 | Multiple races | 25-34 | Heterosexual contact | 216 | M |
| HIV prevalence | 2014 | Multiple races | 25-34 | Injection drug use | 102 | M |
| HIV prevalence | 2014 | Multiple races | 25-34 | Male-to-male sexual contact | 5091 | M |
| HIV prevalence | 2014 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 546 | M |
| HIV prevalence | 2014 | Multiple races | 25-34 | Other | 102 | M |
| HIV prevalence | 2014 | Multiple races | 35-44 | Heterosexual contact | 557 | M |
| HIV prevalence | 2014 | Multiple races | 35-44 | Injection drug use | 272 | M |
| HIV prevalence | 2014 | Multiple races | 35-44 | Male-to-male sexual contact | 5290 | M |
| HIV prevalence | 2014 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 901 | M |
| HIV prevalence | 2014 | Multiple races | 35-44 | Other | 33 | M |
| HIV prevalence | 2014 | Multiple races | 45-54 | Heterosexual contact | 1030 | M |
| HIV prevalence | 2014 | Multiple races | 45-54 | Injection drug use | 1075 | M |
| HIV prevalence | 2014 | Multiple races | 45-54 | Male-to-male sexual contact | 7846 | M |
| HIV prevalence | 2014 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 1649 | M |
| HIV prevalence | 2014 | Multiple races | 45-54 | Other | 39 | M |
| HIV prevalence | 2014 | Multiple races | 55 | Heterosexual contact | 968 | M |
| HIV prevalence | 2014 | Multiple races | 55 | Injection drug use | 1654 | M |
| HIV prevalence | 2014 | Multiple races | 55 | Male-to-male sexual contact | 4637 | M |
| HIV prevalence | 2014 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 1074 | M |
| HIV prevalence | 2014 | Multiple races | 55 | Other | 31 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 17 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 2 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 0 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 0 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 1 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 105 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 9 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 8 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 5 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 137 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 4 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 1 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 12 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 6 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 146 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 12 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 9 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 7 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 89 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 5 | M |
| HIV prevalence | 2014 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV prevalence | 2014 | White | 13-24 | Heterosexual contact | 63 | M |
| HIV prevalence | 2014 | White | 13-24 | Injection drug use | 78 | M |
| HIV prevalence | 2014 | White | 13-24 | Male-to-male sexual contact | 3090 | M |
| HIV prevalence | 2014 | White | 13-24 | Male-to-male sexual contact and injection drug use | 300 | M |
| HIV prevalence | 2014 | White | 13-24 | Other | 411 | M |
| HIV prevalence | 2014 | White | 25-34 | Heterosexual contact | 539 | M |
| HIV prevalence | 2014 | White | 25-34 | Injection drug use | 638 | M |
| HIV prevalence | 2014 | White | 25-34 | Male-to-male sexual contact | 18984 | M |
| HIV prevalence | 2014 | White | 25-34 | Male-to-male sexual contact and injection drug use | 2368 | M |
| HIV prevalence | 2014 | White | 25-34 | Other | 281 | M |
| HIV prevalence | 2014 | White | 35-44 | Heterosexual contact | 1447 | M |
| HIV prevalence | 2014 | White | 35-44 | Injection drug use | 1815 | M |
| HIV prevalence | 2014 | White | 35-44 | Male-to-male sexual contact | 33433 | M |
| HIV prevalence | 2014 | White | 35-44 | Male-to-male sexual contact and injection drug use | 4600 | M |
| HIV prevalence | 2014 | White | 35-44 | Other | 334 | M |
| HIV prevalence | 2014 | White | 45-54 | Heterosexual contact | 3304 | M |
| HIV prevalence | 2014 | White | 45-54 | Injection drug use | 5161 | M |
| HIV prevalence | 2014 | White | 45-54 | Male-to-male sexual contact | 77826 | M |
| HIV prevalence | 2014 | White | 45-54 | Male-to-male sexual contact and injection drug use | 9081 | M |
| HIV prevalence | 2014 | White | 45-54 | Other | 506 | M |
| HIV prevalence | 2014 | White | 55 | Heterosexual contact | 3720 | M |
| HIV prevalence | 2014 | White | 55 | Injection drug use | 5573 | M |
| HIV prevalence | 2014 | White | 55 | Male-to-male sexual contact | 68229 | M |
| HIV prevalence | 2014 | White | 55 | Male-to-male sexual contact and injection drug use | 5826 | M |
| HIV prevalence | 2014 | White | 55 | Other | 444 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 3 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 13-24 | Injection drug use | 3 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 77 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 9 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 13-24 | Other | 8 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 15 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 25-34 | Injection drug use | 30 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 286 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 32 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 25-34 | Other | 2 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 33 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 35-44 | Injection drug use | 25 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 294 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 54 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 35-44 | Other | 3 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 52 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 45-54 | Injection drug use | 76 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 428 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 97 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 45-54 | Other | 3 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 55 | Heterosexual contact | 49 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 55 | Injection drug use | 67 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 238 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 62 | M |
| HIV prevalence | 2015 | American Indian/Alaska Native | 55 | Other | 3 | M |
| HIV prevalence | 2015 | Asian | 13-24 | Heterosexual contact | 3 | M |
| HIV prevalence | 2015 | Asian | 13-24 | Injection drug use | 5 | M |
| HIV prevalence | 2015 | Asian | 13-24 | Male-to-male sexual contact | 329 | M |
| HIV prevalence | 2015 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 10 | M |
| HIV prevalence | 2015 | Asian | 13-24 | Other | 30 | M |
| HIV prevalence | 2015 | Asian | 25-34 | Heterosexual contact | 72 | M |
| HIV prevalence | 2015 | Asian | 25-34 | Injection drug use | 34 | M |
| HIV prevalence | 2015 | Asian | 25-34 | Male-to-male sexual contact | 1669 | M |
| HIV prevalence | 2015 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 54 | M |
| HIV prevalence | 2015 | Asian | 25-34 | Other | 12 | M |
| HIV prevalence | 2015 | Asian | 35-44 | Heterosexual contact | 259 | M |
| HIV prevalence | 2015 | Asian | 35-44 | Injection drug use | 106 | M |
| HIV prevalence | 2015 | Asian | 35-44 | Male-to-male sexual contact | 2378 | M |
| HIV prevalence | 2015 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 120 | M |
| HIV prevalence | 2015 | Asian | 35-44 | Other | 16 | M |
| HIV prevalence | 2015 | Asian | 45-54 | Heterosexual contact | 298 | M |
| HIV prevalence | 2015 | Asian | 45-54 | Injection drug use | 124 | M |
| HIV prevalence | 2015 | Asian | 45-54 | Male-to-male sexual contact | 2442 | M |
| HIV prevalence | 2015 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 119 | M |
| HIV prevalence | 2015 | Asian | 45-54 | Other | 16 | M |
| HIV prevalence | 2015 | Asian | 55 | Heterosexual contact | 259 | M |
| HIV prevalence | 2015 | Asian | 55 | Injection drug use | 125 | M |
| HIV prevalence | 2015 | Asian | 55 | Male-to-male sexual contact | 1462 | M |
| HIV prevalence | 2015 | Asian | 55 | Male-to-male sexual contact and injection drug use | 61 | M |
| HIV prevalence | 2015 | Asian | 55 | Other | 19 | M |
| HIV prevalence | 2015 | Black/African American | 13-24 | Heterosexual contact | 607 | M |
| HIV prevalence | 2015 | Black/African American | 13-24 | Injection drug use | 113 | M |
| HIV prevalence | 2015 | Black/African American | 13-24 | Male-to-male sexual contact | 12975 | M |
| HIV prevalence | 2015 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 276 | M |
| HIV prevalence | 2015 | Black/African American | 13-24 | Other | 2001 | M |
| HIV prevalence | 2015 | Black/African American | 25-34 | Heterosexual contact | 3856 | M |
| HIV prevalence | 2015 | Black/African American | 25-34 | Injection drug use | 912 | M |
| HIV prevalence | 2015 | Black/African American | 25-34 | Male-to-male sexual contact | 43490 | M |
| HIV prevalence | 2015 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 1600 | M |
| HIV prevalence | 2015 | Black/African American | 25-34 | Other | 895 | M |
| HIV prevalence | 2015 | Black/African American | 35-44 | Heterosexual contact | 8568 | M |
| HIV prevalence | 2015 | Black/African American | 35-44 | Injection drug use | 2756 | M |
| HIV prevalence | 2015 | Black/African American | 35-44 | Male-to-male sexual contact | 31418 | M |
| HIV prevalence | 2015 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 2352 | M |
| HIV prevalence | 2015 | Black/African American | 35-44 | Other | 111 | M |
| HIV prevalence | 2015 | Black/African American | 45-54 | Heterosexual contact | 16500 | M |
| HIV prevalence | 2015 | Black/African American | 45-54 | Injection drug use | 10133 | M |
| HIV prevalence | 2015 | Black/African American | 45-54 | Male-to-male sexual contact | 41110 | M |
| HIV prevalence | 2015 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 5884 | M |
| HIV prevalence | 2015 | Black/African American | 45-54 | Other | 158 | M |
| HIV prevalence | 2015 | Black/African American | 55 | Heterosexual contact | 17830 | M |
| HIV prevalence | 2015 | Black/African American | 55 | Injection drug use | 20874 | M |
| HIV prevalence | 2015 | Black/African American | 55 | Male-to-male sexual contact | 27482 | M |
| HIV prevalence | 2015 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 5797 | M |
| HIV prevalence | 2015 | Black/African American | 55 | Other | 229 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 13-24 | Heterosexual contact | 119 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 13-24 | Injection drug use | 57 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 5146 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 253 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 13-24 | Other | 730 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 25-34 | Heterosexual contact | 1366 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 25-34 | Injection drug use | 787 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 24547 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 1708 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 25-34 | Other | 525 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 35-44 | Heterosexual contact | 3606 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 35-44 | Injection drug use | 2737 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 30467 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 2937 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 35-44 | Other | 99 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 45-54 | Heterosexual contact | 4878 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 45-54 | Injection drug use | 7129 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 36743 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 4408 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 45-54 | Other | 95 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 55 | Heterosexual contact | 4492 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 55 | Injection drug use | 9108 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 55 | Male-to-male sexual contact | 20506 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 2789 | M |
| HIV prevalence | 2015 | Hispanic/Latino | 55 | Other | 123 | M |
| HIV prevalence | 2015 | Multiple races | 13-24 | Heterosexual contact | 29 | M |
| HIV prevalence | 2015 | Multiple races | 13-24 | Injection drug use | 9 | M |
| HIV prevalence | 2015 | Multiple races | 13-24 | Male-to-male sexual contact | 1220 | M |
| HIV prevalence | 2015 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 86 | M |
| HIV prevalence | 2015 | Multiple races | 13-24 | Other | 208 | M |
| HIV prevalence | 2015 | Multiple races | 25-34 | Heterosexual contact | 224 | M |
| HIV prevalence | 2015 | Multiple races | 25-34 | Injection drug use | 96 | M |
| HIV prevalence | 2015 | Multiple races | 25-34 | Male-to-male sexual contact | 5369 | M |
| HIV prevalence | 2015 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 515 | M |
| HIV prevalence | 2015 | Multiple races | 25-34 | Other | 119 | M |
| HIV prevalence | 2015 | Multiple races | 35-44 | Heterosexual contact | 505 | M |
| HIV prevalence | 2015 | Multiple races | 35-44 | Injection drug use | 242 | M |
| HIV prevalence | 2015 | Multiple races | 35-44 | Male-to-male sexual contact | 5206 | M |
| HIV prevalence | 2015 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 848 | M |
| HIV prevalence | 2015 | Multiple races | 35-44 | Other | 32 | M |
| HIV prevalence | 2015 | Multiple races | 45-54 | Heterosexual contact | 1035 | M |
| HIV prevalence | 2015 | Multiple races | 45-54 | Injection drug use | 943 | M |
| HIV prevalence | 2015 | Multiple races | 45-54 | Male-to-male sexual contact | 7851 | M |
| HIV prevalence | 2015 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 1585 | M |
| HIV prevalence | 2015 | Multiple races | 45-54 | Other | 31 | M |
| HIV prevalence | 2015 | Multiple races | 55 | Heterosexual contact | 1029 | M |
| HIV prevalence | 2015 | Multiple races | 55 | Injection drug use | 1691 | M |
| HIV prevalence | 2015 | Multiple races | 55 | Male-to-male sexual contact | 5219 | M |
| HIV prevalence | 2015 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 1149 | M |
| HIV prevalence | 2015 | Multiple races | 55 | Other | 38 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 20 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 1 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 1 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 1 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 118 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 8 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 8 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 6 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 151 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 6 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 1 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 14 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 4 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 157 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 12 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 10 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 9 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 100 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 7 | M |
| HIV prevalence | 2015 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV prevalence | 2015 | White | 13-24 | Heterosexual contact | 50 | M |
| HIV prevalence | 2015 | White | 13-24 | Injection drug use | 90 | M |
| HIV prevalence | 2015 | White | 13-24 | Male-to-male sexual contact | 2999 | M |
| HIV prevalence | 2015 | White | 13-24 | Male-to-male sexual contact and injection drug use | 301 | M |
| HIV prevalence | 2015 | White | 13-24 | Other | 386 | M |
| HIV prevalence | 2015 | White | 25-34 | Heterosexual contact | 552 | M |
| HIV prevalence | 2015 | White | 25-34 | Injection drug use | 681 | M |
| HIV prevalence | 2015 | White | 25-34 | Male-to-male sexual contact | 19757 | M |
| HIV prevalence | 2015 | White | 25-34 | Male-to-male sexual contact and injection drug use | 2393 | M |
| HIV prevalence | 2015 | White | 25-34 | Other | 301 | M |
| HIV prevalence | 2015 | White | 35-44 | Heterosexual contact | 1349 | M |
| HIV prevalence | 2015 | White | 35-44 | Injection drug use | 1703 | M |
| HIV prevalence | 2015 | White | 35-44 | Male-to-male sexual contact | 31508 | M |
| HIV prevalence | 2015 | White | 35-44 | Male-to-male sexual contact and injection drug use | 4317 | M |
| HIV prevalence | 2015 | White | 35-44 | Other | 324 | M |
| HIV prevalence | 2015 | White | 45-54 | Heterosexual contact | 3269 | M |
| HIV prevalence | 2015 | White | 45-54 | Injection drug use | 4816 | M |
| HIV prevalence | 2015 | White | 45-54 | Male-to-male sexual contact | 76337 | M |
| HIV prevalence | 2015 | White | 45-54 | Male-to-male sexual contact and injection drug use | 8841 | M |
| HIV prevalence | 2015 | White | 45-54 | Other | 486 | M |
| HIV prevalence | 2015 | White | 55 | Heterosexual contact | 4039 | M |
| HIV prevalence | 2015 | White | 55 | Injection drug use | 6026 | M |
| HIV prevalence | 2015 | White | 55 | Male-to-male sexual contact | 75235 | M |
| HIV prevalence | 2015 | White | 55 | Male-to-male sexual contact and injection drug use | 6468 | M |
| HIV prevalence | 2015 | White | 55 | Other | 478 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 3 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 13-24 | Injection drug use | 3 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 86 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 11 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 13-24 | Other | 7 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 14 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 25-34 | Injection drug use | 32 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 332 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 38 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 25-34 | Other | 2 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 33 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 35-44 | Injection drug use | 30 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 320 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 48 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 35-44 | Other | 3 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 56 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 45-54 | Injection drug use | 74 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 429 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 98 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 45-54 | Other | 4 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 55 | Heterosexual contact | 49 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 55 | Injection drug use | 73 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 276 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 69 | M |
| HIV prevalence | 2016 | American Indian/Alaska Native | 55 | Other | 4 | M |
| HIV prevalence | 2016 | Asian | 13-24 | Heterosexual contact | 5 | M |
| HIV prevalence | 2016 | Asian | 13-24 | Injection drug use | 4 | M |
| HIV prevalence | 2016 | Asian | 13-24 | Male-to-male sexual contact | 350 | M |
| HIV prevalence | 2016 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 10 | M |
| HIV prevalence | 2016 | Asian | 13-24 | Other | 35 | M |
| HIV prevalence | 2016 | Asian | 25-34 | Heterosexual contact | 77 | M |
| HIV prevalence | 2016 | Asian | 25-34 | Injection drug use | 28 | M |
| HIV prevalence | 2016 | Asian | 25-34 | Male-to-male sexual contact | 1900 | M |
| HIV prevalence | 2016 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 57 | M |
| HIV prevalence | 2016 | Asian | 25-34 | Other | 11 | M |
| HIV prevalence | 2016 | Asian | 35-44 | Heterosexual contact | 259 | M |
| HIV prevalence | 2016 | Asian | 35-44 | Injection drug use | 111 | M |
| HIV prevalence | 2016 | Asian | 35-44 | Male-to-male sexual contact | 2449 | M |
| HIV prevalence | 2016 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 105 | M |
| HIV prevalence | 2016 | Asian | 35-44 | Other | 18 | M |
| HIV prevalence | 2016 | Asian | 45-54 | Heterosexual contact | 312 | M |
| HIV prevalence | 2016 | Asian | 45-54 | Injection drug use | 128 | M |
| HIV prevalence | 2016 | Asian | 45-54 | Male-to-male sexual contact | 2657 | M |
| HIV prevalence | 2016 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 135 | M |
| HIV prevalence | 2016 | Asian | 45-54 | Other | 17 | M |
| HIV prevalence | 2016 | Asian | 55 | Heterosexual contact | 287 | M |
| HIV prevalence | 2016 | Asian | 55 | Injection drug use | 135 | M |
| HIV prevalence | 2016 | Asian | 55 | Male-to-male sexual contact | 1627 | M |
| HIV prevalence | 2016 | Asian | 55 | Male-to-male sexual contact and injection drug use | 67 | M |
| HIV prevalence | 2016 | Asian | 55 | Other | 19 | M |
| HIV prevalence | 2016 | Black/African American | 13-24 | Heterosexual contact | 575 | M |
| HIV prevalence | 2016 | Black/African American | 13-24 | Injection drug use | 96 | M |
| HIV prevalence | 2016 | Black/African American | 13-24 | Male-to-male sexual contact | 12576 | M |
| HIV prevalence | 2016 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 242 | M |
| HIV prevalence | 2016 | Black/African American | 13-24 | Other | 1854 | M |
| HIV prevalence | 2016 | Black/African American | 25-34 | Heterosexual contact | 3947 | M |
| HIV prevalence | 2016 | Black/African American | 25-34 | Injection drug use | 827 | M |
| HIV prevalence | 2016 | Black/African American | 25-34 | Male-to-male sexual contact | 47420 | M |
| HIV prevalence | 2016 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 1581 | M |
| HIV prevalence | 2016 | Black/African American | 25-34 | Other | 1093 | M |
| HIV prevalence | 2016 | Black/African American | 35-44 | Heterosexual contact | 8292 | M |
| HIV prevalence | 2016 | Black/African American | 35-44 | Injection drug use | 2550 | M |
| HIV prevalence | 2016 | Black/African American | 35-44 | Male-to-male sexual contact | 32412 | M |
| HIV prevalence | 2016 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 2269 | M |
| HIV prevalence | 2016 | Black/African American | 35-44 | Other | 128 | M |
| HIV prevalence | 2016 | Black/African American | 45-54 | Heterosexual contact | 16215 | M |
| HIV prevalence | 2016 | Black/African American | 45-54 | Injection drug use | 9043 | M |
| HIV prevalence | 2016 | Black/African American | 45-54 | Male-to-male sexual contact | 41101 | M |
| HIV prevalence | 2016 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 5446 | M |
| HIV prevalence | 2016 | Black/African American | 45-54 | Other | 144 | M |
| HIV prevalence | 2016 | Black/African American | 55 | Heterosexual contact | 19328 | M |
| HIV prevalence | 2016 | Black/African American | 55 | Injection drug use | 21582 | M |
| HIV prevalence | 2016 | Black/African American | 55 | Male-to-male sexual contact | 30780 | M |
| HIV prevalence | 2016 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 6218 | M |
| HIV prevalence | 2016 | Black/African American | 55 | Other | 242 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 13-24 | Heterosexual contact | 126 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 13-24 | Injection drug use | 58 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 5258 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 251 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 13-24 | Other | 663 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 25-34 | Heterosexual contact | 1302 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 25-34 | Injection drug use | 734 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 26384 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 1679 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 25-34 | Other | 595 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 35-44 | Heterosexual contact | 3583 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 35-44 | Injection drug use | 2579 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 31422 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 2904 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 35-44 | Other | 100 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 45-54 | Heterosexual contact | 4945 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 45-54 | Injection drug use | 6603 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 37809 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 4266 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 45-54 | Other | 95 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 55 | Heterosexual contact | 4937 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 55 | Injection drug use | 9691 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 55 | Male-to-male sexual contact | 23298 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 3121 | M |
| HIV prevalence | 2016 | Hispanic/Latino | 55 | Other | 133 | M |
| HIV prevalence | 2016 | Multiple races | 13-24 | Heterosexual contact | 24 | M |
| HIV prevalence | 2016 | Multiple races | 13-24 | Injection drug use | 9 | M |
| HIV prevalence | 2016 | Multiple races | 13-24 | Male-to-male sexual contact | 1096 | M |
| HIV prevalence | 2016 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 72 | M |
| HIV prevalence | 2016 | Multiple races | 13-24 | Other | 195 | M |
| HIV prevalence | 2016 | Multiple races | 25-34 | Heterosexual contact | 228 | M |
| HIV prevalence | 2016 | Multiple races | 25-34 | Injection drug use | 85 | M |
| HIV prevalence | 2016 | Multiple races | 25-34 | Male-to-male sexual contact | 5501 | M |
| HIV prevalence | 2016 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 502 | M |
| HIV prevalence | 2016 | Multiple races | 25-34 | Other | 134 | M |
| HIV prevalence | 2016 | Multiple races | 35-44 | Heterosexual contact | 494 | M |
| HIV prevalence | 2016 | Multiple races | 35-44 | Injection drug use | 213 | M |
| HIV prevalence | 2016 | Multiple races | 35-44 | Male-to-male sexual contact | 5268 | M |
| HIV prevalence | 2016 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 804 | M |
| HIV prevalence | 2016 | Multiple races | 35-44 | Other | 34 | M |
| HIV prevalence | 2016 | Multiple races | 45-54 | Heterosexual contact | 993 | M |
| HIV prevalence | 2016 | Multiple races | 45-54 | Injection drug use | 829 | M |
| HIV prevalence | 2016 | Multiple races | 45-54 | Male-to-male sexual contact | 7693 | M |
| HIV prevalence | 2016 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 1513 | M |
| HIV prevalence | 2016 | Multiple races | 45-54 | Other | 29 | M |
| HIV prevalence | 2016 | Multiple races | 55 | Heterosexual contact | 1096 | M |
| HIV prevalence | 2016 | Multiple races | 55 | Injection drug use | 1719 | M |
| HIV prevalence | 2016 | Multiple races | 55 | Male-to-male sexual contact | 5808 | M |
| HIV prevalence | 2016 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 1245 | M |
| HIV prevalence | 2016 | Multiple races | 55 | Other | 40 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 15 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 1 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 1 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 1 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 1 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 119 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 13 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 6 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 4 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 159 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 5 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 1 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 18 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 6 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 155 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 11 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 10 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 9 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 113 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 10 | M |
| HIV prevalence | 2016 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV prevalence | 2016 | White | 13-24 | Heterosexual contact | 64 | M |
| HIV prevalence | 2016 | White | 13-24 | Injection drug use | 84 | M |
| HIV prevalence | 2016 | White | 13-24 | Male-to-male sexual contact | 2938 | M |
| HIV prevalence | 2016 | White | 13-24 | Male-to-male sexual contact and injection drug use | 297 | M |
| HIV prevalence | 2016 | White | 13-24 | Other | 349 | M |
| HIV prevalence | 2016 | White | 25-34 | Heterosexual contact | 575 | M |
| HIV prevalence | 2016 | White | 25-34 | Injection drug use | 733 | M |
| HIV prevalence | 2016 | White | 25-34 | Male-to-male sexual contact | 20369 | M |
| HIV prevalence | 2016 | White | 25-34 | Male-to-male sexual contact and injection drug use | 2404 | M |
| HIV prevalence | 2016 | White | 25-34 | Other | 325 | M |
| HIV prevalence | 2016 | White | 35-44 | Heterosexual contact | 1293 | M |
| HIV prevalence | 2016 | White | 35-44 | Injection drug use | 1622 | M |
| HIV prevalence | 2016 | White | 35-44 | Male-to-male sexual contact | 30411 | M |
| HIV prevalence | 2016 | White | 35-44 | Male-to-male sexual contact and injection drug use | 4064 | M |
| HIV prevalence | 2016 | White | 35-44 | Other | 301 | M |
| HIV prevalence | 2016 | White | 45-54 | Heterosexual contact | 3137 | M |
| HIV prevalence | 2016 | White | 45-54 | Injection drug use | 4457 | M |
| HIV prevalence | 2016 | White | 45-54 | Male-to-male sexual contact | 73235 | M |
| HIV prevalence | 2016 | White | 45-54 | Male-to-male sexual contact and injection drug use | 8421 | M |
| HIV prevalence | 2016 | White | 45-54 | Other | 470 | M |
| HIV prevalence | 2016 | White | 55 | Heterosexual contact | 4415 | M |
| HIV prevalence | 2016 | White | 55 | Injection drug use | 6400 | M |
| HIV prevalence | 2016 | White | 55 | Male-to-male sexual contact | 82737 | M |
| HIV prevalence | 2016 | White | 55 | Male-to-male sexual contact and injection drug use | 7225 | M |
| HIV prevalence | 2016 | White | 55 | Other | 511 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 13-24 | Heterosexual contact | 2 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 13-24 | Injection drug use | 1 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact | 66 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 13-24 | Male-to-male sexual contact and injection drug use | 10 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 13-24 | Other | 6 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 25-34 | Heterosexual contact | 15 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 25-34 | Injection drug use | 37 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact | 388 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 25-34 | Male-to-male sexual contact and injection drug use | 51 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 25-34 | Other | 2 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 35-44 | Heterosexual contact | 34 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 35-44 | Injection drug use | 31 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact | 346 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 35-44 | Male-to-male sexual contact and injection drug use | 46 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 35-44 | Other | 2 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 45-54 | Heterosexual contact | 50 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 45-54 | Injection drug use | 75 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact | 442 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 45-54 | Male-to-male sexual contact and injection drug use | 94 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 45-54 | Other | 6 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 55 | Heterosexual contact | 57 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 55 | Injection drug use | 82 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 55 | Male-to-male sexual contact | 305 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 55 | Male-to-male sexual contact and injection drug use | 80 | M |
| HIV prevalence | 2017 | American Indian/Alaska Native | 55 | Other | 4 | M |
| HIV prevalence | 2017 | Asian | 13-24 | Heterosexual contact | 2 | M |
| HIV prevalence | 2017 | Asian | 13-24 | Injection drug use | 3 | M |
| HIV prevalence | 2017 | Asian | 13-24 | Male-to-male sexual contact | 413 | M |
| HIV prevalence | 2017 | Asian | 13-24 | Male-to-male sexual contact and injection drug use | 9 | M |
| HIV prevalence | 2017 | Asian | 13-24 | Other | 41 | M |
| HIV prevalence | 2017 | Asian | 25-34 | Heterosexual contact | 71 | M |
| HIV prevalence | 2017 | Asian | 25-34 | Injection drug use | 28 | M |
| HIV prevalence | 2017 | Asian | 25-34 | Male-to-male sexual contact | 2097 | M |
| HIV prevalence | 2017 | Asian | 25-34 | Male-to-male sexual contact and injection drug use | 60 | M |
| HIV prevalence | 2017 | Asian | 25-34 | Other | 12 | M |
| HIV prevalence | 2017 | Asian | 35-44 | Heterosexual contact | 246 | M |
| HIV prevalence | 2017 | Asian | 35-44 | Injection drug use | 112 | M |
| HIV prevalence | 2017 | Asian | 35-44 | Male-to-male sexual contact | 2514 | M |
| HIV prevalence | 2017 | Asian | 35-44 | Male-to-male sexual contact and injection drug use | 99 | M |
| HIV prevalence | 2017 | Asian | 35-44 | Other | 18 | M |
| HIV prevalence | 2017 | Asian | 45-54 | Heterosexual contact | 337 | M |
| HIV prevalence | 2017 | Asian | 45-54 | Injection drug use | 132 | M |
| HIV prevalence | 2017 | Asian | 45-54 | Male-to-male sexual contact | 2832 | M |
| HIV prevalence | 2017 | Asian | 45-54 | Male-to-male sexual contact and injection drug use | 142 | M |
| HIV prevalence | 2017 | Asian | 45-54 | Other | 15 | M |
| HIV prevalence | 2017 | Asian | 55 | Heterosexual contact | 319 | M |
| HIV prevalence | 2017 | Asian | 55 | Injection drug use | 147 | M |
| HIV prevalence | 2017 | Asian | 55 | Male-to-male sexual contact | 1883 | M |
| HIV prevalence | 2017 | Asian | 55 | Male-to-male sexual contact and injection drug use | 79 | M |
| HIV prevalence | 2017 | Asian | 55 | Other | 23 | M |
| HIV prevalence | 2017 | Black/African American | 13-24 | Heterosexual contact | 550 | M |
| HIV prevalence | 2017 | Black/African American | 13-24 | Injection drug use | 91 | M |
| HIV prevalence | 2017 | Black/African American | 13-24 | Male-to-male sexual contact | 12026 | M |
| HIV prevalence | 2017 | Black/African American | 13-24 | Male-to-male sexual contact and injection drug use | 205 | M |
| HIV prevalence | 2017 | Black/African American | 13-24 | Other | 1721 | M |
| HIV prevalence | 2017 | Black/African American | 25-34 | Heterosexual contact | 3939 | M |
| HIV prevalence | 2017 | Black/African American | 25-34 | Injection drug use | 817 | M |
| HIV prevalence | 2017 | Black/African American | 25-34 | Male-to-male sexual contact | 50901 | M |
| HIV prevalence | 2017 | Black/African American | 25-34 | Male-to-male sexual contact and injection drug use | 1547 | M |
| HIV prevalence | 2017 | Black/African American | 25-34 | Other | 1289 | M |
| HIV prevalence | 2017 | Black/African American | 35-44 | Heterosexual contact | 7982 | M |
| HIV prevalence | 2017 | Black/African American | 35-44 | Injection drug use | 2339 | M |
| HIV prevalence | 2017 | Black/African American | 35-44 | Male-to-male sexual contact | 34197 | M |
| HIV prevalence | 2017 | Black/African American | 35-44 | Male-to-male sexual contact and injection drug use | 2208 | M |
| HIV prevalence | 2017 | Black/African American | 35-44 | Other | 146 | M |
| HIV prevalence | 2017 | Black/African American | 45-54 | Heterosexual contact | 15675 | M |
| HIV prevalence | 2017 | Black/African American | 45-54 | Injection drug use | 8018 | M |
| HIV prevalence | 2017 | Black/African American | 45-54 | Male-to-male sexual contact | 40372 | M |
| HIV prevalence | 2017 | Black/African American | 45-54 | Male-to-male sexual contact and injection drug use | 4999 | M |
| HIV prevalence | 2017 | Black/African American | 45-54 | Other | 132 | M |
| HIV prevalence | 2017 | Black/African American | 55 | Heterosexual contact | 20927 | M |
| HIV prevalence | 2017 | Black/African American | 55 | Injection drug use | 22235 | M |
| HIV prevalence | 2017 | Black/African American | 55 | Male-to-male sexual contact | 34382 | M |
| HIV prevalence | 2017 | Black/African American | 55 | Male-to-male sexual contact and injection drug use | 6654 | M |
| HIV prevalence | 2017 | Black/African American | 55 | Other | 255 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 13-24 | Heterosexual contact | 114 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 13-24 | Injection drug use | 56 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 13-24 | Male-to-male sexual contact | 5200 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 13-24 | Male-to-male sexual contact and injection drug use | 238 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 13-24 | Other | 589 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 25-34 | Heterosexual contact | 1261 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 25-34 | Injection drug use | 685 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 25-34 | Male-to-male sexual contact | 28080 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 25-34 | Male-to-male sexual contact and injection drug use | 1668 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 25-34 | Other | 672 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 35-44 | Heterosexual contact | 3489 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 35-44 | Injection drug use | 2433 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 35-44 | Male-to-male sexual contact | 32637 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 35-44 | Male-to-male sexual contact and injection drug use | 2817 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 35-44 | Other | 107 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 45-54 | Heterosexual contact | 4987 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 45-54 | Injection drug use | 6097 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 45-54 | Male-to-male sexual contact | 38539 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 45-54 | Male-to-male sexual contact and injection drug use | 4157 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 45-54 | Other | 98 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 55 | Heterosexual contact | 5377 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 55 | Injection drug use | 10299 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 55 | Male-to-male sexual contact | 26387 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 55 | Male-to-male sexual contact and injection drug use | 3461 | M |
| HIV prevalence | 2017 | Hispanic/Latino | 55 | Other | 140 | M |
| HIV prevalence | 2017 | Multiple races | 13-24 | Heterosexual contact | 23 | M |
| HIV prevalence | 2017 | Multiple races | 13-24 | Injection drug use | 7 | M |
| HIV prevalence | 2017 | Multiple races | 13-24 | Male-to-male sexual contact | 917 | M |
| HIV prevalence | 2017 | Multiple races | 13-24 | Male-to-male sexual contact and injection drug use | 63 | M |
| HIV prevalence | 2017 | Multiple races | 13-24 | Other | 178 | M |
| HIV prevalence | 2017 | Multiple races | 25-34 | Heterosexual contact | 215 | M |
| HIV prevalence | 2017 | Multiple races | 25-34 | Injection drug use | 82 | M |
| HIV prevalence | 2017 | Multiple races | 25-34 | Male-to-male sexual contact | 5603 | M |
| HIV prevalence | 2017 | Multiple races | 25-34 | Male-to-male sexual contact and injection drug use | 461 | M |
| HIV prevalence | 2017 | Multiple races | 25-34 | Other | 149 | M |
| HIV prevalence | 2017 | Multiple races | 35-44 | Heterosexual contact | 456 | M |
| HIV prevalence | 2017 | Multiple races | 35-44 | Injection drug use | 199 | M |
| HIV prevalence | 2017 | Multiple races | 35-44 | Male-to-male sexual contact | 5336 | M |
| HIV prevalence | 2017 | Multiple races | 35-44 | Male-to-male sexual contact and injection drug use | 778 | M |
| HIV prevalence | 2017 | Multiple races | 35-44 | Other | 34 | M |
| HIV prevalence | 2017 | Multiple races | 45-54 | Heterosexual contact | 953 | M |
| HIV prevalence | 2017 | Multiple races | 45-54 | Injection drug use | 716 | M |
| HIV prevalence | 2017 | Multiple races | 45-54 | Male-to-male sexual contact | 7384 | M |
| HIV prevalence | 2017 | Multiple races | 45-54 | Male-to-male sexual contact and injection drug use | 1441 | M |
| HIV prevalence | 2017 | Multiple races | 45-54 | Other | 28 | M |
| HIV prevalence | 2017 | Multiple races | 55 | Heterosexual contact | 1166 | M |
| HIV prevalence | 2017 | Multiple races | 55 | Injection drug use | 1729 | M |
| HIV prevalence | 2017 | Multiple races | 55 | Male-to-male sexual contact | 6465 | M |
| HIV prevalence | 2017 | Multiple races | 55 | Male-to-male sexual contact and injection drug use | 1329 | M |
| HIV prevalence | 2017 | Multiple races | 55 | Other | 40 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Heterosexual contact | 0 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Injection drug use | 0 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact | 16 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Male-to-male sexual contact and injection drug use | 0 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 13-24 | Other | 2 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Heterosexual contact | 3 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Injection drug use | 1 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact | 135 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Male-to-male sexual contact and injection drug use | 13 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 25-34 | Other | 0 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Heterosexual contact | 6 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Injection drug use | 5 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact | 159 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Male-to-male sexual contact and injection drug use | 7 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 35-44 | Other | 1 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Heterosexual contact | 18 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Injection drug use | 7 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact | 157 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Male-to-male sexual contact and injection drug use | 11 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 45-54 | Other | 0 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Heterosexual contact | 12 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Injection drug use | 8 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact | 126 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Male-to-male sexual contact and injection drug use | 10 | M |
| HIV prevalence | 2017 | Native Hawaiian/Other Pacific Islander | 55 | Other | 0 | M |
| HIV prevalence | 2017 | White | 13-24 | Heterosexual contact | 63 | M |
| HIV prevalence | 2017 | White | 13-24 | Injection drug use | 86 | M |
| HIV prevalence | 2017 | White | 13-24 | Male-to-male sexual contact | 2973 | M |
| HIV prevalence | 2017 | White | 13-24 | Male-to-male sexual contact and injection drug use | 280 | M |
| HIV prevalence | 2017 | White | 13-24 | Other | 316 | M |
| HIV prevalence | 2017 | White | 25-34 | Heterosexual contact | 576 | M |
| HIV prevalence | 2017 | White | 25-34 | Injection drug use | 810 | M |
| HIV prevalence | 2017 | White | 25-34 | Male-to-male sexual contact | 20817 | M |
| HIV prevalence | 2017 | White | 25-34 | Male-to-male sexual contact and injection drug use | 2395 | M |
| HIV prevalence | 2017 | White | 25-34 | Other | 343 | M |
| HIV prevalence | 2017 | White | 35-44 | Heterosexual contact | 1275 | M |
| HIV prevalence | 2017 | White | 35-44 | Injection drug use | 1600 | M |
| HIV prevalence | 2017 | White | 35-44 | Male-to-male sexual contact | 30330 | M |
| HIV prevalence | 2017 | White | 35-44 | Male-to-male sexual contact and injection drug use | 4078 | M |
| HIV prevalence | 2017 | White | 35-44 | Other | 300 | M |
| HIV prevalence | 2017 | White | 45-54 | Heterosexual contact | 3004 | M |
| HIV prevalence | 2017 | White | 45-54 | Injection drug use | 4081 | M |
| HIV prevalence | 2017 | White | 45-54 | Male-to-male sexual contact | 68508 | M |
| HIV prevalence | 2017 | White | 45-54 | Male-to-male sexual contact and injection drug use | 7813 | M |
| HIV prevalence | 2017 | White | 45-54 | Other | 438 | M |
| HIV prevalence | 2017 | White | 55 | Heterosexual contact | 4789 | M |
| HIV prevalence | 2017 | White | 55 | Injection drug use | 6830 | M |
| HIV prevalence | 2017 | White | 55 | Male-to-male sexual contact | 90852 | M |
| HIV prevalence | 2017 | White | 55 | Male-to-male sexual contact and injection drug use | 7960 | M |
| HIV prevalence | 2017 | White | 55 | Other | 551 | M |
# Here I read in all the CDC data for both early latent and congential syphilis rates from 2008 to 2017. I still should rename the columns so that it is clear which values are for which variable when I join the datasets.
syphilis <- read_xlsx("Data_Sets/CDC_Data/Atlas_Congenital&EarlyLatentSyphilis.xlsx",
skip = 7) %>%
clean_names()
syphilis[syphilis == "Data not available"] <-NA
syphilis <- syphilis %>%
gt()
syphilis
| indicator | year | cases | rate_per_100000 |
|---|---|---|---|
| Congenital Syphilis | 2000 | 580 | 14.1 |
| Congenital Syphilis | 2001 | 506 | 12.4 |
| Congenital Syphilis | 2002 | 460 | 11.3 |
| Congenital Syphilis | 2003 | 432 | 10.4 |
| Congenital Syphilis | 2004 | 375 | 9 |
| Congenital Syphilis | 2005 | 339 | 8.1 |
| Congenital Syphilis | 2006 | 372 | 8.6 |
| Congenital Syphilis | 2007 | 435 | 10 |
| Congenital Syphilis | 2008 | 446 | 10.4 |
| Congenital Syphilis | 2009 | 431 | 10.3 |
| Congenital Syphilis | 2010 | 387 | 9.6 |
| Congenital Syphilis | 2011 | 358 | 9 |
| Congenital Syphilis | 2012 | 334 | 8.4 |
| Congenital Syphilis | 2013 | 362 | 9.1 |
| Congenital Syphilis | 2014 | 462 | 11.5 |
| Congenital Syphilis | 2015 | 492 | 12.3 |
| Congenital Syphilis | 2016 | 639 | 16.1 |
| Congenital Syphilis | 2017 | 918 | 23.1 |
| Early Latent Syphilis | 2000 | NA | NA |
| Early Latent Syphilis | 2001 | NA | NA |
| Early Latent Syphilis | 2002 | NA | NA |
| Early Latent Syphilis | 2003 | 8361 | 2.9 |
| Early Latent Syphilis | 2004 | 7768 | 2.7 |
| Early Latent Syphilis | 2005 | 8176 | 2.8 |
| Early Latent Syphilis | 2006 | 9186 | 3.1 |
| Early Latent Syphilis | 2007 | 10768 | 3.6 |
| Early Latent Syphilis | 2008 | 12401 | 4.1 |
| Early Latent Syphilis | 2009 | 13066 | 4.3 |
| Early Latent Syphilis | 2010 | 13604 | 4.4 |
| Early Latent Syphilis | 2011 | 13136 | 4.2 |
| Early Latent Syphilis | 2012 | 14503 | 4.6 |
| Early Latent Syphilis | 2013 | 16929 | 5.4 |
| Early Latent Syphilis | 2014 | 19452 | 6.1 |
| Early Latent Syphilis | 2015 | 24173 | 7.5 |
| Early Latent Syphilis | 2016 | 28924 | 8.9 |
| Early Latent Syphilis | 2017 | 34013 | 10.4 |
With this project, I have aggregrated data from diverse sources including the CDC, Rollins School of Public Health with Gilead Sciences, and academic researchers. The ultimate goal of this project is to assess the cost benefit of a popular new medication called PrEP which is used to protect individuals who are at high risk of HIV transmission.
In order to make such an assertion, it is neccessary that we track the incidences of specific sexually transmitted infections (STIs). From the data, it is clear that the rates of HIV have been decreasing in recent years, but this has been accompanied by an increase in the number of cases of other STIs. One possible reason for this, is the advent of PrEP. It is possible that this potential safeguard against HIV has led individuals to engage in other risky sexual behaviors that may begin to explain the increase in STI rates.
Additionally, I have pulled in data regarding the estimated costs for all STIs which include the direct medical costs of HIV. With this information, we can see if the decreased numbers of HIV has saved the U.S. healthcare money, or if the extra resources devoted towards STI treatment has surpassed any potential savings. This type of analysis will make it possible to consider if PrEP has been a financially effective treatment in the eyes of the U.S. health system.